0001262463-14-000150.txt : 20140219 0001262463-14-000150.hdr.sgml : 20140219 20140219144646 ACCESSION NUMBER: 0001262463-14-000150 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140219 DATE AS OF CHANGE: 20140219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Plandai Biotechnology, Inc. CENTRAL INDEX KEY: 0001317880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453642179 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51206 FILM NUMBER: 14625251 BUSINESS ADDRESS: STREET 1: 2226 EASTLAKE AVENUE EAST #156 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (435) 881-8734 MAIL ADDRESS: STREET 1: 2226 EASTLAKE AVENUE EAST #156 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Diamond Ranch Foods, Ltd., NEW DATE OF NAME CHANGE: 20050215 10-Q 1 plpl123113q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(MARK ONE)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: December 31, 2013

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the transition period from ______ to_______

Commission file number 000-51206

 
PLANDAÍ BIOTECHNOLOGY, INC.
(Name of small business issuer in its charter)

 

   
Nevada 45-3642179
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
   
2226 Eastlake Avenue East #156, Seattle, WA 98102
(Address of principal executive offices) (Zip Code)

 

 
Registrant’s telephone number, including area code:  (435) 881-8734

 

     
Securities registered under Section 12(b) of the Exchange Act:   None
     
Securities registered under Section 12(g) of the Exchange Act:   Common stock, par value $0.0001 per share
    (Title of Class)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

1
 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

   
Large accelerated filer           ¨     Accelerated filer                    ¨     
Non-accelerated filer             ¨      Smaller reporting company   x

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨       No x

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:  As of February 5, 2014, the issuer had 125,670,956 shares of its common stock issued and outstanding.

 

 

 

 

2
 

 

 

 

PART 1 – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

 

 

 

 

 

 

 

 

 

 

3
 

PLANDAI BIOTECHNOLOGY, INC.

CONSOLIDATED BALANCE SHEETS

       
       
    
    December 31,    June 30, 
    

2013

(Unaudited)

    

2013

(Audited)

 
ASSETS          
Current Assets:          
Cash  $131,545   $498,917 
Inventory   3,769    6,439 
Accounts Receivable   7,007    13,638 
Related Party Receivable   —        
Total Current Assets   142,321    518,994 
           
Deposits   15,522    10,649 
Other Assets   361,138    380,929 
Fixed Assets – Net   8,212,899    7,924,910 
Total Assets  $8,731,880   $8,835,482 
           
LIABILITIES & STOCKHOLDERS' EQUITY          
Current Liabilities:          
Accounts Payable and Accrued Expenses  $209,810   $516,007 
Accrued Interest   12,472    93,184 
Convertible Note Payable   323,480    103,500 
Derivative Liability   2,131,663    45,227 
Related Party Payables   1,501    145,822 
Total Current Liabilities   2,678,926    903,740 
           
Loans from Related Parties   482,958    501,518 
Credit Line   —      752,503 
Capitalized Lease Obligation   1,182,217    988,381 
Long Term Debt, Net of Discount   10,085,791    9,173,702 
TOTAL LIABILITIES   14,429,892    12,319,844 
           
STOCKHOLDERS' DEFICIT          
Common Stock, authorized 500,000,000 shares, par value $.0001, 111,070,760 and 106,270,760 shares issued and outstanding as of December 31, 2013 and June 30, 2013   11,108    10,628 
Additional Paid-In Capital   8,755,999    7,833,976 
Stock Payable   1,056,600    261,600 
Retained Deficit   (14,592,562)   (10,903,813)
Cumulative Foreign Currency Translation Adjustment   282,939    169,437 
Total Stockholders’ Deficit   (4,485,916)   (2,628,172)
Non-controlling Interest   (1,212,096)   (856,190)
Equity Allocated to Plandaí Biotechnology   (5,698,012)   (3,484,362)
Total Liabilities and Stockholders' Deficit  $8,731,880   $8,835,482 
 
The accompanying notes are an integral part of these financial statements.		  
4
 

PLANDAI BIOTECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

   Three Months Ended  Six Months Ended
   December 31,  December 31,  December 31,  December 31,
   2013  2012  2013  2012
Revenues  $13,187   $113,816   $240,002   $249,903 
    Cost of Sales   166,914    —      343,855    375,129 
Gross Profit   (153,727)   113,816    (103,853)   (125,226)
                     
Expenses:                    
Salaries & Wages   914,004    115,513    1,038,196    170,465 
Professional Services   31,498    180,884    71,206    150,799 
Rent   116,060    —      241,625    —   
Utilities   13,229    18,526    29,580    19,237 
Insurance   15,245    —      32,473    72,959 
Depreciation   49,235    14,412    99,278    46,680 
General & Administrative   21,307    193,640    102,326    238,657 
Total Expenses   1,160,578    522,975    1,614,684    698,797 
                     
Operating Loss   (1,314,305)   (409,159)   (1,718,537)   (824,023)
                     
Other Income (Expense)                    
   Derivative Interest   (1,858,399)   —      (2,086,436)   2,653 
   Interest Expense   (147,860)   (33,576)   (239,682)   (105,692)
                     
Net Loss  $(3,320,564)  $(442,735)  $(4,044,655)  $(927,062)
                     
Loss Allocated to Non-controlling Interest   178,138    110,665    355,905    246,022 
                     
Net Loss, Adjusted  $(3,142,426)  $(332,070)  $(3,688,750)  $(681,040)
Other Comprehensive Income (loss):                    
Foreign Currency Translation Adjustment   115,228    410    113,502    (9,372)
                     
Comprehensive (Loss)  $(3,027,198)  $(331,660)  $(3,575,248)  $(690,412)
 
Basic & diluted loss per share		  $(0.03)  $(0.00)  $(0.04)  $(0.01)
Weighted Avg. Shares Outstanding   106,270,760    110,895,300    106,270,760    110,895,300 
                     

 

 

The accompanying notes are an integral part of these financial statements.

 

5
 

PLANDAI BIOTECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

       
   For the six months ended December 31,  For the six months ended December 31,
   2013  2012
           
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net Loss  $(4,044,655)  $(927,062)
Adjustments to reconcile net loss to net cash          
      provided by operating activities:          
Depreciation   99,278    46,680 
Forgiveness of Interest   —      4,426 
Common Stock Issuable   795,000    —   
Derivative Liability   2,086,436    —   
Capitalized Lease Obligation   193,836    —   
Foreign Currency Translation Adjustment   113,502    (9,372)
Increase in Prepaid Expenses   —      (41,133)
Decrease (Increase) in Accounts Receivable   6,632    (12)
Increase in Deposits   (4,874)   —   
Decrease in Inventory   2,670    —   
Decrease (Increase) in Other Assets   19,791    (19,450)
(Decrease)Increase  in Accounts Payable and Accrued Expenses   (306,197)   20,272 
(Decrease) Increase in Related Party Payables   (144,320)   150,790 
Increase in Accrued Interest   49,288    26,970 
Net Cash Used in Operating Activities   (1,133,613)   (747,891)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Deposits on Equipment   —      (415,818)
Purchase of Fixed Assets   (387,267)   (885,285)
Net Cash Used in Investing Activities   (387,267)   (1,301,103)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Increase in Long-term Debt, Net of Discount   912,088    2,133,088 
Net Borrowings under Convertible Debt   219,980    —   
Proceeds from the Sale of Common Stock   15,000    —   
Net Borrowings under Credit Line   25,000    1,120,837 
Loans from Related Parties   (18,560)   175,869 
Net Cash Provided by  Financing Activities   1,153,508    3,429,794 
           
Net (Decrease) Increase in Cash and Cash Equivalents   (367,372)   1,380,800 
Cash and Cash Equivalents at Beginning of Period   498,917    5,112 
Cash and Cash Equivalents at End of Period  $131,545   $1,385,912 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid during the year for:          
Interest  $—     $—   
Income taxes  $—     $—   
           

 

The accompanying notes are an integral part of these financial statements.

 

 

6
 

.
PLANDAI BIOTECHNOLOGY, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED DECEMBER 31, 2013

(UNAUDITED)

 

NOTE 1 - NATURE OF OPERATIONS AND GOING CONCERN

 

Plandaí Biotechnology, Inc.’s (the “Company” or “Plandaí”) consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustment relating to recoverability and classification of recorded amounts of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company's continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company.

 

Plandaí and its subsidiaries focus on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. The company grows much of the live plant material used in its products on a 3,000 hectare estate it operates under a 49-year notarial lease in the Mpumalanga region of South Africa. Plandaí uses a patented extraction process that is designed to yield highly bioavailable products of pharmaceutical-grade purity. The first product to be brought to market is Phytofare™ Catechin Complex, a green-tea derived extract that has multiple potential wellness applications. The company’s principle holdings consist of land, farms and infrastructure in South Africa. The Company is actively pursuing additional financing and has had discussions with various third parties, although no firm commitments have been obtained. Management believes these efforts will generate sufficient cash flows from future operations to pay the Company's obligations and realize positive cash flow. There is no assurance any of these transactions will occur.

 

These financial statements should be read in conjunction with the Company’s annual report for the year ended June 30, 2013 previously filed on Form 10-K. In management’s opinion, all adjustments necessary for a fair statement of the results for the interim periods have been made.  All adjustments made were of a normal recurring nature.

 

Organization

 

On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (“GES”), an Irish corporation. Under the terms of the share exchange, GES received 76,000,000 shares of the Company’s common stock that had been previously issued to Plandaí in exchange for 100% of the issued and outstanding capital of GES. Concurrent with the share exchange, the Company sold its subsidiary, Diamond Ranch, Ltd., together with its wholly-owned subsidiary, Executive Seafood, Inc., to a former officer and director of Diamond Ranch. Under the terms of the sale, the purchasers assumed all associated debt as consideration. During the three months ended September 30, 2011 and through the date of the share exchange, Diamond Ranch, Ltd. and Executive Seafood, Inc. had negligible revenues from operations, generated a net loss of $126,000, and as of September 30, 2011, liabilities exceeded assets by over $5,000,000. The Company subsequently changed its name to Plandaí Biotechnology, Inc. and dissolved GES.

 

For accounting purposes, the share exchange has been treated as a reverse merger since the acquired entity now forms the basis for operations and the transaction resulted in a change in control, with the acquired company electing to become the successor issuer for reporting purposes. The accompanying financial statements have been prepared to reflect the assets, liabilities and operations of Plandaí Biotechnology, Inc. exclusive of Diamond Ranch Foods since the acquisition and sale were executed simultaneously. For equity purposes, the shares issued to acquire GES (76,000,000 shares) have been shown to be issued and outstanding since inception, with the previous balance outstanding (25,415,300 shares Common) treated as a new issuance as of the date of the share exchange. The additional paid-in capital and retained deficit shown are those of Plandaí and its subsidiary operations.

 

In management’s opinion, all adjustments necessary for a fair statement of the results for the presented periods have been made.  All adjustments made were of a normal recurring nature.

 

7
 

Basis of Presentation

 

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements represent the consolidated results of operations for the three and six months ended December 31, 2013.

 

NOTE 2 – SUMMARY OF ACCOUNTING POLICIES

 

This summary of accounting policies for Plandaí Biotechnology, Inc. and its wholly-owned subsidiaries, is presented to assist in understanding the Company's financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.

 

Use of Estimates

 

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

 

Revenue recognition

 

The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company’s Phytofare™ botanical extracts commences in 2014, revenues will be recognized when product is shipped.

 

Concentration of Credit Risk

 

The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and amortization.  The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years. Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.  At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.

 

Impairment of Long-Lived Assets

 

In accordance with ASC Topic 360, formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.

8
 


Earnings per Share

 

Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At December 31, 2013, the Company had three convertible debentures outstanding that if-converted would result in 2,900,000 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.

 

Income Taxes

 

The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, Accounting for Income Taxes, as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (“FIN No. 48”). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, Accounting for Contingencies. As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.

 

The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.

 

The Company is not currently under examination by any federal or state jurisdiction.

 

The Company’s policy is to record tax-related interest and penalties as a component of operating expenses.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Emerging Growth Company

 

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

 

Fair Value of Financial Instruments

 

Fair value of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.

 

9
 

 

Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.

 

Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:

 

Level 1

 

Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it’s available for sale securities using Level 1.

 

Level 2

 

Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3

 

Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.

 

Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.

 

Advertising

 

Advertising costs are expensed as incurred.

 

Principles of Consolidation

 

Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:

 

Cannabis Biosciences, Inc. 100% owned by Plandaí Biotechnology, Inc.  
Phyto Nutricare, Inc. 100% owned by Plandaí Biotechnology, Inc.  
Phyto Pharmacare, Inc. 100% owned by Plandaí Biotechnology, Inc.  
Dunn Roman Holdings—Africa, Ltd 82% owned by Plandaí Biotechnology, Inc.  
Breakwood Trading 22 (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa  
Green Gold Biotechnologies (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa  

 

 

10
 

During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Plandaí. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.

 

All intercompany balances have been eliminated in consolidation.

 

Straight-lining of Lease Obligation

 

Plandaí’s subsidiaries have two long-term, material leases which either have escalating terms or include several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.


Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

 

All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.

 

11
 

NOTE 3 –LOANS FROM RELATED PARTIES

 

As of December 31, 2013, the Company had outstanding loans from its Chief Executive Officer in the amount of $482,958. These loans were provided for short-term working capital purposes, bear interest at rates between 8-10%, and mature on January 1, 2014. Subsequent to year end, the loans were converted into 2,036,000 shares of restricted common stock of the Company.

 

NOTE 4 - LINE OF CREDIT

 

During the year ended June 30, 2012, the company entered into a line of credit agreement for $500,000 which was later increased to $1,000,000. The line of credit matures on January 5, 2014 and bears interest at the rate of ten percent (10%) per annum. As of December 31, 2013, the balance drawn down on the credit line was $777,503 and accrued interest was $115,852. On December 31, 2013, the company converted the balance outstanding plus accrued interest into 5,000,000 shares of restricted common stock.

 

NOTE 5 – DEBENTURE PAYABLE

 

In May 2013, the Company issued an 8% interest rate convertible debenture in the amount of $103,500 which becomes due and payable in February 2014. The debenture is convertible into common stock of the Company at a discount of 42% off the market price of the Company’s common stock six months after issuance (November 2013). The Company repaid the debenture in full on November 11, 2013.

 

On August 20, 2013, the Company executed two convertible promissory notes totaling $550,000. The notes bear interest at the rate of 8% per annum and become due and payable six months from the date of issuance. During the first 90 days from issuance, the notes are repayable without incurring any interest charges. As of December 31, 2013, the Company had been advanced $210,000 against the two notes. Subsequent to December 31, 2013, $150,000 of the unpaid principal plus accrued interest was converted into 2,717,035 shares of restricted common stock.

 

On November 13, 2013, the Company executed a convertible promissory note of $113,500, which includes prepaid interest of $10,000. The note bears interest at 10% per annum and is due and payable twelve months from the date of issuance. At the holder’s option, the unpaid principal and interest can be converted into common stock at a 42% discount to market after six months.

 

The Company has recorded a derivative liability of $2,131,663 representing the estimate value of the shares over and above the amount of debentures that would be issued on conversion.

 

NOTE 6 – LONG-TERM DEBT

 

In June 2012, the Company, through the majority-owned subsidiaries of Dunn Roman Holdings, Inc., executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa. The total loan is comprised of multiple agreements totaling, between Green Gold Biotechnologies (Pty) Ltd. and Breakwood Trading 22(Pty) Ltd., 100 million rand. The loans all bear interest at the rate of prime plus 0.5% per annum and are all due in seven years. In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa. By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.

 

As of December 31, 2013, a total of $8,128,526 had been drawn down against the loans by Green Gold Biotechnologies (Pty) Ltd., which was used to purchase fixed assets that will be employed in South Africa to produce the company’s botanical extracts. Additionally, $2,431,615 had been drawn down against the loans by Breakwood Trading22 (Pty) Ltd. to fund the rehabilitation of the Senteeko Tea Estate, including the repair of roads, bridges, and onsite worker housing, and the pruning, weeding and fertilizing of plantation.

12
 

 

During the year ended June 30, 2012, the Company issued 1,500,000 shares of restricted common stock to three individuals in exchange for shares of Dunn Roman Holdings stock which had been previously issued. The acquired Dunn Roman shares were then provided to thirds parties in order to comply with the BEE provisions associated with the loan from the Land Bank of South Africa, which required that 15% of Dunn Roman be black owned. The Company has therefore determined to treat the value of the shares issued to acquire the Dunn Roman stock ($585,000) as a cost of securing the financing and recorded as a loan discount which will be amortized over the life of the loan (7 years) once payment of the loan commences in July 2014.

 

As of December 31, 2013, the loan balance was:

 

 

Loan Principal  $10,420,791 
Less: Discount   585,000
      
Net Loan per Books  $9,835,791 
      

 

During the quarter ended December 31, 2013, the company borrowed $250,000 from an unrelated third party. The note bears interest at 6% per annum and is due June 30, 2015.

 

NOTE 7 – CURRENCY ADJUSTMENT

 

The Company’s principal operations are located in South Africa and the primary currency used is the South African Rand. Accordingly, the financial statements are first prepared in using Rand and then converted to US Dollars for reporting purposes, with the average conversion rate being used for income statement purposes and the closing exchange rate as of December 31, 2013 applied to the balance sheet. Differences resulting from the fluctuation in the exchange rate are recorded as an offset to equity in the balance sheet. As of December 31, 2013, the cumulative currency translation adjustments were $282,939.

 

NOTE 8 – FIXED ASSETS

 

Fixed assets, stated at cost, less accumulated depreciation at December 31, 2013 consisted of the following:

 

   December 31,
2013
      
Total Fixed Assets  $8,421,830 
Less: Accumulated Depreciation   (208,931)
      
Fixed Assets, net  $8,212,899 
      

 

Depreciation expense

 

Depreciation expense for the three months ended December 31, 2013 was $49,235.

 

NOTE 9 – COMMON STOCK

 

During the six months ended December 31, 2013, the Company engaged in the following common stock transactions:

 

·A total of 50,000 shares of restricted common stock were issued in exchange for proceeds of $15,000.
·A total of 250,000 shares that had been issued in prior periods for services previously rendered were cancelled.
·A total of 5,000,000 shares of restricted common stock were issued in satisfaction of a credit line and accrued interest totaling $907,503.

 

13
 

NOTE 10 – NON-CONTROLLING INTEREST

 

Plandaí owns 82% of Dunn Roman Holdings—Africa, which in turn owns 74% each of Breakwood Trading 22 (Pty, Ltd. and Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the non-controlling ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, non-controlling interest has been shown in the Equity Section, separated from the equity of Plandaí, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.

 

NOTE 11 – CAPITALIZED LEASE OBLIGATIONS

 

In February 2012, the Company entered into a long-term (49 year) lease of tea, avocado, macadamia and timber plantation estates totaling roughly eight thousand acres in South Africa. Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend. The first payment of R20,883 ($2,610) was due April 2012, but by mutual agreement this payment was extended until funding is received under the loan from the Land Bank of South Africa. On March 1, 2012, the Company entered into a 10 year lease for office space for its subsidiary Dunn Roman Holdings. Under the terms of the lease, payments are $2,500 a month.

 

Both of these leases either have escalating terms or included several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.

 

NOTE 12 – RELATED PARTY TRANSACTION

 

In addition to the loans payable and receivables as discussed above, the Company had the following related party transactions during the quarter ended December 31, 2013.

 

Office Lease

 

The Company leases its South African Office space from a trust of which one of the beneficiaries serves on the Board of Directors of Dunn Roman Holding—Africa, Ltd., a subsidiary of the Company. The lease agreement calls for monthly payments of $2,500. During the quarter ended December 31, 2013, a total of $4,971 was paid in rent expense.

 

Compensation to Officers and Management

 

Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06 per share. At December 31, 2013, the Company accrued compensation expense for services completed in the amount of $1,056,600, which has been recorded as Stock Subscription Payable.

 

NOTE 13 – SUBSEQUENT EVENTS

 

Management was evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that besides listed below, no material subsequent events exist through the date of this filing.

 

  1. On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission. The Company received $300,000 in proceeds under the agreement in exchange for 480,000 shares of restricted common stock sold upon the execution of the stock purchase agreement.

  1. On February 4, 2014, the Company closed on an agreement to acquire the license to the intellectual property and trade name associated with “Diego Pellicer.” Under the terms of the agreement, the Company granted warrants to purchase 5,000,000 shares of the Company’s stock at a purchase price of $0.01 per share.

  1. On January 6, 2014, the Company retired $482,958 plus accrued interest payable to the Company’s chief executive officer in exchange for 2,036,000 shares of restricted common stock, which represented a conversion at the closing bid price. The debt obligation originated from a short-term working capital loan made in prior periods into the company’s subsidiary, Dunn Roman Holdings – Africa (Pty), Ltd.

  1. In February 2014, the company issued a total of 700,000 shares of restricted common stock in exchange for cash proceeds of $300,000.

  1. In February 2014, the company received a total of $850,000 in long-term debt financing. The loan bears interest at 6% and is payable June 30, 2015.

 

 

 

14
 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This statement includes projections of future results and "forward looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this Quarterly Report, other than statements of historical fact, are forward looking statements. Although management believes that the expectations reflected in these forward looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

BUSINESS

Plandaí Biotechnology, Inc., (the “Company”) through its recent acquisition of Global Energy Solutions, Ltd. and its subsidiaries, focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principal holdings consist of land, farms and infrastructure in South Africa.

The Company was incorporated, as Jerry's Inc., in the State of Florida on November 30, 1942. The Company catered airline flights and operated coffee shops, lounges and gift shops at airports and other facilities located in Florida, Alabama and Georgia. The Company's airline catering services included the preparation of meals in kitchens located at, or adjacent to, airports and the distribution of meals and beverages for service on commercial airline flights. The Company also provided certain ancillary services, including, among others, the preparation of beverage service carts, the unloading and cleaning of plates, utensils and other accessories arriving on incoming aircraft, and the inventory management and storage of airline-owned dining service equipment. In March of 2004 we moved our domicile to Nevada and changed our name to Diamond Ranch Foods, Ltd. Diamond Ranch Foods, Ltd. was engaged in the meat processing and distribution industry. Operations consisted of packing, processing, custom meat cutting, portion controlled meats, private labeling, and distribution of our products to a diversified customer base, including, but not limited to; in-home food service businesses, retailers, hotels, restaurants and institutions, deli and catering operators, and industry suppliers. On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc. consummated a share exchange with Global Energy Solutions Corporation Limited, an Irish corporation. Under the terms of the Share Exchange, GES received 76,000,000 shares of Diamond Ranch that had been previously issued to Plandaí Biotechnologies, Inc. in exchange for 100% of the issued and outstanding capital of GES.  On November 21, 2011, the Company filed an amendment to the articles of incorporation to change the name of the Company to Plandaí Biotechnology, Inc. 

 

We will continue to seek to raise additional capital through the sale of common stock to fund the expansion of our company. There can be no assurance that we will be successful in raising the capital required and without additional funds we would be unable to expand our plant, acquire other companies, or further implement our business plan. In April 2012, through our subsidiary companies, we secured a 100 million Rand (approximately $13 million) financing with the Land and Agriculture Bank of South Africa which will be used to build infrastructure and further operations.

 

PRODUCTS AND SERVICES

 

Plandaí Biotechnologies has a proprietary technology that extracts a high level of bio-available compounds from organic matter including green tea leaves and most other organic materials. Numerous documented scientific studies have been conducted over the past ten years using this technology that releases bioavailable antioxidants and other phytonutrients in form the body can easily absorb. The Company intends to use its notarial leases to focuses on the farming of whole fruits, vegetables and live plant material and the production of Phytofare™ functional foods and botanical extracts for the health and wellness industry using its proprietary extraction technology.

 

The company is presently developing for market two unique extracts: Phytofare™ Catechin Complex and Phytofare™ Limonoid Glycoside Complex.

COMPETITION

The Company faces competition from a variety of sources. There are several large producers of farm products including green tea and there are numerous companies that develop and market nutraceutical products that include bio-available compounds including those from green tea extract. Many of these competitors benefit from established distribution, market-ready products, and greater levels of financing. Plandaí intends to compete by producing higher quality and higher concentration extracts, producing at lower costs, and controlling a vertically integrated market that includes all stages from farming through production and marketing.

15
 

CUSTOMERS

 

Plandaí will market to end users as well as other nutraceutical companies that require high-quality bio-available extracts for their products. In addition, the Company anticipates having surplus farm products including avocado, and macadamia nuts.

SALES

For the three months ended December 31, 2013, revenues were $13,187 compared to revenues of $113,816 for the quarter ended December 31, 2012, a decrease of approximately $100,000. Sales consisted of timber from the company’s tea estate in South Africa. In the prior year, sales also included avocados and macadamia nuts. In 2013, the company subleased the farming of avocados and macadamia nuts to a third party, the proceeds from such lease being offset to rent expense.

Revenues for the six months ended December 31, 2013 were $240,002 which included $196,906 from the sale of a license agreement, compared to revenues of $249,903 for the six months ended December 31, 2012. Sales of Phytofare™ extracts are not expected to commence until spring 2014, when the commercial-grade extraction facility is completed.

Cost of sales for the quarter ended December 31, 2013 was $166,914, which consists of expenses incurred with managing and restoring the Senteeko Tea Estate. There were no such costs associated in the prior year as the company had not yet begun rehabilitating the property and therefore no associated farming costs. A third party harvested the fruit and timber and paid the company a fixed price per unit.

 

EXPENSES

 

Total expenses for the three months ended December 31, 2013 were $1,160,577 compared to $522,975 for the same period of the prior year, and increase of $637,602, or 122%. Expenses in 2013 consisted primarily of salaries and rent. Expenses were comparable from year to year with the exception of rent expense, which did not exist in 2012, and a reduction in professional services from 2012 to 2013. In addition, salary expense of $914,004 in 2013 included $795,000 recorded in connection with stock payable as part of management employment agreements. General and Administrative expenses in 2013 included a reduction due to the receipt of rent income from the macadamia and avocado farm and a rebate on insurance paid in prior periods.

 

Total expenses for the six months ended December 31, 2013 were $1,614,684 compared to $698,797 for the same period of the prior year, an increase of $915,887, or 131%. Expenses in 2013 consisted primarily of salaries and rent. Expenses were comparable from year to year with the exception of rent expense, which did not exist in 2012, and a reduction in professional services from 2012 to 2013. . In addition, salary expense of $1,1038,196 in 2013 included $795,000 recorded in connection with stock payable as part of management employment agreements

LIQUIDITY AND CAPITAL RESOURCES

For the six months ended December 31, 2013, the Company's cash used in operating activities totaled $1,133,613, which was primarily attributable to a loss from operations, and cash used in investing activities was $387,267, which consisted of the purchase of fixed assets to be used in production. Cash provided by financing activities was $1,153,508, generated an increase in long term borrowings. As of December 31, 2013, the Company had current assets of $142,321 compared to current liabilities of $2,678,926, of which $2,131,663 related to accrued derivative liability.

PLAN OF OPERATION

The Company's long-term existence is dependent upon our ability to execute our operating plan and to obtain additional debt or equity financing to fund payment of obligations and provide working capital for operations. In June 2012,[see Note 6 to financial statements] the Company through majority-owned subsidiaries of Dunn Roman Holdings Africa (Pty) Limited, executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa and has begun rehabilitating the Senteeko Tea Estate so that it can begin yielding green tea feedstock by the end of 2013. The Company has also commenced construction of the factory and associated equipment necessary to begin the extraction process on live botanical matter, including green tea and citrus, with a goal to have the factory completed by the end of March 2014.

16
 

The loans all bear interest at the rate of prime plus 0.5% per annum and are all due in seven years. In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first draw down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa. As of December 31, 2013, a total of $8,128,526 had been drawn down against the loans by Green Gold Biotechnologies (Pty) Ltd., which was used to purchase fixed assets that will be employed in South Africa to produce the Company’s botanical extracts. Additionally, $2,431,615 had been drawn down against the loans by Breakwood Trading22 (Pty) Ltd. to fund the rehabilitation of the Senteeko Tea Estate, including the repair of roads, bridges, and onsite worker housing, and the pruning, weeding and fertilizing of plantation.

On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission. The Company received $300,000 in proceeds under the agreement in exchange for 480,000 shares of restricted common stock sold upon the execution of the stock purchase agreement.

 

CRITICAL ACCOUNTING POLICIES

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are a number of significant accounting policies affecting our financial statements, we believe the following critical accounting policies involve the most complex, difficult and subjective estimates and judgments.

Revenue recognition

The Company derives its revenue from the production and sale of farm goods, raw materials and the sale of bioavailable extracts in both raw material and finished product form. Revenues are recognized when product is ordered and delivered. Product shipped on consignment is not counted in revenue until sold.

Intangible and Long-Lived Assets

We follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 360, “Property Plant and Equipment”, which establishes a “primary asset” approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

Goodwill is accounted for in accordance with ASC Topic 350, “Intangibles – Goodwill and Other”. We assess the impairment of long-lived assets, including goodwill and intangibles on an annual basis or whenever events or changes in circumstances indicate that the fair value is less than its carrying value. Factors that we consider important which could trigger an impairment review include poor economic performance relative to historical or projected future operating results, significant negative industry, economic or company specific trends, changes in the manner of our use of the assets the plans for our business, market price of our common stock, and loss of key personnel. We have determined that there was no impairment of goodwill during 2013 or 2012. The share exchange did not result in the recording of goodwill and there is not currently any goodwill recorded.

17
 

Potential Derivative Instruments

We periodically assess our financial and equity instruments to determine if they require derivative accounting. Instruments which may potentially require derivative accounting are conversion features of debt and common stock equivalents in excess of available authorized common shares.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Non-Controlling Interest

 

Plandaí owns 82% of Dunn Roman Holdings—Africa, which in turn owns 74% each of Breakwood Trading 22 (Pty, Ltd. and Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the non-controlling ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, non-controlling interest has been shown in the Equity Section, separated from the equity of Plandaí, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.

Currency Translation Adjustment

The Company maintains significant operations in South Africa, where the currency is the Rand. The subsidiary financial statements are therefore converted into US dollars prior to consolidation with the parent entity, Plandaí Biotechnology, Inc. US GAAP requires that the weighted average exchange rate be applied to the foreign income statements and that the closing exchange rate as of the period end date be applied to the balance sheet. The cumulative foreign currency adjustment is included in the equity section of the balance sheet.

 

ITEM 3. QUANTITATIVE AND QUALITIVE DISCLOSURES ABOUT MARKET RISK RISKS RELATED TO OUR BUSINESS

 

This item is not applicable as we are currently a smaller reporting company.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur cause of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

18
 

 

As of December 31, 2013, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures are effective as of December 31, 2013 to cause the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods prescribed by SEC, and that such information is accumulated and communicated to management, including our chief executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal controls over financial reporting identified in connection with the requisite evaluation that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II  

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

This item is not applicable as we are currently considered a smaller reporting company.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended December 31, 2013, the Company sold 50,000 shares of unregistered, restricted common stock for proceeds of $15,000. Each of the recipients of those shares was an accredited investor, and each of the issuances of these shares was exempt from registration under the Securities Act in reliance on an exemption provided by Section 4(2) of that Act.

 

During the three months ended December 31, 2013, the Company also issued a total of 5,000,000 shares of unregistered, restricted common stock to satisfy a credit line obligation and accrued interest totaling $907,503. The recipient of those shares was an accredited investor, and the issuances of these shares was exempt from registration under the Securities Act in reliance on an exemption provided by Section 4(2) of that Act.

 

On January 15, 2014, the Company issued a total of 2,036,000 shares of unregistered restricted common stock to satisfy a loan obligation of $482,958. The recipient of those shares was an accredited investor, and the issuances of these shares was exempt from registration under the Securities Act in reliance on an exemption provided by Section 4(2) of that Act.

 

On January 30, 2014, the Company issued a total of 2,717,035 shares of unregistered restricted common stock satisfy loan obligations of $150,000. Each of the recipients of those shares was an accredited investor, and each of the issuances of these shares was exempt from registration under the Securities Act in reliance on an exemption provided by Section 4(2) of that Act.

 

In February 2014, the company issued a total of 8,640,000 shares of unregistered restricted common stock to employees, including officers of the company, under compensation agreements entered into in prior years. The value of these shares was accrued as Common Stock Issuable in the accompanying financial statements. Each of the recipients of those shares was an accredited investor, and each of the issuances of these shares was exempt from registration under the Securities Act in reliance on an exemption provided by Section 4(2) of that Act.

 

 

19
 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINING SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Plandaí Biotechnology, Inc. includes herewith the following exhibits:

 

     
Exhibit Exhibit Description Filed herewith
4.2 Amendment No. 1 to Registration Rights Agreement, dated as of February 4, 2014, by and between the Company and Lincoln Park Capital Fund, LLC. X
31.1 Certification of the Chief Executive Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. X
31.2 Certification of the Chief Financial Officer pursuant to Rule 13A-14(A)/15D-14(A) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X
32.1 Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002). X
     
101.INS XBRL Instance Document X
101.SCH XBRL Taxonomy Extension Schema Document X
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document X
101.LAB XBRL Taxonomy Extension Label Linkbase Document X
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document X
101.DEF XBRL Taxonomy Extension Definition Linkbase Definition X

 

 

 

 

 

 

 

 

20
 

 

 

 

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Plandaí Biotechnology, Inc.
(Registrant)

 

Date:  February 19, 2014

By: /s/ Roger Duffield

Roger Duffield, President

(On behalf of the Registrant and as
Principal Executive Officer)

 

 

 

 


                                       

 

21
 

 

 

 EX-4 2 ex42.htm EXHIBIT 4.2

AMENDMENT NO. 1 TO

REGISTRATION RIGHTS AGREEMENT

This Amendment No. 1 (this “Amendment”) to that certain Registration Rights Agreement, dated as of February 4, 2014 (the “Agreement”), by and between PLANDAÍ BIOTECHNOLOGY, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”), is entered into as of February 19, 2014 (the “Amendment Date”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Agreement.

Recitals

Whereas, Section 10 of the Agreement provides that the Agreement may be amended by a written instrument signed by the Company and the Investor, provided that the Agreement may not be amended by the parties from and after the date that is one Business Day immediately preceding the filing of the Registration Statement with the SEC;

Whereas, the Company has not filed the Registration Statement with the SEC and shall not file the Registration Statement with the SEC until at least one Business Day has elapsed after the Amendment Date in accordance with Section 10 of the Agreement; and

Whereas, the Company and the Investor now desire to amend the Agreement as set forth herein.

Agreement

Now, Therefore, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in the Agreement and this Amendment, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

1.               Amendment of Section 2(a). Effective as of the Amendment Date, the first sentence of Section 2(a) of the Agreement shall be amended and replaced with the following:

“The Company shall, within thirty (30) calendar days after the date hereof, file with the SEC an initial Registration Statement covering the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices), as mutually determined by both the Company and the Investor in consultation with their respective legal counsel, subject to the aggregate number of authorized shares of the Company’s Common Stock then available for issuance in its Articles of Incorporation.”

 

2. Continuing Effect of Agreement. Except as expressly set forth in this Amendment, all other provisions of the Agreement remain in full force and effect.

3. Governing Law. This Amendment shall be governed by and construed in accordance with the internal procedure and substantive laws of the State of New York, without giving effect to the choice of law provisions of such state.

4. Counterparts. This Amendment may be executed in counterparts, all of which taken together shall constitute one and the same original and binding instrument and shall become effective when all counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties hereto need not sign the same counterpart.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]

 

1
 

In Witness Whereof, the parties hereto have caused this Amendment No. 1 to the Agreement to be executed and delivered as of the Amendment Date.

 

 

  PLANDAÍ BIOTECHNOLOGY, INC.
  By: /s/ Roger Duffield
Name:  Roger Duffield
Title: Chief Executive Officer    
   
 

LINCOLN PARK CAPITAL FUND, LLC
BY: LINCOLN PARK CAPITAL, LLC
BY: ROCKLEDGE CAPITAL CORPORATION

By: /s/ Josh Scheinfeld
Name: Josh Scheinfeld
Title: President

 

 

 

 

 

 

2
 

 

 

 

 

 

 

 

 EX-31 3 ex311.htm EXHIBIT 31.1

EXHIBIT 31.1

 

 

Certification of Chief Executive Officer Pursuant to

Securities Exchange Act Rules 13a-14(a) and 15d-14(a)

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Roger Duffield, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Plandai Biotechnology, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

February 19, 2014

 

/s/ Roger Duffield
Roger Duffield President
(Principal Executive Officer)

 

 

 

 
 

 

 EX-31 4 ex312.htm EXHIBIT 31.2

EXHIBIT 31.2

 

Certification of Chief Financial Officer Pursuant to

Securities Exchange Act Rules 13a-14(a) and 15d-14(a)

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Roger Duffield, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Plandai Biotechnology, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

February 19, 2014

 

/s/ Roger Duffield

Roger Duffield, Chief Financial Officer

(Principal Financial and Accounting officer)

 

 

 

 
 

 EX-32 5 ex321.htm EXHIBIT 32.1

EXHIBIT 32

 

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Plandai Biotechnology, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

February 19, 2014

 

/s/ Roger Duffield
Roger Duffield, President
(Principal Executive Officer)

 

February 19, 2014

 

/s/ Roger Duffield
Roger Duffield, Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

 

 

 
 

 

 EX-101.INS 6 plpl-20131231.xml XBRL INSTANCE FILE 0001317880 2013-06-30 0001317880 2012-06-30 0001317880 plpl:DiamondRanchLtdAndExecutiveSeafoodIncMember 2011-07-01 2011-09-30 0001317880 plpl:DiamondRanchLtdAndExecutiveSeafoodIncMember 2011-09-30 0001317880 plpl:GlobalEnergySolutionsIncMember 2011-11-17 0001317880 plpl:GlobalEnergySolutionsIncMember 2011-11-16 2011-11-17 0001317880 plpl:GlobalEnergySolutionsIncMember 2011-07-01 2012-06-30 0001317880 us-gaap:LineOfCreditMember 2012-06-30 0001317880 us-gaap:LineOfCreditMember 2011-07-01 2012-06-30 0001317880 us-gaap:ConvertibleNotesPayableMember 2013-05-31 0001317880 us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-31 0001317880 us-gaap:CollateralizedDebtObligationsMember 2012-06-30 0001317880 us-gaap:CollateralizedDebtObligationsMember 2012-06-01 2012-06-30 0001317880 us-gaap:CollateralizedDebtObligationsMember currency:ZAR 2012-06-30 0001317880 us-gaap:ProductiveLandMember 2012-02-29 0001317880 us-gaap:ProductiveLandMember 2012-02-01 2012-02-29 0001317880 us-gaap:BuildingMember plpl:DirectorOneMember 2012-02-28 2012-03-01 0001317880 us-gaap:ProductiveLandMember currency:ZAR 2012-02-01 2012-02-29 0001317880 us-gaap:ProductiveLandMember 2012-04-30 0001317880 us-gaap:ProductiveLandMember currency:ZAR 2012-04-30 0001317880 plpl:EmploymentAgreementsMember plpl:OfficerAndManagerMember 2013-02-27 2013-03-01 0001317880 plpl:EmploymentAgreementsMember plpl:OfficerAndManagerMember 2013-12-31 0001317880 2013-07-01 2013-12-31 0001317880 2014-02-05 0001317880 2012-07-01 2012-12-31 0001317880 us-gaap:MinimumMember 2013-07-01 2013-12-31 0001317880 us-gaap:MaximumMember 2013-07-01 2013-12-31 0001317880 plpl:SubsidiariesOneMember 2013-12-31 0001317880 plpl:SubsidiariesTwoMember 2013-12-31 0001317880 plpl:SubsidiariesThreeMember 2013-12-31 0001317880 us-gaap:LoansPayableMember 2013-07-01 2013-12-31 0001317880 us-gaap:LoansPayableMember 2013-12-31 0001317880 us-gaap:LineOfCreditMember 2013-12-31 0001317880 us-gaap:ConvertibleDebtMember 2013-08-20 0001317880 us-gaap:ConvertibleDebtMember 2013-08-19 2013-08-20 0001317880 us-gaap:ConvertibleDebtMember 2013-12-31 0001317880 us-gaap:CollateralizedDebtObligationsMember plpl:SubsidiariesThreeMember 2013-12-31 0001317880 us-gaap:CollateralizedDebtObligationsMember plpl:SubsidiariesTwoMember 2013-12-31 0001317880 us-gaap:RestrictedStockMember 2013-07-01 2013-12-31 0001317880 us-gaap:BuildingMember plpl:DirectorOneMember 2013-10-01 2013-12-31 0001317880 2013-12-31 0001317880 2013-10-01 2013-12-31 0001317880 2012-10-01 2012-12-31 0001317880 2012-12-31 0001317880 plpl:SubsidiariesFourMember 2013-12-31 0001317880 plpl:SubsidiariesFiveMember 2013-12-31 0001317880 plpl:SubsidiariesSixMember 2013-12-31 0001317880 us-gaap:LineOfCreditMember us-gaap:RestrictedStockMember 2013-12-30 2013-12-31 0001317880 plpl:ConvertibleDebtOneMember 2013-11-13 0001317880 plpl:ConvertibleDebtOneMember 2013-11-12 2013-11-13 0001317880 plpl:LoansPayableOneMember 2013-12-31 0001317880 plpl:LoansPayableOneMember 2013-10-01 2013-12-31 0001317880 us-gaap:SubsequentEventMember us-gaap:LoansPayableMember us-gaap:RestrictedStockMember 2014-01-05 2014-01-06 0001317880 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2014-01-31 2014-02-14 0001317880 us-gaap:SubsequentEventMember plpl:LoansPayableTwoMember 2014-01-31 2014-02-14 0001317880 us-gaap:SubsequentEventMember plpl:StockPurchaseAgreementMember us-gaap:RestrictedStockMember 2014-02-03 2014-02-04 0001317880 us-gaap:SubsequentEventMember us-gaap:LicensingAgreementsMember us-gaap:NoteWarrantMember 2014-02-04 0001317880 us-gaap:SubsequentEventMember us-gaap:LicensingAgreementsMember us-gaap:NoteWarrantMember 2014-02-03 2014-02-04 0001317880 us-gaap:ConvertibleDebtSecuritiesMember 2012-07-01 2013-06-30 0001317880 us-gaap:ConvertibleDebtSecuritiesMember 2013-10-01 2013-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ZAR utr:acre Plandai Biotechnology, Inc. 0001317880 10-Q 2013-12-31 false --06-30 No No Yes Smaller Reporting Company Q2 2014 103500 210000 323480 93184 115852 12472 752503 777503 501518 482958 482958 8128526 2431615 10420791 126000 Global Energy Solutions, Inc. ("GES"), an Irish corporation 1.00 5000000 76000000 25415300 P3Y P5Y 0.82 1.00 1.00 1.00 0.74 0.74 0.08 0.10 2014-01-01 2015-06-30 2015-06-30 500000 1000000 2014-01-05 0.10 103500 13000000 100000000 550000 113500 250000 0.08 0.08 0.10 0.06 <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">The debenture is convertible into common stock of the company at a discount of 42% off the market price of the company&#146;s common stock six months after issuance (November 2013).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the holder&#146;s option, the unpaid principal and interest can be converted into common stock at a 42% discount to market after six months.</p> February 2014 P7Y P6M P12M <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">During the first 90 days from issuance, the notes are repayable without incurring any interest charges.</p> Prime plus 0.50 % per annum Green Gold Biotechnologies (Pty) Ltd and Breakwood Trading 22(Pty) Ltd <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">In addition, the loans have a 25-month &#147;holiday&#148; in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Planda&#237;. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Planda&#237; and outside of South Africa.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.</p> 241625 4971 116060 8421830 208931 P49Y P10Y 8000 <p style="margin: 0">Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend.</p> 30000 2500 250000 2610 20883 <p style="margin: 0pt">Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06/share</p> 0.0001 0.0001 500000000 500000000 106270760 111070760 106270760 111070760 8835482 8731880 7924910 8212899 380929 361138 10649 15522 518994 142321 13638 7007 6439 3769 12319844 14429892 9173702 10085791 988381 1182217 903740 2678926 145822 1501 45227 2131663 516007 209810 8835482 8731880 -3484362 -5698012 -856190 -1212096 -2628172 -4485916 169437 282939 -10903813 -14592562 261600 1056600 1056600 7833976 8755999 10628 11108 -4044655 -927062 -3320564 -442735 239682 105692 147860 33576 -2086436 2653 -1858399 -1718537 -824023 -1314305 -409159 1614684 698797 1160578 522975 102326 238657 21307 193640 99278 46680 49235 14412 32473 72959 15245 29580 19237 13229 18526 71206 150799 31498 180884 1038196 170465 914004 115513 -103853 -125226 -153727 113816 343855 375129 166914 240002 249903 13187 113816 -3688750 -681040 -3142426 -332070 -355905 -246022 -178138 -110665 -0.04 -0.01 -0.03 -0.00 -3575248 -690412 -3027198 -331660 113502 -9372 115228 410 106270760 110895300 106270760 110895300 498917 5112 131545 1385912 -367372 1380800 1153508 3429794 -18560 175869 25000 1120837 15000 15000 300000 219980 912088 2133088 850000 -387267 -1301103 387267 885285 415818 -1133613 -747891 49288 26970 -144320 150790 -306197 20272 19791 -19450 2670 -4874 6632 -12 -41133 193836 2086436 4426 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - NATURE OF OPERATIONS AND GOING CONCERN </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237; Biotechnology, Inc.&#146;s (the &#147;Company&#148; or &#147;Planda&#237;&#148;) consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustment relating to recoverability and classification of recorded amounts of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237; and its subsidiaries focus on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. The company grows much of the live plant material used in its products on a 3,000 hectare estate it operates under a 49-year notarial lease in the Mpumalanga region of South Africa. Planda&#237; uses a patented extraction process that is designed to yield highly bioavailable products of pharmaceutical-grade purity. The first product to be brought to market is Phytofare&#153; Catechin Complex, a green-tea derived extract that has multiple potential wellness applications. The company&#146;s principle holdings consist of land, farms and infrastructure in South Africa. The Company is actively pursuing additional financing and has had discussions with various third parties, although no firm commitments have been obtained. Management believes these efforts will generate sufficient cash flows from future operations to pay the Company's obligations and realize positive cash flow. There is no assurance any of these transactions will occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements should be read in conjunction with the Company&#146;s annual report for the year ended June 30, 2013 previously filed on Form 10-K. In management&#146;s opinion,&#160;all adjustments necessary for a fair statement of the results for the interim periods have been made.&#160; All adjustments&#160;made were of a normal recurring nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Organization </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 17, 2011, the Company, through its wholly-owned subsidiary, Planda&#237; Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (&#147;GES&#148;), an Irish corporation. Under the terms of the share exchange, GES received 76,000,000 shares of the Company&#146;s common stock that had been previously issued to Planda&#237; in exchange for 100% of the issued and outstanding capital of GES. Concurrent with the share exchange, the Company sold its subsidiary, Diamond Ranch, Ltd., together with its wholly-owned subsidiary, Executive Seafood, Inc., to a former officer and director of Diamond Ranch. Under the terms of the sale, the purchasers assumed all associated debt as consideration. During the three months ended September 30, 2011 and through the date of the share exchange, Diamond Ranch, Ltd. and Executive Seafood, Inc. had negligible revenues from operations, generated a net loss of $126,000, and as of September 30, 2011, liabilities exceeded assets by over $5,000,000. The Company subsequently changed its name to Planda&#237; Biotechnology, Inc. and dissolved GES.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For accounting purposes, the share exchange has been treated as a reverse merger since the acquired entity now forms the basis for operations and the transaction resulted in a change in control, with the acquired company electing to become the successor issuer for reporting purposes. The accompanying financial statements have been prepared to reflect the assets, liabilities and operations of Planda&#237; Biotechnology, Inc. exclusive of Diamond Ranch Foods since the acquisition and sale were executed simultaneously. For equity purposes, the shares issued to acquire GES (76,000,000 shares) have been shown to be issued and outstanding since inception, with the previous balance outstanding (25,415,300 shares Common) treated as a new issuance as of the date of the share exchange. The additional paid-in capital and retained deficit shown are those of Planda&#237; and its subsidiary operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In management&#146;s opinion, all adjustments necessary for a fair statement of the results for the presented periods have been made.&#160; All adjustments made were of a normal recurring nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;). The accompanying financial statements represent the consolidated results of operations for the three and six months ended December 31, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 &#150; SUMMARY OF ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This summary of accounting policies for Planda&#237; Biotechnology, Inc. and its wholly-owned subsidiaries, is presented to assist in understanding the Company's financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Use of Estimates </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Cash and Cash Equivalents </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Revenue recognition </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company&#146;s Phytofare&#153; botanical extracts commences in 2014, revenues will be recognized when product is shipped.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Concentration of Credit Risk </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Property and equipment </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation and amortization.&#160;&#160;The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years.<b>&#160;</b>Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.&#160;&#160;At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 360, formerly SFAS No. 144, <i>Accounting for the Impairment or Disposal of Long-Lived Assets,</i> the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company&#146;s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><br /> <b>Earnings per Share </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At December 31, 2013, the Company had three convertible debentures outstanding that if-converted would result in 2,900,000 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Income Taxes </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, <i>Accounting for Income Taxes,</i> as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, <i>Accounting for Uncertainty in Income Taxes,</i> (&#147;FIN No. 48&#148;). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, <i>Accounting for Contingencies. </i>As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is not currently under examination by any federal or state jurisdiction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s policy is to record tax-related interest and penalties as a component of operating expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Off-Balance Sheet Arrangements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We have no off-balance sheet arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Emerging Growth Company</b></p> <p style="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We qualify as an &#147;emerging growth company&#148; under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Fair Value of Financial Instruments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value of certain of the Company&#146;s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, &#147;Fair Value Measurements and Disclosure&#148; defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company&#146;s credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 1</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it&#146;s available for sale securities using Level 1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 2</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 3</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Advertising </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Principles of Consolidation </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237; Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td style="width: 50%">Cannabis Biosciences, Inc.</td> <td style="width: 50%">100% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Phyto Nutricare, Inc.</td> <td>100% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td>Phyto Pharmacare, Inc.</td> <td>100% owned by Planda&#237; Biotechnology, Inc</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Dunn Roman Holdings&#151;Africa, Ltd</td> <td>82% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td>Breakwood Trading 22 (Pty) Ltd.</td> <td>74% owned by Dunn Roman Holdings-Africa</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Green Gold Biotechnologies (Pty) Ltd.</td> <td>74% owned by Dunn Roman Holdings-Africa</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Planda&#237;. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Straight-lining of Lease Obligation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237;&#146;s subsidiaries have two long-term, material leases which either have escalating terms or include several months of &#147;free&#148; rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><br /> <b>Recent Accounting Pronouncements </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 3 &#150;LOANS FROM RELATED PARTIES </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2013, the Company had outstanding loans from its Chief Executive Officer in the amount of $482,958. These loans were provided for short-term working capital purposes, bear interest at rates between 8-10%, and mature on January 1, 2014. Subsequent to year end, the loans were converted into 2,036,000 shares of restricted common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 4 - LINE OF CREDIT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2012, the company entered into a line of credit agreement for $500,000 which was later increased to $1,000,000. The line of credit matures on January 5, 2014 and bears interest at the rate of ten percent (10%) per annum. As of December 31, 2013, the balance drawn down on the credit line was $777,503 and accrued interest was $115,852. On December 31, 2013, the company converted the balance outstanding plus accrued interest into 5,000,000 shares of restricted common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#150; DEBENTURE PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2013, the Company issued an 8% interest rate convertible debenture in the amount of $103,500 which becomes due and payable in February 2014. The debenture is convertible into common stock of the Company at a discount of 42% off the market price of the Company&#146;s common stock six months after issuance (November 2013). The Company repaid the debenture in full on November 11, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 20, 2013, the Company executed two convertible promissory notes totaling $550,000. The notes bear interest at the rate of 8% per annum and become due and payable six months from the date of issuance. During the first 90 days from issuance, the notes are repayable without incurring any interest charges. As of December 31, 2013, the Company had been advanced $210,000 against the two notes. Subsequent to December 31, 2013, $150,000 of the unpaid principal plus accrued interest was converted into 2,717,035 shares of restricted common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 13, 2013, the Company executed a convertible promissory note of $113,500, which includes prepaid interest of $10,000. The note bears interest at 10% per annum and is due and payable twelve months from the date of issuance. At the holder&#146;s option, the unpaid principal and interest can be converted into common stock at a 42% discount to market after six months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has recorded a derivative liability of $2,131,663 representing the estimate value of the shares over and above the amount of debentures that would be issued on conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 6 &#150; LONG-TERM DEBT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2012, the Company, through the majority-owned subsidiaries of Dunn Roman Holdings, Inc., executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa. The total loan is comprised of multiple agreements totaling, between Green Gold Biotechnologies (Pty) Ltd. and Breakwood Trading 22(Pty) Ltd., 100 million rand. The loans all bear interest at the rate of prime plus 0.5% per annum and are all due in seven years. In addition, the loans have a 25-month &#147;holiday&#148; in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Planda&#237;. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Planda&#237; and outside of South Africa. By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2013, a total of $8,128,526 had been drawn down against the loans by Green Gold Biotechnologies (Pty) Ltd., which was used to purchase fixed assets that will be employed in South Africa to produce the company&#146;s botanical extracts. Additionally, $2,431,615 had been drawn down against the loans by Breakwood Trading22 (Pty) Ltd. to fund the rehabilitation of the Senteeko Tea Estate, including the repair of roads, bridges, and onsite worker housing, and the pruning, weeding and fertilizing of plantation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2012, the Company issued 1,500,000 shares of restricted common stock to three individuals in exchange for shares of Dunn Roman Holdings stock which had been previously issued. The acquired Dunn Roman shares were then provided to thirds parties in order to comply with the BEE provisions associated with the loan from the Land Bank of South Africa, which required that 15% of Dunn Roman be black owned. The Company has therefore determined to treat the value of the shares issued to acquire the Dunn Roman stock ($585,000) as a cost of securing the financing and recorded as a loan discount which will be amortized over the life of the loan (7 years) once payment of the loan commences in July 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2013, the loan balance was:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left; width: 71%">Loan Principal</td> <td style="width: 10%">&#160;</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 17%">10,420,791</td> <td style="text-align: left; width: 1%">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt">Less: Discount</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">585,000</td> <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left">Net Loan per Books</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">9,835,791</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the quarter ended December 31, 2013, the company borrowed $250,000 from an unrelated third party. The note bears interest at 6% per annum and is due June 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 &#150; CURRENCY ADJUSTMENT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s principal operations are located in South Africa and the primary currency used is the South African Rand. Accordingly, the financial statements are first prepared in using Rand and then converted to US Dollars for reporting purposes, with the average conversion rate being used for income statement purposes and the closing exchange rate as of December 31, 2013 applied to the balance sheet. Differences resulting from the fluctuation in the exchange rate are recorded as an offset to equity in the balance sheet. As of December 31, 2013, the cumulative currency translation adjustments were $282,939.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#150; FIXED ASSETS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets, stated at cost, less accumulated depreciation at December 31, 2013 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, <br />2013</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left; text-indent: -16.5pt; padding-left: 16.5pt; width: 71%">Total Fixed Assets</td> <td style="width: 10%">&#160;</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 17%">8,421,830</td> <td style="text-align: left; width: 1%">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -16.5pt; padding-left: 16.5pt">Less: Accumulated Depreciation</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">(208,931</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-indent: -16.5pt; padding-left: 16.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -16.5pt; padding-left: 16.5pt">Fixed Assets, net</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">8,212,899</td> <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-indent: -16.5pt; padding-left: 16.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Depreciation expense</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the three months ended December 31, 2013 was $49,235.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 &#150; COMMON STOCK</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the six months ended December 31, 2013, the Company engaged in the following common stock transactions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="margin-top: 0px; font-size: 10pt; margin-bottom: 0px; width: 100%"> <tr style="vertical-align: top"> <td style="width: 20.4pt">&#160;</td> <td style="width: 18pt"><font style="font-family: Symbol">&#183;</font></td> <td>A total of 50,000 shares of restricted common stock were issued in exchange for proceeds of $15,000.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="margin-top: 0px; font-size: 10pt; margin-bottom: 0px; width: 100%"> <tr style="vertical-align: top"> <td style="width: 20.4pt">&#160;</td> <td style="width: 18pt"><font style="font-family: Symbol">&#183;</font></td> <td>A total of 250,000 shares that had been issued in prior periods for services previously rendered were cancelled.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="margin-top: 0px; font-size: 10pt; margin-bottom: 0px; width: 100%"> <tr style="vertical-align: top"> <td style="width: 20.4pt">&#160;</td> <td style="width: 18pt"><font style="font-family: Symbol">&#183;</font></td> <td>A total of 5,000,000 shares of restricted common stock were issued in satisfaction of a credit line and accrued interest totaling $907,503.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 &#150; NON-CONTROLLING INTEREST</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237; owns 82% of Dunn Roman Holdings&#151;Africa, which in turn owns 74% each of Breakwood Trading 22 (Pty, Ltd. and Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the non-controlling ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, non-controlling interest has been shown in the Equity Section, separated from the equity of Planda&#237;, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 &#150; CAPITALIZED LEASE OBLIGATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2012, the Company entered into a long-term (49 year) lease of tea, avocado, macadamia and timber plantation estates totaling roughly eight thousand acres in South Africa. Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend. The first payment of R20,883 ($2,610) was due April 2012, but by mutual agreement this payment was extended until funding is received under the loan from the Land Bank of South Africa. On March 1, 2012, the Company entered into a 10 year lease for office space for its subsidiary Dunn Roman Holdings. Under the terms of the lease, payments are $2,500 a month.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Both of these leases either have escalating terms or included several months of &#147;free&#148; rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 &#150; RELATED PARTY TRANSACTION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the loans payable and receivables as discussed above, the Company had the following related party transactions during the quarter ended December 31, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Office Lease</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company leases its South African Office space from a trust of which one of the beneficiaries serves on the Board of Directors of Dunn Roman Holding&#151;Africa, Ltd., a subsidiary of the Company. The lease agreement calls for monthly payments of $2,500. During the quarter ended December 31, 2013, a total of $4,971 was paid in rent expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Compensation to Officers and Management</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06 per share. At December 31, 2013, the Company accrued compensation expense for services completed in the amount of $1,056,600, which has been recorded as Stock Subscription Payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 &#150; SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management was evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that besides listed below, no material subsequent events exist through the date of this filing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <ol style="list-style-type: decimal; margin-top: 0in"> <li style="font-size: 10pt; text-align: justify; margin: 0">On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission. The Company received $300,000 in proceeds under the agreement in exchange for 480,000 shares of restricted common stock sold upon the execution of the stock purchase agreement.</li> </ol> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <ol start="2" style="list-style-type: decimal; margin-top: 0in"> <li style="font-size: 10pt; text-align: justify; margin: 0">On February 4, 2014, the Company closed on an agreement to acquire the license to the intellectual property and trade name associated with &#147;Diego Pellicer.&#148; Under the terms of the agreement, the Company granted warrants to purchase 5,000,000 shares of the Company&#146;s stock at a purchase price of $0.01 per share.</li> </ol> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <ol start="3" style="list-style-type: decimal; margin-top: 0in"> <li style="font-size: 10pt; text-align: justify; margin: 0">On January 6, 2014, the Company retired $482,958 plus accrued interest payable to the Company&#146;s chief executive officer in exchange for 2,036,000 shares of restricted common stock, which represented a conversion at the closing bid price. The debt obligation originated from a short-term working capital loan made in prior periods into the company&#146;s subsidiary, Dunn Roman Holdings &#150; Africa (Pty), Ltd.</li> </ol> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <ol start="4" style="list-style-type: decimal; margin-top: 0in"> <li style="font-size: 10pt; text-align: justify; margin: 0">In February 2014, the company issued a total of 700,000 shares of restricted common stock in exchange for cash proceeds of $300,000.</li> </ol> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <ol start="5" style="list-style-type: decimal; margin-top: 0in"> <li style="font-size: 10pt; text-align: justify; margin: 0">In February 2014, the company received a total of $850,000 in long-term debt financing. The loan bears interest at 6% and is payable June 30, 2015.</li> </ol> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Use of Estimates </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Cash and Cash Equivalents </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Revenue recognition </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company&#146;s Phytofare&#153; botanical extracts commences in 2014, revenues will be recognized when product is shipped.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Concentration of Credit Risk </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Property and equipment </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation and amortization.&#160;&#160;The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years.<b>&#160;</b>Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.&#160;&#160;At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 360, formerly SFAS No. 144, <i>Accounting for the Impairment or Disposal of Long-Lived Assets,</i> the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company&#146;s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Earnings per Share </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At December 31, 2013, the Company had three convertible debentures outstanding that if-converted would result in 2,900,000 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Income Taxes </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, <i>Accounting for Income Taxes,</i> as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, <i>Accounting for Uncertainty in Income Taxes,</i> (&#147;FIN No. 48&#148;). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, <i>Accounting for Contingencies. </i>As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is not currently under examination by any federal or state jurisdiction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s policy is to record tax-related interest and penalties as a component of operating expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Off-Balance Sheet Arrangements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We have no off-balance sheet arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Emerging Growth Company</b></p> <p style="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We qualify as an &#147;emerging growth company&#148; under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Fair Value of Financial Instruments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value of certain of the Company&#146;s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, &#147;Fair Value Measurements and Disclosure&#148; defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company&#146;s credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 1</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it&#146;s available for sale securities using Level 1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 2</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Level 3</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Advertising </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Principles of Consolidation </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237; Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td style="width: 50%">Cannabis Biosciences, Inc.</td> <td style="width: 50%">100% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Phyto Nutricare, Inc.</td> <td>100% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td>Phyto Pharmacare, Inc.</td> <td>100% owned by Planda&#237; Biotechnology, Inc</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Dunn Roman Holdings&#151;Africa, Ltd</td> <td>82% owned by Planda&#237; Biotechnology, Inc.</td></tr> <tr style="text-align: left; background-color: rgb(204,238,255); vertical-align: top"> <td>Breakwood Trading 22 (Pty) Ltd.</td> <td>74% owned by Dunn Roman Holdings-Africa</td></tr> <tr style="text-align: left; background-color: white; vertical-align: top"> <td>Green Gold Biotechnologies (Pty) Ltd.</td> <td>74% owned by Dunn Roman Holdings-Africa</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Planda&#237;. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Straight-lining of Lease Obligation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Planda&#237;&#146;s subsidiaries have two long-term, material leases which either have escalating terms or include several months of &#147;free&#148; rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Recent Accounting Pronouncements </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2013, the loan balance was:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left; width: 71%">Loan Principal</td> <td style="width: 10%">&#160;</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 17%">10,420,791</td> <td style="text-align: left; width: 1%">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt">Less: Discount</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">585,000</td> <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left">Net Loan per Books</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">9,835,791</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets, stated at cost, less accumulated depreciation at December 31, 2013 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, <br />2013</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: left; text-indent: -16.5pt; padding-left: 16.5pt; width: 71%">Total Fixed Assets</td> <td style="width: 10%">&#160;</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 17%">8,421,830</td> <td style="text-align: left; width: 1%">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -16.5pt; padding-left: 16.5pt">Less: Accumulated Depreciation</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">(208,931</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-indent: -16.5pt; padding-left: 16.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -16.5pt; padding-left: 16.5pt">Fixed Assets, net</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">8,212,899</td> <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr> </table> 585000 795000 5000000 2036000 10000 907503 482958 50000 700000 250000 0.06 300000 480000 5000000 0.01 <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission.</p> 340984 2900000 125670956 9835791 EX-101.SCH 7 plpl-20131231.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Nature Of Operations And Going Concern link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary Of Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Loans From Related Parties link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Line Of Credit link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Debenture Payable link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Long Term Debt link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Currency Adjustment link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Non-Controlling Interest link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Capitalized Lease Obligations link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary Of Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Long Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Long Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Nature Of Operations And Going Concern (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary Of Accounting Policies (Property And Equipment) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary Of Accounting Policies (Earnings Per Share) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Summary Of Accounting Policies (Principles Of Consolidation) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Loans From Related Parties (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Line Of Credit (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Debenture Payable (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Long Term Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Common Stock (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Capitalized Lease Obligations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Related Party Transaction (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Subsequent Events (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 plpl-20131231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 plpl-20131231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 plpl-20131231_lab.xml XBRL LABEL FILE Common Stock Equity Components [Axis] Additional Paid-In Capital Stock Subscription Payable Accumulated Deficit Minority Interest Cummulative Currency Translation Adjustment South Africa Geographical [Axis] United States Diamond Ranch Ltd And Executive Seafood Inc Legal Entity [Axis] Global Energy Solutions, Inc (GES) Business Acquisition [Axis] Global Energy Solutions Ltd Dunn Roman Holdings-Africa, Ltd Breakwood Trading 22 (Pty) Ltd Green Gold Biotechnologies (Pty) Ltd Loans From Related Parties - Chief Executive Officer Long-term Debt, Type [Axis] Chief Executive Officer Related Party [Axis] Line Of Credit Convertible Notes Payable Short-term Debt, Type [Axis] Loan - Land And Agriculture Bank Of South Africa Various Third Parties Supplier [Axis] Restricted Common Stock Award Type [Axis] Three Individuals Former Director Officers And Directors Subsequent Event Subsequent Event Type [Axis] Two Convertible Promissory Notes South Africa, Rand Currency [Axis] Tea Estate Property, Plant and Equipment, Type [Axis] Office Space Director of Dunn Roman Holding, Ltd Three Employment Agreements Other Commitments [Axis] Two Officers And Manager CRS Technology Inc Officer And Director Affiliated Company Minimum Range [Axis] Maximum Non convertible promissory note issued Convertible debenture issued in May 2013 Cannabis Biosciences, Inc Phyto Nutricare, Inc Phyto Pharmacare, Inc Convertible Promissory Note - November 13, 2013 Loan From Unrelated Third Party Loan Stock Purchase Agreement Subsidiary, Sale of Stock [Axis] License To Acquire Intellectual Property and Trade Name Finite-Lived Intangible Assets by Major Class [Axis] Warrants Convertible Debenture Antidilutive Securities [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Inventory Accounts Receivable Related Party Receivable Total Current Assets Deposits Other Assets Fixed Assets – Net Total Assets LIABILITIES & STOCKHOLDERS' EQUITY Current Liabilities: Accounts Payable and Accrued Expenses Accrued Interest Convertible Note Payable Derivative Liability Related Party Payables Total Current Liabilities Loans from Related Parties Credit Line Capitalized Lease Obligation Long Term Debt, Net of Discount TOTAL LIABILITIES STOCKHOLDERS' DEFICIT Common Stock, authorized 500,000,000 shares, par value $0.0001, 111,070,760 and 106,270,760 shares issued and outstanding as of December 31, 2013 and June 30, 2013 Additional Paid-In Capital Stock Payable Retained Deficit Cumulative Foreign Currency Translation Adjustment Total Stockholders' Deficit Non-controlling Interest Equity Allocated to Plandai Biotechnology Total Liabilities and Stockholders' Deficit Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares Issued Common Stock, Shares Outstanding Income Statement [Abstract] Revenues Cost of Sales Gross Profit Expenses: Salaries & Wages Professional Services Rent Utilities Insurance Depreciation General & Administrative Total Expenses Operating Loss Other Income (Expense) Derivative Interest Interest Expense Net Loss Loss Allocated to Non-controlling Interest Net Loss, Adjusted Other Comprehensive Income (loss): Foreign Currency Translation Adjustment Comprehensive (Loss) Basic & diluted loss per share Weighted Avg. Shares Outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash provided by operating activities: Forgiveness of Interest Common Stock Issuable Derivative Liability Capitalized Lease Obligation Increase in Prepaid Expenses Decrease (Increase) in Accounts Receivable Increase in Deposits Decrease in Inventory Decrease (Increase) in Other Assets (Decrease) Increase in Accounts Payable and Accrued Expenses (Decrease) Increase in Related Party Payables Increase in Accrued Interest Net Cash Used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Deposits on Equipment Purchase of Fixed Assets Net Cash Used in Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Increase in Long-term Debt, Net of Discount Net Borrowings under Convertible Debt Proceeds from the Sale of Common Stock Net Borrowings under Credit Line Loans from Related Parties Net Cash Provided by Financing Activities Net (Decrease) Increase in Cash and Cash Equivalents Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid during the year for Interest Cash paid during the year for Income taxes Nature Of Operations And Going Concern Nature Of Operations And Going Concern Summary Of Accounting Policies Summary Of Accounting Policies Loans From Related Parties Loans From Related Parties Line Of Credit Line of Credit Debt Disclosure [Abstract] Debenture Payable Long Term Debt Long Term Debt Currency Adjustment Currency Adjustment Property, Plant and Equipment [Abstract] Fixed Assets Common Stock Common Stock Non-Controlling Interest Non-Controlling Interest Capitalized Lease Obligations Capitalized Lease Obligation Related Party Transaction Related Party Transaction Subsequent Events Subsequent Events Summary Of Accounting Policies Policies Use Of Estimates Cash And Cash Equivalents Revenue Recognition Concentration Of Credit Risk Property And Equipment Impairment Of Long-Lived Assets Earnings Per Share Income Taxes Off-Balance Sheet Arrangements Emerging Growth Company Fair Value Of Financial Instruments Advertising Principles of Consolidation Straight-lining of Lease Obligation Recent Accounting Pronouncements Long Term Debt Tables Schedule Of Long Term Debt Fixed Assets Tables Schedule Of Fixed Assets Long Term Debt Details Loan Principle Less: Discount Net Loan Per books Fixed Assets Details Total Fixed Assets Less: Accumulated Depreciation Fixed Assets, net Statement [Table] Statement [Line Items] Net loss Name of acquired entity Percentage of ownership acquired Excess of liabilities over assets taken over Shares issued to GES Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment estimated useful life Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share Noncontrolling Interest [Table] Noncontrolling Interest [Line Items] Holding by Plandai Biotechnology Inc Holding by Dunn Roman Holdings-Africa Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt instrument interest rate, minimum Debt instrument interest rate, maximum Debt instrument maturity date Line of Credit Facility [Table] Line of Credit Facility [Line Items] Line of credit available at the time of entering into agreement Line of credit increase during the period Line of credit maturity date Interest rate on line of credit Accrued interest Line of credit Debt instrument face amount Debt instrument interest rate Debt instrument conversion terms Debt instrument maturity description Debt instrument term Debt repayment terms Convertible note payable Prepaid interest Interest rate on loan Loan duration Loans executed through Loan description Loan covenants description Amount drawn against loan Stock issued during period for cash, shares Proceeds from sale of common stock Cancellation of shares issued for services, shares Stock issued in conversion of debt, shares Stock issued in conversion of debt, value Lease period Land area Lease terms Lease rent due in April 2012 Monthly rent Rent expenses Employment agreements description Stock Subscritption Payable Stock issued upon execution of stock purchase agreement, shares Stock issued upon execution of stock purchase agreement, value Stock purchase agreement terms No.of warrants granted to acquire intellectual property and trade name Purchase price of warrants, per share Proceeds from issuance of long term debt Debt instrument interest rate Stock subscriptions payable Policy disclosure for off balance sheet arrangements Policy disclosure for emerging growth company Diamond Ranch Ltd and Executive Seafood Inc Global Energy Solutions Inc Subsidiary of the company Subsidiary of the company Subsidiary of the company Various third parties Three individuals Director one Employment agreement Officer and Manager CRS Technology Inc Officer and director Assets, Current Assets Liabilities, Current Liabilities Additional Paid in Capital Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Net Income (Loss) Attributable to Noncontrolling Interest Income (Loss) from Continuing Operations Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Increase (Decrease) in Derivative Liabilities Capital Lease Obligations Incurred Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Proceeds from Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Nature of Operations [Text Block] Significant Accounting Policies [Text Block] Debt Disclosure [Text Block] DisclosurePrepaidExpensesAbstract Long-term Debt [Text Block] Foreign Currency Disclosure [Text Block] DisclosureCommonStockAbstract Stockholders' Equity Note Disclosure [Text Block] Noncontrolling Interest Disclosure [Text Block] Leases of Lessee Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Subsequent Events [Text Block] Other Long-term Debt, Noncurrent Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Debt Instrument, Interest Rate During Period EX-101.PRE 11 plpl-20131231_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`=?[]DX`$``+H6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F-UNVC`8AL\G[1XBGT[$ MV-FZMB+T8#^'&]+8!;CQ!XE(;,MV.[C[.8&B"E$J5*2^)T00^WL?K.B1\D[N MUEV;/9(/C34E$_F8960JJQNS+-G?^<_1-VIC]6*>?MR2>VL"R;]N%?5;)E'-M4ZF82/FCT0:<:\\1](G]8'/AP$1<&Z?_?,/A,#@G"48!P M?`;A^`+"<07"\16$XQJ$XP:$0XQ10%",*E"4*E"<*E"D*E"L*E"T*E"\*E#$ M*E#,*E',*E',*E',*E',*E',*E',*E',*E',*E',*E',6J"8M4`Q:X%BU@+% MK`6*68OW,FM,S2#QX?/MC^DPYI5J*L1-2^'"KY/;H:\EU\J3_A-]ZE`O#O!\ M]BF.U##.O'4A=:V>SC^%IS*UWSUR:1#YV-"^3CU62^X34T][?N!!+TI]$ZQ) M'\GF0_,\_0\``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)? M]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBR MBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'% M#U1?````__\#`%!+`P04``8`"````"$`Z,')Y]\!``"K%0``&@`(`7AL+U]R M96QS+W=OZP*4BK!91/-)I(=U;FZ,[TGD^N;C\VZ>/,AKKJV-#29FL*W55>O MVF5IGI_N3BY,$9-K:[?N6E^:K8_F9GY\=/W@UR[E'\5FU<_;?&?1A8U+>1F6MG?5BUMZR]/IS(:?9YCYP9G%?5V:<%^3F.)I MV^='_W]XMUBL*G_;5:\;WZ9?GF'?N_`2&^]3/M2%I4^E&;:BW=TAF63-QOXA M)_NA*^<"R>&9LAR>03FD+8>0'#E5EB.G2,ZYLIIS)(9860TQE*-M#D%W^$S9 M'3Y#[HAV"`H,01DU!&/C@J\?4\C,B=GVKUP^V$;F:# MK='?2)N5$)6DK8:@'-8F-T-R\ZCD'D:G?;<,6U_3%,/Q148-O92G3K^7LEO: MW16&"VDSDB`C29N1!!DIVB006"QM$$`.:%<*%HJTK2'H#6LSDB$C>51&#BFW M3YMAZSOXX'PIVIDC,'-$&YH"H:D-*1]IDI8!HD6EP(940;5V\&BYB=MZ.'9F.Y3NU^\Z'>U- M#!5[H22IC^\]]_-ISB]>"A$\,VVXDOTP/NJ$`9.9RKE<]L.?LYLO)V%@+)4Y M%4JR?KAA)KP8?/YTOE;Z::[44P`"TO3#E;7E6129;,4*:HY4R20\62A=4`N7 M>AF94C.:FQ5CMA!1TND<1P7E,MPJG.F/:*C%@F?L2F55P:3=BF@FJ(7RS8J7 M)AR<+[A@#]N.`EJ6=[2`NE]$&`AJ['7.+G:2<- MH\&NR8D.^,+U?V]2;(1TB_=A#VJ3\#6;?WZ@B!29%K:;G= MD%NY=9\K&*%S_18ZB\-`GW'X1]_FL2L,VY'Y![DN&5+I(I7NPEJ;*B.*.P/>=*;VV MRAVUE6;_MM9;TL@0;/ZFX)"@6M)C)%-#@5N:5D5!]<;I#+-,53`CN203L#OC M<*;V$TJ_(IFO[6K&BDI#;K0JR`_'/0QJ0K5M2<"AW35TXDEP6;,-?P)RA,4UZNQB\^`WRBD)),K4J>\)[8=!BC[0[ M)>'L6*V$<%.]E99IR!8L@!F+/Q!]9AQ&'4]7EP*=3% MI,4>:DU>R,S1ANOH8=P@5ULQAB?_QF+,7.(QU]K[BEG*!=X\P=C!Q:'-WUB- M\4L\_`Z'#;:PURC#(_+P+&#M;A8))A,N6OT<%H)N]D*8S>VOXL<#$,[77@@3 MFGB$OA^!Y(YJI--K>.WA.F[DH%OKTOV904C!S+$./OR)1ZL7C`TIK(.=3CUL M6^0=J`<;G7H$C]0^PAJEM$GN89]3C^2#F41P7S@64H_I=T.I+@[KX%1(WT"Z ME4R-YI#.,8X'>-$"HJ,:+GAIRJC(X&W.?;@@JH<0O;[+#OX"``#__P,`4$L# M!!0`!@`(````(0#Y42XWN`8``$<;```8````>&PO=V]R:W-H965T&ULE)G;CMI($(;O5]IWL'P/],&G1L-$\2&[D;+2:K6':P\8L`(8V9Y, M\O9;[3:XJYP!JOIKLR^*U@$+IV;E[MOVO%PL MFO6^..;-O#H7)_AF6]7'O(6/]6[1G.LBWW0O'0\+P5BP..;ER346EO44&]5V M6ZZ+M%J_'HM3:XS4Q2%O8?[-OCPW%VO']11SQ[S^^GJ>K:OC&4R\E(>R_=$9 M=9WC>OEY=ZKJ_.4`NK]S+U]?;'[4Q7;E?N3+3(3NXOFI<]"_9?'66'\[S;YZ^ZTN-U_*4P'>ACCI"+Q4 MU5>-?M[H1_#R8O3VIRX"?];.IMCFKX?VK^KM]Z+<[5L(MP^*M+#EYD=:-&OP M*)B9"U];6E<'F`#\ZQQ+G1K@D?Q[]_];N6GW*U<&E#$B>B/P1F^$B[F(?.X']ZTLS(PZ@6G>YL]/=?7F0-;`F,TY MUSG(EV#YHLS,XZKU/:F@41OYJ*VLW-!U0$4#\?GV'+*GQ3=PZ;I'XI\@'"/) M!=$.U&;3RX/!+'DENQ`Z>J#H*@N<9:`NL]>PGOUEW-@\`-M7.8),=4R$ M!$G'""&R,6$907+D(W(T#!EFS3Z4>/JQ03P+\3&1W"72NT1VBT#R8"+3HZ7A ME0N^NP8G]/#D8X-$72)RR:,0?Y^@[[F,>("!U`:$QQBCH<.`4FSP,%(&2VJZ M,@T3920LL4$"HRP(%"?2$P/`]*[>D52<;4-Z,O+)(!D"0I\+=74/$A<\(D[# M1!R96&P0(V[&?1D*&CB;X#\+G`W,.`-Q0V"ZFI)A0OA"#--`ZJ":30^=ALF: M(W./#6)'AO@]N4ND=XGL%H'DZ=[$*ORW*Z2&2?"B:TYT?HT-8H(':"TR.[;06+U)OZY-3DI@6P]X.(=`EQS_0BI;`*6A?@!`.1 M;]6$#D@1()1/_9@A@"LAA^6/Q>E-?[HXTR(@<60KBKEA>G&^\(CKDQZX'4#; MB!0>[1@R-$H('G@O0_6F/UV?:1&0/E(68FX8H\\#SX[TV0#W/$X\E"(+2HF0 MK-\,`5X06-'%P0,?/B!.TV3YD<(0<\/T"X=+-J1-GYDVP)4,/+(^4V2",R%I M\F:($#(*_&$4K$_O_-.#9_H$%#P2FUC_2D+EQ:?.3Q`"V[$*B9$4$3S@7D`+ M;(:00$6A>D^BWO^G2S3=`I)(:G?,<4T"Q)(4@YG:',8,01-+:BGN5AH%U>776>#]$=@2+`H\R&1I+!%:CBD7J MWF"Z2--)()%#I>X$Q-SN-F;<"Z/QGH\0*?V09'V*C0BI@HB4W0PCG/F!&A"D M43S4UG0TKJN*%,6X9TQ=G4DI8'12>Q/,>)X(Z=:2$H1YT'*2M9UA!G87%KPG MDS0V^K!%@O3;O;<8-SB*-C@]T_<`800_C7#_E6""L\#JG;NT2!$A?5_1*I8A M0G@!$^\)A?R;GK-"TR2>@V&3LSUSB2?WA$>WN80P$'-Z")42)(BBT">IDV$F MB#BSMERA_);B)8I&Y`+)$3 MDU:_16)*UE\L#-,G+8>M?Y2TAO"ZXPZ/DTBEQ(#T1\V.G>7"2]5"Q<8W9][N+`JX!B?S0'>5E5[ M^:`/ZZ]78,__`P``__\#`%!+`P04``8`"````"$`.0CUWM<$```+%```&0`` M`'AL+W=ON4JVR\_?I>Y,H; MJNH,ESO56.FJ@LH4'[/RO%-_?(^^;%2E;I+RF.2X1#OU`]7JU_WOOVWON'JM M+P@U"C"4]4Z]-,W5U;0ZO:`BJ5?XBDIH.>&J2!IXK41N!OROEB$[)+6_^P?<_4':^-!!N&SPBCKG'CP#5 M*2@*-"O3)DPISF$"\*L4&5D:H$CRWC[OV;&Y[%3+6=E/NF4`7'E!=1-EA%)5 MTEO=X.(_"C(Z*DIB=B3P[$@,$)*3A`G$?9AJ4(?"? MQ1T"3D@.A&6G0G\(:0V+]6UOK9^VVALLL+3#>"+&9!&^B+!T%A)0R'K3CK$V MUJ;-`D(*@-_13)Y93"1BN)G$(L*RC8%%`^T&`6%M\@):D&W3>=+K13H1O4C> M$`$]WN#SAH`:6,(@'F!UIQ`%`/##R+R MBTB*"#K$4UMJ])7.)YND/9*.$',,GQ08V#26BT/`4,K'GELVY[O7@<;EFH/X M.1.))03A+)(?'<.,PJ`G_&0I&MS%FO0.3YHD2ZM9(-Q;BS/,JS+UB" MSL+48]MAEV$H=(L$2]Q9V(1_[)V,A^1P/=JLY_TB8#Y/N#7L4>?48F`.94!9A@`2;L,#-QB1;0Q/,8 M9F49Y%PX2D!28BQ0?#X1VUYLA>E-HQ(CF@+1%/8FINXXW/87]:@'?C9DRI7#+4+/H""'?@F8UGK#I93/(*:.'T&'F(EN*(=$S#BF(9YB MXED25BARX%LN%#T>LD)Q&X0'7_"D_,PXZ*BDLR3&R!.YF#.6'W#!<^ M\$2\;[CPG2?:#XY[F/+0X=$/P3:J3H],)XZ9_(0,,UWC[_P$` M`/__`P!02P,$%``&``@````A`(F\+I&!`P``Y0L``!D```!X;"]W;W)K&ULE)9=;YLP%(;O)^T_(-^7SY`/E*0J(=TF;=(T[>/: M`2>Q"AC93M/^^QUC0L%L),U%`//Z]7F.#[:7]R]%;CT3+B@K5\BS7621,F49 M+0\K].OGX]T<64+B,L,Y*\D*O1*![M M28&%S2I2PIL]XP66\,@/CJ@XP5G=J<@=WW6G3H%IB;1#Q&_Q8/L]34G"TE-! M2JE-.,FQA/C%D5;BXE:DM]@5F#^=JKN4%158[&A.Y6MMBJPBC;X<2L;Q+@?N M%V^"TXMW_3"P+VC*F6![:8.=HP,=,B^)DOT(/7K1=(&>] MK//SFY*SZ-Q;XLC.GSC-OM*20+)AFM0$[!A[4M(OF6J"SLZ@]V,]`=^YE9$] M/N7R!SM_)O1PE##;(0`IKBA[38A((:%@8_NA8Z5-_,8$KHV)Y]O^//3"Z3M< M@L8%KJW+S2%,FLX0]*5S<',(CDY*G>,$2[Q>!,Z7Y.I4 MM.G^7[8AS?0XIWW.\6E48I//^%1BK1GCNZI(M"*L^2;> M=&*N'6,./3I8Z[JS.$ZGQ":=,7*L-6-T5Q5)HYC5>*YM?`?;,8,>G#HY=3:% M<3@E-N&,=236FJ:L_,G,*-U-]_TB\.9&#=J?M`*>L"A_( M-\P/M!163O8PE&O/8(G@^IRF'R2KZH/&CDDX7]6W1SA.$]A%71O$>\;DY4$- MT![0UW\!``#__P,`4$L#!!0`!@`(````(0``U%8G%P,``#L)```9````>&PO M=V]R:W-H965TQ=:5K:`D[R;5E1MXWM2M"6NP88C%>SAX4;", MICS;U;11AD30BBC0+TO6R@-;G;V'KB;B:=?>9+QN@6+#*J9>.U*,ZBQ^W#9< MD$T%OE_\"NYYX2Y<8%HMIGWS_E;)MJ6"U(S"D?<7Y:TIE!H$"C1-$FBGC%0B`7U0SW1D0"'GI MKGN6JS+!X=2)9E[H`QQMJ%0/3%-BE.VDXO5?`_)[*D,2]"1P[4G\P`GFD1]- M/\`2]BQPM2SOEC#I)\/UPSY6_WS,&&GJ1MZ![2ON['`^OQ0&H&3@6%X<2*'DB"13^5 M=%F*!D.CGA@-P\CR&G4&`ZMFPQ@AUE<1Z27$0#V4.56O&^5ZH'I2@B$CJS`, MIR,7!G/)Q55$VB-F7>MYCC>W-08>X'7_N`<]:>QA9OG-2AC,)0]7$6F/.'CP M;8F!A>G0PN4FTN"Q]&,T1KK!7))^%9$:1-2E/_&GD^-;.]`.^\-I_)>U:_!0 M^V1A(S'2#61NRLZ#133RMCX%1)X?^2,`G%JZR)L,1KDYE,R.65.QI6M:51)E M?*@,9C=_[,>PFY^-K/X9-!<9=.P'.KI9LZ7?>5"\[?;O#5=P:G6W)7RD4-BX/`?`!>?J\*`+V,^>U3\```#_ M_P,`4$L#!!0`!@`(````(0`4CUT!,0,``%@,```9````>&PO=V]R:W-H965T M1[I$Y91NOM MRO_]Z_ENYGM"XCK#):O)RO\@PK]??_ZTW#/^*@I"I`<,M5CYA93-(@Q%6I`* MBX`UI(9OT;A@5WX6!Y3E/RQ-)=16II M2#@IL83]BX(VXL!6I2YT%>:ON^8N954#%!M:4OFA27VO2A)_G*?T"+1S3WP_52 M&_2'DKTX^>R)@NV_<)I]HS4!M^&KG_4)_.!>1G*\ M*^5/MO]*Z+:0<-QCJ$@5ML@^GHA(P5&@">*Q8DI9"1N`5Z^BJC7`$?RNW_!HE".#>A@CY3!6E[Z4[(5GUUX!02V5(XI8$WEL2%`?Q;(S&D]LL MH=F1+O`)2[Q>#U1'G6\>G>/!C,ZP8P[1$\Y M&:*LP'!N)ZQ)?.0UR@;CH`P0]YH5V*YYTE5DE`UF--6'@;HO>^7"L;J+*K`M M.NUXC:C!.)0[&:*LP+>,-A@'Y>D0906V:[:--ICK1JO8/_E-7>]H!;9%9Y;1 M!N-0[GR(L@+?,MI@')01A*I[T1IM5VU;W8*N>XVL`+MNMD;;NG/+[1;D4O2@ M[$(FF*Y'2`MR$5=IX]QFR&13/SG/'&\#S,1(%,PN1#:"[0V05FC+]"2R33<@ ME[H'Y9BZIF]V>0MR$;>B3-V7";3^C;8S>=4S/SFFM$E3U(;:P?SI\5[KQ3@: ME&D:;9M_/-96NDVUD\OM>+7UQ0=E&S+!=:/CG=,-1KQ>VSF:;S+LAOEMT%TT MW\R&9G1J\)9\QWQ+:^&5)(<6B((I]!DWDZ%YD*S1(]*&29CH],<")G@"\U,4 M`#AG3!X>U.S9_4^P_@<``/__`P!02P,$%``&``@````A`._Z0TBK`@``S@8` M`!D```!X;"]W;W)K&ULE%7;;J,P$'U?:?_!\GLQ MEUR:**1J4W6WTE9:K?;R[!@#5C%&MM.T?[]C.Z$DV499'@##F>,S9X9A& MN;Z$0Y6E8/Q>L8WDK0TDFC?4@GY3B\[LV22[A$Y2_;SIKIB2'5"L12/LFR?% M2++Y8]4J3=<-Y/V:C"C;<_O%";T43"NC2AL!'0E"3W.>D1D!IN6B$)"!LQUI M7N;X-IFOQI@L%]Z?WX)OS>`>F5IMOVA1?!,M![.A3*X`:Z6>'?2Q<(\@F)Q$ M/_@"?->HX"7=-/:'VG[EHJHM5'L,";F\YL7;/3<,#`6:*/4RF&I``)R1%*XS MP!#ZZJ];4=@ZQ]DD&D_C+`$X6G-C'X2CQ(AMC%7R3P`E3E1/DNY(X+HC2<;1 M*!U/K_^')=NQP'7/,KF8A82\O$WWU-+E0JLM@M8#Y::CKI&3.3`[?S)P.633 M._:189"D([EU+#F>8@3A!HK\LLR2V8*\0&78#G,7,'#N,=/D$+(ZA63Q.X:` MY%XW>#G4_>]Z[N4YL)/GBN+TWH4'0RWID9131!;WD`,EX-KE2APXQT#>FY"E M[[Q!7,",!IAQO[-'K,XA#K0!R5";J^[HP^[?N^6"H`L&^V?I>Q6"QH`YI_$< MXD`CZ#G6Z#KP?$5=T+&/1R6\"YB);\=T%KOCR,J*]$:U/`20N-H"IOK,)#" MPJK.?XYK96&0^-L:_AL<^C6.`%PJ9?<+-_+Z/]'R+P```/__`P!02P,$%``& M``@````A`+A@K3RS`@``70<``!D```!X;"]W;W)K&ULE%7+;MLP$+P7Z#\0O$K&4;6L29G MM6Y$AE^%Q3?+CQ\6&VV>;"6$0\#0V`Q7SK5S0BROA&(VT:UHX$VAC6(.;DU) M;&L$R[LB59/A8#`ABLD&!X:YN81#%X7DXE[SM1*-"R1&U,R!?EO)UN[8%+^$ M3C'SM&ZON%8M4*QD+=UK1XJ1XO/'LM&&K6KP_4)'C.^XNYL3>B6YT587+@$Z M$H2>>KXFUP28EHM<@@,?.S*BR/`MG=_-,%DNNGQ^2[&QO6MD*[WY;&3^538" MPH9E\@NPTOK)0Q]S_PB*R4GU0[<`WPW*1<'6M?NA-U^$+"L'JST&0][7/'^] M%Y9#H$"3#,>>B>L:!,`1*>EW!@3"7KKS1N:NRG`Z2<;304H!CE;"N@?I*3'B M:^NT^A-`=$L52(9;$CAO2>@X&0W'T]D%+"0HZ@S>,\>6"Z,W"#8-]+0M\UN0 MSH'9.TLAGZ`C>OV75?#H26X]2X:G&$&YA>5Y7H*U!7F&3/D6V0=YT]V'?VH7LI=^%!O\U>R$&;]#UM/#C#P!W%IS2-\D/G@!GU M,..(..@,D+[!7>;GC?HB6)L>>TI'D3\H")@+%,"N>[\"7W2P=Q@R")B^@I3.8DXAA3#FPA10PI3BDZAKB[A>^Q%&X?.-3^-TO1UV M`S*^@.G6LE)\8Z:4C46U**!TD$QA_4V8C^'&Z;:;,2OM8*YUEQ7\Q@1\J8,$ MP(76;G?C)W#\,2[_`@``__\#`%!+`P04``8`"````"$`,V[2H!@#``"8"0`` M&0```'AL+W=OP?-^P M95=(U01UIM)4&HUFN7;`@%7`R'::]NWG&"<4DS2E-ZR??_]GP69U^U(6Z)D* MR7@58F_D8D2KF">LRD+\Y_?]S1PCJ4B5D()7-,2O5.+;]=/(.*TPK>I%R41,&MR!Q9"TJ29E!9.+[K3IV2L`H;A:48 MHL'3E,4TXO&^I)4R(H(61(%_F;-:GM3*>(A<2<33OKZ)>5F#Q(X53+TVHAB5 M\?(AJ[@@NP+B?O'&)#YI-S=G\B6+!9<\52.0,YMA9KYK\_&7T(#O72.;\\$VPY`>K*"0;RJ0+L./\2:,/B7X$@YVS MT?=-`7X*E-"4[`OUBQ^^4Y;E"JH]@8!T7,OD-:(RAH2"S,B?:*68%V``CJAD MNC,@(>0EQ#Y,S!*5ASB8CB8S-_``1SLJU3W3DAC%>ZEX^<]`WE'*B`1'$3B? M1+Q/BXR/(G`^B0QVXIBHFB1%1)'U2O`#@L8#W[(FNHV])0A?S@JD0[-W&@[Q M#",(6$(EG]?^8K%RGB']\9'9&`:.+1.XKLUL+S&>S43GS.P-<W7M[UL+S%CFXDN,9.6L0Q#%W0-ZXX,H*^OYUX/LHR;![;Q MH)VP"6X[@(DN,=-6QS(.#=(U?MVPAIO/IFT$K]\(&\/`L67>4F8B^)"(##%O MVM'SIVYG$LL\?*U=\\.RK@?9003NK$V.Z2##=(,(W+G-;,^97J#1-<**8VK' M<;T(&N[[[W^QAAG/3`9[QH\OWZ]0=(VPC,.Z\?D"Z$&]`+S>1N M/R0B0Y@NFD`/O=M&^K=@\(*IX;[[MU7,M(]AIDWV9[I]NU.;CZ"+^).Q-SE; M4F$'U3-=SH&I@MDAS>)?4I'1+2T*B6*^U[N?!_.W3]N-^2YH]M;V!6R,-8K=7<*%XW6\N.*]@2F\L<_H`H++CN"."4&ULE)A;;ZLX$,??5]KO@'@_`4,($"4Y2L)E MC[0KK59[>:;$25`!1T";]MOO&'.SX6#:AZ89_QB/_Q[&4^^^?V2I\HZ+,B'Y M7D4K755P'I-+DM_VZC]_!]\<52FK*+]$*#H4C^4I9JAZQLMBY)< M91ZVQ1(?Y'I-8NR1^"W#><6<%#B-*HB_O">/LO66Q4O<95'Q^O;X%I/L`2Y> MDC2I/FNGJI+%VQ^WG!312PKK_D#K*&Y]UU]&[K,D+DA)KM4*W&DLT/&:7_D&1;)Y?-ET7LS-RK)U$WW!B=TX M@<]V0;#TA:%H3)U:;"^JHL.N($\%,AB67SXB^CZ@+7B>5A<$H>R1PGL5,-"M MA)1X/Y@;>Z>]PS;-B#/SN&(,GSF/"U-<\XXT9P8LO)8(Q,9HG'#/]/!I( MU.D$"3#4B6:C"3D]KQ=]B.I%,XH*>&(&F+03Q]PX_-+/4XS+,]X"QE_`!`N8 M<(*Q?R(2Y/E0I'EQ*,R)PPSL_:-JG5O#C%K>!&/VT=6J^U.,SBL:3#"VP(03 MS&#WN'19?T4)"G-*,,-`"='@M889:?P%3##!V(B7)FP96JV'KP34O^6[3>&] M"KG49[YE\A.=&`/3=8S%$V=&.'7I0:9>__"()W7B2XF`$1LV#9M%%Y-A&(IA M4:@+A%,):OYRE2@LJ&2+*C%F3J4Q8=IB@1TS@M:^E`BD1#A'<"K!F;)<)0J+ M*@G1GQ@SI]*8,.U-MX=UY?#&C#"/+R4"*1'.$9Q*M+<='-;+#B'ZD*B6>&@S M9DZM,6':PLGEC1E1+2D12(EPCN#4CK%6V4YV6KGZQUZWJ?6Q#4^ M3E\PV,=KN#12C-<9"2S*AZ1/7?;>+&E._H>?6Q#4"CM"P>2W5 M/^B/3<'8%'(F?EVT>1NL2Y()K-7CHQ0/8L2@IAO1UX9NNT*RG!MF-A&&;AP$ M_]$9PC'D5(($?"%K'K'E!?Z?V6\$K1-G!Y6K&FD4LK4SA%3_220Z:4%/'D7GPY$L@1 M>@=$P[5JH=8&)D<\&*$%9?P,E-QB-02B&V MJ9$CA%;7/B&RHPLA3RWFY$+$4P.>"P%/#?@NQ#LU$+@0;CV@=;/#7=@CNN$_ MHN*6Y*62XBNHK=>%O&"W:>Q+11ZP"W"512JX!*O_O,.M)X9_P/45[.V5D*K] M`GIHW3WJX7\```#__P,`4$L#!!0`!@`(````(0#<-:R4;`,``%,+```9```` M>&PO=V]R:W-H965TGEVP`1K`2/;V>S^?<DC`<'Y\S,YA9W[\4N?&,&2>T MW)C.Q#8-7,8T(>5A8_[Z^7BW-`TN4)F@G)9X8[YB;MYO/WY8GRA[XAG&P@"& MDF_,3(C*MRP>9[A`?$(K7,*=E+("";AD!XM7#*.D7E3DEFO; MPD'3E,0XI/&QP*50)`SG2(!^GI&*-VQ%_!:Z`K&G8W47TZ("BCW)B7BM24VC MB/TOAY(RM,_!]XLS17'#75]F:!?<\L+H2&)5C*3IV=$`FT73-Z,J#C0#"OD.Q?QP?" M)BW*1)NH?^4)$B1)'B3+QER8!J2`0VV?M]YRNK:>H2#Q&;.[QCA]1-`@9/8E M;:@'(A6`[\L^MMVR6."I-0:Y[AJ[7>=&OP1+_(A08) M%:2K5D-$0XB>&^B8M[N1X)X;/1#H@5`%NE*]Y:SO.!K&].1"/[Y=K@3WY.J! M0`^$*J`>+MDI41/HU,OV6OT];=#E76VRXSTX3H8;1"[:F%"N2^,MYRU_W1$[ MA0$E+4;+8#"*"!5B7C]",QL^_3VB(8:>RWG?Y;`["=;=+?H[[Q1F62MSI+3^ M_4#=[[KWM`2%(Q31-<4E@3US<-"\OX1RD6YRV3>Q4YBNB8L"]=B/(D*%4"5T M;]5PB*)G4XX>VMD\WJERD6YSI=E4F"&;HXAP%!$I1*>7.SW3\[GZ'Y]RD>9S MI?7D3F&&?(XBPE$$3"U2B7HR5O9B=G7PJ*%$O78+S`XXP'G.C9@>Y<`QA4>J MC;:ST,-4OHRT^,[QX9UX(^[ZNUOXP/7A[`2\U1+!3%.A`_Z&V(&4W,AQ"A+L MR0(.%J:F(G4A:%4/!WLJ8)JI_V8PO&(X;.T)@%-*17,A-VC'X>U?````__\# M`%!+`P04``8`"````"$`]VVU"P4$``#B#@``&0```'AL+W=OR\+[0T1FN-JI]N&I6NH2G&65^>= M_N\_\5=/URA+JBPI<(5V^@>B^K?]'U^V-TQ>Z04AIH%"17?ZA;':-TV:7E"9 M4`/7J()_3IB4"8-'"3.1KX=,I3%.+T6J** M21&"BH1!_^DEKVFK5J9SY,J$O%[KKRDN:Y`XYD7./H2HKI6I__U<89(<"_#] M;KM)VFJ+AY%\F:<$4WQB!LB9LJ-CSQMS8X+2?IOEX("772/HM--?;#^V;=W< M;T6!_LO1C?9^:_2";W^2//N15PBJ#>/$1^"(\2M'OV<\!(W-4>M8C,`OHF7H ME%P+]C>^_87R\X7!<"_!$3?F9Q\AHBE4%&0,9\F54EQ`!^!3*W,^-:`BR?M. M=R!QGK'+3E^LC.7:6MB`:T=$69QS25U+KY3A\G\)"4>=R*(1@>]&Q'8,V[56 MG]!P&PW(VFJL#==9KKW/]&35J,!W:P>$']LP94E$A<.$)?LMP3<-IBV8IG7" M%X'M@^!T2:&6G'WA\$Y?ZQI4B\(\>-LO-O;6?(.Q2QOF(!GX[#'.D`E:A@\5 M%P[;P(-&4(VT&MD65TF$PQV+F'DY[OD,'?9)CK(`*3K65ITB82#8(I9 M#9EPBE%THBE&T8FGF'67:V`<9NM\XQP>&)>!H7&W2R2-SV#"&4PT@XFG&*_K MS\`XK(CYQCD\,"X#`^.K>R)I?`833C#K^Q05.M$,)IY@-IMIX["WS#?.X8%Q M&1@8WRR[1-)XR[3K(VP#O?6Q5K:%:`833S"]J@^&%[:J^2XY+';_;OVZO8U" MF#I(!NK<8Q0/P9A12A,^):*G1#PF7.N^@0ZJ`#OQ_"IP6*V"LOL<)+,26[MG MJ44*Y-_](JD%>$I$3XGX$3&PS^]WL\\N#L,AU^^\:RF;V4%"?48Q�RT,=N MHBA(^!R)GB/Q0V10ALVP#.)V9,%:>GR6\U:B'NTR/LA(W[QK*=Z"IM7]<`Q' MD6@4B?N10==MN`O.'T)!JU-8.1P/#=2WH9IH$$],#>$0=$NJ-$ED!>^>6%M$3DC`)4%%1+\95?YWGN+MJ]:KR(*[X:]_R7 M#;^Q*?'`\V'.CN.AY\/,'<,.KDC'XFY)Q75"O0 M";IL&6M8>42^H\@'AFMQS3YB!N\6XN<%WB41W'LM`^`3QJQ]X`FZM]/];P`` M`/__`P!02P,$%``&``@````A`*N3V!+T!0``R1<``!@```!X;"]W;W)KTKZ:U=7^_%'YU-"TS1+SE5S MB3'"7;7`8-T]:D:@+\_-M?^%NV\6Q+N7'6?GZ_O=NWY M"B$>FU,S?!N#QM%Y=_?;TZ7MJL<3W/=7PJO=+?;X9A;^W.RZMF\/PP;")0@Z MOV>5J`0B/=SO&[@#G?:HJP_;^`.Y*QF+DX?[,4'_-O5+[_P?]NV?_> M7&K(-M1)5^"Q;3]KZ6][_1'\.)G]^M-8@3^[:%\?JN?3\%?[\FO=/!T'*+>` M.](W=K?_]K'N=Y!1"+.A0D?:M2<`@+_1N=&M`1FIOHZO+\U^.&YCEFU$GC(" M\NBQ[H=/C0X91[OG?FC/_Z&(F%`8A)H@\&J"$+JA4A"1K8C"3!1XG:*\A9#@ M[8S9^5@-U<-]U[Y$T'(`W%\KW<#D#@*^G@[(@]9^T.+Q)W"G/=3PRP-5]\D7 M2/O.2(I7)+ZBG"M8.DD2P)K8($W+V;08BA)'$QLC4]@1OT`)=R3"5Y0_4GAH M<)WE:%J\C2&V1:/^A0N4R#&GA!'!0S)7P)54))\B>&!P=\O!M#@`8U-8S!E* MLA&,Y5E0[M+].N/,?NU!P0I9#J7%`10/H%""4'F:VE2,S*7[-6$9D]///:IL M#946!U1!B0J40$9LF;/IRD@VE]@@'EN^ADV+`[8@)05*,&.$4T:#M5&Z`D&D M4C;G'ICVP\7S0HL#,%L+["^4&#`A:+`P2N_[-./?Z3"U!DN+`RP;%K%08MH^ M(\3I(:RD)Y"I<@:AER\"3K4\8:/:1^-V."*:T2";I(1"L8(V\R2YHEP1&\7' M6S?_<7:[DXP'C500U!B\G!$I[;4Q=[Y$,L&E+;N/IP?RXG8C.+YA5$XKD-O` M)GNH<5>I78(&[T<2'T]/90=/;RH8%/P-%\59#E>QF.'8):C!+-)42:>`AM)5 M")*Y8]"'U#/:@7P##B>Z!V='@/MPJ?R!S@^#!]"^,QA05;#[+@KJ7GH3#.+2# MW(=;91!D[A#1$G)I`WBT^FQO7C.41SR[IP3P1@KC,;0I:D4N;(7-W@8!S6P*V=Y:L/X M?(%9_'@.T[E)"%L64US7`@CG%)X+[,4-GZ>AC"C)OS.-J9[:RQ.(,Q["3YTE M;&`#B!JW^T*S'2^ZC5^7^/D+S$*;;0Z?O9''N6F(@*'0S]Y@++J$P*GVZ5;]"Y;X1SMS`:I'M'N%`4#EJFJQL^#'03 MI6`>DMB5YB,&YK%LOT?G)B*"'7MA-$A!P42<1VG#Z=H,R11GMA@>I-Z`+E_& MH]HWD$];Y[S^B/SJR?9H$>NC5!M@9,HQHBW M3)6B71?XU\^[T25&QM*VI(UJ>8&?N<%7BX\?YENE'TS-N47@T)H"U]9V,T(, MJ[FD)E(=;^&?2FE)+0SUFIA. MVF"B>4,M\)M:=.;%3;)3["35#YMNQ)3LP&(E&F&?O2E&DLWNUZW2=-5`WT_) M!64OWGYP8"\%T\JHRD9@1P+H8<]3,B7@M)B7`CIPL2/-JP)?)[-ECLEB[O/Y M+?C6O+E'IE;;SUJ47T7+(6R8)CG/2^=#]!,3FHOO,3\%VCDE=TT]@? M:ON%BW5M8;8S:,CU-2N?;[EA$"C81&GFG)AJ``"^D11N94`@],E?MZ*T=8'' M>91-XG$"-X+R&`MV>$N,YG=$70"T:OC-G>WK=Q$R07 M;R0#Q?*8HH<(SWF+>#P^)RXP>+^BY0.T()GZ;)-/HT&ZRW?_[D%!9Z=#.?$` M:C*`"I+<0V7Q[M/7+(]K>GBP;T['<^(!WF7_T3=!$O"2)(DG\21_75%^RI<] M39RG?4T/+S\'SXD'>-,!7I` M=3C@PL"JSF_6E;)P,/G;&MY#''9R'(&X4LJ^#-P1NG^S+?X"``#__P,`4$L# M!!0`!@`(````(0"D`""EQ3P``&Z\```4````>&POY]KD6PCSB1`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`1>:C'2>"?8Q2P,WES\/C;IG5Z-1S?LI.W?CJ=8ELM\?I?MYU>+=?$PFUYG^]A,^<[F^BY/+WO' MV?%1[_W1\='ET<%%\X&+R].]W_S-Z?'^P?G%5]G^P>'1WM%E\Z&Z`>DO%[?3 MN:UV=VMK'?>B_\T*LROKV0RS_;D_7N;9\ZU-^9[U;'M[>WWKS=;ZF]=;)A#; M6Z_7=\*__;5L),,\M%^GI67*^H7M#FV[NT*ZH^NVY]#Z?*76]X90&_JA3F?] MT7#C:((]-3(W-V=F<95(G><+8A46MI]?CP:C%GWWEG=+V"Z1.YS.\]$-TY@; M&]QGE[CY0C]B>WO#/RR+A1QBC"89_)/;)VHF&?]N[4N@T6/Q=<]UU^62V[#L)X,./!3_82]+\ MI,H3=/S M'!^X;%N\O2G!/PRZZ(_;/WZ83XLB.YM/K]NJ$JU_RP,S4G^.QNR MOA_R"=P9AY7VAG>CB87S,@#-"5RQXZZ;OP8VH\7'D*SUJ_GRP*VU,$8K[*GX MNU6F(/X]^M[F1'(?70O0W^H&Y*G&)XZX'FQ>.PGS0`6=A/IEI:[O]2[^)CL\/OW=179X?OHQ.ST[..]='IU\R'I[ET?? MF4MOD4LLT!Z:*R^=4)'A$I#R*2:6H&H27M!?]=\#K6LVGWX>D4-G5_<9:;V, M$M**^1U][H[]X-(-O)R@IS(04?2:JZ@::\O'NJ)HY`'4@$AH-,&!3A MUK9(ZOW9M?C6"[V60M'5,7A\7H^O"JO3Z#RS,B](#]67\%!(OA;?>2'A3YM- MJ_XI`?2*L:H1Z7V,<%KD:\QND?HJWDFR3&@_%0@&%"G-6"\)1HOA#1D^.OGN MX.(Q&8[LR'#\BF=F7;'3V7(^N)646,!0ICC-%;26+486)L]/7_;AT4GO9.\1 MU:L24Z'ZQN+)H;H6^7XZGT^_H&<%@!BQ8(;Q2*F/`O[FSO"+@SP?AA0$KV%^ M6?2HJEGSK>ZI5B)D3`]^P^QF*0!!]Z2SY4/ M9GT(!IXVF<@PL67'*9J;??!]X5'IY(G1[+/QZ[K;G:EF0)!;%9G;)SYV+'N)9IPM&&(R70\$B M]UD_Y80L1WFBQ,7=,CKO&`M/P9P*YNH+GIQ MBY[<*6:!:+AW`N="4&9Q.UV.A[:AP!']OIP8;,,Z1+,1&8!R\`9Q6UBTMAT& M`0*-;PZS_`?"8VH*^/$B&^;`/T-4/%O.H"T05A8W69V._\Y_R`=$8O9(&7K` M/M@,.7AB>J6\'!*F+'^(=90\Y9[\!B9,"-%8'"HRX&7M?RIF>^3OS$P$635" M]F4T'NO=_N?^:"SRK&NBUE\EA3+W;&LPR&>+2$B)3"!.BW!1]&U?HDBQO"I& MPY$G1-="7&U8AB`>&RZ36/*O&4F3@=)7H(83I=80SA)DW`$+U+R3Y6).JK2T MS-LFF0'3W*'ZX4^CR1!@0NF7"^_`E3.[P0\5V=T2Y4$)--18<;IX@#2A1W/E MYLL0!FCE87VVWG[VTC"AVWS`"O,,9\LK\#-$DFBA^[=^]NJ;#;./:`>;9LQQ MC/LTZJ,F=!V"9\10R^Q M-HD]^T`73!0+H!J>093N1SEJ<(N"C.^SJ]$T<;FRH^NL3K:-FWD?+9YAXQ?W M4>OG),:!"!H7@;F:3Y?2._YUUY]_CS-D[K/;^\7T&JK\^3__BV'\@ULD60(R MSG]8EZK-L6T$#GTT!D"SW(DOGX`'OHP7(Y[/9L"AJ"ED^T*UPT+O_FPV#I:B MSE,SP@@-,;]>%=J$R3%UQ53"&HP=ZK6>L3@),9HVFES/^X@'C M^5!@HG!FR#(&=(284N#K$?`G@GHW,D2MZA'<+N3#S>QC?P*08'#253X>@6:8 MY<=@Y]=H!P)K"GQC&3VR62ROA?#)/`WDCJ\M+3-D]WIINP^6"/\DAL[Z]Z86 M8?N8O6D";9UX[F/$(P%8*$\:-]HD2%:S1_(*KFTL$^&=%.Z'PEJG@\%RWC(A M\("G.YU.,/%((FL1-V6:_["8WA!(-".BTPGEBL^.7&^_ ML>H48'B%XOJ'F0CS=%_0R/']!O5*Z)C\`-7?Y"3>5ZK"IA6D&YOK8FJQO)-1 M)AYPT`+C1V8TN6&C4JH/X^D57#T`O;JY1X?!.6`":J4!LC5BL`\'%PJ_4#32 MW/D(!2#`0`8LXMC,/EDVHJ6[APL^P<#[--=ZQBB(CDIC+.7-ZT9M(/*P*F]2 M8PQTH=HDU,`\RRK$Z"[*5J@.H':)%@ASVJ,$9GMKZV=Q@A7%A($7`/04"]U$ M[B?BN50^Z4)S1Q5N990E42*$K\J<_1$A&*;R'"SQ=CT[7@SAR&)ZD_.F@@2H MKU=6,O?`8AV9!XK4U],I]M>YRF91`H238::R3?Q_V>3A"`I3G-0V:I.OYA*) ME"H!N,4_9>Q9 M719N$RZ(=D*!QHNPV[;2*-QZ:RC_OT)J:KMP$MK[*TAC$C+);RB164D0$V1( MM9?A2BN]GD7C+K68X'T-V&,1S[=W7#9M&G;+W]I[6*_%_@@;B;8(YKF"4#'" M].SY;I1RCP."<)N,$(LB7-A&UT47G@E]'W(@29*K6AUZ/0*C8NFT&%^FFF%0U7X@0?!!*F&1FTDY M:A-B#69R@OD8$3>!4QS%7WUAQ9+`&J+,"3;4QV&K<%=5I8$S0L2QT?13IWOL M2"3ARSR_UNR^,.-U71"D@Y6=(SH/HM\\69-T*H;R6`VZAV*79BG0 M6W=4(2'B3R.%?OU);CYW4T7'F/%T2$#A=+(P-S#53/1:RS2_0$98HME=H@9: M9J`$<<,*2^IKEL#,Y$@JK)R%@``Q(9A$H*K5W+6=W?57V[OK+U.Y6+$'IN0% M@E.1S$G^Q6:V`5P]'[8A@>-E-B@(9@.YBR9?Y)S'6N[0RZO*@-FH\A-B2Q2A MRDJ]4#?U%::WE'%UG./V-67Z?VF8`UD+M!%E>G*@0^3UE\0Y[U01,8MXYG-: M!-"T/I>8"5@G9;6P[JGZ)5.`7LZ'QEHS`%4C%I.3(IANXB$]+_=B9D12\&DR MTK\N%!G:.NDU4R9H8\ MH:6X*S15'?U0=XF@^_66A9;,7"AD`X"Q?))-Q/$)@9W+J^A"]V)P2>W)P?% M8J3`O&C!I=*@KN'-'OE2?&EATW+$_UOUQ;(SGRCRI6L]ZY4,#J.@:(%PGFP[>E/WU+SZ.&BIH00-$+$)>$!N(8,B`C@7 M(S`]4P4ZNQU%]$/6@&QQ2BVG[-!J2W;A/@F&,MY-U3<\)_;4\X[,?SAB6\0? M:OSB49BM>I)Q>C,KF2[?LA1&]D7#5014%H3(>_K%[*#^=24P!`R3"&Y`'BB: M172TU%J1/S8>DJH%['<(2`LWA..3)0B#4I%FSDA`KKS@O0RV=[7M>6-925"9 M&QL,[9RRF7G1M%7=(KZZL-+0D'>'["^&)^(ED]0S^X2,A/@U&(B4A1"NDJ8$ MC&Y,I[A*)0)\1Q.A4T)Y,#\AN8':"BS[B">XC?3&IJQD+2R'YA6#<8AQ;')) M=2A`B99:(?BAI$W_>8T-8PUP M3F_P:D(JFZ2[9/9(#7BI(`#+!7>)*`GOV'9(?Y(L>MBH+8^L9\ZT\@8/2>`( M[CV.&&5$;)%.YM5(POU,2H0]!L@VH808\CKV%U=O-L$VH/Y%$W21+"*A_#P$ M?R/5X-=`61"_!3']?#,[58@8'M7V@W!40XL:7MH!=0^((%5B@!H3]?6_6H\D M";`9+`X43@NL+*ZX'\ST^'"R>81`YZS-,Z(DE*^F(U^<:VYSJSL>))Z8\9 M7SP`**L:R4P-L8O>1HF$M"P61@X(V!$VX+P?_U37"#-U#@<^^"IF.'HY-1&J M'+9!$Z6R7X)_5$"YO.0VVO&A#/?UDGJ$:5H03"O4L4P'`6)YT2@9%5!V!CF_ M5LHG5Q*I"V7T/V?\GZNO.:[R#^J2Y?C+UC/^A M0&S%5C>5N;=[BUC:&7(#_\D9!;G)4*CS"/`M_\)A$#,[(SK"A)>:-??"K=E@ M[`:,2>RXMG@`G-*88*.&-$\]R28C/3?;6$![ELR/D,4L-%0FK@`JP1#"4R;L MD&D'44Q`93T3TY\JI[8F)F0SN(@0(T3W[WL5RN')A<3R!EI*50V@,H-J&`1O M\W=MOC,/"38+5E<.0!V1E%$?D>=B?]:#X&.&HG:KV+ MO>P2_'Z0O7P-S(<=PH0CA!>'O0N`[LUL^Q6VUR>HB-\(Z?PKB6"OQ+_DB$6H MZO;G:HM/K&Z18KVUU+_.,KM=B:TV>G:!)OD7]^=CM0W)Z$0KXT%&R5:Y6$%W MF<('=(V=.[YH'G`PFF--E6ZY2QRJ%JA4%9,K`@TP_/?F`"QZ#!Z7`-9-&D&3 M`#_K%<#ZP5[Y3F93-3MD9H!B11$E#/H6!L.BO5'PD&#:+]@`'EUS5MUY#&HQ MD6'D^K(P:82SB*XBDK"F-%@TSN8<]0!Q63CYP&RA3E<&DZ0X%FQ6PO..ITQ; M/1ZD9+)B-=J&K<8J))6]0GK@4\^,4A04I='3!&N`N,H77]2SD@8B^XW;85$R MG;YU61QM+3'*_DP68IO6ZQ4LG9UU)VT5LFMMXFC_BPPPE)7M`4.AQHOH!"$R M^?AB'2&#/J:6!^3%O$?%%BUN6I6B(/^7(UE0-?*$98A.0@F7N][.)#AG5KP MD+N<:`]4`W-PB4B.N?SL$QD/"D\^7)_`6#>ZUM$0/8HB.!_=9UA4O/Y-.*0C M9+6^5$]F'.=%R!;U`F][61RC9(2.1=4V_?B:7K[:6O_F[2OJ,@^NR&UT.M_; M+3H4S%0BN%2'7$-H5GNX2Q@2Z1TR7ZMK[Y-W5] M50K\&_LUHCWZU>:D.4@BBK.*=D0-[REU4D^>"9FWC$I1Q*NW_Z:4_(3?G*NY MC$2'X.O_(L*J3$\3LH5:K]XZP,U)L=S":;I#H[=LX6)8TF$.G3FM(I:89[86 MO-(]J3[H_JET)P[76:B`2]($>M6\4/#+K9EX3G;[CA8NS)12J&CZ2!0&,DT: MAO298>SE/D&/NY[08P?)`V*8D(3J*C6Z\@H?2R$$)J\@,.F9]W0I*H$U/)]2 M"M"P@$S@U?@;*:7ZV;Y7JQ*S3\P]VC(*:?Y,&:?`",/HS&-"P":A09G`I$*H M%'I](HQ0#8U<_AJM^I*2LVN M\RM!5Y9$=T5[J.Z$BJ;E>WU3,&)R1Q.G$R2\?XWN)PO@"AF2`3+;_+,Z.LU\ M^$E(U1DL#NS4D@+H3LFJR6F"FL#O.6)HJUN%0BLTX?/`_'!Y6^.$U, MJQ4:6E\E3RM-9)6[6XHS!;>Y(1C=4HR7JGL\%/796Y5!3@W;!V)?+,:N!JEY MH9N&%DK9+J38LB:*VNNLC?6G)VBX0G&L39V@$FJ'2321:*&F:?8P'M$::;90 MLJ?;5E!U@`YN24`:U?FA2H:>U(LD,[ZGA&H^OJ#Z1H;`\6)@8I6E&&1&:D`+ M3(N5&AH%6?9RDIYUGQ#X50'+*IC&):N,H1I\IOWJ#U93FC)X)58+,UD-^)I> M'8'=?R#Z+LB!C05R.280[+P.9E_*+>4W=I9;=E?<9;B\#^9:'P+/49G?Z%>/ M80)5(V@DEHWEYC1Y=0K_MQ73:KCP'Y;#&S.TXCF]O/07_T[UC&L"934A.<1; M9P!$`5U6+J9TJ"1/E13KCKVZW^5@^+A"/`8&4*3QT9R.LAU6'<[YJ__6_01< ML`P&'8&'>=:CF7B0;,F+*7:-^ M2"8[Y_#N9E6*B=NP!0XOT$+,5C8B,ZQ;5.9!Q$O)\EZ%4B]28W?T7"M#AO8U`;^'\+BWQVH/TMVD\/5 M7Y"#H`@=$_P]5?%VOL7<0!^0:6-;:S7!%/;&ANF9499&27BH_A' M&%0(=D1!),I#%+>#*]%2KQ'QA5:[8$E)4B"M+E%*+-0@CVAY$Q9K@1"G*D9VTC#;328/0KR9N2W,. M!3A]%[&V,J#C6'PLJ#8ES%Y)X$\D0N!KD,I&,U"U/(NIYNB3V&``G32P67D% M6W-$MU'G]C^JY=Y/W_"4'5.-NKDN[X,>APL@X=+*N,O6Z%64X:T,_`&U07:"?],IU_;YK@ MB9=H_/!J?E+W#%2&G)1QT]*8^`J(JSZ)3M3:/KIES00'QJ@5:@I

QPW(_+#U'2NNT*DQM+%!2LWL[W)=()IQM53=!P0NWJLZ7K<:!F! M9$@=Z]/[55M0J6"WY$+FQ]>ZT%UWN@`0\A-8E.(93SZ:N,@06O.Y*AK+%I!KY%803'="9(>%6+/2P+6LDI,^3PKH^A MI+!JI#.9N^:DDWJ-['RCSX04#CEC.FD]N9RTGL7WNBTDHRGD`&,)O[2?MR-B M=TXJ>*Y0F<(3%]FWJGIB4SP#;=]'=@P^1(C:=&6_7>(OB`!E;CB8S*%7Z]#- MAR^4KLA($*JYIL9@!PYBTRE\6;%KA9$P(PS:1`R@`#O`9!7^(;(_MT/"T968 M653ASSQG>?9029+U?Q=EO.-H6MA22YO\[ZTK?^I;M6'A$FER]^K:^_\YDE:E MEH8HMZAE/C9>BY!XZT#DGS.?1#4X:TO-Z]-9OB:C4!$D+:%;/7YNDAC&3*_B M`*R>FLPL2FAE><;!3<^G5SKHA$!@GRO3!%.-];>#.$JL%-$M.&XI?X(.JD)J M)Z*B85C!<=2C*8+.KI?-/W]J*XP)5?=V6022*.H4R]F,,,3W@!D`II#=(-T( MNS"AEGF0JI:O51J2S+RRIZ2'[9S'(A<3V:H"NM%.(!?C7($X>[3@"]+J?<,A ML3;BI8EPEE'A4;\2TBB74I^.AQB`,$V*1O$`;L(2,*=RQ(I]H$IL,'2U^:K# M+F5K#!NX4ION12!P`AT\(&)G940478`'"K$C M]];HT`V&%RV\$]F.TF+SM$W%S0:H$$`1E/)/T3!6,1<MI<9V4C.JL$@0Y'"Q2$-N=^4@>^;%"\ M'P#B0D4P>^6.-&48Y4VS$AXKR?$#U*Y5]4YXT!*%MND])2V&$(C)72AKQWTG M$RZ,('KG$%NAT]-XR.[KBOU\IIUMQ1',-^\O)Q+OOLK\)Y^;__,?_ZE<0V(G%Y@MO=WZ6^4G>G[C;]^C< M]U\$1E]RQX`8L;.3K9TM[E_8V=+F/&]>5>;I6.6&K['YV@>Z%"=<$D/24CU^ MJ.1X]5S[I=VQ'GG,%K)3.Q!>2P#0>B):KSJ:QY%LFD1RS''ED>0OA'-0.YT& MA_-4$+)!;!$P&0V>,4 M8(&ELDPE^3I;<&F6T$81-(@=MN5;#6X%B=KV7U5.\Q(:<=5;HJN=(_;P)5(. MR^KL"Y)PV2H]1RF)\`E'T4*C5$62"03.PX3(: MJO)C=3THA1?$M:6':&2SU1>2U8OIGE4B M0ZG?0B_"]WB14#6`-K@Y&J[0U^AAO@X-&LFNZAWMG?5*,.+B8`];[%5` M]J6E3DCR6*-N7K'$JKP(1(;;5,Z.Z+A:JJ,2.#_(8B`7+9+!L"ED#63HBDM: M9/![N0\?OY>[6Q).=!?:2YVV/#[MZ`\?E!>*B^QZ9T#4W7>K^*V$0%)GLXH?@PDJY?_X*R?YF]ZUY M$()Q'\?\2$!4O+G#@&R_A5`HL>Q3/!,=#RNMPR;@@+(V1B$7JU&V!+W=V-[Z MF?/:CE21638:3K9?43@B,O4+#\3?&""XM%16AQ]0^&U.@>=VUK=>VET,J77R M&O.#M:)DRS.X%VNKM.M!3-T3O-CF.:BR3M/ZF9QFQ+.?T.LS.ZDP/`BWT<=; MI9LO'&LXINP>SB3D5;;!W>HG=E?>WOG!?OOF],=#IAVG$!N=J?Z)XMI)*;A! M^9=0PQ<18-2^[H:RG$>>Y'FX?CTX,YD\F7MS6T21`>;#"H8KVDU6FD,Z1Q'= MDJ6[_@D4BUPD&@I&M"JAT@O3?LF':,/YC]1&L8:0O-"_>(^^V$(@7LN&\ M_X4ZFP[B!]T/6[6=FQ5_\^;-^N[62P^D0N4G+C1>Q-N6-!^@+3E+ZP'7G M)GN[LDYZREU7>-9[_>]]\<'S5&/)MR$=6_?NW%!BX8H^`#*!V]_5O+7 M&!MH9$!GZCF.SJAB@K:W7L*8K2!^5P0-.J>DTZCR_*$8I_?XLL[1S)82OE&I=>R]+`+L,V#4!A9!!J(NI%>FZ14"9+B=C8V]LT6#4_W`$QR MP?$YWZ4O3B&"*.F?"1$LJ(JBHRO:D!U2B&8'Y$MM78_8E,B@=(.4U=`&N)'G M.]O^D8J^H4UNQ$1<6TO3=W6X\.?;3MXH4\N)R4`"E+D8LV?] MS?8;G-[N7V!#D)M2N)"9!R2'"WD.A9QV=Z2Z;.' M&\)E(4/=+V#^&Q*ER+PA3?08*UL/>=0#`M5S'OD!#%-=;Z-S$6J17P8G+3A< M]=D@?$WUS8C(<"1#@KN-2+GU2Y9RWU+?R]*H$,=:KX*G2^'&1I)(]ECF(B+@ MSCK?X%I__?JEA-Z3]9@KXE>]%<&!=9Z6GL:3)`1+[OFN.(5EOY06.)F?4*1* M-7,I'&*/,7(BJ)FXM0T=B,LN277QF>V;I' M,0@(80RQ3-!#L*6OBY_H_S(5U'8\;ED8D/_ MVTO'Y'.^/`5#C=RYD"-3@CX!U>*\SV%OLG M@6^VH"XPL,3G^+!.9=]T0#B>%'(!PYR:@;VV&ST`RU:SNPS7UN9N4WEEGS6$ M-!@7+@1D$@\P$53$BSU='SV^#SG=SNZ&Z;F80!UW`N3#[@7O5 MO(,9-1MNG0ZJG=UH)=PW:^7N6JHAXS5>E]Z4$-E:+J6%`A93T4F,*/Q"EX-HCR;[BW.CJT68=\R['CLO>F**-U.X9GY#,A'*^H#=!BK6GOMUNV>B5F`*-_E;08_3G M;]>W=]ZN[^Z\QAM!2B'[%1VIACRNIQ#[228HA@:*8F+32+QD!5W4]Q:"2AG. M%7$L7;0^O>='J%;E1N`\&N1^3);3NE'_":B!S=2OL";62]>YC:D7X$%?R8-N M[SY]ERWS62NE:#VR'B8*?(K&3R;7Q#\9@Q*G;=H+RP;L,DYZCX8(UM5\-"16 M=;P$T)N3MK1_B0BUZI.);0O\RH^V:9I5H`M$\J8K;@K785KP72M. MI(XS(1$Q6.GTXV#/*KRXT4D2BN6HW^[J-CS=/5DQ!V%T`[=06[O.V\]TV>*X M)UJMGQ`-_47FK.%/S)6`87"2GW]_<"#30ULP<0*J3B(5;CU-CYB52&%I:3$A M4%64HV:4AEA]&#+!/%A9^14V9MQ7U4F%3]]AB(XL M`'?%A"&Z8X?Q4D<9L\JT3O"UY[MO#;&@@8'=0@[R,M;G)@CATEL!394KEK">D16$0@ MH"8L&/?K)=PBC'S5$O259C`-%)$<;%6K2'VLB/$LME@VX]?GS3\-1B5.U\JAV8JQH%601!7MB2GD^>,'$YN>2[HA&BEDUBE+/\C""LTMANBN:B`\#<&'41J: MR[++A6F$KNJ%!1T>VV(5L610F!5XU]*YY@[SQW3.6##-/EUD^PIT`6AEA'E5 M.HDJE\A^,FSQQH(R'_0\P(^[V38T!BB`0""K2!K.'(>*2[#"M>9(]M_2"0R, M+!\!<>,[G1Q@TCEP,]0EWFJ7\8$:V2UZKO_XGU"N3^;W>KQ4/=$ZMJ&'R->8 M%981A)8'#4JXC4I)?&(TY=/T,<_RPRVA_O]\ M1\68E]^T)+GZW=VF4)Z%JX?\?G=">/A\D&[56OUA1DO,WYKH'Q[]1^I1O8N+ M@\N+YO`^M<=GX>@7&L[6V^A?:O%M_6EO^J4'!AI?_NX.@N"-M.WBINS M=3V3FN@\3@K8U@I;ZX7I5]^L[[SL,'P.>U\H7FK-G"H#6#+FL(=6U:Y,1KYQ M\WCZ\>/I26;?^6V-6:*V)=SUL)<(9I2';DA>S$Z964L=9]@/5A=B/M,:=9XB M.RVW_./_;*ZGA]ZJ2Q$!"ZZG#"Q7Q:<6%8:("%U/!D+6C&#/OX[&@""XAH\_ M,&?T=V%22VI2O%I.@1/0V-2M=7VWYE$WO'625X):/-C0*GFV0"#)`6=7B`$? MF/\GE)>\[ZA.:5%/J(]OSK0RFCF0IH5+2.U+/GS;[:LP-9:FC[YN3=] M_'O#)FW;6R9N)ZR]]3]9F=TV7(KV8N-?0T%G[&$8EQ(%*:C)X`(I5D(*3L$`" M+>:%U%E%R0G'&KQJOZ/AF.-"M<]3*^>9ZWI-!JU]#X-0$F0Q?)NZ,I7&#P$( M2J5_^7UX\R7WY*%"A1[DU.G&BA3:`!J>^I.U MV$!G">O[2,".L'Y#5VBJH%X=(HO`(\ZERLR5O=M,&F_^"T2#FE'L+8%4B[ZO MH!EV>:S87(C9):^(1`(*\&;81*ON):+$433"Q>DFJ+QXZD@DO[>T?^^!K](W MG6X@5>`\->Z M(=(7-==>?6-`Y`MO6Q,-N+068.4S8C6)`:/RVGP"P)'/&\D01MP0?"8XR(F:Y^ M=AZ;1M:>6=Y3$!*[$8D+(2QRPUZ#GU*S?OGV9K8'(O=[F M=<&#PNW].@`O`W$609;OCB]GX<\3@`Q=L5H!_;<7TY%E1_V%Q\DGF6T+WQ$J MS:&A"FF3R8AJ577VH-@?=8#,+R=HU*6(76I2A>74-T'[&][UMJ5Y[SFY'-@''T-?YA-;584P"UC^ M_[VJ-PBR+FE7>HG9KMR^Z!=?_K_2JTJ7J8,N9X`X]SH5$#\+UXRI/`[SCT14 MFQ5_GUV>T\6H+X:?GC1?P@#'6E[,TJ5FIJ5VPE-6L%KIDK:3BRSMP`GGP#]S M(J-J\!0QZ]\I/>1MWX`P6EQXN0'9C=0W\@A(U=(2;XWT-O'FIB[+<"KJCU2X M:B3X=K7U5D8MEZ^FJ#)7.($]\6#3COXZ7'EE%PJ!%^O8L47\_+_@OM]/N?=* M;^US&FW`M[E6U`/K1T8V<5=5J\+[%3HZKN8VJ;2?]%`#O\LDF>G`7R7#PNMN M5VK=.(]054M(.=?S5^O?O-DVLQPZ0&`=/BKDPBT.*&`E27:`!L3%"2&TQL3G(@HE@ M2GM+(H28N&Q14??I[NOUUV6C40I1J\B=H1G60IR."9YY:UA+ZBI]Q@=V`7)3 MOMP,6O$E+@H@18G+EF'3%5!/?+L6PRRQ+%0A)D?ZP:D^D:>4M67J0 MLZTPI&Q^0-W[RL_<)EL(ZE<,!=5,0`!Y'S[,KY$2@AN_NPD5U*K)6NKZ[JX4 M>T&P[SV)D#?T$XK0D MR3NK'Y8D/]`FNZ3TOMI[4BU2V?FZ2S$YU6Y? M68KG/$)*V`3Q\/X6I-4]C+MB=-/.(%1EKUGB)S2*$H* M*@R0<4C2HX.,#NN*$T%&%%!+5^7#V;G+#KL)(I0("CB6@IY.YCRTI6IK*PYV\#J,Z\ M=FV[%,6[FE(70(@Z53!OG_P`>9!J>@9O8O=P'??BP2_<07;=UDO?8@?V'<#N\O;QW\Z>:8UT,^%H2:+ZDJOY" M\\EJ<7'EG+6''I^Q^GASOOIJLK5]?=MTS$5A:S0Y9\\?VVYXO#TJ>I]XT_SU M!$#>.E\D0%?MSI?%N^J*'U]3[>D5*SJQ;[&+_B52;2K\8:K`S[208M#:B?RX MVNZAP&.TV,H^*H[DD*O:89J[Y#+,AW[F_`4?NGEC+KM5ML/?.8:^HTV0A7EZ`U!_^H MB]"6=\T_1S>PHN'C6$<]C_19EK];]::Y7V6=YD`JGX\![_=/E5VWC/I7+[UC MNSGF1]WKUE[D5[O=CS_BDM?:WF4%L;(UE!:N^2=-.'F"6"SG>4LS.I]J;J*' MX`Y'8S\K7)V[D:R/B(DJKW4[&\?('YM#N^=M&R/(+HRA^+! MRAQY=+8DQMX=VUSZ8P1-9KB0]8,:H8)'F+V"LLT9]JCK=-[-TWR0.O\`B\@W MV84C8#%4'@$&?8@J(8X6%.*Y"_#)TG69FM6]? M.<[&J@L%FFO1"3!8!HQ@QZH>9+T]6][L2T(9Y$6=@%1>NZW?8V]UFZ/F6W9: M72T1`CZ;FS`EEK)X*/[3B%@[[<]-T@&;#X,26FW*RQN!!807Q,\/ M8N%`]M`L2U03(M&Y_'(XJKMT@9/25&HD6!.:CAYY\4$:)>6VMDU2=E3>@@'? M1'-HNO!JY^";O]=)T/P5[KEUCV?>?YI@5UW`R?]B[VI:XX:AX%_)S3V49,M" MH9?"ICT&4C8NA=Y"0T^A"6S^/YV9)\GR2-Z/0T,#>[7D)]G[+,V;-T^KBN;$ M"?LX**:^!+DI%+7VQA&)@=H2MN%<0RVCWC\0WKIO;(\AG`71%.>Z;7?GWTPP M!UE^J.OL*SO4&*@"/]T8M%1MN%(='JC`]R?>Q"<6:A@9_G_J@_U7GC[(Z11$?YZA ML*LDZ;W5+?)']3[#QU0PV30@I!%SWKB!S%)Q'KFWKJM\!;N-I8N__[^L[/=) MUQ_:'Q87)*;3^WU3_15UJ)@]0(NW>Z!\#'YG"/VN%T,CTL&!+^3`R.1LJLK0 M:U8+W\YE*#Z5.OO\7F7*WN/G9NN7%'`+(WPOU1>CJB\D!_#N[?(.D.&=!F#+ MJO)W=5%5:7A?C8\=2.C9&X=4#>K7`]F4W%)*7'FOX1C0I)"G!^!*&;2;C1DO M?VG@<[/@(7("C\)AY^)E/^`RL_W8'OCUGXN7H;9@FDA%UJ]0O-QU[%+!C/U[ MEW/EWO/ZK5<]AT+K06=#Y?IE?J;^H%\"3(1ZX"2\OYU2IK41'R`L)RHI`?$` MX5)`,&.#5++4(7XK<&84'RBWE;/)@$(%5_D="-A9)%"(BI1!2J/7TI*E,6?3 M19JGPH&`:4!\.*BR/]MC[J0VH@FZ]LJ$^WC?G_O#7L85P`C@_E.?(IWJLMWH M/0(:OP:%:B%4&[85$J/+BU4H? M45!_DA5T@*5Q[D?C)UL\2A;S-8V5A<)04+VTN,F<97R,HK%Y//.H,JV-KR3C MN](2[@X3*_@=9`^`!2\ALEK@2]@):02Z0TCH3O-;K,FGW?C?Q(.A^_?I/T2.,3,LR2\XG^+IJD MG+-1&#)*D\3LF9N9[9X27,W$5CO-LNB$RO=UU&9\BKGN#AV3:T='Q4R'&KJM MY"[II<_W@Q+6(1I>>C"*C!@S!+7%C9'EEUGP%MIJ['YGR2"Y!"2KXI]2"423 M9-`=#'^IC)=8U&I9OH9P)*OK2(`4MT6,@M<+^IKV)RF=6RW?S7-HBJ<1\)=D M2XFK.:XE.-61F9C>(P^4HU,):4Z#7>UV+Y__`@``__\#`%!+`P04``8`"``` M`"$`$B)7T3L+``#N8```#0```'AL+W-T>6QE%(YUX[*K:VXXCQ9>^#36__IH7PQU M;9TXX<+QH]`=ZZ_N6O_N]M>_NEDGK[[[Z=EU$PU$A.NQ_IPDJ^M.9SU_=@-G M?1FMW!`^649QX"3P-G[JK%>QZRS6V"CP.V:W>]4)'"_44PG7P5Q$2.#$+YO5 MQ3P*5D[BS3S?2UZ9+%T+YM^(#;QY'ZVB97(*X M3K1<>G-W'^6H,^J`I-N;//*C M6$O`RV`?NQ(Z@9M^8^KXWBSV\&M+)_#\U_2RB1=88&3?"SQP$U[LI!K.JV>& M:'*;A@B#LZF'5ZA-`9CDX,5ZFYR?*FSB=/6;=1W#'Z>+65%OES1=^W&QQ^$Q MN@I?$3WQTVRLVS;4$*/;15JIPTZD;#3M@KZS*;OJG\VRGMVS!U(MXV)QWV^H ML&?+I+)!H?U^<'+DS!W::3S& MI')%GZ5>61L?O$VO9T<`*A]Y/15#[2Z6@D6ZAIPX]DH>_[^"-9J`W_3:5Q MFN6.)0MD(4]+/)PB=B\'H]%H:%P-A\.1U3,LBY$\RR+:"Q?NUL59HS2:]A'T M`<&H-QQ=F0"D:PV9JK,BZ`&`0;\_[!LCTX+_6=4]/0+9G/9UU5XE"!1YE2!0 MY%4V2^E(J/Q9IL""C>)<)0@4>94@4.35@>0*/%#N58)`D5<)`D5>96MK$G,5 M%D(5YRI!H,BK!($BKTH;?&85>*3C!'3*_=WOCN,H$9:>P]/>/O)%K!O[,H M26!_Y_9FX3E/4>CX\+*3M\A_U[2$'3#8[!KKR;,W?P%EW`)+RDVJXE0:BJIG MX6S"&EC=@=4WK]()FR35@;OP-L&^=87NRK@$&I';9L,)AV&A)`N'5JP`<1$'A*"+6386"YXB]I(6HC92!H(VDA:B-H(J5.57#F3BV@# MFZ^[#K;M83==:VL=+]4""?"*B&ELL\]G8Y,*1AO;B'*:DP?U92\W)B;^L-%Q MA:4-+?;M;&A0865#"U$;^;BIM+A8NL#R7(%DAV_NZV^#`8K2ACF>G2*8U2?< M\TAW/83#ES=W3\^.*;+T")M!V`5L5=UBUC]"=SMW??\3=H!_7Q9]+BQCW=YL ME^2,`APT]AX+*%.#T5\WT<)>X\8:==V!KZ(3R]`WB,3)`(GF/T MPY&,2A*!)V$^CM$/"SV5^H$7I?HAN(3URXP'/->3!36X@`9U'1Z9"&`ZGR,` M)ZA`@.>0,@X@/%4@@&E2C@`"M$0`<&JBXI@\,$@U@Q@H58+^4ZF$&I-;R:D\ MH96'RB_HK['2YLKO4323>@N!7M(,;VH`'*7R4(E556*(VR'32@K@30T%-O2Z MJA))(*BJD,03O1.7R`Y=-DT74>GZZ>A-ZZ?:=MFXD&HPIG3F"+]A5;%UKHUPZ/T=@.9Z(1LO9 MI+YQ87XG,OC%[<8(:02!BSNJ,2#7&0;I(2`I13!S5=,$G:1R#-15T&&*U0H; MF,/BTU#-&F.5*D2? M4W0D.,G*M?=V9SMUX6&S]5!T]<%1NQD+%F M"Z:J1[Q\M_Z&NLT.8+7K93G09ZG4C91B/<[&I:=&)P<+[I2)=VJ3;+ON#3UR M(]Q#T<@Y=A]N^W!\DQ%'AJ>4"MU(X:'H.WOIT_!V39QDI,G^-077Y))6D/[O]12:+9E:]XTOR"8ZP= MT>Q76B,YY4T)_:84EDH/GNRHRQ%AA*V MJ^YO#D948\K3C1#Q#8!J%&^H!'FA+",_OU*%G.T>PGXAN?N"O_>BV%W4\-E. M,"3M_E:[T-[/46C1=1NP=C';>#[<,XW;AKCS.X>%WRB8I!>SO;HZ645%QJ)$ M9<'@IJTLD)`6"Q-/`Q!<$*UM98'Z5%8/K"6RX,:4UK+@A$8F"\]JE+@LV(]I MBPN:9+)X[ON"W%M5?F2GFDI<:+((+BJK]"..2HDL,+FMK-*/X#@J"TQN*ZOT M(R`DLBQ0TE96Z4?P`I4%X=965N%'"QQ'9/4%N;^J]",?JW@$0007E57ZD8_5 MGF"L4EFE'_E819/;XBK]"%()7Q9\T%96Z4>^3EB"=8+:6/J1Y[XOR/UN1>4C MWA2,^%1*Z3MX13C">:P(1ZF4TFM\E/<$HSR54OJ+CV]+,+Y3*:6G0!ZQR((/ MQ"TJ?-3CV;4$V9TXB[SJ\@&#_8P(#'AJ\7SCP].D(WP6-3MB`X\ZI@;A>HZ0 MI&=W_J)-X8[)0A"?#]B-B@BZWZY\)W22*'[5\%A-(8YW>E]0W!^CJ."(EV#" M6Q%`?X(G=\-#P37@)66(CV$<4;414^0"3P^>L6\C!EJG:/CXP_%O&S'0.A7# M%U4(B(]>^.(N^,CA&38!I(BD!W>3Q$X1?WQ*F8+$ M/.!]MH4,OD2DCY[,;PK.QI\/<%MM3B*.M$DQP-&_"/"_;!)"([8B0G!C4$3( MHY?`XP?R).9$("PA$1$<=2M$[%0401E_<^(0LX5+W9T8/6!1>7`01O^+;7G/ M->,]P6?;L[NQB_D`$+5PE\[&3QZ+#\=Z^?K/[,$>$$S9M[[W/D<)$S'6R]]N\&'8GPPNKY_8O1OW)W47? MFD[N[NQ1U^Q._PN4X1\"N(8GR1_QH'WV!P'@Z*!A7:]]>!Q_G!F;@?]47AOK MY$T*GSTF`6##^EQN1&==_*&"V_\!``#__P,`4$L#!!0`!@`(````(0#[8J5M ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O M;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[ M=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN M>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V% M2B6;E8KT81C+RSPA,S*A M/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2' M&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^> M?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q M%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*); MY`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ? MW7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#U MO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+ M33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD< ME9$".S1P1%H$B)Z9B1)?7B?-AOZ M'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V( M9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+ M=)$,\9BD/M)Z+_NH9IR4Q M>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3 MKX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQ MH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`? MJ5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H& M#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:] M69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5P MD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULG)I;;Z,X%,??5]KO@'B?<$U"4))1PQWM2JO57IXI M(0EJ"!'0=N;;SS&&!-LIAW8>FN;TYS_V^?N*9_W]1W&6WK*JSLO+1M9FJBQE ME[3__[9^+ZN7^I1EC00*EWHC MGYKF:BM*G9ZR(JEGY36[P%\.954D#7RMCDI]K;)DWQ8JSHJNJ@NE2/*+3!7L M:HI&>3CD:>:6Z6N171HJ4F7GI('ZUZ?\6O=J13I%KDBJE]?KM[0LKB#QG)_S MYFN_TBR!=Y6I5U>6AF(*?0BHIM7BDK!92V MZWT.+2!IEZKLL)&?-#O6+%G9KML$_9=G[_7@=ZD^E>]!E>__R"\99!M\(@X\ ME^4+0:,]"4%A12CMMP[\54G[[)"\GIN_R_0XM(P^S]3S>K4\@H MR,ST.5%*RS-4`'Y*14ZZ!F0D^=%^ON?[YK21C<5LOE0-#7#I.:L;/R>2LI2^ MUDU9_$\AK9.B(GHG8D#MN[_K,]V::_/%)U3,3@4^OUX5J'3;'OCL1'30F]B. M15<8/OMV+#_?CF6G`I^?KP*,2^H'Z0F?-42AYK9]Q4V:9+NNRG<)!B#85U\3 M,IPU6P/EOI=03V_]YJ-N`_V%J#P1F8T,[8(>44-??]N:VF*MO$'_3#MF)S(: M2S@]03HCD77Y@,<'_#YP?["AJJQLT#.];,@'(CX0#P(*9.J6+NC/3+H>#Z8^ M*X0F6>D?O.L#]]KJ;%T=D5ARB$L1J.$MUQSAH80O$J:V9*L23&#"!XS.I3]Z MQ'#.Q^,,8P%,)8P%I,<:T'/'K2"E&"OX@,,'7!H8YMDP3#9'W@/&FK.,+S*F M9K%,,($))S#1!"8>9YA0# M/A\(^$#8!^YY%GI[](#A\QR+C*G?1PV3'UA,OY`?4FHCPX1QF_Y,G1MR.\J` M53>&(QR4<%'"0PD?)0*4"%$BHL2"+KN6"O]N_;%=1N,Q"<816,"_X`@IQ3O" M+_Z4&7,$)5R4\%#"1XD`)4*4B"AAM8[`?D1T9$R"<82Y[Q$=(>(*$4^(^$(D$"*A$(FZR'"/8^K%F/R0,X+ M3.>#CBXTB`(R&.1#@2=PB=[.?MU'*?[5EW MR!EF^M2A$9QSQ;A+MPO)KH-&7:$Z(XB+JW@XXN-(@",ACD0X$G?(JIWPU9EZ M/]ZPEI!CSM"2B0.&GHZ&6Q[#$@8,A4;R[F@HXN*(AR,^C@0X$G8([>JZ:BR$ M933"5>)1A'6''(R^X`X]3S'NK(2!0Z%1=U#$U5#$PQ$?1P(<"3NDWW7JJSFW M;D2X2#R*L.9`ZKYB#BG&SFJ&Q>]-R7X)H%%S4,3%5;P.&4S>[$;=QS4"1F/9 M+@"L2(B+1#@2CR*L->3(-QPWXWM4\@Y:L(3?HW80S91&UCFVD4X'##TS.%_= M!PRWZ?.PY_BX1L!H/-KMA[A(A"/Q*,(Z0@Y\0TE(<>F+,[^]3.D_&CI,MXF@HXN*(AR-^CRS[O1`W*H,>^/CX M&>)(A"/Q*,)Z0LY^G_"$'A493PQN%.S@:@]=5%#$[53F]-V.MC"Y>=##'^.S M&KK&O[(+<(T01R(<(=>='^>$.D*O,^D559%5Q\S)SN=:2LM7U3?LN'T"P=J+AY8-IR!Q7AHV7`2%N.Q9<-15XS#/>U3>S_*Z>\T&ZZC1-XG M][H/XCO=WCW2<70;WNB*.D^6_?2H/CO+WCV*.Y8-[PY$'=>RX0V"&/_[:\G MN.C/X`6^.@/X4)9-_X4\X/9?![:_````__\#`%!+`P04``8`"````"$`[#&< MDD0$``"E#P``&0```'AL+W=O$_!U8520VOU='B MYXHF^V90D5N.;6.K2++2E`JD>D:#'0Y92GV67@I:UE*DHGE2P_SY*3OS3JU( MGY$KDNKMHQ+ZVE!4J;U3Z#"(3M1D4/:W.+2+PPK>?C%YY[[?!3^RZ MJ[+];UE)P6Q(DTC`*V-O@AKO!02#+6UTV"3@C\K8TT-RR>L_V36BV?%40[;G M$)"(B^P_?*T(C"B%4'.Q%G,T1S_A`IN5>!Y4WEZ"B_M M8'C^_SA@331FP+,5<9:3Q7P^PXN7Y]U8MBKP[*8R&XO#DFEILNPG=;)95>QJ MP,H!X_DY$>L0$1#LTBN3<4OXC_(-B18B6Z&R-L$;2"6'&GW?S.S%RGJ'PDI; MCJMS7M"0XG44449"U^^`NZXR).@8W9!0`K)^A,:N`^X:4]L>?CCJ.)U*W`'W M0;W)6N#=S4"HS;Z!C]=%YY,@"Y^Z[[@=%(JO4Q1&H#-4D5"G M3!67=I("UO2RO!Q.-](YRESBKQ@#9Z<_XZP@#YQ5`4\%?!4(5"!4@9T$!@X@ MQ:7H"4ZL`"[([/NR#(:Q/J[%ZG2*E"5W(6S5Z%$+:QDD9/$F"*-Y$I'M:ZW]=P M9@AZT9`0C&N$.D41V8TRHE%&+!DRVMGR1UL9-,;G319D:!I]@V9H.C3`;4G] MQJ"$YXU3_'%*,$X)QRD[2>F'I,PV&A>)OZ0,BAILZ?O=]%X,J?JZAXA1C?&W M)M(B][;B:8BO(8&&A!JRDTC?D!F:#7,<::/B/C((6-P)>H>-K^,49'45*^EP M):==Q?8<8[6S>Y+1CT#1\$1R* MM%F>XN7YKJ#5D7HTS[F1LHLXH2,,N]T-EK>'"!-((%22@L>80!IU/'0(]`,= MWV*R?<1W,7$?X1XF4*2ZCH\)E*J.!YA`P>IXB`F4K8[#K6C[:)XN(G#*U/D^ M(G"4U''7(>XC'<\AT$IUON\0Z*@Z'C@$&BO@ULUHN"6=DR/]/:F.6<^2+S4[0^[@@,]JN!\U/T]P':9PMK4G0#XP5G!:A@#8% M+UES2-$_?S]]N4>!5*0I2<4;FJ(W*M'7[<\_;2,M[2!)WLN:J+@4AQ"V0I*RNZEN@KC*$K"FK`&&8>UF.+!]WM6T$=> MG&K:*&,B:$44\,LC:^7%K2ZFV-5$/)_:+P6O6[#8L8JIM\X4!76Q_G9HN""[ M"L;]BN](\#K' M"0JWFRY!_S)ZEM;O0![Y^1?!RM]80R';,$^*[/ZB%2T4+6'F4*!G9,?YLW[U M&]R*((CL!#J(_/\2YB'64<(AC/W[$O*IF[8_1%#2/3E5ZD]^_I6RPU%!I`6D M06=C7;X]4EG`-$"L6;S0K@6OP`(^@YKI]01I)*^&CI7JF*)Y,ELLHSD&>;"C M4CTQ;8F"XB05K_\S(MQ;&9.X-X'OLWD>?]YDWIO`=V^"XUE\O\"+Y&.4T`RK MR]@C462[$?PKXT669NV'%C+^Y8,1\4#@AD83J( M%L.2L,9[-[@:,J.XLQ0+5Y'_2.&0@8*QV;+MK01[2ROK-3_F,SZVYA:?WJRG\YFMW>:+ M_;+%1F/'COVZ?4=SBT]OV=/YS`;O\/FEB\>'0.Q54?Z.YA8?C-/FF[@.]5ON M.HR],LVPT=AYO#)T!97WDJ3;AJ!+2I;1:G$M*;=@/G5PZ+[-!_2B9[W&!HRO MP7O"R:<'M+-.(C\HY/'Y$8\*>7PZQ*-"'FNNPS3Y,[VOZ>1J*@XTIU4E@X*? M="^+(??#W:$Y[[OFX0&TN2TYT-^).+!&!A7=PZO1;`G9$:91-A>*MUV?N.,* M&MSNYQ'^!5'HNZ(9B/>&ULC)5= M;YLP&(7O)^T_(-\7`PD)1"%5DZI;I4V:IGU<.\8$JQ@CVVF:?[_7=L)"4FW< M8)P\/C[O\0?+^S?1!*],:2[;`L5AA`+64EGR=E>@GS^>[C(4:$/:DC2R904Z M,HWN5Q\_+`]2O>B:,1.`0JL+5!O3+3#6M&:"Z%!VK(5_*JD$,=!5.ZP[Q4CI M!HD&)U$TPX+P%GF%A1JC(:N*4_8HZ5ZPUG@1Q1IBP+^N>:?/:H*.D1-$O>R[ M.RI%!Q);WG!S=*(H$'3QO&NE(ML&ZGZ+IX2>M5WG1EYPJJ26E0E!#GNCMS7G M.,>@M%J6'"JPL0>*505ZB!>;%.'5TN7SB[.#OG@/="T/GQ0OO_"60=BP3'8! MME*^6/2YM#_!8'PS^LDMP#<5E*PB^\9\EX?/C.]J`ZN=0D&VKD5Y?&2:0J`@ M$R;.!I4-&(!G(+C=&1`(>7/M@9>F+E"2AUF:3F?9'&2V3)LG;C510/?:2/'; M4[%UU:LD)Q5H3RIQ$B99&J> MR5RLV32)LXM4G/N-)]YW/_`&R'AO%K[V-ANFLO;,S"]YE.63>`AL/`#//OR_ MY0VLP38?;\W"U];RX3+-X^OMYJ\-?RXZLF-? MB=KQ5@<-JZ">*+1'7/E+PW>,[-PYV$H#9]V]UG"W,S@D40AP):4Y=^RUU'\M M5G\```#__P,`4$L#!!0`!@`(````(0"?"3WHEP0``*@/```9````>&PO=V]R M:W-H965TVSRQQ$K2`(TPVN_^^8VR#C6F4JOL2DI.9PYR9\=C>?'TO"^>-U"RGU=;U M)U/7(55&CWEUWKH_OB=?5J[#FK0ZI@6MR-;](,S]NOOYI\V=UJ_L0DCC`$/% MMNZE::Z!Y['L0LJ43>B55/#/B=9EVL#/^NRQ:TW28^M4%AZ:3A=>F>:5*QB" M^AD.>CKE&8EH=BM)U0B2FA1I`_&S2WYEBJW,GJ$KT_KU=OV2T?(*%"]YD3[/TLSQ=W^L.C+/*LIHZ=F`G2>"-36O/;6'C#M-L<< M%/"T.S4Y;=V]'R0^=KW=IDW07SFY,^V[PR[T_DN='W_+*P+9ACKQ"KQ0^LI- MOQTY!,Z>Y9VT%?BC=H[DE-Z*YD]Z_Y7DYTL#Y9Z#(BXL.'Y$A&604:"9H#EG MRF@!`<"G4^:\-2`CZ7O[O.?'YK)U$9[,EU/L@[GS0EB3Y)S2=;(;:VCYMS#R M)94@09($GI($+WJ2!XY8.L)3.OKS"5K-_?F"O_Z!YTQZPE.]\CE'H&T%PU.] M*.ID0>T_019GX;)40*$"-)T##OWF`UV=22?,0F(+273$T`8+Y1.T<19H7'AHXI`9>2B-'HGK M3#IQ%A);2*(CACA8N4-Q:#[IUO/3JXKSM/)46*%$UKI@C$W!A\Y(N446$EM( MHB.&&I@*NIKQ4:X&`3-=E4?+"2RD-A"$ATQXH/"/A\?-S;C$PCN M%_E!(JMNV4>=C=9G>&:F/>Z,5-H3'3%"YL<=:^A.^,1O+GGV&E*QQXVD&L-P M%2.7G@^PM38CE!"&/:8?+W@X&*45FO7MHB"8?KTC M&LRE6%GQ)+WM5C/DK_!@STR437MD,]7QG>__]I`OMD\8H*K!1H05/H*B-N`Z(8V5)ZC,Y MD*)@3D9O_*@/#KM-!XM[2#@+8/L$@B$^#V`C&L$7`6P`(_@R"-N&&_`*F)7XT]`I)A]L2;>"&U'Z]P(V8 MP(%ZR@\A)TH;]8._H+MC[_X!``#__P,`4$L#!!0`!@`(````(0"4&PO=V]R:W-H965T::)DZ`&'`'=Z?G[K3(V^,)F,JM^:3J'JO(Y M5;;+>//YO2R<-UHW.:NV;C#Q78=6&3OFU7GK_O4G^;1TG:9-JV-:L(INW6^T M<3_O?OYI>UV076J;-A%UI!6].K"[3%G[69Z^Y MUC0]R\$+?GWMEFE=N%V%=/Q*#G4YY1F.6O9:T:KL@-2W2%O@WE_S:R&AE M]DBX,JU?7J^?,E9>(<1S7N3M-Q[4=5S!+,QF;_[#"EWE6 MLX:=V@F$\SJBMN:5M_(@TFYSS$$!IMVIZ6GK/@5K$OJNM]OP!/V=TUNC_.\T M%W;[IT/3+$2%P]BQOPBOP>^TXY3H4C/(5CN+CK,!,.\!0. MT6091;/YH3?IA5E(8B%$131ML$`^0!M&@8D+ MCSOBA-$]<;U)+\Y"$@LA*J*)@T6LBAO?X^3206.N08Z]%PBT/D75W)AGO9%T MBRTDL1"B(AIE6/J/4T9CG;)`5OU*.5A(;"&)A1`5T?A!]51^?)L*9I-A5WUX MJ\)(.GF!K+1\+XQ\]T9]OBTDL1"B(IH>/-RU/]@6,(I.7"!ZKI=&KGNC/M<6DE@(41%-2P"G%57,_61S M:YVTA)1TVU!L0XD-$0W2:6(O4^8$YGP^_3]3/.BZ(NR+,H%["4&2E$UE921^ ML)*.L0TE-D0T2%>%W4U1]9WD=[U08RX@-?D6%`<6E-@0T2"=)G:JQVF*OJ8F M6$!:@D/?3'!O-238@I+`@H@&Z%%EHG M76$U.,;!J&.H3Z!$6D7\D!WXL]!?K(SH1!I-W"UH MS''BA=$$%O`/'BEX(+T]"P@?RN0S#\R#E500VU!B0W@MPN=V=\'!/S*[:X[N M.[JD]9D>:%$T3L9>\0H#LK#;]'!WO[(/HC5N.S"V]68%;_BN9KX)?7DI8[X! MEU&/`#S@A#$V"ESP0)<>>Q/"FW#TS13>\$W$'#^8P1L^KXPW<(_T-!X+',;& M@,%'[6'HL9&?9A!_5"`P&B.TA[R/IGV^AJ^-D70LUG!J'\&7:S@M`^[UBN%^ MZIJ>Z6]I?&ULE%;);MLP%+P7Z#\0O$>;=\%R MX#1(6Z`%BJ++F98HBX@D"B0=)W_?]TA9E6P'42ZR]3R)_3WKX>;)27:L#ICI:QY0E^XIK>;CQ_61ZD>=<&Y(#[.9RR],1M7R[H*Y$JJ65N/*#SW48O/:_\E0],FW4FP`&FG2B> M)W0;QG?AA/J;M4W0'\&/NO>=Z$(>/RN1?1,UAVQ#G;`".RD?$?HUPQ`L]B]6 M/]@*_%`DXSD[E.:G/'[A8E\8*/<,'*&Q.'NYYSJ%C`*-%\V0*94E;`">I!+8 M&I`1]FP_CR(S14*CJ3>-9HME"'BRX]H\".2D)#UH(ZN_#A6V7(XE:EG@LV69 MS+W9(IB,(/'=CJS!>V;89JWDD4#7@*1N&/9@&`/Q=4=@!;%;!"=T00GL54,9 MGC91L%S[3Y"ZM,7<.0P\.TS8(7P0[91!;;PR@E$9W>:C8-7Q.F6'F?8PLPXQ,`B0\081##7HTU[FUH'ZF%>DH:G&2R/82G?) M;2.#/(3!=9?S]T@A>"C51NSP#K('7=:W8$:V=Q6J$'5PXU&@C0SNO='\(9]UX/Q8]%#N% M+AV%..F]5%E+XVH,/4VN=UR(L]\3?N/,0O296ANZX@F'NT>- MGN;3$9;F;)73GN1*ZXVO-/O"PU2>4!KY,(SM@NVEUU M6[OO\_@TWKHKT.]^@2NH87O^G:F]J#4I>0Z<@;>`"BEWB;D7(QM($-Q#TL#= M8[\6\&>#PSD;H/=<2G-Z`7]^]_=E\P\``/__`P!02P,$%``&``@````A``YV MNK*3`@``BP8``!@```!X;"]W;W)K/ZF&/(*Q4K1[J#%+Z4VBCMSK\UO"SHY^$UOKW6 M%SZ$F]G)[KN^`=\-*:#DV\;]T+LO(*O:8;=G:,C[RHKG6[`""XHT43KS3$(W MF``^B9)^,K`@_*E_[V3AZIQ.)E%Z.4MF<\23#5AW)STG)6)KG59_`BK9\"SI>P3=N*ME:TD")E''OQ83;)"R<[C!SO!"TPTN@_UGCI0\X M\'&$QDNMW6&!PFSX&UG]!0``__\#`%!+`P04``8`"````"$`A>DVT9`"``"5 M!@``&````'AL+W=O[%Q-$FG;-7B"8XW/NN??@+*^? M=$,>I77*M#F-HQDELA6F4&V5TU\_[\XN*7&>MP5O3"MS^BP=O5Y]_+#<&?O@ M:BD]`8;6Y;3VOLL8W#MCL31G=`L5&-\L\] M*25:9/=5:RS?-.#[*;[@8L_=/QS1:R6L<:;T$="Q4.BQYRMVQ8!IM2P4.,"V M$RO+G*[C[&9!V6K9]^>WDCLW^4U<;7:?K2J^JE9"LV%,.("-,0\(O2]P"3:S MH]UW_0"^6U+(DF\;_\/LODA5U1ZFG8(A])45S[?2"6@HT$1)BDS"-%``7(E6 MF`QH"'_J[SM5^#JG21HEEVFN.P`IBUPC.Z8(2J-7! M%!Y7D,,E>X36B0%S$S!P'3'QB&`@.BJ#VNG*"$9E["V6O*`#G=(()A!E/:8^D`FF+>D(903:4QK\D=8/[#B6&%0C/ MQ,W+X(1C('PE6MI*?I)-XX@P6_S$$\C]N#J>/NL$H_ER_2);]Y%EXPLX%3I> MR6_<5JIUI)$E4,ZB!7BQX5P)#]YT4#D<#<;#<=#_K.'XEQ#]&1HOC?'[!Q!F MXQ_*ZB\```#__P,`4$L#!!0`!@`(````(0`^*P"DI0P``/E$```8````>&PO M=V]R:W-H965T&ULK%Q;;]LZ$GY?8/^#X?<36[[(4I#DH$W1 MW0/L`HO%7IY=1TF,QE9@NTW[[_<;7J29X=@QO7TY.9T+.?R&_#BB*-_\_F/S M,OC>[/;K=GL[+*[&PT&S7;4/Z^W3[?#?__K\6S4<[`_+[O:.++^F5]^.D:'0XVJ^L_GK;M;OGE M!>/^49&/M!TS/6H'J&ENYN'-49`L`]VS>/M M\$-Q?5^,Z^'H[L8A])]U\[9G_S_8/[=O?]FM'_ZVWC:`&XFB%'QIVZ]D^L<# MB>`\2KP_NQ3\8S=X:!Z7WUX._VS?_MJLGYX/R/<<0Z*173_\_-3L5X`4S5Q- MYM32JGU!`/CO8+.FN0%(EC_^#3#!$-[^=4G3M;A&6Q$#WT*'RC%0@`8U\H%:N1TNA@,,>(]4?K\K9L7- MZ#O07P6;CX:-M+B/%I0TA-?%"'!^08S4"L5(B:2@/T9!'_1$!10M=$``ZA<$ M1*U@SIP$S=L4'-FY"K(ST5'.?DF4U`HF!_ZH8?)*9;->.BL/39(&1 M,APT*T1'EQ<9&K':V0DO/`=B_7B7C.#R#0%`\@B-@,)S:DR6F`2TS#>J-E/JVH?LC.?.`L'DD0R][JP2*+/J;I/071,@VFO;;GA!)*(A[V")X)_,IQ1%1TMR7F=?E M7&^5##>+XB8IQ441G^A'*6ZB*(XR7URPR[MVU((+M";SKHNZZ)AN1!,BJO,S M$6B-K\$@XD!PDXKT%$7I@*UX7=Y/.2N=]FD5PSEKB'41\F@N1 M&.Y4$9S+^\P=$^1N\ZXI%8I5X,UU@1<=T]1/L]C/6:L``B'VS\KWTK&(Y27]67%'C3E/VB"-.< MK0)=X/56"119[#=-V2^*V*(7(@F%8K]W,A\(C2WZ:1#)S.L"K[=*ADM\=#;K M3,E:370O$HN>B^1PB7Q8;Y>2_320&`=7D7'=,5/\MB/VK:K[?2ZV.6Q8S.6N7"DZ6`@HLD%(H93]/!+&6_*)+#U;5?;Y4, M-XO]9BG[!9$8KK>R,J_8CS(_F5]A6)E'/+.4&*-((J&+O]XJ02*+&&$2"8>87)B?"?Q9*VF61`ACG[;*W7Q-^NL]'#G6?3GK&4`0<03+T1BN'-% M?Z>'ZZQ5;Y[AT!L?KJ[O@J,Q\^99#.>L50"!]%AVHY43R>$JAGMGN"F+S8-( M9E?7=[U5DMTL%IM[?N+GE4&$XP(T[9]@A4@.5['8Y?7=/&6X(**#"S;1=7W7 M6R509#'X[B65.8#5"^RY[H M%H'IV(-^%,G,Z]*OM]*+8)%%?LY:09&27["R@%?D=WK-+P*?\>%ZD5W[1,5WRBRSV<]8J M`$YU?M<+5A;N!OL5Q>R2$YY%6A9&D<1"EX6]5;((LNAOD=)?%+'G'R&2?$#L M=3;]+ M6:O>K/JNTO5==$QG>I5%<`I#D\=F#AAN%PDAYM%<55*<5$DLEOI*JZW MTI.YRJ(X9ZV&&UB/9Y>+Y'!_%<55:8$716)95[K`ZZT2)+(HKO)\QI_SHX@C M$:R,::8H[IUYGK)8%42\-RZ2N&=15I525A0!]IY$*ETRVE9]I25CRB*V*B6V M*`+&+"9=S-A61V*JL[C.6[OXD*:FAE0@022X MO-9T$QV-V++8M4[9-8HX$D?9MMAAL(5PZWYZB0^,Y*;UUU%I4Z:Q5` M8%<^7"X2"ZT89[&D-Y?]11E=:NNYN]; M7/<8&`Z3F\V$?B_T<[]S39]/BG$6[7ES'80G/CD3N$PM`(/Z+GI2+\8I]T49 M@N&(Z/V:F:5K(XO^BG'*?U$F$?%VYMK(HL!B'*B,[72=C'&0E*D<*,ZC[8?> M66:^_:8O_/3NT\GD4NQKH3@G@RM;BOYC/_^%VZ;9/37WS69:JK2.=62ZJK2>>BUKH:*NP/ M9F]C\G+7<+476)-T[@5GJIN0;F*W.27=U-;-2.=FB&ZSPL#Q_&-$6<,)!9*E M`<@H9BP-($8I86G0#RH!2P-XL9$;F@I0X'3!T@`(G!=8&L"`1W1+@_'@H=O2 M8#QXF+4T&`^>10W-`CXXX[,T\,%YG*4!!C@+LS3``.=6E@:S"`=*AJ;"),+A MCZ$IX8,S>$.S@`_.RRT-L,9AM:4!UCA8MC3`&B>^E@98X\#6T)3PP8LP2P,? MO,>R-,`:;Y,L#;#&RR!+`ZSQVL72`&N\-3$T<_C@%;:E@<_<]@'6>-=K^)3` M&N]E+0VPQEM12P.L\0;3T,SA`TZV-/#!G0]+`ZQQ&8F@*^."7!RP-?/#5G:4!UOAHSM(`:W_ZK4=:`&M_N*`U$V#MZTJM@8N9 MG0(>^/[5ZA](X_-32P.D\:FHI0'2^(;3T@!I?\JK(L/O0WRPVX*#U1*EV9+3 M@C+D'V;7'XY4:;0X#8^/2*.91231S"%2:&80"71K9=0-&;\[\;I\:OZ^W#VM MM_O!2_.(4N?CYB?:`GYQP__N,GQAI\'L'8[J_\]BV MA_@/@#WJ?K3D[G\```#__P,`4$L#!!0`!@`(````(0"45-P.L@,``,H-```8 M````>&PO=V]R:W-H965T&ULE%??;^(X$'Y?Z?Z'*.]+<`*T M(9M7;E?:DT^E^/+N)`:M)'-FFM/_]SMA)&B<&P@LBP_B;^6;&7X;UM_?YZ'P9*TS*CN2C9)OQ@*ORV_>W+^B3D MJSHPI@-`*-4F/&A=K:)(I0=64#41%2OAEYV0!=7P*/>1JB2CF3E4Y%$\G2ZB M@O(RM`@K.09#['8\94\B/1:LU!9$LIQJR%\=>*4:M"(=`U=0^7JLOJ:BJ`#B MA>=E1?&_ M=2(F*8ME4GNBFF[74IP"Z#=XJXKB])`5`#71&KIA M8G^8Q`V#S!/HZ>5P>`C\NB0&1*W/K.,S]V<`+N.)HC,TJ0L[K+%UZOJ<"0T# MTPV-Y.,%CMT5_GC.9-'6N[9`Y3[[FDS]A!=NU,NE1F7SM+%Q>8LKTXF'G+Q M:XM+Y_4R9ST9)XQ+"9D[TPM8JXI!)_?PAJ02?R MY089[UXT!`"3AY1'/0B93ZY.'+'J`/>XO4&-R>4T.\,)K_AX3E80G&BUR<,) MK_)XZ/KB=XG4)D<>DS,*1&X2`^/=:TXM!QXB'CU(QDW<4!"(5Q$69[ISDR20 MH28T)@\ICRK$B_L1$S=4!N*5ACL_I_@F:3#>;J,:TY!3[)&&Q>PZ)7.N%\0K M#/=G*-TD#'&M`IU);TP>2CUAN*PY\5`-&I-[B3Z7*7=5NDD-XJ$:-"8/D9X: MH&R3:3SBI8I;1.]5U)@:Z"5!QQ*XYAKVRM[<;^ M8#+OVV>K!PB)RWC["VS2%=VS/ZG<\U(%.=L!YM30D787MP]:5$`4]FFA88Z^=*>BJ*SH,*EW=FGKKL^.$Z;GXHJ:[?UM;C`*X>Z MJ;(.?FV.3GMMBFS?OZDZ.]QU`Z?*RHN-%1Z:-37JPZ',BT]U_E(5EPZ+-,4Y MZX"_/977]E:MRM>4J[+FR\MUD]?5%4H\E^>R^]X7M:TJ?_CM>*F;[/D,Z_[& MO"R_U>Y_F92ORKRIV_K0;:&<@Z#3-<=.[$"EI\=]"2N0MEM-<=C9']E#*D+; M>7KL#?JW+%Y;[6>K/=6OOS3E_O?R4H#;L$]R!Y[K^HN4_K:7?X(W.Y-W?^YW MX,_&VA>'[.7<_56__EJ4QU,'V^W#BN3"'O;?/Q5M#HY"F2WW9:6\/@,`_&M5 MI6P-<"3[UO__6NZ[T\X6P=8/7<%`;CT7;?>YE"5M*W]IN[KZ#T5,E<(B7!41 M0*]>YUL>^

S/UZG2^@J6YDB13":.*]*:0.P%T`R(L7$><-_U& M(L621&Z"1$OP#U![0./&YTX5X2@A)&"03B+-$M!,RT3R3:#3`.*8$B0H\32) M3Q7IDH(@0A$=<1E-BG0$-5&_J1O/];S`-^&().:A&]SQ#YI= MAY/^>7>/T6U'Y9NH?\PU6B=!#7`,"S$9EQ3$P(`R+ALHQ=3`2!C^H23`0P'F M&.>.2T324(!IWH\";>(:* M-6P,)L=ZXWHUI?/-4Z`TB,=B$4WHE&(5GAS'VKZN&W8,A[@^4F*/ME6B-`J3 M"=_LS90H-K&X-X^9'-T:XW+O]6IJ(7,G<)@&=QSJNR!5A7`!&X\Q,;8P:3\F MQ[;&M])#'/:ZA\PUYEG2E][9R!`$PCC>J7K=P[G-QI M$8:BFSE1:#B<*L$=ARF>G-J:?S_`PQE/?0O-YD,1XO$@',>MVMMI4&BGB-*] M*2K8-"N8:X1!HD1(Q^(P-HYX2@0;%GO^N``*9P3&RM:;2P[S:H7IN;`1;@"@ MU.642+C+[QY@(SQ64LZD"!M]P%'-]!C9,,\3W)"D1,)\-XQ'!37S33G"ID'" MF+&1B1+A3GLQCXQ62(F`!['6J82-ORE&>K5QA+7A@-8ID3K"$ZH M)O3"2.M5"OBN(.$8)#`*ATLZ`*%MEBB1/DJ,.9DN2BCGF\*$8TZ08<.,49AGPF1)AA3J)$^-DB"F$>4H=3HH@B'[YO M#@I*)\?^ZE'-I=IL0S-)E$BUX3P>UKEUJG`9<\P8ZLI3%W!X>#K$HKY MKGSA,_G"S'Q1(L3D+(ZU[T0*$\OHAFOGBG*^*V'X3,*8\9$H$7)"?$R^IRC! M*LPW)0R?21AN)HP2*1OG\+"*XI?M(,;.)B;*FQSK#W>OIH?;,_=8:?"S-RSR M@S%Z<8^)@H5^%(PU*-R[\D5,OZ@P/EXEXX%1HIM#/GQ5,4\,D0B/PS7;F`*4 MT\B7=0=;S.0,'T>\-$)Q8DB M]-.+X9)A;#B%J2M\IEV:4$8Y][6T6&OPU.+CUS>J#;^GL#3C/[6OS.\``\3KMFQ^"-KCN6EM<[%`4JZVQ!V MN,''$?A+5U_[6_K/=0>/$?H?3_#8J(`;X>X6Q(>Z[FZ_R-OLPX.HI_\!``#_ M_P,`4$L#!!0`!@`(````(0!<_B&X3@(``(H%```9````>&PO=V]R:W-H965T MIX M"U\JI26UL-0;8CK-:>DWR8:D<3PBDHH6!\)4/\-052487RJVD[RU`:)Y0RW$ M;VK1F0M-LF=PDNKMKGMA2G:`6(M&V).'8B39]'W3*DW7#>1]3(:47=A^<8>7 M@FEE5&4CP)$0Z'W..D:G5 MX9,6Y1?14W+TY(;!@4%3)3Z,)AJ(`"X(BE<9T!!Z-'?#Z*T=8$'<92-XT$" MV8FA:AA=.0][KH]N$33#*TW6*_YQ!LSSSDY<8&!?.?_E!N>@F?B*)/$PC<=Y M\M@:HGO>VHEOK-/;<@?-R%MGDRR.X\?&T&?/&SOQC7$^ZKDAYZ`).>>307:? M^NM;(P!/ZQAG\>A]:#<<&H M4LI>%FY<^[_H_`\```#__P,`4$L#!!0`!@`(````(0!W$C&O@@(``'\&```9 M````>&PO=V]R:W-H965T%?R5G=0T">P]'K]\<-JK\V];0`< M08;.%K1QKL\9LZ(!Q6VB>^CP2Z6-X@Z7IF:V-\#+$*1:ELUFETQQV='(D)M3 M.'1520&W6NP4="Z2&&BYP_QM(WO[S*;$*72*F_M=?R:TZI%B*UOIG@(I)4KD M7^M.&[YMT?=C>L'%,W=8'-`K*8RVNG()TK&8Z*'G)5LR9%JO2HD.?-F)@:J@ MFS2_65"V7H7Z_)&PMY/?Q#9Z_]G(\IOL`(N-Q^0/8*OUO8=^+?T6!K.#Z+MP M`#\,*:'BN];]U/LO(.O&X6G/T9#WE9=/MV`%%A1IDFSNF81N,0%\$B5]9V!! M^&-X[V7IFH)FF,,6K+N3GHH2L;-.J[_Q8SI0Q.!L",;W$'Q^F&;TGV"LH:7ON.R_-D?BX$73@L1L/+NB"$LS58O$?UEFV6+$' MK)@8,#<1@\\1DXX(AJ*C,JJ=KNS!7MF7U*=R$S>F,MEQF?/WR'AP0?$Y)G]H M,&(N)ICY<66$G&[0@_$,IK2'TA$TQ?Q'&OOA=&D/#M)C<8<=;,U)':Z.N[Q\ MCY0'OY0:=K(P=M/VP"Z;6@B3MGRS0WW42X%A!R,G7I:OO,2!CX.AP-3P"=K6 M$J%W?I@S;/5Q=[QG-B'GU_L7^29T*1L_X/SWO(;OW-2RLZ2%"BEGR0*+;.(- M$A=.]Y@Y#K)V>`.$GPU>](#=/DL07&GMGA?^CAK_.M;_````__\#`%!+`P04 M``8`"````"$`Q^RE9(T#``"O"P``&0```'AL+W=OR"DU@%C&RG:?_] M[L4QM0G-.JDO`4[N/3X^OK;OXN-C57H/5$C&ZZ4?CL:^1^N<%ZS>+_U?/V\_ MS'U/*E(7I.0U7?I/5/H?5^_?+4Y>;X"8`IM6B8#`#M-T3=+?TUV&:A:$?K!:M0;\9 M/4GKW9,'?OHD6/&5U136ID1158+P4\>U"=,3C8$JSU,@=AXJ&5T MKKYD*KB))&MD6?HSWP.[)%3"PRJ*HT7P`*N7GV,VES&A&[$U$;A42)M90`!Z M.]%@\!N(1A84;8;;&,":14^AB3`IF04X"F%QWT`ALD!5.K9.7$D;'1/:WB=N MR+8+Z63;B*,;2N`-=",+%!0\KM3#.>B:\"ZD$VXCCG#8`;;PX3/`E"L&M_H, M[T8C$2RGI3CN^=@%F;3,1APYT_^1@\&N'(V`'#/2]@+);,09&QRUK<`M'24C MD/J?FQIY7%D:B>"DMESJ5UL79+1G-N(HQ9O8.GRN+QH&NW(T`G+,2-L+)+,1 M9^P;=VQT:3+'B^*%^\/4#N:Y,C023YYE=(CMT]2MIFPP:-8%.6)#L-QVZM5J MVT17[AFR]3Y#UP0/1\U?4(QGM[6VJ#@![/H:0[O0=_<,.7)U%$!7Y0Y&W?3D MZNY"7XD5%7NZI64IO9P?L7.`*:\6'=RU->MV8_;P#;8[6`-]/$KAFAC`)VG6 MUDPO?AVG:]TV]?[8Q&D6#Q$E*1Q$`P-,4S@D!O!9"EMR`)^GL%T`#[J!H5UJ MR)Y^(V+/:NF5=`>FC$?8'@G=<.D/Q1LP"YH0KJ!/:E\/T!A3N,3'>/+L.%?F M`P?H6NW57P```/__`P!02P,$%``&``@````A`%G+&ULK%==KZ,V$'VOU/^`>-_PD9`$E&25 M!&A7VDI5U6V?"3C!NH`1=F[N_?<=8\S:F-WFX;Z$<')\F#,S-I/=Y[>ZLEY1 M1S%I]K:W<&T+-3DI<'/;V]_^3C]M;8NRK"FRBC1H;[\C:G\^_/K+[D&Z%UHB MQ"Q0:.C>+AEK(\>A>8GJC"Y(BQKXY4JZ.F-PV]T7XKKMVZ@PW MME"(NFK\&;DZZU[N[:>X5^XL\?D?X5C(H=P".N+&H>(\1S2&C(+/P`ZZ4 MDPH"@$^KQKPU("/96W]]X(*5>]M?+X*-N_2`;ET092GFDK:5WRDC];^"Y`U2 M0L0?1.`ZB'CKIQ>OAL5PE1$\O19"[*.'Z[`V7&R#8+7>;OXW>D=DHD]LG+'L ML.O(PX)N!:^TS7CO>Q'8D!D5_L<<_RC%D%LNWMC6Y`]"GWQ>O"WFYWS M"K7,!\[)Y'@ZXRP9O'!<-IX"R11(%<`!1Z,M*,X'V.(JW)8,Z"0!Q>?$@V3( M)?$42*9`J@":A^6'>.`J>QL^E=)L]:!/@N.I]0MTRGFDC,8,)#&05$4T;]#_ M'U`?K@*-"Q?%7*A'?AI(/S,W4D9S!I(82*HBFCG8C:JY^=-);AU.[CW(9Y\& M)%1=^:[NZCR2Y++80!(#255$"QFV_O,A<[(>\H"$XTXY&TAL((F!I"JBQ0?5 M>SX^3M;C&Q`E/@.)#20QD%1%M/CXA*$*.$, MGO&[A.>)EP/7T.T*Q(=J*W:7>MSG@?3]](T'9#LF(!F0L/<6;`/7G>R3='S4 MU!G,*9JU&0LP%$@//5LW,4"3HJTF+B1+J9J$]&I/RR99HF[A=AF899.<)<^( MJ)N8G<0KOD;=#9U155$K)W<^%_%$C>@XLQU]OGZ"G_@L-X?[$;RQ9OC+"(Y[ M$S^NHB/$:?YP6D5PA,[@003GU`R^CN!\F,$W$>Q+P)W1`&ULK)S;;N-(#H;O%]AW,'P_L27K:"09V&KT[@`[P&*Q MAVNWHR1&QU9@NSL];[]_'55D,7:DGIOI"ZFR-B\=(?V;OI'>YK^>O_7O]R^ M=<>OI^>V/4_0P^%T-WT^GU^7L]EI^]SN-Z>;[K4]0//8'?>;,_X\/LU.K\=V M\Z`;[5]FZ7Q>S/:;W6%J>E@>/])']_BXV[:?NNVW?7LXFTZ.[NWUU^VW?X577S9O>S.?^A.IY/]=OG;TZ$[;KZ\8-X_DFRS M=7WK/Z+N][OML3MUC^<;=#S^5D?HO[OV[13\_^3TW+W][;A[^,?NT"+<2)1*P9>N^ZI,?WM0(C2>1:T_ MZQ3\\SAY:!\WWU[._^K>_M[NGI[/R'>.*:F9+1_^^-2>M@@INKE)M1O;[@4. MX+^3_4[5!D*R^:'_?=L]G)_OIHOB)B_GBP3FDR_MZ?QYI[J<3K;?3N=N_S]C ME"BG?">I[03_ND[F?2<7&BYL0_SK&A8W238OU.!QNYEQ7L?BT^:\N;\]=F\3 M5!C<.[UN5+TF2_3E@F!Z\&%Y+RJ8B>IDI7JYFY;3"29\0BZ_WZ=E>CO[CO!O MK,L5-;@GO<1P?D3?%2]*!]5^)73:R<(G&8..0ON$`+%'5J@_N3* M<3%2C5`C)$8+.N#:V"1A('-JTG@3[E06.Z7*>6`F52^H!?P3I#*C/JRMT24W MO0EW$RZ%L;L<,V6LO?%)LQ)0V/N79,R_QAOQP8LA@RMC.KB1I)HKNH::4$)J M%K$)IZG7U1SU-#`=JAOJ@Y74)`"\2+P1#X"Z>OW\]1$7"?%A;([CB,\5, M&F_"W<3L0C">J/6MP)3-. M:A$IE$0@\*)2EYRAM:)[8IX8I":8:Q")DD7"-12<4P3\^7I)#$@955A"UL[J M4L7T-E'6%!@#5R_73&(QFOD4K9V(5DW%8V4;5JHA3:1"WL<=L(`,';"BL&Q" M$1U-,2X830&F6-R4(\K&TC+TQ(IHV=0\%-XJ"@7C[-A=A2=P7[UIR:IWG5BK MBV7C;2)7%2J#.%XI&V7-EI@5D;+)YSQ6WBIR0$'PXPXH:^:`%85E$XIHV2CJ M!:.IS(RDC>5G6#961,HFCW9YWHJ'`A?6R+D16QC=C8Y16#9L(:^=%1+CTJO(`4;F*PYX`*,?N_NU(@TRLYE) M0Q$IFY3!=>QV1O=#R]>):-&PC7'36T6!8-@=R9K4\[C/1UHRY*V=U<6BL3WI M.PT:107,8/%=R5G,9;4I4*L_+)JTXJSIK:)8,2Y?<<#CMR\:(\*Z<*(F#45T MNHIYP71U9C)]-SUT:Y-:?(8+R(IHW40KV%M%L5",Y-XAO@,WZ*E%+9+NUW%: M,>:MG16\\5:1J[8GH6X4,0-7KZ3-\C6,E16%=9/D;/_5I-Z*QTK=W'[<`6U- M%[D3!=,=\8)Q=R1N=#?:L[X@ MTHKA?^VL+I5-;Q-EC4'[*'&!HON*`)S#Z,=>HA1&% MN"$B6C:,KCHS(VZY%S%WG0@+Q"_?)&<7AZ:WB@(QB+N+F+M61`+Q+G<7BGD! M+G0@BGS,O8'NBBT@3]0@%@6_!KF&P@)2F`N\NU(4%HH!S!9&1&(1BFA1**8% MHZE8C+M-6E@ZAIY8$2F+@K&_<0WC4&2#L*JM:2ZL*`P%$9%09`RKEP.OK=EH M$CH+QJS&-12FR]!YQ0&[&0WBG1D1F6XHHM-E]%.93_.;X5?X+`:C$]'$\SUK M;\5YD#$PZA4ZPC-/S'`ILH>A:ST8,GGI(M+;1*XRJEY)6LS.S(JP1'MV%LS) MIK>*'!C$SBQFIQ61JGF7G1ECYY7I6A:&-6I$&"V<+M_KZ6%0C^8-5?BN(U,H M8\`:<0^LN]'+-W2#[?C6SNIB:1BVHGRBS"C\!:Y>B96%91@K*Z*EP9QL,F_% M'<@'\5-;4Z)9$>ZRT;6Y!R8B`I2<\5,MVG';4MT3\\2P5=WO!ZN$;TMM0^,O M=8ZQ=211<@_=WHVT8F!;.ZM+9=/;1%EC8+Y<-GE,7R>B9<.WI;U5Y`"C[Q4' M/&1=C:QS(PJ)0D0T,PR@/U$V,5QS*\(2"4@^FEKYH`!(HE$***1$.B7)-F8!U-EC#\GHOCCV\+>*JH*AC^5 MIQ%W7J6!(#WK4#$LK9T5%BZ&,4?F^'KM;2)7![%3G0E@[XR="&O4#Y_PMUU- M;Q4Y,(B=9GF15#$_ MG2@H]GP:!LHI!Z40T3GRO(UOU^P`:IT$XK6*<.A&-$[_2RE;]LPGJDP):<$-\ MI9XL_@+$5U9$XE3S^W_9JK\YICX-0FD5H]2)2)QJ_L)$MGK'IWH07;4U98H3 M!:NY+5/:/,Q<0U%*;+4#IRPU-[QH9N M,*"NG=6E#4]OP_<;]2#":FL6*P-==?@MB!5SLK$-814Y,`BG=8Q3*PKOH8B( M+DD&2I69<6\AZABB3D3+AE]L>JLH%(R88\O&H[3/2%HQ-]:UM;I8-MZ&NYK, M!Y'4F-/"\3($,JB<_JIK5EE@%CLQ"+#)W.(TN.XY65@]5$;*1S]D#B^T*D6C MGD:8GGA$#&;A3!@1OC-P38W/S+]!H$WF,6F=C$;$V(DC#H)M,K=H)3GPN$6& M7=9#&9NC0%?U:F_@T4/U=22_L?KNQ'FDR%Y;ELL$01$*[!@E"?=NIWW[%. M?_:I7\C&NE2UTP2.=0NE6\CC94JG$Q:WRY5.?]_)=36:X1(9SV!5Y\L5*!AK M<"U#&[FW`II";%-"HU^O1QY4T(CC5`@%[@4%#RH$`K=R@J9&V+'7DS0(.O9E MD@;C8%I<0://5:-GBJ)6D0-SQNDC2(&QX-21K$31QG M55;(CSP.(HH'+%)OJ%<\U1`T%>*&)Q"2!G'#_;^@*3`.'HI+&HR#1]."IL0X M>(PL:3`.'N)*&N0'CV4E#?*#AYV"ID`;O**2-&B#]T.2!IG#NQQ)@\SA)8ND M0>;PCD32('-X&R%H=`J:`K'&6TE)@UCC M=6&L666H*F`ZUN`4)0V\QOE@20.O<;Q7TL!KG*.5-*@W'(.5-*@W'#@5-!GJ#8=#8\TJ11;P M@46LP>'(O=0&,\7'$Y(&,\47 M"X)F@9GBZP))@^H5QUDE!38R8F_0-/C$4.@MP7S,L3A^W4[@-3[2D=K`:W&< M53I'%L2J@J8Q&U<^3HKYF,-@D0;5:^Y5(PVJ5QQGA23@2V#!:R$H> M!0VDGE2$);FB@R!?J5V1(%\KTDER."K&`_4HEB.J4?<_\QG'KY6\;I[:WS?' MI]WA-'EI'[&1G^O7K4?S>R?FCW/WB@T^?K.D.^-W2O3_/N.':5K\2`9^C&0Z M>>RZL_L#(9WYG[JY_S\```#__P,`4$L#!!0`!@`(````(0!QK@HKDP4``!<5 M```9````>&PO=V]R:W-H965T^K+/OYO2RL-UHW.:MV-IG-;8M6&3OFU7EG__4U^;2VK:9-JV-:L(KN[&^TL3_O M?_YI>V/U2W.AM+6`H6IV]J5MKX'C--F%EFDS8U=:P9L3J\NTA3_KL]-<:YH> M.Z>R<-SY?.F4:5[9G"&H'^%@IU.>T8AEKR6M6DY2TR)M(?[FDE\;R59FC]"5 M:?WR>OV4L?(*%,]YD;??.E+;*K/@R[EB=?I<@.YWXJ>9Y.[^,.C+/*M9PT[M M#.@<'JBI>>-L'&#:;X\Y*,"T6S4][>PG$B3NW';VVRY!?^?TUBC_MYH+N_U2 MY\??\HI"MJ%.6(%GQE[0],L1(7!V#.^DJ\`?M76DI_2U:/]DMU]I?KZT4.X% M*$)AP?%;1)L,,@HT,W>!3!DK(`#XURIS;`W(2/K>/6_YL;WL;&\Y6ZSF'@%S MZYDV;9(CI6UEKTW+RG^X$1%4G,05)/"<(+GCZ`E'>`I'LIBYZP59+/'S=SQ] MX0E/^Z_\6E<(2G<'2'1)F1.CS17=VBM$WWVYK= M+%@,D,KFFN+2(@%PR8)QAKZ$WZL@E`Y)GI!E9Z]L"XK30-N][5UOOG7>H%4R M81.:-D2W.$@+[`NDC<9`/`82!7!`42\+:O\_R$(6E"4#"B6@Z!QID!;2)1H# M\1A(%$#3`&TXUN#!BIQ>2[(2Z`2K1JO$*,\AMR%JN18C&;U)K\-`8@-)5$23 M`NMB+`6WA0]V&;)`G\+C3IL)HWOB>I->G('$!I*HB"8.A*CB[M<'C3L-\MLA M1USH`D65.ZI';R3=(@.)#211$2UD6.F/AXS&>L@"V?0+XV`@D8'$!I*HB!8? M5$^-#WZ(B6L@$-D(U9CZW9C@TVTN>O80,6@:&PT2N/9A/8FHAB:ZEXX7]4Q$C M(46-A#9\U,W)J('BP:"7HD&Z%AQB#_<'X2,/=D%)'0H(AH.$#B84"<@?K&(3 M2C1(#Q/GU.-A\JFFA!D4M>^2 M]?@,DD@;#S.EJ\/9I:C[L882`W"(/20<\D#5$+NWU#O_(*STB"0UM%TLN M+0_>2N=*I"-LKLH7U[V5+ANGFB)[8KW`T;=?,&(&JOHX!$4=>H]#6@4%U.6] M6WPQCG%8?-[`E0C(G:@.3C(ES!^K#A^'6DMR:%2=39\KOMWB405"U:HC'.$Q M)-EL26&UY"WI$G>]&9$GDGQIMB2.QSNBO[+K]_8XM69BR`YY#@F'M)IQ2*N9 M@-2:"<>!*Q%<4S7#>:B$_Q^M):;G0!WB`16W9^6884*1"<4FE&B0O@)P+#X> M)A^B6@]QR-=6N#_Z]7,@O95<)Y$)Q2:4:)`>.4['QR/GLU2+7$!J@@TH@OR/ MRA";4*)!6IAP'1LS?N,' M\'-C@FL1P)E^`E\&<):>P%(@.4[@+B9W"O0!^HT[P^\#/;[;Z2L"U MU#4]T]_3^IQ7C570$Y1^WITP:WZQQ?]HQ2[\S%JXD.HVY`M<0%*XOYCC+Y83 M8ZW\`[[L]%>:^W\!``#__P,`4$L#!!0`!@`(````(0!)M%,>?0,``&D,```9 M````>&PO=V]R:W-H965TGDUBP&H21[8I[=_OC.U&N0'A!<@P/L=S/,<,R[NW(G=> MJ9",ERLW]`+7H67*,U;N5NZ?WT\W,]>1BI09R7E)5^X[E>[=^O.GY9&+%[FG M5#F`4,J5NU>J6OB^3/>T(-+C%2WAFRT7!5'P*':^K`0EF5Y4Y'X4!(E?$%:Z M!F$AQF#P[9:E])&GAX*6RH`(FA,%^Y=[5LD/M"(=`U<0\7*H;E)>5`"Q83E3 M[QK4=8IT\;PKN2";'.I^"V.2?F#KAQY\P5+!)=\J#^!\L]%^S7-_[@/2>IDQ MJ`!E=P3=KMS[P(;S%TQ] MSC`$B_W>ZB=]`C^%D]$M.>3J%S]^HVRW5W#<$Z@("UMD[X]4IJ`HP'C1!)%2 MGL,&X-4I&+8&*$+>]/N196H/GV9>&`<)9#L;*M430T3720]2\>*?S;%(!B.R M&/!N,6X3;S(-;L/+(+[9CR[OD2BR7@I^=*!G@%)6!#LP7`#P<#U0".;>8_+* MG;H.[%7"(;RNHR1>^J\@7&IS'DP.O-8Y89WA`VG-#&SCF3$9F5%9W,J#"31I MHF&:VVMH,'GEPFN]^7Z!)B=NY$R&F2%E?(&8#&?0A.U3FZ1FS@EJ:*KQU)BL MJ6MQ;:2MPPFJY!HJ3&Y3V8BV;JL]H,N:):#ADMB#G9UO45S69K`1:)C&H2;# M1X;7]6@W8'*;RD;ZQ"J]H$)A*#"HU:IL.UA'#)C2]&9[?) M;"C6%V/3N2%Z?+1,.KN#;"^)OE`A^KH!K94*(F]Z\>#UR@Z-N20Z0O9^C[IGP0ZM0&MY8IF^!MTH;?PQZO3 M7#;4D6M^0JZK?!_VC6]#`W)UG'_A(/J&#TTH'I"KXV^4:Q*.::Z^UT,3:JLU M#4ZHU;D`+M34-WYHG=_K@.@JE^OLMDEL:$"MJ&/ST6KIA1T6X_B.6JWT]=>/QXA[@ MP?5^_0T,>A79T1]$[%@IG9QN`3/0;27,J&@>%*]`%9CWN((93W_$""^D_"^C\```#__P,`4$L#!!0`!@`(````(0"BB#G^M0(``&,' M```9````>&PO=V]R:W-H965T M/"DEBB\?RD8;MJW!]W,R8?S`[5].Z)7D1EM=N`CHXI#HJ>=%O(B!:;W*)3C` MLA,CBHQNDN7M@L;KE:_/3RGV]N@[L97>?S0R_RP;`<6&-F$#MEH_(O0AQQ`< MCD].W_L&?#4D%P7;U>Z;WG\2LJP<='L*AM#7,G^Y$Y9#08$F2J?(Q'4-"<"3 M*(F3`05AS_YS+W-7932=1Y-T.K].`$^VPKI[B9R4\)UU6OT*J*3C"BQIQP*? M'%H MOM%?/.>3Z,O<1885F9Q7G0U5_SU*"!Y*=9&QOXG'@P+S=N)F[&_:&W;PX%"C MB\#P'#7X+^W#W7WQS4#P4*J+I"=V%D->OTMF<)'?:@Z>&TITD:&;V:OFA*46 M[KP2IA0?1%U;PO4.%U8*M[B/]KMTX[-^'9\L-W['QOT/L.-:5HHOS)2RL:06 M!5".HCEX,6%+AA>G6\@<%IUVL-S\UPK^S`1,Y6)NDCQ M[U^/=Y\P,I;6&:U4S5/\S`V^7W[\L#@HO34EYQ8!0VU27%K;)(085G))3:`: M7L.;7&E)+2QU04RC.":654;@.@(S[0RYSG9$Z`:;G(!&3@RHXTSU.\BI+U#)/EHJW/'\$/9O", M3*D.7[3(OHF:0[&A3:X!&Z6V#OJ4N2TX3"Y./[8-^*%1QG.ZJ^Q/=?C*15%: MZ/8$$G)Y)=GS`S<,"@HT03QQ3$Q5$`!FSO!Y'9,L7Q*(C&X130 M:,.-?12.$2.V,U;)OQX3=4R>(^XXX-YQC*;!9!:.HO=)B(^G3>^!6KI<:'5` M8!F0-`UU!HP2(+Z>#R3BL"L'3O$,(XC50`_VRW@2+L@>"LLQX@)E<5P;([0DZ M,/1@2'LI[4%#S"O28*JAM'-K/'7.?*?![EP;15_G;N>\)*]T='JN^K:7'/A< MJML9M1_BT"E@N(MLYE"%MP7L,VCO2]OX$>"_$&PO=V]R:W-H965TU+57K/7&DAZX0$_HAXO$YE)NIM0O[\?KB9$4\;5F>L ME#5/R"O7Y';U^=-R+]63+C@W'C#4.B&%,%5; MJAO%668/524-1Z.85DS4Q#$LU#4<,L]%RN]ENJMX;1R)XB4SX+\N1*,/;%5Z M#5W%U-.NN4EEU0#%1I3"O%I2XE7IXG%;2\4V)<3]$DQ8>N"V+R?TE4B5U#(W M/M!1Y^AIS',ZI\"T6F8"(L"T>XKG"5D'B[L@(G2UM`GZ*_A>][Y[NI#[KTID MWT7-(=M0)ZS`1LHGA#YF:(+#].3T@ZW`3^5E/&>[TOR2^V]<;`L#Y8X@(@QL MD;W>+9%&@V7)L' M@9S$2W?:R.J?0P7H5<<2MBSPV;*,8S^:CL8!B%X@H` MI&X8]F"P`.+S$8$3B%TC."%3XH&O&LKPO`JCZ9(^0^K2%G/G,/#L,$&'H"#: M*8/:]^-/9K&&-O7B@PGK->='EN+<.4S,X''`]5W^\E!`^E6DMH MKV*_4Z#ACJ.))_[%8/#84*&U0._TZCL_'PS.[JLO!H*'4JWE-)CY1W@1/.1U MELF@\>/1^1`"&'37QV#10[&#Z32*`*]Y+SUV(@;1Y:+8@T911^IM9/C3$QXLWLQ7:!V=6I]LL%5=;_H67I?92N<.U M&,*NZ*S=RE[;$AS;)XNU6^6T^P56:<.V_`=36U%KK^0Y<(Y\7)W*+6/W8F0# MOL,JE`9VJ/U:P)\F#OMBA)V92VD.+U`TVOT-6_T'``#__P,`4$L#!!0`!@`( M````(0`F]),",@$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0!**`` M`0`````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````"& M>TOI%K.1EB5J=G*)B3,NWA"^K<1"":#=_KVLZ^J,GCR2]^7A^3[*Q5XWR2M`8J=`"/%NSZJA26BM;!HVLMN*#` M)Y%D/!6V0G4(EF+L10V:^RPV3`RWK=,\Q*/;8$PR@K^[`9SV?U[HDXNF5N%@XTR#[B5;BE,X MMO=>C<6NZ[)NTFM$?X(WJX>G?M14F>.N!"!VW$_#?5C%56X5R-L#V[^Y)O&^ M+O'OK)2BMZ/"`0\@D_@>/=F=DY?)W?UZB5B1DVF:%RF9K\F<3F=T.G\M\;DU MW&`:SW_OGG[`L``/__`P!02P,$%``&``@````A`/"G]+?Z`@`` M0`D``!``"`%D;V-0&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G%91;]HP$'Z?M/^`\MZ&EG::JI"*A7:=U!6T MT.[1,LX!'HZ=V0Z"_?J=DT$3,*SJ2^38=]]]]YW/=G2[SD5G!=IP)?O!Q7DW MZ(!D*N-RW@^>)_=GGX..L51F5"@)_6`#)KB-/WZ(QEH5H"T'TT$(:?K!PMKB M)@P-6T!.S3DN2UR9*9U3B[]Z'JK9C#,8*E;F(&UXV>U^"F%M06:0G14[P*!& MO%G9]X)FBCE^YF6R*9!P'`V*0G!&+689?^=,*Z-FMG.W9B"BL+D8(;L46*FY MW<3=*&S^1BFC`A($CF=4&(C"UXGH`:@3;4RY-G&TLC]>5!8[: ME@ZA9H(+;8X3;@68T6Q,M?50[ETW.5X-TJ0P:HPU>%6\`;)2WSG.J-\QDPIDH43,[)&.5@ MV$)>ET=%I2'W6N7D!XA*-%>JH^9<5I02#1FW7L0A3%$-1WU,-W0J_((\*F0V M`9T3M/<#):76>$QLR"#[51KK-/8&O.=K+/7`F+W-O%,R47FN)$FM8DLOPI.2 M6""KE1!.L&_2@@;CCY;0@ELJL.$R\@C8;F0T%7Q>U\>+WM1U0R8:!:?,'1)> MZ[2<&OA=8K+D;H5??]E.5_K"B]R6G$Q<;?SH345/V>TA#L%2+MX`>N_PN?+Z'&\P\D2UWZ759,[,M?\*L%508*_+0=.UO+PN>\5[ M2Y1F([4"'*_[R78A7F)'^Z4*Z74Y:)H6NZ9+ZZK:NYP>N5R:YV*BAG@.;F_? M]F24+B@>?7@O;==?)Z('O'@UGB!+DRRHG$.VM3E<<&^%E_I!%%]&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$` MRX"_F8(#```/"P``#P````````````````!>"@``>&PO=V]R:V)O;VLN>&UL M4$L!`BT`%``&``@````A`/E1+C>X!@``1QL``!@`````````````````#0X` M`'AL+W=O MUP0```L4```9`````````````````/L4``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`(F\+I&!`P``Y0L``!D````````````` M````"1H``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`._Z0TBK`@``S@8``!D`````````````````=R0``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%B7 M-703!0``C!4``!D`````````````````DBT``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*N3V!+T!0``R1<``!@` M````````````````NSH``'AL+W=O&PO&PO M,``!X;"]T:&5M92]T:&5M93$N>&UL4$L!`BT`%``&``@````A M`#_&/+YA!@``?R```!D`````````````````S)(``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)1RVO5B M!0``(!4``!D`````````````````7ZD``'AL+W=O&PO=V]R:W-H965TDVT9`"``"5!@``&``````` M``````````#WM```>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`#XK`*2E#```^40``!@`````````````````O;<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%G+&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`$FT4QY]`P``:0P``!D`````````````````J>\``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`%TH1JD@`P``RPD``!D`````````````````#/D``'AL+W=O XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capitalized Lease Obligations (Narrative) (Details)
 1 Months Ended 1 Months Ended 0 Months Ended
Feb. 29, 2012
Tea Estate
USD ($)
acre
Apr. 30, 2012
Tea Estate
USD ($)
Feb. 29, 2012
Tea Estate
South Africa, Rand
ZAR
Apr. 30, 2012
Tea Estate
South Africa, Rand
ZAR
Mar. 01, 2012
Office Space
Director of Dunn Roman Holding, Ltd
USD ($)
Lease period 49 years       10 years
Land area 8,000        
Lease terms

Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend.

        
Lease rent due in April 2012   $ 2,610   20,883  
Monthly rent $ 30,000   250,000   $ 2,500

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Accounting Policies (Property And Equipment) (Narrative) (Details)
 6 Months Ended
Dec. 31, 2013
Minimum
  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 3 years
Maximum
  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 5 years
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line Of Credit
 6 Months Ended
Dec. 31, 2013
DisclosurePrepaidExpensesAbstract  
Line of Credit

NOTE 4 - LINE OF CREDIT

 

During the year ended June 30, 2012, the company entered into a line of credit agreement for $500,000 which was later increased to $1,000,000. The line of credit matures on January 5, 2014 and bears interest at the rate of ten percent (10%) per annum. As of December 31, 2013, the balance drawn down on the credit line was $777,503 and accrued interest was $115,852. On December 31, 2013, the company converted the balance outstanding plus accrued interest into 5,000,000 shares of restricted common stock.
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R M.6%F-61E,68B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O5]/9E]!8V-O=6YT:6YG7U!O;&EC:65S M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D1E8F5N='5R95]087EA8FQE/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K5]!9&IU#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I;VX\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-U;6UA#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D9I>&5D7T%S#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]/9E]!8V-O=6YT:6YG M7U!O;&EC:65S-#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DQO86YS7T9R;VU?4F5L871E9%]087)T:65S7TYA#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DQI;F5?3V9?0W)E9&ET7TYA M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E8F5N='5R95]087EA8FQE7TYA#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQO;F=?5&5R;5]$96)T M7TYA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UO;E]3=&]C:U].87)R871I=F5?1&5T86EL#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I;VY?3F%R#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I!8W1I=F53:&5E=#X- M"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM M/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@ M8F4@;W!E;F5D('=I=&@@36EC'1087)T7SAE M-F0Y,C0R7V,Y,C)?-&4P,%]A.#0W7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)U!L86YD86D@0FEO=&5C:&YO;&]G>2P@26YC+CQS<&%N M/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)S`P,#$S,3'0^1&5C M(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3QS<&%N/CPO2!# M;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)S(P,30\3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T M-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO2!296-E:79A8FQE M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E2!087EA8FQE'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D($QE87-E($]B;&EG M871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPOF5D(#4P,"PP M,#`L,#`P('-H87)E2!!;&QO8V%T960@=&\@4&QA;F1A M:2!":6]T96-H;F]L;V=Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@U+#8Y."PP,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPOF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D M.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!4'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!43PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@Q-#0L,S(P*3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!&:6YA;F-I;F<@06-T:79I=&EE M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&IUF%T:6]N M(&]F(&%S2!A9&IU2!B M92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N+CPO<#X- M"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GDG2!T;R!C;VYT:6YU92!T;R!E M>&5C=71E(&ET2X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M6EE;&0@:&EG:&QY(&)I;V%V86EL86)L92!P'0M86QI9VXZ(&IU28C,30V.W,@86YN=6%L(')E<&]R="!F M;W(@=&AE('EE87(@96YD960@2G5N92`S,"P@,C`Q,R!P2!F;W(@82!F86ER M('-T871E;65N="!O9B!T:&4@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&(^3W)G86YI>F%T:6]N(#PO8CX\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2P@=&AR;W5G:`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`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M M86QI9VXZ(&IU28C,30V.W,@ M9FEN86YC:6%L('-T871E;65N=',@:&%V90T*8F5E;B!P2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E6EN9R!F:6YA M;F-I86P@7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`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`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A;F0@ M97%U:7!M96YT(&%R92!S=&%T960@870@8V]S="!L97-S#0IA8V-U;75L871E M9"!D97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;BXF(S$V,#LF(S$V,#M4 M:&4@0V]M<&%N>2!P2!A'1E;F0@=&AE('5S969U;"!L:69E M(&]F(&%N(&%S2!A;F0@97%U:7!M96YT+"!T:&4@8V]S="!A;F0@6EN M9R!A;6]U;G0@;V8@=&AE2!N;W0@8F4@9G5L;'D@'0M M86QI9VXZ(&IU2!D:79I9&EN9R!T:&4@ M;&]S2!H860@;VYE(&-O;G9E2!A8V-O=6YT M&5S('5N9&5R#0I!4T,@5&]P:6,@-S0P+"!F;W)M M97)L>2!31D%3($YO+B`Q,#DL(#QI/D%C8V]U;G1I;F<@9F]R($EN8V]M92!4 M87AE2!!4T,@5&]P:6,@-S0P+"!F;W)M M97)L>2!&05-"($EN=&5R<')E=&%T:6]N#0I.;RX@-#@L(#QI/D%C8V]U;G1I M;F<@9F]R(%5N8V5R=&%I;G1Y(&EN($EN8V]M92!487AE"!A6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU2`Q+"`R,#`W+B!02!H860@ M86-C;W5N=&5D(&9O2!!4T,@5&]P:6,@-#4P+"!F;W)M97)L>2!& M24X@3F\N(#0X+`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`[/"]P/@T*#0H\<"!S='EL93TS1"=C;VQO28C,30X.R!U;F1E2P@=V4@8V%N(&1E;&%Y('1H92!A9&]P=&EO;B!O9B!C97)T86EN M(&%C8V]U;G1I;F<@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU28C,30V.W,- M"F9I;F%N8VEA;"!I;G-T&EM871E(&-O'!A;F1S(&1I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M5F%L=6%T:6]N('1E8VAN:7%U97,@87)E(&=E;F5R86QL>2!C;&%S2!R97%U:7)E('-I9VYI9FEC86YT(&IU M9&=M96YT(&%N9"!A2P-"F%N M9"!T:&4@<75A;&ET>2!A;F0@879A:6QA8FEL:71Y(&]F(&EN<'5T&EM:7IE('1H92!U2!F;W(@:6YP=71S(&%N9"!R97-U;'1I;F<-"FUE87-U6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU3L@86YD M(&EN<'5T2!A;F0@ M=&AA="!A6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1F%I2!P6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6EN9R!F:6YA M;F-I86P@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`U,"4G M/D-A;FYA8FES($)I;W-C:65N8V5S+"!);F,N/"]T9#X-"B`@("`\=&0@2!0;&%N9&$F(S(S-SL@ M0FEO=&5C:&YO;&]G>2P@26YC+CPO=&0^/"]T71O($YU=')I8V%R92P@ M26YC+CPO=&0^#0H@("`@/'1D/C$P,"4@;W=N960@8GD@4&QA;F1A)B,R,S<[ M($)I;W1E8VAN;VQO9WDL($EN8RX\+W1D/CPO='(^#0H\='(@71O M(%!H87)M86-A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU2!B M>2!0;&%N9&$F(S(S-SLN($%L;"!L:6%B:6QI=&EE65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^06QL(&EN=&5R8V]M<&%N>2!B86QA;F-E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^4&QA;F1A)B,R,S<[ M)B,Q-#8[F5D($QE87-E($]B;&EG871I;VXN($%S(&]F($1E8V5M M8F5R(#,Q+"`R,#$S+"!T:&4@86UO=6YT(&]F('1H:7,@9&5F97)R960@;&EA M8FEL:71Y#0IW87,@)#$L,3@R+#(Q-RX\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&IU3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P M7V$X-#=?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^07,@;V8@1&5C96UB97(@,S$L M(#(P,3,L('1H92!#;VUP86YY(&AA9"!O=71S=&%N9&EN9PT*;&]A;G,@9G)O M;2!I=',@0VAI968@17AE8W5T:79E($]F9FEC97(@:6X@=&AE(&%M;W5N="!O M9B`D-#@R+#DU."X@5&AE2`Q+"`R,#$T+B!3=6)S97%U96YT('1O('EE87(@96YD+"!T:&4@;&]A M;G,@=V5R92!C;VYV97)T960@:6YT;R`R+#`S-BPP,#`-"G-H87)E2X\+W`^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T M,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA'!E;G-E'0^)SQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y M96%R(&5N9&5D($IU;F4@,S`L(#(P,3(L('1H92!C;VUP86YY#0IE;G1E2!C;VYV97)T960@=&AE M(&)A;&%N8V4@;W5T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]412`U("8C M,34P.R!$14)%3E154D4@4$%904),13PO8CX\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B/CPO M<#X-"@T*/'`@2!R97!A:60@=&AE(&1E M8F5N='5R92!I;B!F=6QL(&]N($YO=F5M8F5R(#$Q+"`R,#$S+CPO<#X-"@T* M/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^3VX@075G=7-T(#(P+"`R,#$S+"!T:&4@0V]M<&%N>2!E>&5C=71E M9"!T=V\-"F-O;G9E7,@9G)O;2!I6%B;&4@=VET:&]U="!I;F-U6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@3F]V96UB M97(@,3,L(#(P,3,L('1H92!#;VUP86YY(&5X96-U=&5D#0IA(&-O;G9E"!M;VYT:',N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU2!H87,@0T*;V8@)#(L,3,Q+#8V,R!R M97!R97-E;G1I;F<@=&AE(&5S=&EM871E('9A;'5E(&]F('1H92!S:&%R97,@ M;W9E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^ M)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU28C,30X M.R!I;B!W:&EC:`T*;F\@<&%Y;65N=',@;W(@:6YT97)E0T*=&\@<')O9FET M&-L=7-I=F4@ M;V8@;W!E2!W87D@;V8@;&]A;@T*8V]V96YA;G1S+"!T:&4@ M8F]R2!C;W9E'0M M86QI9VXZ(&IU&5D(&%S65D(&EN(%-O=71H M($%FFEN9R!O9B!P;&%N=&%T:6]N+CPO<#X-"@T*/'`@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y M96%R(&5N9&5D($IU;F4@,S`L(#(P,3(L('1H92!#;VUP86YY#0II&-H86YG92!F;W(@2!W:71H('1H92!"144-"G!R;W9I2!H87,@=&AE6UE;G0-"F]F('1H92!L;V%N(&-O;6UE;F-E'0M86QI9VXZ(&IU M'0M86QI9VXZ(&IU6QE M/3-$)W=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%PF4Z(#$P<'0G/@T*/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)W=I M9'1H.B`Q,"4G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,36QE M/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXY+#@S-2PW.3$\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE M/@T*/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M2!C=7)R96YC>2!U&-H86YG M92!R871E(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S(&%P<&QI960@=&\@=&AE M(&)A;&%N8V4@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X M-#=?-S'0O:'1M;#L@8VAA&5D($%S&5D M($%S'0^)SQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]412`X M("8C,34P.R!&25A%1"!!4U-%5%,\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,38N-7!T.R!P861D:6YG M+6QE9G0Z(#$V+C5P=#L@=VED=&@Z(#6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)V)A8VMG'0M86QI M9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V)A8VMG&5D($%S'0M86QI9VXZ(&QE9G0G/B0\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SXX+#(Q,BPX.3D\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG M+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^1&5P2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'!E;G-E(&9O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R M7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O M:'1M;#L@8VAA'0M86QI9VXZ M(&IU6QE/3-$)VUA#L@9F]N="US:7IE M.B`Q,'!T.R!M87)G:6XM8F]T=&]M.B`P<'@[('=I9'1H.B`Q,#`E)SX-"CQT M6QE/3-$)VUA M#L@9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM8F]T=&]M M.B`P<'@[('=I9'1H.B`Q,#`E)SX-"CQT6QE/3-$)VUA#L@9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM8F]T=&]M.B`P<'@[('=I M9'1H.B`Q,#`E)SX-"CQT'1087)T7SAE M-F0Y,C0R7V,Y,C)?-&4P,%]A.#0W7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&(^)B,Q-C`[/"]B/CPO<#X-"@T*/'`@2UO=VYE9"!S=6)S:61I87)I97,L('1H870@<&]R=&EO;B!O M9B!S=6)S:61I87)Y(&YE=`T*97%U:71Y(&%T=')I8G5T86)L92!T;R!T:&4@ M;F]N+6-O;G1R;VQL:6YG(&]W;F5R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]412`Q,2`F(S$U,#L@0T%0251!3$E:140@ M3$5!4T4@3T),24=!5$E/3E,\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^26X@ M1F5B65A2!E:6=H="!T:&]U2!I M2!W:71H(&$@4C4P,"PP,#`@*"0V,"PP,#`I(&%N;G5A;"!M:6YI;75M(&1I M=FED96YD+B!4:&4@9FER65A6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^0F]T:"!O9B!T:&5S92!L96%S97,@ M96ET:&5R(&AA=F4@97-C86QA=&EN9PT*=&5R;7,@;W(@:6YC;'5D960@2!!8V-E<'1E9"!!8V-O=6YT:6YG(%!R:6YC:7!L97,L('1H92!#;VUP86YY M(&AAF5D($QE M87-E#0I/8FQI9V%T:6]N+B!!3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P M7V$X-#=?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^26X@861D:71I;VX@=&\@=&AE(&QO86YS M('!A>6%B;&4@86YD(')E8V5I=F%B;&5S#0IA6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ M(&IU2!L96%S97,@:71S(%-O M=71H($%F2!O9B!T:&4@0V]M<&%N>2X@5&AE M(&QE87-E(&%G2!P87EM96YT6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^4'5R&5C=71E M9"!A9W)E96UE;G0@=VAI8V@@=V%S("0P+C`V('!E'!E;G-E(&9O3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E M,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU&ES=`T*=&AR;W5G:"!T:&4@9&%T92!O9B!T:&ES(&9I;&EN9RX\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\;VP@7!E.B!D96-I M;6%L.R!M87)G:6XM=&]P.B`P:6XG/@T*#0H\;&D@&-H86YG92!#;VUM:7-S:6]N+B!4:&4@0V]M<&%N>2!R M96-E:79E9"`D,S`P+#`P,"!I;B!P&-H86YG92!F;W(@-#@P+#`P,"!S:&%R97,@;V8@&5C=71I;VX@;V8@ M=&AE('-T;V-K('!U'0M86QI9VXZ(&IUF4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU2!G M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P M<'0[('1E>'0M86QI9VXZ(&IU2`V+"`R,#$T+"!T:&4@0V]M<&%N>2!R971I28C,30V M.W,@8VAI968@97AE8W5T:79E(&]F9FEC97(@:6X@97AC:&%N9V4@9F]R(#(L M,#,V+#`P,"!S:&%R97,@;V8@2DL M($QT9"X\+VQI/@T*#0H\+V]L/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&-H86YG92!F;W(@8V%S:"!P6%B;&4@2G5N92`S,"P@,C`Q-2X\ M+VQI/@T*#0H\+V]L/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!/9B!!8V-O=6YT:6YG(%!O;&EC:65S(%!O;&EC:65S/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`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`S M-C`L(&9O28C,30V.W,@86)I;&ET>2!T M;R!R96-O=F5R('1H92!C87)R>6EN9R!V86QU92!O9B!I=',@87-S971S(&)A M2!I'0M86QI M9VXZ(&IU2!D:79I9&EN9R!T:&4@;&]S M2!H860@;VYE(&-O;G9E'0^)SQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5S(#PO8CX\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU&5S+#PO:3X@87,@8VQA"!B87-E M"!R871E'!E M8W1E9"!T;R!R979EF5D+CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@861O<'1E9"!T:&4@<')O=FES:6]N M"!C;VYT:6YG96YC:65S(&EN(&%C8V]R9&%N8V4@ M=VET:"!3=&%T96UE;G0-"F]F($9I;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD M87)D2!R96-O9VYI>F5S('1H92!F:6YA;F-I M86P@2!A M9G1E2!T:&%N(&YO="!S=7-T86EN('1H92!P M;W-I=&EO;B!F;VQL;W=I;F<@86X@875D:70N($9O0T*1DE.($YO M+B`T."!T;R!A;&P@=&%X('!O2!&24X@3F\N(#0X+"!T:&4@0V]M<&%N>2!D:60@;F]T(')E8V]G;FEZ M92!A;GD@8VAA;F=E(&EN('1H92!L:6%B:6QI='D@9F]R('5N2!I&-E<'1I;VYS+"!T:&4@0V]M<&%N>2!I"!E>&%M:6YA=&EO;G,@8GD@=&%X(&%U=&AO65A2!I2!A;GD@9F5D97)A;"!O28C,30V.W,@<&]L:6-Y(&ES('1O(')E8V]R M9"!T87@M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V-O;&]R.B`C,#$P,3`Q.R!F;VYT.B`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`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'!E;G-E9"!A'0M86QI9VXZ M(&IU2P@26YC+B!A;F0@:71S#0IS=6)S:61I87)I97,L(&%R92!E;F-O;7!A'0M86QI M9VXZ(&IU6QE/3-$)W=I9'1H M.B`Q,#`E.R!B;W)D97(M8V]L;&%PF4Z M(#$P<'0G/@T*/'1R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I M9'1H.B`U,"4G/C$P,"4@;W=N960@8GD@4&QA;F1A)B,R,S<[($)I;W1E8VAN M;VQO9WDL($EN8RX\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG2!0;&%N9&$F M(S(S-SL@0FEO=&5C:&YO;&]G>2P@26YC/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG2D@3'1D+CPO=&0^#0H@("`@/'1D/C2!$=6YN(%)O M;6%N($AO;&1I;F=S+4%F'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y96%R(&5N9&5D($IU;F4@,S`L(#(P M,3,L('1H92!#;VUP86YY#0ID971E2P@ M1VQO8F%L($5N97)G>2!3;VQU=&EO;G,L('=A2!T;R!O M<&5R871I;VYS(&%N9"!D96-I9&5D('1O(&1I2!3;VQU M=&EO;G,@9'5R:6YG('1H92!P97)I;V1S('!R97-E;G1E9"X@1VQO8F%L($5N M97)G>2!3;VQU=&EO;G,-"G=A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^4&QA;F1A)B,R M,S<[)B,Q-#8[F5D($QE87-E($]B;&EG871I;VXN($%S(&]F($1E M8V5M8F5R(#,Q+"`R,#$S+"!T:&4@86UO=6YT(&]F('1H:7,@9&5F97)R960@ M;&EA8FEL:71Y#0IW87,@)#$L,3@R+#(Q-RX\+W`^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^06QL(')E M8V5N="!A8V-O=6YT:6YG('!R;VYO=6YC96UE;G1S(&ES7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^ M)SQS<&%N/CPO'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`W,24G M/DQO86X@4')I;F-I<&%L/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(')I9VAT M)SXU.#4L,#`P/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T M,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA&5D($%S&5D($%S&5D($%S'0^)SQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1FEX960@87-S971S+"!S=&%T M960@870@8V]S="P@;&5S6QE/3-$ M)W=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%PF4Z(#$P<'0G/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE M/3-$)V)O6QE/3-$)V)A M8VMG&5D($%S6QE/3-$)W=I9'1H.B`Q,"4G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,36QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M:6YD96YT.B`M,38N-7!T M.R!P861D:6YG+6QE9G0Z(#$V+C5P="<^3&5S'0M86QI9VXZ(')I9VAT)SXH,C`X+#DS,3PO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F6QE/3-$)W1E>'0M:6YD96YT.B`M M,38N-7!T.R!P861D:6YG+6QE9G0Z(#$V+C5P="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)W!A9&1I;F7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA&5D($%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO&5D($%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T M93`P7V$X-#=?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)T=L;V)A;"!%;F5R9WD@4V]L=71I;VYS+"!);F,N("@B1T53(BDL(&%N($ER M:7-H(&-O'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E M,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO M2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M'0^)SQS<&%N/CPO2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!? M83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!0;&%N9&%I($)I;W1E M8VAN;VQO9WD@26YC/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!0;&%N9&%I($)I;W1E8VAN;VQO9WD@ M26YC/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`N,#`E/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^)SQS<&%N/CPO2!0;&%N9&%I($)I;W1E8VAN M;VQO9WD@26YC/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,BXP M,"4\'0^)SQS<&%N/CPO2D@3'1D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO2!$ M=6YN(%)O;6%N($AO;&1I;F=S+4%F3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F M-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)? M8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M&5C=71I=F4@3V9F:6-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!? M83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\X939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E M,68-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR M,E\T93`P7V$X-#=?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6%B;&4@*$YA2`S,2P@,C`Q,SQB2!.;W1E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M28C M,30V.W,@8V]M;6]N('-T;V-K('-I>"!M;VYT:',@869T97(@:7-S=6%N8V4@ M*$YO=F5M8F5R(#(P,3,I+CPO<#X\'0^)SQS<&%N/CPO'0M86QI9VXZ(&IU'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQP('-T>6QE/3-$)VUA M2!I;G1E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2D@3'1D/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB2D@3'1D/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@ M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S<@>65A'0^)SQS<&%N/CPO&5C=71E9"!T:')O=6=H/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T=R965N($=O;&0@0FEO=&5C:&YO;&]G:65S("A0='DI($QT9"!A;F0@ M0G)E86MW;V]D(%1R861I;F<@,C(H4'1Y*2!,=&0\'0^)SQS<&%N/CPO'0^)SQP('-T M>6QE/3-$)VUA28C,30X.R!I;B!W:&EC:"!N;R!P87EM M96YT'1E;F1S('1H2!T;R!P2!$=6YN M(%)O;6%N($AO;&1I;F=S#0IE>&-L=7-I=F4@;V8@;W!E'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0M M86QI9VXZ(&IU2!O9B!L;V%N(&-O=F5N86YT'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2G5N(#,P+`T*"0DR M,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X M939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=? M-S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAAF5D($QE87-E($]B;&EG871I;VYS("A.87)R871I=F4I M("A$971A:6QS*3QB'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO2!I2!W:71H(&$@4C4P,"PP,#`@*"0V,"PP,#`I M(&%N;G5A;"!M:6YI;75M(&1I=FED96YD+CPO<#X\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!R96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,P+#`P,#QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X M939D.3(T,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=? M-S'0O:'1M;#L@8VAA2!4 M6UE;G0@06=R965M96YT'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQP('-T>6QE/3-$)VUA2!T:&4@0V]M<&%N>2!W:71H('1W;R!O9B!I M=',@;V9F:6-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5C M=71I=F4@3V9F:6-E&5C=71I;VX@;V8@'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`T+"`R M,#$T+"!T:&4@0V]M<&%N>2!E>&5C=71E9"!A;B!S=&]C:R!P=7)C:&%S92!A M9W)E96UE;G0@:6X@=&AE(&%M;W5N="!O9B`D,34L,S`P+#`P,"!W:&EC:"!P M97)M:71S#0IT:&4@0V]M<&%N>2!T;R!S96QL('-H87)E'0^)SQS<&%N/CPO2!A;F0@=')A9&4@ M;F%M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X939D.3(T M,E]C.3(R7S1E,#!?83@T-U\W-S4R.6%F-61E,68-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&4V9#DR-#)?8SDR,E\T93`P7V$X-#=?-S&UL#0I#;VYT96YT+51R86YS M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z M('1E>'0O:'1M;#L@8VAA&UL;G,Z M;STS1")U XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line Of Credit (Narrative) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Jun. 30, 2013
Jun. 30, 2012
Line Of Credit
Dec. 31, 2013
Line Of Credit
Line of Credit Facility [Line Items]        
Line of credit available at the time of entering into agreement     $ 500,000  
Line of credit increase during the period     1,000,000  
Line of credit maturity date     Jan. 05, 2014  
Interest rate on line of credit     10.00%  
Accrued interest 12,472 93,184   115,852
Line of credit    $ 752,503   $ 777,503
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Loans From Related Parties (Narrative) (Details) (USD $)
 6 Months Ended
Dec. 31, 2013
Jun. 30, 2013
Dec. 31, 2013
Loans From Related Parties - Chief Executive Officer
Debt Instrument [Line Items]      
Debt instrument interest rate, minimum     8.00%
Debt instrument interest rate, maximum     10.00%
Debt instrument maturity date     Jan. 01, 2014
Loans from Related Parties $ 482,958 $ 501,518 $ 482,958
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debenture Payable (Narrative) (Details) (USD $)
 1 Months Ended 0 Months Ended 0 Months Ended
Dec. 31, 2013
Jun. 30, 2013
May 31, 2013
Convertible Notes Payable
Aug. 20, 2013
Two Convertible Promissory Notes
Dec. 31, 2013
Two Convertible Promissory Notes
Nov. 13, 2013
Convertible Promissory Note - November 13, 2013
Debt Instrument [Line Items]            
Debt instrument face amount     $ 103,500 $ 550,000   $ 113,500
Debt instrument interest rate     8.00% 8.00%   10.00%
Debt instrument conversion terms    

The debenture is convertible into common stock of the company at a discount of 42% off the market price of the company’s common stock six months after issuance (November 2013).

    

At the holder’s option, the unpaid principal and interest can be converted into common stock at a 42% discount to market after six months.
Debt instrument maturity description     February 2014      
Debt instrument term       6 months   12 months
Debt repayment terms      

During the first 90 days from issuance, the notes are repayable without incurring any interest charges.

    
Convertible note payable 323,480 103,500     210,000  
Prepaid interest           $ 10,000
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long Term Debt (Narrative) (Details)
 1 Months Ended 3 Months Ended
Dec. 31, 2013
USD ($)
Jun. 30, 2012
Loan - Land And Agriculture Bank Of South Africa
USD ($)
Dec. 31, 2013
Loan - Land And Agriculture Bank Of South Africa
Green Gold Biotechnologies (Pty) Ltd
USD ($)
Dec. 31, 2013
Loan - Land And Agriculture Bank Of South Africa
Breakwood Trading 22 (Pty) Ltd
USD ($)
Jun. 30, 2012
Loan - Land And Agriculture Bank Of South Africa
South Africa, Rand
ZAR
Dec. 31, 2013
Loan From Unrelated Third Party
USD ($)
Debt instrument face amount   $ 13,000,000     100,000,000 $ 250,000
Interest rate on loan   Prime plus 0.50 % per annum        
Loan duration   7 years        
Loans executed through   Green Gold Biotechnologies (Pty) Ltd and Breakwood Trading 22(Pty) Ltd        
Loan description  

In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa.

        
Loan covenants description  

By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.

        
Amount drawn against loan $ 10,420,791   $ 8,128,526 $ 2,431,615    
Debt instrument interest rate           6.00%
Debt instrument maturity date           Jun. 30, 2015
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Loans From Related Parties
 6 Months Ended
Dec. 31, 2013
Loans From Related Parties  
Loans From Related Parties

NOTE 3 –LOANS FROM RELATED PARTIES

 

As of December 31, 2013, the Company had outstanding loans from its Chief Executive Officer in the amount of $482,958. These loans were provided for short-term working capital purposes, bear interest at rates between 8-10%, and mature on January 1, 2014. Subsequent to year end, the loans were converted into 2,036,000 shares of restricted common stock of the Company.
XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock (Narrative) (Details) (USD $)
 6 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Restricted Common Stock
Dec. 31, 2013
Restricted Common Stock
Line Of Credit
Stock issued during period for cash, shares     50,000  
Proceeds from sale of common stock $ 15,000    $ 15,000  
Cancellation of shares issued for services, shares     250,000  
Stock issued in conversion of debt, shares       5,000,000
Stock issued in conversion of debt, value       $ 907,503
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2013
Jun. 30, 2013
Current Assets:    
Cash $ 131,545 $ 498,917
Inventory 3,769 6,439
Accounts Receivable 7,007 13,638
Related Party Receivable     
Total Current Assets 142,321 518,994
Deposits 15,522 10,649
Other Assets 361,138 380,929
Fixed Assets – Net 8,212,899 7,924,910
Total Assets 8,731,880 8,835,482
Current Liabilities:    
Accounts Payable and Accrued Expenses 209,810 516,007
Accrued Interest 12,472 93,184
Convertible Note Payable 323,480 103,500
Derivative Liability 2,131,663 45,227
Related Party Payables 1,501 145,822
Total Current Liabilities 2,678,926 903,740
Loans from Related Parties 482,958 501,518
Credit Line    752,503
Capitalized Lease Obligation 1,182,217 988,381
Long Term Debt, Net of Discount 10,085,791 9,173,702
TOTAL LIABILITIES 14,429,892 12,319,844
STOCKHOLDERS' DEFICIT    
Common Stock, authorized 500,000,000 shares, par value $0.0001, 111,070,760 and 106,270,760 shares issued and outstanding as of December 31, 2013 and June 30, 2013 11,108 10,628
Additional Paid-In Capital 8,755,999 7,833,976
Stock Payable 1,056,600 261,600
Retained Deficit (14,592,562) (10,903,813)
Cumulative Foreign Currency Translation Adjustment 282,939 169,437
Total Stockholders' Deficit (4,485,916) (2,628,172)
Non-controlling Interest (1,212,096) (856,190)
Equity Allocated to Plandai Biotechnology (5,698,012) (3,484,362)
Total Liabilities and Stockholders' Deficit $ 8,731,880 $ 8,835,482
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature Of Operations And Going Concern
 6 Months Ended
Dec. 31, 2013
Nature Of Operations And Going Concern  
Nature Of Operations And Going Concern

NOTE 1 - NATURE OF OPERATIONS AND GOING CONCERN

 

Plandaí Biotechnology, Inc.’s (the “Company” or “Plandaí”) consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustment relating to recoverability and classification of recorded amounts of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company's continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company.

 

Plandaí and its subsidiaries focus on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. The company grows much of the live plant material used in its products on a 3,000 hectare estate it operates under a 49-year notarial lease in the Mpumalanga region of South Africa. Plandaí uses a patented extraction process that is designed to yield highly bioavailable products of pharmaceutical-grade purity. The first product to be brought to market is Phytofare™ Catechin Complex, a green-tea derived extract that has multiple potential wellness applications. The company’s principle holdings consist of land, farms and infrastructure in South Africa. The Company is actively pursuing additional financing and has had discussions with various third parties, although no firm commitments have been obtained. Management believes these efforts will generate sufficient cash flows from future operations to pay the Company's obligations and realize positive cash flow. There is no assurance any of these transactions will occur.

 

These financial statements should be read in conjunction with the Company’s annual report for the year ended June 30, 2013 previously filed on Form 10-K. In management’s opinion, all adjustments necessary for a fair statement of the results for the interim periods have been made.  All adjustments made were of a normal recurring nature.

 

Organization

 

On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (“GES”), an Irish corporation. Under the terms of the share exchange, GES received 76,000,000 shares of the Company’s common stock that had been previously issued to Plandaí in exchange for 100% of the issued and outstanding capital of GES. Concurrent with the share exchange, the Company sold its subsidiary, Diamond Ranch, Ltd., together with its wholly-owned subsidiary, Executive Seafood, Inc., to a former officer and director of Diamond Ranch. Under the terms of the sale, the purchasers assumed all associated debt as consideration. During the three months ended September 30, 2011 and through the date of the share exchange, Diamond Ranch, Ltd. and Executive Seafood, Inc. had negligible revenues from operations, generated a net loss of $126,000, and as of September 30, 2011, liabilities exceeded assets by over $5,000,000. The Company subsequently changed its name to Plandaí Biotechnology, Inc. and dissolved GES.

 

For accounting purposes, the share exchange has been treated as a reverse merger since the acquired entity now forms the basis for operations and the transaction resulted in a change in control, with the acquired company electing to become the successor issuer for reporting purposes. The accompanying financial statements have been prepared to reflect the assets, liabilities and operations of Plandaí Biotechnology, Inc. exclusive of Diamond Ranch Foods since the acquisition and sale were executed simultaneously. For equity purposes, the shares issued to acquire GES (76,000,000 shares) have been shown to be issued and outstanding since inception, with the previous balance outstanding (25,415,300 shares Common) treated as a new issuance as of the date of the share exchange. The additional paid-in capital and retained deficit shown are those of Plandaí and its subsidiary operations.

 

In management’s opinion, all adjustments necessary for a fair statement of the results for the presented periods have been made.  All adjustments made were of a normal recurring nature.

 

Basis of Presentation

 

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements represent the consolidated results of operations for the three and six months ended December 31, 2013.
XML 26 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Narrative) (Details) (USD $)
 6 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Loans From Related Parties - Chief Executive Officer
Dec. 31, 2013
Restricted Common Stock
Feb. 14, 2014
Subsequent Event
Loan
Feb. 14, 2014
Subsequent Event
Restricted Common Stock
Jan. 06, 2014
Subsequent Event
Restricted Common Stock
Loans From Related Parties - Chief Executive Officer
Feb. 04, 2014
Subsequent Event
Stock Purchase Agreement
Restricted Common Stock
Feb. 04, 2014
Subsequent Event
Warrants
License To Acquire Intellectual Property and Trade Name
Stock issued upon execution of stock purchase agreement, shares               480,000  
Stock issued upon execution of stock purchase agreement, value               $ 300,000  
Stock purchase agreement terms              

On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission.

  
No.of warrants granted to acquire intellectual property and trade name                 5,000,000
Purchase price of warrants, per share                 $ 0.01
Stock issued in conversion of debt, shares             2,036,000    
Stock issued in conversion of debt, value             482,958    
Stock issued during period for cash, shares       50,000   700,000      
Proceeds from sale of common stock 15,000      15,000   300,000      
Proceeds from issuance of long term debt $ 912,088 $ 2,133,088     $ 850,000        
Debt instrument interest rate         6.00%        
Debt instrument maturity date     Jan. 01, 2014   Jun. 30, 2015        
XML 27 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long Term Debt (Details) (USD $)
Dec. 31, 2013
Long Term Debt Details  
Loan Principle $ 10,420,791
Less: Discount 585,000
Net Loan Per books $ 9,835,791
XML 28 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature Of Operations And Going Concern (Narrative) (Details) (USD $)
 0 Months Ended 12 Months Ended 3 Months Ended
Nov. 17, 2011
Global Energy Solutions, Inc (GES)
Jun. 30, 2012
Global Energy Solutions, Inc (GES)
Sep. 30, 2011
Diamond Ranch Ltd And Executive Seafood Inc
Net loss     $ 126,000
Name of acquired entity Global Energy Solutions, Inc. ("GES"), an Irish corporation    
Percentage of ownership acquired 100.00%    
Excess of liabilities over assets taken over     $ 5,000,000
Shares issued to GES 76,000,000 25,415,300  
XML 29 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 30 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Accounting Policies
 6 Months Ended
Dec. 31, 2013
Summary Of Accounting Policies  
Summary Of Accounting Policies

NOTE 2 – SUMMARY OF ACCOUNTING POLICIES

 

This summary of accounting policies for Plandaí Biotechnology, Inc. and its wholly-owned subsidiaries, is presented to assist in understanding the Company's financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.

 

Use of Estimates

 

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

 

Revenue recognition

 

The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company’s Phytofare™ botanical extracts commences in 2014, revenues will be recognized when product is shipped.

 

Concentration of Credit Risk

 

The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and amortization.  The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years. Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.  At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.

 

Impairment of Long-Lived Assets

 

In accordance with ASC Topic 360, formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.


Earnings per Share

 

Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At December 31, 2013, the Company had three convertible debentures outstanding that if-converted would result in 2,900,000 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.

 

Income Taxes

 

The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, Accounting for Income Taxes, as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (“FIN No. 48”). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, Accounting for Contingencies. As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.

 

The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.

 

The Company is not currently under examination by any federal or state jurisdiction.

 

The Company’s policy is to record tax-related interest and penalties as a component of operating expenses.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Emerging Growth Company

 

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

 

Fair Value of Financial Instruments

 

Fair value of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.

 

Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.

 

Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:

 

Level 1

 

Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it’s available for sale securities using Level 1.

 

Level 2

 

Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3

 

Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.

 

Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.

 

Advertising

 

Advertising costs are expensed as incurred.

 

Principles of Consolidation

 

Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:

 

 

Cannabis Biosciences, Inc. 100% owned by Plandaí Biotechnology, Inc.
Phyto Nutricare, Inc. 100% owned by Plandaí Biotechnology, Inc.
Phyto Pharmacare, Inc. 100% owned by Plandaí Biotechnology, Inc
Dunn Roman Holdings—Africa, Ltd 82% owned by Plandaí Biotechnology, Inc.
Breakwood Trading 22 (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa
Green Gold Biotechnologies (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa

 

 

During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Plandaí. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.

 

All intercompany balances have been eliminated in consolidation.

 

Straight-lining of Lease Obligation

 

Plandaí’s subsidiaries have two long-term, material leases which either have escalating terms or include several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.


Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

 

All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.
XML 31 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
Dec. 31, 2013
Jun. 30, 2013
Statement of Financial Position [Abstract]    
Common Stock, Par Value $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 500,000,000 500,000,000
Common Stock, Shares Issued 111,070,760 106,270,760
Common Stock, Shares Outstanding 111,070,760 106,270,760
XML 32 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transaction
 6 Months Ended
Dec. 31, 2013
Related Party Transaction  
Related Party Transaction

NOTE 12 – RELATED PARTY TRANSACTION

 

In addition to the loans payable and receivables as discussed above, the Company had the following related party transactions during the quarter ended December 31, 2013.

 

Office Lease

 

The Company leases its South African Office space from a trust of which one of the beneficiaries serves on the Board of Directors of Dunn Roman Holding—Africa, Ltd., a subsidiary of the Company. The lease agreement calls for monthly payments of $2,500. During the quarter ended December 31, 2013, a total of $4,971 was paid in rent expense.

 

Compensation to Officers and Management

 

Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06 per share. At December 31, 2013, the Company accrued compensation expense for services completed in the amount of $1,056,600, which has been recorded as Stock Subscription Payable.
XML 33 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
 6 Months Ended
Dec. 31, 2013
Feb. 05, 2014
Document And Entity Information    
Entity Registrant Name Plandai Biotechnology, Inc.  
Entity Central Index Key 0001317880  
Document Type 10-Q  
Document Period End Date Dec. 31, 2013  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   125,670,956
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2014  
XML 34 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
 6 Months Ended
Dec. 31, 2013
Subsequent Events  
Subsequent Events

NOTE 13 – SUBSEQUENT EVENTS

 

Management was evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that besides listed below, no material subsequent events exist through the date of this filing.

 

  1. On February 4, 2014, the Company executed an stock purchase agreement in the amount of $15,300,000 which permits the Company to sell shares, at its option generally based on current market prices for the 30 month period commencing upon the execution of the stock purchase agreement, subject to the registration of resale of the underlying shares with the Securities and Exchange Commission. The Company received $300,000 in proceeds under the agreement in exchange for 480,000 shares of restricted common stock sold upon the execution of the stock purchase agreement.

 

  1. On February 4, 2014, the Company closed on an agreement to acquire the license to the intellectual property and trade name associated with “Diego Pellicer.” Under the terms of the agreement, the Company granted warrants to purchase 5,000,000 shares of the Company’s stock at a purchase price of $0.01 per share.

 

  1. On January 6, 2014, the Company retired $482,958 plus accrued interest payable to the Company’s chief executive officer in exchange for 2,036,000 shares of restricted common stock, which represented a conversion at the closing bid price. The debt obligation originated from a short-term working capital loan made in prior periods into the company’s subsidiary, Dunn Roman Holdings – Africa (Pty), Ltd.

 

  1. In February 2014, the company issued a total of 700,000 shares of restricted common stock in exchange for cash proceeds of $300,000.

 

  1. In February 2014, the company received a total of $850,000 in long-term debt financing. The loan bears interest at 6% and is payable June 30, 2015.
XML 35 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Operations (USD $)
 3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Income Statement [Abstract]        
Revenues $ 13,187 $ 113,816 $ 240,002 $ 249,903
Cost of Sales 166,914    343,855 375,129
Gross Profit (153,727) 113,816 (103,853) (125,226)
Expenses:        
Salaries & Wages 914,004 115,513 1,038,196 170,465
Professional Services 31,498 180,884 71,206 150,799
Rent 116,060    241,625   
Utilities 13,229 18,526 29,580 19,237
Insurance 15,245    32,473 72,959
Depreciation 49,235 14,412 99,278 46,680
General & Administrative 21,307 193,640 102,326 238,657
Total Expenses 1,160,578 522,975 1,614,684 698,797
Operating Loss (1,314,305) (409,159) (1,718,537) (824,023)
Other Income (Expense)        
Derivative Interest (1,858,399)    (2,086,436) 2,653
Interest Expense (147,860) (33,576) (239,682) (105,692)
Net Loss (3,320,564) (442,735) (4,044,655) (927,062)
Loss Allocated to Non-controlling Interest 178,138 110,665 355,905 246,022
Net Loss, Adjusted (3,142,426) (332,070) (3,688,750) (681,040)
Other Comprehensive Income (loss):        
Foreign Currency Translation Adjustment 115,228 410 113,502 (9,372)
Comprehensive (Loss) $ (3,027,198) $ (331,660) $ (3,575,248) $ (690,412)
Basic & diluted loss per share $ (0.03) $ 0.00 $ (0.04) $ (0.01)
Weighted Avg. Shares Outstanding 106,270,760 110,895,300 106,270,760 110,895,300
XML 36 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Currency Adjustment
 6 Months Ended
Dec. 31, 2013
Currency Adjustment  
Currency Adjustment

NOTE 7 – CURRENCY ADJUSTMENT

 

The Company’s principal operations are located in South Africa and the primary currency used is the South African Rand. Accordingly, the financial statements are first prepared in using Rand and then converted to US Dollars for reporting purposes, with the average conversion rate being used for income statement purposes and the closing exchange rate as of December 31, 2013 applied to the balance sheet. Differences resulting from the fluctuation in the exchange rate are recorded as an offset to equity in the balance sheet. As of December 31, 2013, the cumulative currency translation adjustments were $282,939.
XML 37 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long Term Debt
 6 Months Ended
Dec. 31, 2013
Long Term Debt  
Long Term Debt

NOTE 6 – LONG-TERM DEBT

 

In June 2012, the Company, through the majority-owned subsidiaries of Dunn Roman Holdings, Inc., executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa. The total loan is comprised of multiple agreements totaling, between Green Gold Biotechnologies (Pty) Ltd. and Breakwood Trading 22(Pty) Ltd., 100 million rand. The loans all bear interest at the rate of prime plus 0.5% per annum and are all due in seven years. In addition, the loans have a 25-month “holiday” in which no payments or interest are due until 25 months after the first drawn down of funds. The loans are collateralized by the assets and operations, including the Senteeko lease, agriculture production and receivables of Dunn Roman Holdings, which is the African operating arm of Plandaí. In addition, Dunn Roman Holdings was required to grant a 15% profit share agreement to the Land Bank which extends through the duration of the loan agreements (7 years unless pre-paid). The profit share agreement extends only to profits generated by Dunn Roman Holdings exclusive of operations of Plandaí and outside of South Africa. By way of loan covenants, the borrowing entities are required to maintain a debt to equity ratio of 1.5:1, interest coverage ratio of 1.5:1, and security coverage ratio of 1:1.

 

As of December 31, 2013, a total of $8,128,526 had been drawn down against the loans by Green Gold Biotechnologies (Pty) Ltd., which was used to purchase fixed assets that will be employed in South Africa to produce the company’s botanical extracts. Additionally, $2,431,615 had been drawn down against the loans by Breakwood Trading22 (Pty) Ltd. to fund the rehabilitation of the Senteeko Tea Estate, including the repair of roads, bridges, and onsite worker housing, and the pruning, weeding and fertilizing of plantation.

 

During the year ended June 30, 2012, the Company issued 1,500,000 shares of restricted common stock to three individuals in exchange for shares of Dunn Roman Holdings stock which had been previously issued. The acquired Dunn Roman shares were then provided to thirds parties in order to comply with the BEE provisions associated with the loan from the Land Bank of South Africa, which required that 15% of Dunn Roman be black owned. The Company has therefore determined to treat the value of the shares issued to acquire the Dunn Roman stock ($585,000) as a cost of securing the financing and recorded as a loan discount which will be amortized over the life of the loan (7 years) once payment of the loan commences in July 2014.

 

As of December 31, 2013, the loan balance was:

 

 

Loan Principal   $ 10,420,791  
Less: Discount     585,000  
Net Loan per Books   $ 9,835,791  

  

During the quarter ended December 31, 2013, the company borrowed $250,000 from an unrelated third party. The note bears interest at 6% per annum and is due June 30, 2015.
XML 38 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fixed Assets (Details) (USD $)
Dec. 31, 2013
Jun. 30, 2013
Fixed Assets Details    
Total Fixed Assets $ 8,421,830  
Less: Accumulated Depreciation 208,931  
Fixed Assets, net $ 8,212,899 $ 7,924,910
XML 39 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Accounting Policies (Policies)
 6 Months Ended
Dec. 31, 2013
Summary Of Accounting Policies Policies  
Use Of Estimates

Use of Estimates

 

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing the financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the balance sheet and statement of operations for the year then ended. Actual results may differ from these estimates. Estimates are used when accounting for allowance for bad debts, collect ability of accounts receivable, amounts due to service providers, depreciation and litigation contingencies, among others.
Cash And Cash Equivalents

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.
Revenue Recognition

Revenue recognition

 

The Company presently derives its revenue from the sale of timber and agricultural products produced on its farm and tea estate holdings in South Africa. Revenue is recognized when the product is delivered to the customer. Once production of the Company’s Phytofare™ botanical extracts commences in 2014, revenues will be recognized when product is shipped.
Concentration Of Credit Risk

Concentration of Credit Risk

 

The Company has no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements.
Property And Equipment

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and amortization.  The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the related assets, which range from three to five years. Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized.  At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the results of operations.
Impairment Of Long-Lived Assets

 Impairment of Long-Lived Assets

 

In accordance with ASC Topic 360, formerly SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of its assets based on estimates of its undiscounted future cash flows. If these estimated future cash flows are less than the carrying value of the asset, an impairment charge is recognized for the difference between the asset's estimated fair value and its carrying value. As of the date of these financial statements, the Company is not aware of any items or events that would cause it to adjust the recorded value of its long-lived assets for impairment.
Earnings Per Share

Earnings per Share

 

Basic gain or loss per share has been computed by dividing the loss for the period applicable to the common stockholders by the weighted average number of common shares outstanding during the years. At December 31, 2013, the Company had three convertible debentures outstanding that if-converted would result in 2,900,000 new common shares being issued. At June 30, 2013, the Company had one convertible debenture outstanding that if-converted would result in 340,984 new common shares being issued.
Income Taxes

Income Taxes

 

The Company accounts for income taxes under ASC Topic 740, formerly SFAS No. 109, Accounting for Income Taxes, as clarified by ASC Topic 740, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (“FIN No. 48”). Deferred tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company adopted the provisions of ASC Topic 740, formerly FIN No. 48 on January 1, 2007. Previously, the Company had accounted for tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, Accounting for Contingencies. As required by ASC Topic 450, formerly FIN No. 48, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. At the adoption date, the Company applied ASC Topic 740, formerly FIN No. 48 to all tax positions for which the statute of limitations remained open. As a result of the implementation of ASC Topic 740, formerly FIN No. 48, the Company did not recognize any change in the liability for unrecognized tax benefits.

 

The Company is subject to income taxes in the U.S. federal jurisdiction and that of South Africa. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for the years before April 1, 2007.

 

The Company is not currently under examination by any federal or state jurisdiction.

 

The Company’s policy is to record tax-related interest and penalties as a component of operating expenses.
Off-Balance Sheet Arrangements

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.
Emerging Growth Company

Emerging Growth Company

 

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.
Fair Value Of Financial Instruments

Fair Value of Financial Instruments

 

Fair value of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.

 

Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.

 

Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:

 

Level 1

 

Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities; The Company values it’s available for sale securities using Level 1.

 

Level 2

 

Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3

 

Unobservable inputs for the asset or liability that are supported by little or no market activity and that are significant to the fair values.

 

Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.
Advertising

Advertising

 

Advertising costs are expensed as incurred.
Principles of Consolidation

Principles of Consolidation

 

Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:

 

 

Cannabis Biosciences, Inc. 100% owned by Plandaí Biotechnology, Inc.
Phyto Nutricare, Inc. 100% owned by Plandaí Biotechnology, Inc.
Phyto Pharmacare, Inc. 100% owned by Plandaí Biotechnology, Inc
Dunn Roman Holdings—Africa, Ltd 82% owned by Plandaí Biotechnology, Inc.
Breakwood Trading 22 (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa
Green Gold Biotechnologies (Pty) Ltd. 74% owned by Dunn Roman Holdings-Africa

 

 

During the year ended June 30, 2013, the Company determined that the entity, Global Energy Solutions, was unnecessary to operations and decided to dissolve that corporation, resulting in the stock of Dunn Roman Holdings-Africa being held directly by Plandaí. All liabilities were either satisfied or forgiven and all bank accounts closed. There were no operations in Global Energy Solutions during the periods presented. Global Energy Solutions was officially dissolved during the year ended June 30, 2013.

 

All intercompany balances have been eliminated in consolidation.
Straight-lining of Lease Obligation

Straight-lining of Lease Obligation

 

Plandaí’s subsidiaries have two long-term, material leases which either have escalating terms or include several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

 

All recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future financial statements.
XML 40 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Non-Controlling Interest
 6 Months Ended
Dec. 31, 2013
Non-Controlling Interest  
Non-Controlling Interest

NOTE 10 – NON-CONTROLLING INTEREST

 

Plandaí owns 82% of Dunn Roman Holdings—Africa, which in turn owns 74% each of Breakwood Trading 22 (Pty, Ltd. and Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the non-controlling ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, non-controlling interest has been shown in the Equity Section, separated from the equity of Plandaí, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.
XML 41 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fixed Assets
 6 Months Ended
Dec. 31, 2013
Property, Plant and Equipment [Abstract]  
Fixed Assets

NOTE 8 – FIXED ASSETS

 

Fixed assets, stated at cost, less accumulated depreciation at December 31, 2013 consisted of the following:

 

    December 31,
2013
     
Total Fixed Assets   $ 8,421,830  
Less: Accumulated Depreciation     (208,931 )
         
Fixed Assets, net   $ 8,212,899  
         

 

Depreciation expense

 

Depreciation expense for the three months ended December 31, 2013 was $49,235.
XML 42 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock
 6 Months Ended
Dec. 31, 2013
DisclosureCommonStockAbstract  
Common Stock

NOTE 9 – COMMON STOCK

 

During the six months ended December 31, 2013, the Company engaged in the following common stock transactions:

 

  · A total of 50,000 shares of restricted common stock were issued in exchange for proceeds of $15,000.
  · A total of 250,000 shares that had been issued in prior periods for services previously rendered were cancelled.
  · A total of 5,000,000 shares of restricted common stock were issued in satisfaction of a credit line and accrued interest totaling $907,503.
XML 43 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capitalized Lease Obligations
 6 Months Ended
Dec. 31, 2013
Capitalized Lease Obligations  
Capitalized Lease Obligation

NOTE 11 – CAPITALIZED LEASE OBLIGATIONS

 

In February 2012, the Company entered into a long-term (49 year) lease of tea, avocado, macadamia and timber plantation estates totaling roughly eight thousand acres in South Africa. Under the terms of the lease, the Company is required to pay annual rent of R250,000 ($30,000) plus an annual dividend of 26% of net income generated from the use of the property with a R500,000 ($60,000) annual minimum dividend. The first payment of R20,883 ($2,610) was due April 2012, but by mutual agreement this payment was extended until funding is received under the loan from the Land Bank of South Africa. On March 1, 2012, the Company entered into a 10 year lease for office space for its subsidiary Dunn Roman Holdings. Under the terms of the lease, payments are $2,500 a month.

 

Both of these leases either have escalating terms or included several months of “free” rent, including the 49-year notarial lease for the Senteeko Tea Estate. In accordance with US Generally Accepted Accounting Principles, the Company has calculated a straight-line monthly cost on the leases and recorded the corresponding difference between the amount actually paid and the amount calculated as a Capitalized Lease Obligation. As of December 31, 2013, the amount of this deferred liability was $1,182,217.
XML 44 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transaction (Narrative) (Details) (USD $)
 3 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Jun. 30, 2013
Mar. 01, 2013
Two Officers And Manager
Three Employment Agreements
Dec. 31, 2013
Two Officers And Manager
Three Employment Agreements
Dec. 31, 2013
Office Space
Director of Dunn Roman Holding, Ltd
Rent expenses $ 116,060    $ 241,625          $ 4,971
Employment agreements description          

Pursuant to three employment agreements executed on March 1, 2013 by the Company with two of its officers and one manager, the Company is also obligated to issue 4,000,000 common shares at the end of each completed year for services rendered to the Company. The Company valued the 4,000,000 shares at the closing stock price on the date of the executed agreement which was $0.06/share

    
Stock Subscritption Payable $ 1,056,600   $ 1,056,600   $ 261,600   $ 1,056,600  
XML 45 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fixed Assets (Tables)
 6 Months Ended
Dec. 31, 2013
Fixed Assets Tables  
Schedule Of Fixed Assets

Fixed assets, stated at cost, less accumulated depreciation at December 31, 2013 consisted of the following:

 

    December 31,
2013
     
Total Fixed Assets   $ 8,421,830  
Less: Accumulated Depreciation     (208,931 )
         
Fixed Assets, net   $ 8,212,899  
XML 46 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Accounting Policies (Earnings Per Share) (Narrative) (Details) (Convertible Debenture)
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Jun. 30, 2013
Convertible Debenture
    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share 2,900,000 340,984
XML 47 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,044,655) $ (927,062)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 99,278 46,680
Forgiveness of Interest    4,426
Common Stock Issuable 795,000   
Derivative Liability 2,086,436   
Capitalized Lease Obligation 193,836   
Foreign Currency Translation Adjustment 113,502 (9,372)
Increase in Prepaid Expenses    (41,133)
Decrease (Increase) in Accounts Receivable 6,632 (12)
Increase in Deposits (4,874)   
Decrease in Inventory 2,670   
Decrease (Increase) in Other Assets 19,791 (19,450)
(Decrease) Increase in Accounts Payable and Accrued Expenses (306,197) 20,272
(Decrease) Increase in Related Party Payables (144,320) 150,790
Increase in Accrued Interest 49,288 26,970
Net Cash Used in Operating Activities (1,133,613) (747,891)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Deposits on Equipment    415,818
Purchase of Fixed Assets 387,267 885,285
Net Cash Used in Investing Activities (387,267) (1,301,103)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Increase in Long-term Debt, Net of Discount 912,088 2,133,088
Net Borrowings under Convertible Debt 219,980   
Proceeds from the Sale of Common Stock 15,000   
Net Borrowings under Credit Line 25,000 1,120,837
Loans from Related Parties (18,560) 175,869
Net Cash Provided by Financing Activities 1,153,508 3,429,794
Net (Decrease) Increase in Cash and Cash Equivalents (367,372) 1,380,800
Cash and Cash Equivalents at Beginning of Period 498,917 5,112
Cash and Cash Equivalents at End of Period 131,545 1,385,912
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid during the year for Interest      
Cash paid during the year for Income taxes      
XML 48 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debenture Payable
 6 Months Ended
Dec. 31, 2013
Debt Disclosure [Abstract]  
Debenture Payable

NOTE 5 – DEBENTURE PAYABLE

 

In May 2013, the Company issued an 8% interest rate convertible debenture in the amount of $103,500 which becomes due and payable in February 2014. The debenture is convertible into common stock of the Company at a discount of 42% off the market price of the Company’s common stock six months after issuance (November 2013). The Company repaid the debenture in full on November 11, 2013.

 

On August 20, 2013, the Company executed two convertible promissory notes totaling $550,000. The notes bear interest at the rate of 8% per annum and become due and payable six months from the date of issuance. During the first 90 days from issuance, the notes are repayable without incurring any interest charges. As of December 31, 2013, the Company had been advanced $210,000 against the two notes. Subsequent to December 31, 2013, $150,000 of the unpaid principal plus accrued interest was converted into 2,717,035 shares of restricted common stock.

 

On November 13, 2013, the Company executed a convertible promissory note of $113,500, which includes prepaid interest of $10,000. The note bears interest at 10% per annum and is due and payable twelve months from the date of issuance. At the holder’s option, the unpaid principal and interest can be converted into common stock at a 42% discount to market after six months.

 

The Company has recorded a derivative liability of $2,131,663 representing the estimate value of the shares over and above the amount of debentures that would be issued on conversion.
XML 49 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Accounting Policies (Principles Of Consolidation) (Narrative) (Details)
Dec. 31, 2013
Cannabis Biosciences, Inc
  
Noncontrolling Interest [Line Items]  
Holding by Plandai Biotechnology Inc 100.00%
Phyto Nutricare, Inc
  
Noncontrolling Interest [Line Items]  
Holding by Plandai Biotechnology Inc 100.00%
Phyto Pharmacare, Inc
  
Noncontrolling Interest [Line Items]  
Holding by Plandai Biotechnology Inc 100.00%
Dunn Roman Holdings-Africa, Ltd
  
Noncontrolling Interest [Line Items]  
Holding by Plandai Biotechnology Inc 82.00%
Breakwood Trading 22 (Pty) Ltd
  
Noncontrolling Interest [Line Items]  
Holding by Dunn Roman Holdings-Africa 74.00%
Green Gold Biotechnologies (Pty) Ltd
  
Noncontrolling Interest [Line Items]  
Holding by Dunn Roman Holdings-Africa 74.00%
XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 60 170 1 false 30 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://plandaibiotechnologyinc.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://plandaibiotechnologyinc.com/role/BalanceSheets Consolidated Balance Sheets false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://plandaibiotechnologyinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00000004 - Statement - Consolidated Statements Of Operations Sheet http://plandaibiotechnologyinc.com/role/StatementsOfOperations Consolidated Statements Of Operations false false R5.htm 00000005 - Statement - Consolidated Statements Of Cash Flows Sheet http://plandaibiotechnologyinc.com/role/StatementsOfCashFlows Consolidated Statements Of Cash Flows false false R6.htm 00000006 - Disclosure - Nature Of Operations And Going Concern Sheet http://plandaibiotechnologyinc.com/role/NatureOfOperationsAndGoingConcern Nature Of Operations And Going Concern false false R7.htm 00000007 - Disclosure - Summary Of Accounting Policies Sheet http://plandaibiotechnologyinc.com/role/SummaryOfAccountingPolicies Summary Of Accounting Policies false false R8.htm 00000008 - Disclosure - Loans From Related Parties Sheet http://plandaibiotechnologyinc.com/role/LoansFromRelatedParties Loans From Related Parties false false R9.htm 00000009 - Disclosure - Line Of Credit Sheet http://plandaibiotechnologyinc.com/role/LineOfCredit Line Of Credit false false R10.htm 00000010 - Disclosure - Debenture Payable Sheet http://plandaibiotechnologyinc.com/role/DebenturePayable Debenture Payable false false R11.htm 00000011 - Disclosure - Long Term Debt Sheet http://plandaibiotechnologyinc.com/role/LongTermDebt Long Term Debt false false R12.htm 00000012 - Disclosure - Currency Adjustment Sheet http://plandaibiotechnologyinc.com/role/CurrencyAdjustment Currency Adjustment false false R13.htm 00000013 - Disclosure - Fixed Assets Sheet http://plandaibiotechnologyinc.com/role/FixedAssets Fixed Assets false false R14.htm 00000014 - Disclosure - Common Stock Sheet http://plandaibiotechnologyinc.com/role/CommonStock Common Stock false false R15.htm 00000015 - Disclosure - Non-Controlling Interest Sheet http://plandaibiotechnologyinc.com/role/Non-ControllingInterest Non-Controlling Interest false false R16.htm 00000016 - Disclosure - Capitalized Lease Obligations Sheet http://plandaibiotechnologyinc.com/role/CapitalizedLeaseObligations Capitalized Lease Obligations false false R17.htm 00000017 - Disclosure - Related Party Transaction Sheet http://plandaibiotechnologyinc.com/role/RelatedPartyTransaction Related Party Transaction false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://plandaibiotechnologyinc.com/role/SubsequentEvents Subsequent Events false false R19.htm 00000019 - Disclosure - Summary Of Accounting Policies (Policies) Sheet http://plandaibiotechnologyinc.com/role/SummaryOfAccountingPoliciesPolicies Summary Of Accounting Policies (Policies) false false R20.htm 00000020 - Disclosure - Long Term Debt (Tables) Sheet http://plandaibiotechnologyinc.com/role/LongTermDebtTables Long Term Debt (Tables) false false R21.htm 00000021 - Disclosure - Fixed Assets (Tables) Sheet http://plandaibiotechnologyinc.com/role/FixedAssetsTables Fixed Assets (Tables) false false R22.htm 00000022 - Disclosure - Long Term Debt (Details) Sheet http://plandaibiotechnologyinc.com/role/LongTermDebtDetails Long Term Debt (Details) false false R23.htm 00000023 - Disclosure - Fixed Assets (Details) Sheet http://plandaibiotechnologyinc.com/role/FixedAssetsDetails Fixed Assets (Details) false false R24.htm 00000024 - Disclosure - Nature Of Operations And Going Concern (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/NatureOfOperationsAndGoingConcernNarrativeDetails Nature Of Operations And Going Concern (Narrative) (Details) false false R25.htm 00000025 - Disclosure - Summary Of Accounting Policies (Property And Equipment) (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/SummaryOfAccountingPoliciesPropertyAndEquipmentNarrativeDetails Summary Of Accounting Policies (Property And Equipment) (Narrative) (Details) false false R26.htm 00000026 - Disclosure - Summary Of Accounting Policies (Earnings Per Share) (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/SummaryOfAccountingPoliciesEarningsPerShareNarrativeDetails Summary Of Accounting Policies (Earnings Per Share) (Narrative) (Details) false false R27.htm 00000027 - Disclosure - Summary Of Accounting Policies (Principles Of Consolidation) (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/SummaryOfAccountingPoliciesPrinciplesOfConsolidationNarrativeDetails Summary Of Accounting Policies (Principles Of Consolidation) (Narrative) (Details) false false R28.htm 00000028 - Disclosure - Loans From Related Parties (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/LoansFromRelatedPartiesNarrativeDetails Loans From Related Parties (Narrative) (Details) false false R29.htm 00000029 - Disclosure - Line Of Credit (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/LineOfCreditNarrativeDetails Line Of Credit (Narrative) (Details) false false R30.htm 00000030 - Disclosure - Debenture Payable (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/DebenturePayableNarrativeDetails Debenture Payable (Narrative) (Details) false false R31.htm 00000031 - Disclosure - Long Term Debt (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/LongTermDebtNarrativeDetails Long Term Debt (Narrative) (Details) false false R32.htm 00000032 - Disclosure - Common Stock (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/CommonStockNarrativeDetails Common Stock (Narrative) (Details) false false R33.htm 00000033 - Disclosure - Capitalized Lease Obligations (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/CapitalizedLeaseObligationsNarrativeDetails Capitalized Lease Obligations (Narrative) (Details) false false R34.htm 00000034 - Disclosure - Related Party Transaction (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/RelatedPartyTransactionNarrativeDetails Related Party Transaction (Narrative) (Details) false false R35.htm 00000035 - Disclosure - Subsequent Events (Narrative) (Details) Sheet http://plandaibiotechnologyinc.com/role/SubsequentEventsNarrativeDetails Subsequent Events (Narrative) (Details) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00000004 - Statement - Consolidated Statements Of Operations Process Flow-Through: 00000005 - Statement - Consolidated Statements Of Cash Flows plpl-20131231.xml plpl-20131231.xsd plpl-20131231_cal.xml plpl-20131231_def.xml plpl-20131231_lab.xml plpl-20131231_pre.xml true true ZIP 51 0001262463-14-000150-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001262463-14-000150-xbrl.zip M4$L#!!0````(`-UU4T28QDA7?64```R]`@`1`!P`<&QP;"TR,#$S,3(S,2YX M;6Q55`D``S$*!5,Q"@53=7@+``$$)0X```0Y`0``[#UI<^,VEM^W:O\#US-) M)54MFX=.]S'EL]*`=J@<*IB:S"!U]//CMOG5R?W9U=:#\ M[=-__Y<"_WSXGU9+N238MHZ5^H@D^5CYCBCER&7^O_(YL3SQA ME\3&7#ECDZF-70P-/J1CQ3CLFDJK56+8WS&U&/_M[BH:=NRZT^.CH^?GYT/* MGM`SX]^=0Y.5&^Z>>=S$T5A3>VK_I)_KJF9HNJ%]>](.7X9`P3ERH14>MZ%5 MU>$O;?"@]8[ACVZ4A.0BUW,B2.I+7U7;*OSCO_[AY9';Y%C\K8`0J'/\XI"/ M!S'BGHU#QD='NJIJ1__WY?K>'.,):A'JN(B:^"!\RR;T>]9[VF`P.)*M8=>% MG@)X",,X$LV/R)F/+!`LZ+^`";1:;O1"O'/GR&],="697;M^5Q)VM7"JGX/- MPQ%[.H*&(R&WEJJU#"WLSO$P%^7N$;2&'8G#VKK6*Z+/[Q&^X+D\M_/@"%JC MCDYKA-`TZCQ$SJ/LD8`TMG-G8R7Q'MF2\1!FEWB0;)\OE1^YLBH^@4PMZ M84[,\#V3>=3ELVRN!HT9X$R/<_`->>\%K>)%/?FBL+'HI:F-J(7((V$N-L>4 MV6PT(]0$^YTXL^AI])Q8HF5( MP*])S'!"`"$[SJ[^?O`);!WPZ_7[ZH>C],MS<$>9\`)H4Q``+QOIN>X;/+M MG*`)H]8=N,OQM6N=4.OB!9N>2Y[P/49#QJPK:G[!DT?,7XW'T<`.'DUPC#E1 MDP7(O$QM8A+7QU6Q"/3T8P=PQ\?7>(3L"XGOR0MQ#CX)*SVN0/R'HTPX<1R/ MLI&LIR&@!=P5<_VGN?PB"%';PFL0DL1>&L04*VQIU/I"9=IKT79J48A"HU.\-DA"Y!J+17I2U7 MI1K!2BH*7DNP$JI/P.%OU\#?F^$9QU;(H+>N,]>,CES,)^?XT7V`;--7F*AU M@=Y7G(8VG?;LA?_:PG\;3L)HJ9V6H45Z;3Q5^9BYQ;-$/S>#96Y M'S/N/N3J3"'MK^@[`AFMU7=(&('OV.O$ENI$PJ4$$JOF4E*JM)&XXXS9-@#A MR";_P99@\\VC349(QG"[H43%_78/O5(.)I`>-L7N]30 MI&_AZMBW?YW<[=5JJ5I50>I!Z(_V M^K`%^I">RO0Z4UE-#N/W6$Q;UJWH!NS!XZH@TPY9Y[.XBV)!=&4*%Y?Q_5^91TW8H:Q M/AVOX"IW*E;;@-]\F[':EOOG>8C7CJ<:^ZE]"Z;V9*C7WD"8OU0']C[K1_!9 MFU*\>6T>'%POK,W+X#"(`B\F4YO-!$DG(XZQ^.$DX\2;X9"8F(/XOB"*1ICO MAK.Z<<>8G[')A+B2Z%@XEL^35XX3^TH9LM\51GU0"^[ MK1YQ^O;J42+(O?<>'6(1Q`EVWGQ=/_\`42:9NQH<+I?TPS/[$20=D?D#2WH, M:=H/(>LYH;LJ[1(3_#6#7/E'VBR[2/!^VB]R$7M%V8[M]9N;%/;'<;;@+-9F M!*[V6[J:=89"<&@W9%[^[,25NY3)NN.!?DL;A&MU>QW8!AU(1P5"0I57 MO.*JLY&H8*\NV^`R-A\;E#O&L(O)Y98=;-CGNNM1U+=>[WJ;:KKKY;<2!9D[ M[+BB51( M4_-4:'\88W\8HY*.2U7:(AU/SN5O;$_(QN>2!4?PQABVY(F\3N^U?=?WVDGEO?%=QN5QA3N>N)@LE9$V>WG@L5U+6$9T_ MKJSORZJ3RI))[^Y'00M5[+WX7T_\;Z,4UQ9?#%,[4FO\W]TH0!:Y M!/[3$^'<$_R5"I\7]W3N=F2=XL9B<)W)KH;CZ^:WV?X0X7V@Y=7,+S"']9N? MH87FI[>T=DGSV]O8NFSL32NY47&."91NRY0\(V[9F5U$VZ#C)6.G5]M#]&;T M6MRC.-=KM:1>2X]QZW%SC!P6R=_`;L/VM>537<:-7\;"EU$2BR7WV/0X<0G>D>_KG,"X%KU"' MM%V\F+9G84OP1X12GBO/7MP,+Q"GH-C.+>;W8\3QZ2Q[@,*C:6D>OJI2UKH> MS5CG)WI*;*7?*^5N*^5VK'%X,/=)C?SM_GQ!I288.1['GXC#VKK6.X8^X6!A M4Q*$&"UG?"DU)Q=$P`39J38,P.\V!XY%GD"7%WDKWOWJ33!'+LN8I"OP((UC MUJ@QH.>8L@FAR\`NYTL:;M;`87N""R48"M8&88Z+1GB)X*;PL[;8[A"UENI> M=(]Y#0`G9I'J>2X_1F85_,5^P@MI^7=X1!Q7Q%Y?T00K@8G=X6'QM;?BW)"% MB')*('@SQY39;#1[IUQ1\_##4=[HB]#/0#8T.+AS M9GJ3(#XO#07.O9PU[*]W5A>_,2H\?=X>YH\7!G4"K)7IV[;]3]DSO06<9A03& M<3R8;\N"_WJ3N)\B&]Y1H>$6$+XC.XB@DALXR!%_DO@)? MPK/RQ/Y#3QK!PDCYX(2&50,F4K8L<-%((;",."S^F>!`)`FX\PN"A$$<*,+O MR@81H"@6-@EPVOEXH`H'8W14L)ER4)K`J]BZ)NB1V#*T7E&H`T/KM^?8Y(Z_(B)+[QLK5#RMT^_H&T*R&!.]W:N# M2)S@NI+J=?2.J/1DC5D=WDH"Z?5Z3:.2AO?BD&-*[(\'+G#X0#E*#WONX0<6 M.W0-O/_*J+F:,714K:/UYW05`FD`HZ7W+A8AV^[K@\ZFD5TC1N#2KRB$WW*" M.T.@N)YS>-F^#L3H?P54,NQXSKA6%F*5(WH MN;QB)9:8V*Z^7H+@#N-BJX=J'L&0G3R*(A&,T7/;PX>>O8U M&9:MSN1]L.;6^"/A5)>!VP2&R6^FW'96PQ`(9AR\9NA5;IY!LLZ83.>.YW0& M@=22>++P\QVE/*%ZV(]E.170VAQ%LX@0[H8#K'\ZN]\ M2/%8?@XJF$ZJ^OC"K+R0=K6?E\%41+DA^OW):G/T:^K*]/LH%]/_!;EBE\&L MP@)0X:46XR'3* M.&?/X"_.T!1:4BGS_(/IB5UH%6N>G50R4`6=,J1`V,XQZ?3 MOH*TH&Y]/9WH5,6O#'T7+U/B5Q&$<+4&2$H1:81X6JV";YG6)*FDQSD;:#K8$ZV]^R=R< M??O7R5V,!+F1)].4UTU$N6^)%+K3SB:P+'N+F=9!72(HKAP<\C]_W#&`.+'H$`@2"1E8,0J$*HR^#!9,(H MP&'F=X4-%7%/@_=^PH:`@2`:P<#U$8Y)>O[,G?""^X]>NA MX,#15)"1NZ2X7"IK$FN-6]02`BTKQ?=*3/0"C18$'"/XWW\#.#*<22F?N%(B M8V9;F,<9SZ8B''DG6STZ1<02\J(FF2);"@PB$:$&TBX4$U'E$8#8X=DQ-)<<.F>(D?N8?X3/%W]%5"I1A_0746 MLC+:S,E-RL3+GVY[?^0A*F#6PZK&9^ENNU_6@4<-\[O5]!50`8T(.^9M`*W* MFD80K(_^98TR5S^#/$VA1RSE4'B*\D`PFXLQ1'F?R=21W8$B)BM5G%.SL`:.T M/2NT[WO`#>/O3")ABUK>.P6-(/SR;!FG3#FS//E=&SD0QR8F3\+('8'-N4>I MSTCE?YG\T`X`\$F'L%",?S*$L:`YP$"X`G"_\*I_#,=GFF[TWA\J5]2/'B+F M9XRN/",'D`BV`D&8,!(G=$`N6NN0N(H\L"6(\,^&BUX"DVNIVHA^#Q`$ MY@XI8(@G[UI9*# M1`B-47LF,/*[.ZY#+-G['GZ/ M`RF4<+BE8XPSB*HIVK!)-QK?GLY`F6:"1U+"9D"0XQO]8UBV5\26)K%IR5=. M.<_-U6^"P*;A7Y'2``'B$987Y"A21F)T[;!SK+V+S7X`B(N<-=U#2,[Q3\G. MLGH=:Z6"WP6Y+)2XA96?4.M.I*CVQAIZ^)3UI>ABHN:7;6KKD]JB]]/JBBUW,U3GWEZ8V^% MC<7]MJ[UC>36W`(P&:=)O(DG=[.?8Y@"3.*O*>&IC<4/&.!D(DZC_4<^SQV\ M+OJZVA\8,1UJ"I\TG6'X>BO2_'H^8IE\EX%HP/"OJ,DF^`&]B"Q\C80LA=*( M$X.X#@L#%-O>Q=TS(S\RN0E#+&F2LM_1!Y.5N M@[CO"8NX*_&O+'KWZB+J)WV5,& M%8IEI0),-Q:-RTJ'K'`Z.$1K&CA-6=^`B.^NHX80NP'$ M`*=)L+TLA)83N-4025JNJ68Q'P>S<;!?S)^AFQ%EX5'6Y*IC6;P:IV=%^U^V MLKH%%%:06(7-`NEEX[KDG:$I@>?RK5@^5W#65EP_%L\+*ZN>WHVO.A8CL!ET MJ_!=[?>-NMC?@%OBX"(GQ)7.8OEJ!:A,+ZPG2P,)+.%B,K69K%0M7(`8]+@9 M#HF).02+7Q"%S)07^_>I*SW\K<=%M3BHPL#("HX@Q:LJ6!Y/`L<+F']!W!PK MD!$+-,-J5C@12-_K/LN46!10F(^6$ZT\,2J6$26&"U,(,!U>]-GJ3R2BF(V5 MMO#>TI6'"U/RC(M8F1(C!/,%1N98KD1"2`UOBRJ0,F0"FQ\$M< MHECV5[%Z?23'SIJ$"C1H\0H$P1K_RF'$;[B\$MCZ79`2W@Q6^JSU;^U+0&S,30SHO'-H!D.R@%N*BSFH=18W?16`6AFK--,V@Y5_*&TE M/FEJ5^^IO6X11CZ8E;`IR1]-T]2&L+GQ7'&SKJSPKYM!,5BKX]4@JPKP\L^E MUKT4`N;J3CM^'LX?K@J0$J6IGJ'UX]?"9`/)K>'DG`TN=:_(0&\/M#)5L8R= MWM41*L$+7=/[@T$]A.3DYC-O]?M`C+XZT`>IF3,]^`H8E+@MJ*MI1K\B!N=X M"H&$NYK:@R]H#^*9:VS,&@!+%*4['5TO"=!_NN+51QT-M*R=-KF\JX260RQ! M8ELW=*TL1%-NC((T+%Q_35ZE4AV7967&18A@8*M>&F9TX_I;!&)U=)9+H*>J MO7K87%%QSHGQV0JNMMLV8B85'[$ZM!*^H]N&-NBW8^84&[0R MO#*FU-8'_8%>#AZCH_"[=*O/"@.M9_34..3,X5=!HLPE.6J_D[@DIQP6.<6& MVKR`Z*BO+:UEK(1%F?7,OJYKO"=?4I71ZMP>&T*T" M/'1\P?[4"A-+"4_0[O1U?=')%L%J#K\R<8:JK8;=.>8P6\CR7V,*U(;@IQ>/ M?O)!K(Y."9W2#*W;->HAE.*I6(=N^MK*CM;-G,E+@&PZ@ MKVJ5H-]A"^.)#&P3]VJ$^R^"+[N5N+:O!'?ZG:XVB`FJ#O#U$5""P9JN@:5V MFZ5@44A7X6[<6[$YA]$3U^7DT7/E;0DL&U)MH>A=O:_U"I6F#CZ;I+*$Y-KM M?F>@===-Y0-'U+%E+'EBB8VE\GBM1^5F:62+RTZ#Z\C/@L5`2+9NA@_HI78P MU1VTC=@\5Q^#==-28A;LZX-X_ML<+7=8;,C%5OC5FL3.N*'XTDQM^]%4".W[ MFA%W"LN`-85>&9?5[@ST3GQ*JH[>0BE=W.T2K@C6S@SUK@C1"@KV"2A-X)0X M^UM_<;LXZ^YT7X.J=2)U\O_M?7M3&TN2[U?I..N)@0C!Z(DD^^Z-D#'V,FL# M"WC.G?O/1$MJ27WNHC:U6UPXBK$F&M7<4RWV`^[S>*3P2 M&G:[:=?QA-2J&TP+`I4S6,OPDC>M!SAH5IO-HY95$>!,L?'\:R3/NO-WZ^VJ M+0X?-OVFB?4'C48=;F-S=\N_-Y4^KPC5VXUU=U^KL3NL!VETCVPK,C?%%A1L MR@$H#;L[I6#CZHIFNV.'JG>Q!YNQ0:/1LB7P/01\`7T!V>,\=C"EM,/'5!IE M9PE6&87C&-6)7O9?P7!,ZK+^P$YD2+W:.0([VRQ@EQ3^ZM5ORK_UHU;C=:Q\ M8^%9Z[0Z#?O-?LFKWT$5E,['W?$;76O#3MM69<%$6]*R\7O=J3>K]<9CD+(Y M^S5JS8:-);C+;=GT':]V:ZWN=J2(F-\)K]2.:LTCNT'4TBQ;D;$IFQQU.^UN M$<,^B(IMRB9;[<[N-V,SYFC5Z]UV$9N64?&%2EPB##,,L4P%>URBB-NAWE># M2VR'(.^9<@<4;ORN-CI'K?:OI'!3]JK7&M5?2N"FC%?K-H[L(/>&%-I%JKO@ MN2[8>@ZFGAE^TZDW9:;FT5&GNINI-^629K?>:.UJU1N>?[-9JZ\W-2A'BQ01 M@ZC.(,O*FIML>N:->K/=L"V;Y6FV)653'FC7NZWNXY"R\ M'IN?!<1=]$ZH:NDK*9_:H0;2KM5MR,[U)MX=N1OS4*O:SN6X_U)Z-V4ZL(VZ MG:?`W(WG!MC&<0^:\3><>F-'3:T. M=N?1+J;>W#'3:K3MY,B'K'K34X=KNMZB\?D['WU)DF%VA7B+NU!VFW#:UIW, M3;$%!9N>>J/=JMFZQL,IV%C9.3KJVEBYN]B#!VNTE\%-$"]VXV&K@YRK.OD; M//8F;#;F_9G,:GBA.A;A#&"^P^9F`7=R&\ M&T>=3KOE!`;OFW:]:;]:.GV-(-'?J8&-!^T)8Z MH?R-LRFW9MI6JULM2RC8)H=R)\O8F*/KS:-JO2PMY,F6L;DFU.XXY<#/8QD; M7X9:K7ITM$NF4LF."GGCHY^%`]#./X41(:5LV87+/U#N@]%YF M7T5I[5=2>B\_KZ*T\6OW]!Z6745I=6M*$0PH#29@*E*&`;)\85;U]M*ZW:HW MW03`L@D?2-OF2D6WZH0/'H^TS=6(:KU=Z_ZB;=M8<0`3J+H5:9^3-`C'L MIWQ[G[+K5?++92#X\;MP:6&G-.M\UY]]MW1OGC+::#\#LC=/1FC5[0SCI]ON MS1BZ:1=";D_T[_"]":9C,6;ZV0)S]\]')(0M**`'*P+K(R5M1]'CK6OU/2A% M6JIVNJU&]1FO:_5%>HB_>KS.O:S"09*X/]A_=R-'V&B8V^NBAT?5!S1 M[':Z+ES#&I/MC,+Z6O7ECJKR2^E;TYO6LD/^OWH'UZ$02S(?9Q.YTW&^(_6. MG'1M1QW8A(!=$[]Q#*_1J7:<0K`'$(](2/"]BS1!/.OAQ[OO60!?^AS&?CS` M:F?$OUV&\-E:>6R!]NAZ-M:$;QPA:=:[[6YS%X3#5P9!,"2'H(5#` M/KN)'G9:1R[.7^E\#Z5M\_!SJW/4?3AMV"D]4ZW2=Q*>:3D(IJ5S/8BHC7>K M5J]V[!2DK<@ZE:9^Y^D5"(;S40$\Q;:WN7S3BB?=#9D[Z+2QL_W16.&7039/ MPP$P,)5AKE-D_#2[UX05`.&TB":BAM>:>A%80!S\;:>,JDUJK4^LL;X4US9JW0Y>([?A:UT#6'M7NOQT% M\^^6\HWO=;O9[MCHJ=L3GC>D3^-E,+]=;':S6[=?M76FW16IF]>P=W.Y+CL@ M]0R[CJ\-"+HU1S>;C?I*VN^EXY&6LE6%P6.O9!TDR]TH$-6CFET!O!TIC[>@ MC:](M=ZN/_YRN-9]I=D;JY`M=MME;>@FUH56#J.^)N M4-16DFA-]V#:=M-:-3?G`_6K'/9!I]U=F&K-N7=(\@XV#-U!!KQ(T0!&Y1BF MCX.M088>9=Z-;6:G'.#>*9>L4'^^2(/ST>:E'VY/S!%\Z;U7J\[FWG4XA:,\ M"VZ]RV3JQQ7^1<6[@B,???#<[L@X2!]_.#N_/O%JWH%WUKO^?GGBG7_VSB]. M+GO7I^=G5U[O[)/WY?ST[(MW?'YV?')YYE&CQ[X:@EL^4EM(_L].:/.GLP__ M43NJ/LH4'SSYA5B$$R'SB3_WIIBO!!OHQ:`69)F?WGG9 M)%E$0Z>5*_Q]$9.>`K0,N%X&Z,WR&WWX:YGSJ2Z%U5KVSYG>CZ$7_`RS>0`[ M@;UOA\$,6]-*@]C%#,X(M6%UA/9&PL_25Y9;["J_EP<,&M/9S;&-+F)+`X,H M*%V8H3_'NQ1P6'&DLAR(Z[#K*GP93S9!+F#`$3EX^[C+1O%NPRC"[_LW?ACA MX5?P8TN_I2ZYU$W>'PR"V5RQB=V,]VVPQ9*LQ)/#`\T6_2P$<6&-"^S)#!]L=@^H:S-(.9_&C"C=2L3F MM]D"Q*8?CWWIY#R6/;A*%O.)UQO!"OU#;VE;%XCEYGLSF"J>T[6CS<$OSS`6 MEZ%(!]E&EQ"A([D[]%T8@%B;@,"+8&O#Q'"P6AV1@6?@;.7!./5!.L\6*=P/ M)='3;*Z^AF/#A>BGR0)E*?P+>.5'0/-?3.[FR0A[03-/MAH?O&,?'U#8@V-J M;?VS@E(TA2?L8![X0#$HH\&02)&%\6HF/AY;-`]G2'&":\<=O0VBB/0W?S:+ MY#%PC]QZGK&O-5QN'`'[,V#Q#+VQ(+;H:8.-KGA`[I1?C#`>I3XJ<`-4S(@D M(-L]G>M7I/>T'41C<\'L/ M3!B,X"[-,Q9H8T)3`R[.%HA,'Y(;V,\FWBC"ZS("U=,;+7`7E'0&:OGV)$"A MTS(=GH3$:JN&2V7M`H\M"W%_S-A*5L/6V7*:=`%N.0ZDSDUJOM";#,"L>R-B M]9KVH%#[$U6E3_H;\BN1`AS]AW2RD/;UYG#LR^#'\0+&2ZG3A9:L)+#PY1YZ M?UW$@=>H5CPT-5#!O$&^C/"1C%C1!&MF"NL\^.]#T(1A,8K9\BIQ,@MC(*=B M]M"'4S3*7F8]R$B(#[]LB'J#(J?1;TR46:XG6-R3)[(_RFS<#S=`S/KQ@%CVOC/;]= M.(^],S`Y,!O&J[7I"M0J]DW"?Z1:'J.2<`MO2G1WD-SB@ZMU'OC@2B.29#N: MD15ZBA;3*5E[/EQNTBY^#B:@(@1\D[]$21\X\P2D]?@.7J)H04)1[%`R/HUE M^>7DRC(FX0&)O=,TS-#Z2^'*T[D>>M])5\&%L18K-\V=O>+!8'@A`GR_K?`A'-T_&`<9R>-Q5W$"$G)"Y@R_A5>"/DF2H6``6[^,*IS!4PDUB M:&7#$#9_GN`O70+*#]"/9#6@BL#BLB#-Z(&=BG9%$CC+$D31!!+)#O)%'QH& MBCT^+4@"TO`3T-(\F'H^R>2%N`*#A^^(/!,U-M?X9M"WT'E1PE1$1L%VTA@E M6T2<$P=CN+&8V0@\*9@MI*,8Y:2B=1J\2S&HHQ'B8P,A[VIU9E^"?K^\ MEHKC[`"R@X#<"^Q3Z(.&<@.??M=2E\'5!C.==@>\S2MF9HK]:5#$Y41+@7]) M&`".*L++1]S\)F3P9]0$.&Q#WH`%B*T,AUCF):($-6H2*G-0A^C@T4Y"#D&_ M%%RI,1Q7%J)^B2/XG-,%!A2,#Z9_G-S2U6./&/G+2-@8IA+F=C12T4GD4J&' M0@X;A9;`1U2,N-&3*H,TB.!BBYNK'V!)-2]O,4"%"*8G^982):EJ2J;W@ED. M-XE&@S\1&>OZ"LFU-D(*F#CB;)?M2:Z:'8"+LI9/E.VW0;3`4O$EJ06*(ZIK MN;/(R%`2KR/<;=+(Q#,$OPK1_//C@%Z+0]0]E=.F@#,R>1>4D2+[3N_8WM+[ MM6]M#BC5M[$8M25O"].-_Z&V5M;QJN<,V"`/"@/(1MB;!@2*4/I_\8+QK'`P&0' M[OVNG#N+*=Z(."JS<#QEW7@YHX8M]:T,&^"CC+T[&YLV]'3;PE1M@L(6D$PD_^YU63K9,=##0@\4Y MSM]%!O\>A_BOJSDY3.%(>O`^AP/?LPR8[X=7A]Z77N_",F/X9L74IX%< M(YK1"::I^P836X^;NGVLZ=([%/YT-=Y/<)U1220R&C7VC5CWR,KJ70KGY@.^ M5W`V%,&*YSV]?1=`XP`>WFLXOH\1&DQ/&`2NJT!E"QCJZONW;[W+OV,XN'=\ M?/[][!J#P!?G7T^/3\'4_`5!8$5;[NH\P>6]GH3X&(*QGI*CTF9_.4#BIHUT M_'*SD9P$868]"W/REJ+C&BX4Q1NT=N+Z8HMNAGN)\G0#OZ$:C%,4W-_BB\X. M;?5"B4^=31]RS)N+ST*$):_$&^:38O_FJWJ>7`[^SGK6"1PK$\W[(E@XY@R!C.'V, M2F(530JC#>T>-+QOA;"=XD4-K>Z,RODZ%#49 M\PLHDL[36AY5("FBV#UY'HB`P!R1\F,@(;`HI=2.X.GGRX:95/T`;]@$X_QX ML4*J"Z4E:7_1:^5MP=>F)##0JM]DS,KV/HNF&-U)1D5&VJ5XRTEZ:[XF7QMR M8TC>;WK3QO!F@MA?I.A(4LDO_`-'?G$TS)1@EVC@JS08G5>QE"FA3HA>5#JD M?XDCBIX(*Q6(,U73+?J%X]2`^]\WB0SQHJB7`7I9\4)!5A>`K3UC+E MPL4B^HH)+:B<+T,VOVH6N=DDG,W@U7RMUPLC9T$\3W6RI0#*7(;9CS=]SS#F M$(/V84QYC-L=B/[%&:^D@PWL':1'9\!;F.(69IB0YI,VAJ"4)MI)$03DT@HH M;28IG!D7@Q,4=51?FW![8'@04OSVXUE1O]Q@4I7W)&\"7?3_MKP.)9N`SS]) M7Q#24R$(U.P5>E\`AZ M<_U0PT8%G.@^!WN45=44C490[3C385;((!7Q?V9S"0+)GJ[+&DBG[-,TP1"T M,OZ,<49?`29A:Q%/?XS9VJC38MB=WGR*,QI+O=`%^VH?T-,ILI@R+Q`=Y^`K MY=+TB+-?L?OG=#E8T+LZ]JZ363CP&D?5BN2[1.SUN?KZT%`!K*W-/4^6==@:7LKM&0:R$GPP6AM<,NZ<81?BNA++&TXDHYVE)D( M]3[,)_!0-^07F!]J4G@'80I7"AVQ`_K%$!.2`_8*T144N%%Q!YD,5_'MH'^% M[3@P[-"[I>M>HL#RV<*'LTRQ$BPZHTP8B\H0X\\9*^IER9^F#D,F<2F\(?Q5 M&)^*-B3C!<=DIVUL.<'D0V")AAD=$DH(3A8V9O2A=SK*^8L*/D42,9(,]KB$ M(OBM<8A16INU=#B-=)PS,C3'L.^**E3ZP?PV$+.#!OIS9A.&SP%/J!SS+AV' MP%BV^]KRO94DZ[J9993O#.+XUI5LZOW%#*U$H.I7@2%MCR"AWYSE0,#7[M.(F\&9 M'#I]">.:"Y51U$>7*RA>2J.B+^DT`4H.4+4/5N61G7&))CEZJ_J MSR#=7DPHW>QQYF])3F4X*^S)I25Q"V&JZ MV&MAT8;"O]&L5KJ=YGU4O5H%A]J!>-?^S]M2Y:H:Y7SKJBA,W M.^7S?L=Z5LP5`Q4!>+N,#"M9X_/IF<>CVMD:(!_@Q24WGO^S-/0EYL4PP`QF MS$\3]86J1LVCG>E7VSRP)B62')$P"7[UOD`;BMMIX&.D;6BL54Y:C'VR4G"H M5`?Y(O]6/E3:FR(@=SE69)6:@@E$B!$+M*Q\$HML_P;\8E M&I(F!X88%BC^P*HRTHI0<2!2,CP36GY"[PF&(RCE:[BTZ4RVZ)92CO68LN@Y M7,YA0H%A<2S?A)ERO.G+0M3D+HQF8U2>_^K'"\SPH+>MVC[$Q#$I5UA^3$0: M*'U3>C#I(&-1UM254@^5+OE9,[9U(:_P(?+384:4M;M2 M5A65.?00\S+#28)>LA$K#^)]D4Y()!;1S3*EDLU@/H_X`'0:15;9.R8-"A%AW!.T1$"SNYB(KL@],Q547;!U%X32?!4I6FN?W'=!0W#(3&+/C:RM4R*/I=_*W,825_$UA'3 MB\)G]V(]Z>O)2TIHZ_\1<$6WH\WP-A$ME),Y"K!`*(*ATC`;A@/M-23N7JI@ MQW9T:3!&5Z.N+,X*-Q"*?F100+=GK9%6+6F>1:6])A44`ZPP)`Q&H MC83!?1!\0AU:8];E5`F#VKH"KL.HCM>;I6&D'Z#7SH%X4Z5$#^XTXRA8VZ8L M8ORT8L)$TND=5GK5&^4@&F#6)FV=>/)2NA$'U;,],7;KS3%[P'GY(+DLF+2*B?P MUX2(G_:43[#H#_GY2YK<@HA7%VA]$@9)E*3OO?^HUO!_'[RG+)`=)(K&O(LY8)7.!Q'4^'8A5)[WU_./5Y@_>@@T\,M>J[:5 M6J?^:`+*I#7`K&HNSYV'@)SFF'CK#U&I]:7<4\;C."LJ`EB4R4:`^$6524W) M2$))>\_?WZOO[WW<5P1=8544O\!(%K[".'-TQRA00`BZ]*C\$HQ()P6>50%E MGK$66[J.BG?+H%1#D,UWKB*.SE=VN-BYLGID#W\127V>^2W91KP7F`9R&V(H M"34:?`QFA.JH8'#((%0"(8BT7\+=5YT^+!HO_SO,5FSR2WUI74'Q&0,^?U,1 M%&.%&P#'E_\FK$B'->$NBQ%78SH8H]=.=V4L/\9?D&3C?"9KI3"E6_T2T83T M+U)&E6-5I(+*(2Q4/B")N52:2SE0ZO..KV\&(N`GV\F4_]`/.)3&:\-*S`F" MWTA2KD8+4QJI^`B5+3$CQ"0K."B(.T7Q[4X=K%/+/6H8[!L/*C40,/`GG?9O MB52LSHT#>[8*Y5CVHQ`><%3=1JD_#6Z3]`>)+"95%X#;-"ZYG38JZX']]S') MV!0G8/08##QW(U2J\2NTDC];1^!G<.'CIWA^3DL'$'E"]N,DE# M4\-MY.X1!#?GQFMJ!%!*80+@"X#Y['W`!"N8MJ)8!X3"7L)V\I2R MCM3[DBRR??EF5I&D(5CB`5W)5/ZA2#>'7(*6)^J8`U.$E-?LW'G3%"ALI+ M,S!_9+'&R#C"::G67RRZ,:=FI1=(Q8.`=X'6D#+F!;J4/:U$U\3'E%O80MBF M@4Y/U'=8\Z!YE?#OI%5+.I[@+>K"IC">+4!:>H6[3:536&_&M]?F>=:U1?)X M4\P%F?KPQJ%K4Y(-E7J<]+$JBO(">#8B!)WO]J>1F$6\]-E#/8F]HBJ_!31!YM1>ZA/*K_S^+ MA$`G\!W+O+U%S-E&P7"?]0@"9!(!;MXYO#X^X=50%H4$=?(O#S,)WBL&;>7P MK'5Y0&9\<-0OXC+,SG,RUS1N*8Z'Q2MLA1DKC@.Z1_+4S%(C)^.-3ZSSVT%[TSDSL_I2!*#,R_^JS;N[`>+]5V[\K\O M.4IL!?.NXN8PZTE(T]TM2S^"OYF(^*AD2AX@3`F0+@TP'`T7^=`S).;5*?76 MV8=6H,IY>S"TW!%GROU\R)6-_<"!(I!=R#EX6,^ED!.(K2C4*CG[#V';8Y65 M%7`:I<0?X'0RA@`AG&RN4R6/D2326WFF*K]U/D_#_L+!UM=Y'N^)DKUP'_Z" M.&>879NI]-I@*5=V3Z=1(&D8Z^=_[B-9XS08^Y(8@J[6_%AB*Y+M'T@ZLX4C MB7CK@S34+MU;PK9>>RCA.;FUPDY.63K;3:\V7-,;4B8NL?1;2PVWUUYTD?Y M77+!FS1.FGSO7JRU1S'FG]^IW#\OOU&#((JRF8^]'K`S&/U[AMB<\F^A[38< MSB?O">^HG#O8>9/!*\4)^,]/BC*D:SJ8Z"D9S&-,? M_!BGR2(>'D@`.1WW]^K59J7>Z%3JK=;^!X_$#O;YD&_.DYF9`/'J:))ACN96 M]4_TJ6,_CD']S)`_,VP<,5!XYK1#\^'Z0S&H-P&?@6ZU%LJL-07]F#Y@9^`> MS(.UMX/N*,)+>&?4B@8NW'W+?@9KW/KTS7(ON#G,8ZWWB8_TTR*.63IX_R5( M)@H[I/:!\QD)HWSUJCOU%WO('T$?_G&+N[WN[5W,[_8)FGWUNMM- M:]T%6WG`._C$9_P%FPUY7Q#;/]>(X1FO/Y>/,^\FM5"QJ9^-& M]LBR-]5'NBZ!D>$KY7TW;GW,S3$8S]BHSH6+QPZA0W8A*`Q_'M_JPE')!4RT MZ8?PKXB=7LIA-N07]XC`YE[+0N>04*)M]R>#JX?DW>0>CYCVGQ"6#'4HU8$L M3/#O^_$/D[?!'A#5NXE&BIV%PP)*MFS9NK=030_+OD6TW!+4(6*6DWO3=$08 MWG_>W4]KHO+(0:I"+ M$#Z"NO29+M*O./.KK/LL!MJ7UNT+! M$OQ(O.O`1WA2RH`I@"3Y?N5]T=D-/9459=77&>?$\M.!]5RPR(&`Z?@N[!&O M#I,F,+E!$@IDNSA8+GUK.0$B!6DX2]AE6@98P95H/B&T2E$691&IO`/Y@$T3 M9HP=&ZRA)2:GY%5\:XH+^FW$$H+GDPI3-_B`(OI=K5+KU"OUVF-6JT1E(!.7 M`=70.0>7Q/#S0!S8+_XR_V8MT\G:QI*E=J%#SO73742!.W13"-]( M?T26&$-_UJH=Z97,1_<`O9O^">MU1\CW5/@4].!(&(ZLSW+ETR`OCW!OUK@DO4+?5(1,E0]`<'(<,%5T30@D3F/U-FHR'B=1V MWT#=4XKO&ZH8IHYN+M`0ZE'N'-2J?^(K1:GDP1)X0*UYZ%WICG#4CUE,E8K` M^F@*#?P-I576*]4&]:MB-[_NMXB4@`DXYUYBIK^BF[9?>+5*+DG17>K%0]$: M2&'(S->>1X>2IG?@?3T].\&N),>7)Y].KW]EQ.KI(4'O=W74%?RCT5<#8F3A M+TR@C@,+D-;';MPD[/&*O&L)VA)K]JCA101;`*].&OB2IPI*G],$,3H_BJJH>AZE_&WM# M;'6F^]**O_ M9;3L^OOE";RH?^]]_'KR9"'CYR,=P-#]YM\5/+:ZL:'7^9/F;R(F MY5JI(DRTY6>V5FW`;5&R@=M7@G])CR"\AB@AKW,R>4%V# M9-6SAO+!]Q3@)/ZQB3&7T[A?VFHT:$)"]Q1@+%.J%"'RZM:?R*]EL!WK:%#V\ MZ9W4_5%V%\K,=ZV6]=+P'Y?T,_OQ`!;7KX6\-51^DN-3UJ\,&VB48P7NJ;C! MZ8H\"E.8L5N%3]TI554^QZME`B6U2VX$NIRP@HY3>CA/[LZ]APQDFMWSNMG* M,WEWJ=0*>S2\J]?XY?`I\XQW!#::ZA?H&:9>Z.C0>&R?`<;"*-:]U\;@9]B0%*W@RJ'P0IYC)/F[:OAQ]0BQ^4P M1YK3\X!/@GXBYB;OF7#(S$5_(_QV/7&=@=KM[',)@D\FM>O/14ZI5VH@%(Z. M&J:?II)]"C#9P6;6%_Q&-9/I)S=!3G.P$&#=2EE13+A#%T(FNB$IRSU4J*+F M%5E$`G\Z/;9`93VR5=:OYV=?#JY/+K^A\OK(ANOS8TA03LE.-3;JL0+*F$_2 M9#&>B#+W!Z'7<4_,I5S'DO@XY]54C(Z!?L>(W"Q@!`X$K@"+2C']SIN&481I MII?(L'L,&W`(4K*A__+]ZM.^=CB'(-,Q@@WBD]%NYLH@X5(N">+A8@J2NDQ'ZDXZT_A M"V+!DT.*8O\K="L./:4A`I&B*E`];.65+2H.A&&&C$6`(;]8`4AC($XZEMMN M,(H;^EZ]=4`2V@H*3BA.;4//J,H*HB1.\%&:*FA^0W3*VA[#J-1;CJ9OJ7&V MDV#$S=6-QT#")%"IT+D0I8F'DD!P(K5:>H9?8!Y3$#R-)27S\5?RQDASN87C$YJG!T6&J=87P(7!L\X34;4.YZ. M5WN,I#CCJRJ)H$M@]T/)G+L]7)B.4NKX;=;?:PL8WB*FK@#P_AR@=B`&6`D1 M:B9$'>5`5R(?59U#YZ696X@`"(R,3Z';)[-@"^F4T)L3#H/EF_[Q#C:0*KUQ M56+?W&#G&=4,H(_5?4XV]E+5$6)D,BH0MQ;$$AWXZ_S.([IP]-IAZWVM8GB= M.T:,@Z5/J#.12MF[HD^^?YQZV>?W^)1:5;Z(9U1].I5:O5-IU8\DRB\VEB4E M;..*902PU5H)AA7+H:JJ_56S2)!&/TWG!AVFE4B$%TQG47(GL%86SS'J$_7H M*'5H6DC$,0TF MK&0Z=[\@4R,O/*5/$YJ.B3]4H9DT'(X#@1/!UISP,&$P!_-/$BJ/,['.6;J( MZ1?PC`Y5>=H(C2J0YI+],XM\@9Q](U=A[1""G?(B>GJMTEK70>UIB!!LC',3 M#A?8/"NT>MUQ1$X-4R2<>2#SWFL.G6E<;MW]X9KJ5D246H/)#+=G(CVH['%X<(FV$1+=7O53YJVB4E3 M+-(,=6LS+?SQUN-+ZVX%7/]^Y*,_%+5A6B5185MVF'O%X+%V3BL"#`6BO179 M:W*B&!'B7:,_VAM'F[_WKM6AL,2^`A`ECX+ULKCMM>62&6L3O\1JN#+-11!* M(HIT'@NL'G&J<9K>3Z47['L)-0-EG4^9K/ICNK$G'N1?%Y&XG]_&M5[I-Z3M M40$I>(+^7;]5>_KZK6U*.>!!GR?3505;RT440G:[QG577Y$7+I2[K;SP86G5 M?RK:TY5?+:5%2'FWV1`IYEB:,=JJCJS2K%0PA>'5$/PLP4`>)9.[EQ"I?]0)B!5H M!GF>MCG[S79E0RYXC+M,GST+YA[=8?2[?$R2'UGYVA]Z8;>^I?3%;J73:&UW M,3<[AR>JK/KUM?.6[O[/!2BM@5+?[\E,8=>#N%/?U27*1VHJ,!*B8DAS!=2' M21V^6QDK.LI[_21,9%L1K4(_?J&'/N_&_\S]K8^I,\#@[IDE>+9MG_[Q]\O+ MD[/COWN]3W_]?G7][>3LS3GVK4B3TZI`1_3L$CGI_87-,N8%+@UCN2,ZXYTT MAQC?;)4K3R MN1*L&/F$&E[*$#.F$9G.'#5&H&JU:&):[$#GZCU:RDB2\@4:T\"^J.$,1B:P M/O=H$+N9AO*+U7W=T$<\LTX3@$/0&$S+,K<&49NLHVB!=2;DJI$,H-S,:>": M=^C2&2$XE?%6RA=SLZ\R4=AAR@VJT1NK#YXP<+G'B_1"E:[;:-"_JV/B;Z-; M*&KNER)YN:,:KJ/G%Q/I3E1+[:>40.MFQW5LL?3Y]/^=?/)Z5U\_I?GZ,'5V M0$G)&]L(#S)D8(FP3?%__M;X;1N;PR+9X0^ZAE*=AKRRMM&P_@ZNN\1MMN)9 M6SQR`B'A,[_W#FI'AZV99;KA9X`+Y+`[MJ M*X/WQ3D[-CE^RS'2,^(=1+D1[6_:40)WLP.ZTE9>LK)MV7\.XF)][MBI"-W< M<[&)[^212'@^M[O.9[7A"=K"O.+%P1:^S_I&[+#RSM%0WC!9@!96+O-V_PC6:N\75PU88/SG:2ZA^6+#";AEX M@K)*-"WTQNDO[)I._A]NRO.SE8OV18.I^V,#7.5"VKK)1J93UI-VFMG((<.#'\R3&4PP^[GD>5'3ZS>: M/F2Y<=9US:R'\5JO'C:WT(P4/1WU7?@K+L3>[(.1/PVCN_?>U=VTGT3V'!UY MI_!CYA$K>[M[)EVSM6XB&GF*)=TIGW\V2Y-!$`PS+I*B2/)]Z)P%+^J_3_V7 MG7K=/79*F]-I@>:09VF(IRN(@Y1I&*0WU,3%RAU,40IA`(B!.#!6$47!\-\< M\)PY8`.0A/S59^!+::A(S00%L((`(0HQ($P9?L_.S@^/SL^O+\Z]?3LR_>Z=GUR>7)U=,%R7^U#K0! MYG]R&V<>@4D7ID,O(5,3?:KZUYLOTIB'0+CBP(??PCBE`,\54S%V7P%#12H8 M[/3H/B>71*$OB;@F49K\%R?`ELDT''@GTUD"UY!BV^D"BYO"ZYVOD?0OFDV2H$I(-VE]&M0F!+B032M1VZJ6\DP?Z-I!FX M0L6QVS\4@K4A\,U2,+^RM!8M,2<^%\;1BYQ-L(I$=' M0?459"1:^:E.MW:3]PRSZ97*/[:VYLOORG&NF*31W MUY#:2X7+A-5S/L+X1?`BK-M:S3%O>Q>GU[VOI___Y)/W]:1W=>*=?_QZ^J5W M?7I^]G0)",]'UI^ZF#CUO)UK`+J($"R9$,Q=;Z_9I>J'?8&Z)7@LO^+Y-\#* MPP0Q>>'_@YXEV5,A&=2FK(G:B#N(*E20">IO@/Y(#Z%),M9]4BZ=((G,`E6* M&[]KN2N8OB.#:IM'&G+$[LR_HRQ!/R)$7_SBI5+A]]XUJEQ9PK`BL?HDE0L% M4KZ(.O_1GW+"SY1U:LEAVKRC44?N)I&EWJ4J6MI[=R0SRDS4&WMD$417!J0O M@$AW`%IU$M/->`&1!E0EP' MN0I6C'1PG5O0T/R\%.@F][&(+M/V*6N+4*1\]@6]D?JUL@9Q,A.T3/]C9'SN9LT1VB9WM;(6<3&;M#S_9*D;.M3.G[ M5(*\#G')2=P7F+U];?E#7X0V4;>U"1LK]^_>]67O[*IWC*K$DVD23X>9HC`; ME`W!%=@*BRD'','*0T:UE@OJ!$=H/,O@8:XK7:7_4^*_XTNWFVW<4W'P1N3X MW19^>]<=MD MGN[,11>=O)KD=PQP!-)GG>".CNC(:^E<944*P2'P&]C,!Q-D/BFZ84HHE"#H MLK&#=`$X8/J7M87K%T4JJ4;:)E+J1P:@_3D!MGN&:NC M=A,'[^K[QZN3__E^U?'WG4R"P=>I]4BJ8&,F6_(UP\0:"L#HXG*;J@##;J=31>2I=GA+H8: MK,B"'=.W%830*$0?V+-[19-(38SK/:"?#^9WL^`]M12<^I&."G/<6*78.:-$ MH1-]M4/*A7E[;GK+N>6D;#)6?PF"LX:'T1!66OC9R3JV+&I5&DYG@1D>]CQS MQ@=^R8(H$EE<06%,#PQ+I;%V.?2I#P&"AE)MW]Q!`,]T;24.W:BRGB:Y``HC MANHP9TEL27`+FZIL;15DN3]`U322FP&PCV2VX&^]G2GL%W:B4UF&CD-F="@WFL_ZZ!O]'C:MF:5R_CAM- MGN_&+-AX'BRH6A@=%7%@&LPIJJ.:+16#P;,"H)#"D[(C'%!KIT"W=DI,:R=' M6NEN2/?+*P.IIAO,BFEME>&[ZKW79^1Q!"M'24N8FXGV\GI)&HZY=ZIR5*SH M($486U.\4OG\,WD293<*8!J-"Z(8F=72104GP!$,WGP&#)Z+P39=B!35 M(L4X8MHKTLR().>US'/NP,\F;GJIO-HOX\!:S_[`M#KD0+BVM&:D(^A$#5UM MC5%H4)Z+P6T$TD;)L0)8FQ7G9^7]E1F\>Q:P3%0\YS1/F9'<#ABF01AU5 M[YX:1PN)HM73#Q9YCRQSGI]K[3.JB0KR25O6UK4@/6($O)DM&U0$2C,DUWL4 M>9.0LKJB$+:3N==#[.Y4FE\H4VFHTJ*H2Z-PM%/JEZ2,DB-IODA`8(Z(J4C$ M*3#G]*:`NR=8[83Q7DV"B!NOAJ"`,W"37FPA1Z_%L\MY#_"X+H++8)",8XJ5 M/P\F%[K(V2Z$O3GVMOU78I8!BU(#(@D0I[)+*+Q-\K+RHG$R(SUING,&^S&P M=4:F\._),8*CC;#]!3DW`E\2'ZG_%)E1.;"Y0T^=$*?=X2']2U1[>B$DEQ!G M(H##(`*JK>#2`!::P%..27<#IY]'N>_B8G(W3T8(@R-#`4J_@;)6[E36 M?V6S,JN-NR*;'S6+7,PKGZEBIJ4@SCU79NDQ0>#M6#R=EV'VXY@*9_"GIWI" M;(IPPYDBCTAZR]<,8RDQZ!ZFGSIZ5PY$^Y+8*FI@`WL',ZM];XI;F"T&$U3D M1HRB9XQ;RJ]')JV(8SXSO\*G@Q06_;5),!QS6YH4OUW>_WT%AZT-T_<\Y/Z% M[60-%&V_Q)IZ/@GO)9N`^H&+R$>J!BO/%FK3DIHL;0(X^]):GO[)?6E(WV9# M8N50@OO)6I>5BLJFA107J;X$RJ@8HA4Q6D1>1*^8"'N51.<+.(UX(]DAQ)8) MZEC8&04]GMP2:^6)?<-N0-A!:!#H;C[2$P5WCK4MR0J@4#Z0<4>_U`5!7#.3 M@FEZB^TWR*\QQ>T1<]?NU:32Z'EEW((!@PVX'NZ%9;)B"X^@9_K$P$8%[#&; M2^0710/8DJ#[L:MF5L@@RL63S26U4?9T7=;0`+,P:7)CUP=HFXTA7N\,_JF' M/6Y(Z:5:JLPJDA(#7NQ-UTK=#.GBGO?U=(K'BA\\3S_)+IV/$"SY*_JX>L13 MST.\F?,V1./.(+$'1*T-MOE[:V8I+)4M.RCBPR M,Q$JCEA:H)(HT'E-3SUIS(,PA;N''>RYLD)X!M#(<.K"H@7=B MR7>7E7DF-#^K9_*VP&_@T\21PEO6=U?!SZ6;(4P[4B?X#BHK-A;JJ)$GA30 M]WA!/@MREO.W)'ZXF*,4':JTTJ';ARU;)S>42S=0C;2[@UO=E:U)^*Z%HP,# M8\\7C[49[5BH="7."3IBCF3VXJD.:T">'0@K(`V3?PL)6TT7>UPLVO#=:32K ME6ZG>1]517?^GONZI'M13>FU__-YW&LFQP-Z7G\(SLIY9N6%23;+5_"))!B@AA7TKC=6+\6*FT MK#-1%M_0:OZ@5`7SJIN&%N0^A4GZOL0D5D0'4=!.`Q_#@T-C2W/68>R3#85# MI3HR&?FW5HM3:@$?J^BD=KK:E"H;=R`E`^@"33-45CQ.0R:K3P?OPDPW>#2. MW)#4QRFV2(S"'T%TQZH8:BM$2H9GHF$V*!;(\$##I4UGLD6A30-E#;_JRSE, M9O-`]671W2_M1&ZB)G=A-!NCQJXRR^A5J[8/O0N-PK7\C(@T4$HN;+T3&46. MR5M?&IY#*;"?-6-;%_(*GR`?.WXB9:WR6WMLSW?HF8O:LT+OCK1HMHH7OQRT MTSI\5A;QEZ*W.?,@KA_45HX?88]K:6.N+KE^4L4)%=Q0ZCTR[&(^(2`2ZX$M MO`09G+POO@X]E2D/12?08AC.#[W/*01 M3\F#0H18=P2-(!`L[N8B*[*'3H6%%VR21>%4VBDC/V+7\("ZT'-ANJ_4*#'D M0BP1PG7I6,EZ%]==T#`<$K/H8R,#3X("&SRUZWO`PS MNTS`T69"@VGP_?#JT!L%0X)T^`-L@6P8#K1/D[A["=OC&I_28+R(Y.B13?'Y MQ*HX=X@TR)[%[WAQ M1K"1P4_,@<*O%S@)R)07MI`;H?*X98L4>!*D+9^I-+=?/(R@/WKY+)1US8*SQ1'"\HL M3V6ASJ)9]/Y\-/K(L=LK#-L^#R,5B#H0JCPBR^M9`=X7;[72%+\'#,P3)W8` M7:4OEL6SUS@SYWA/X-7%"/F7-+F=3X0QG\UAO]C MH-NG\#H^*AV_$\9#!/^4=HC&E@]D!XFB,>]BKOZC\\$JW4/`+N^OYQ^O,-/U M4"$E`J%MIC1X\ZI@)EF,PM/)N M^?U7-AFKKJ7KJ'BW!-&,:5C^G:M]HZ^5O2QV5J\>64#60#_(`NNW9!#Q7F#* MRFV(02M48Z@N+0UO\"WDVJ7JIJEHFOVE&Y2H3;/NMQ%$HT)S8-RN=3G M'>??#,3#3S:<*5VC'W!`C]<6IEPJIY*,Z0+9*JHX#95Q@.2'ZJ@"*2X6H2R7G["5@PSJ\0"8]A@\;D;H5*G7Z'9_-DZ`H*` M&)$G`S96'[2X?ZA*4SQ(.H3,";!BI!* MJ0G0.G)`S[1S7*$*^(BJ'\ZH9-DW.4Y3PVWD_Q'P4.?&:VK@-G!\BU*+*)Z- M^?K*F.CC#WA]$#UT>=J*U4U[3]`-II0DI=Z>9)'MRS=1#E".$RSQ@*YD*O_0 M.9S&W69N7(5TX,RA1%:-8DAO<,74AX%53NFR!7NJ4L^"+&8]\I*87^HVXL0N\FL^[HPT&9U&QU%OI5`1!IOBM%3K-A;=F-FS MTBVD`D3ZCG($0LDZUJ2)F$P`[I8'(G$5$]A=NUW19!E*N- M+OLG;8#TX"F^!C=!Y-5>Z!+*K_[_+!*"V&2(FKU%S#E/P7"?]0B"01`!;MXY MO#ZH24@^G$1Y\B\/,PG>*ZHBD7BM=7E`9GQ8AD##'$$G?X[O42008Z!4LH5F M+#R.\,H1O53Q;+%9_84N85TVHW,$D13Y:3%7J"P@E_\^@'C-#V/8Z[XQD9]E M($\S,64&TB0?E#A3ZH"`F[M3ZB]:TE.Y]9??!G[F9%S]52XS&QK="5X@R@1!Z3+3L&#EMQ4NE\^;N.BCXV`>TB!<[XCA.@0"L5^LY5N'B?LO MD\FL>])XH4LHOR??EY_E%?SE"N1L,9,2^CZ6VV+4F-JQ)%HE0T97VHGYFJ4C M25#.O/BOVKBS'RS6=VW\@KXD+;$5;!H#,>M)C-/=+4L_@K^9$/FH9$H>($00 M7JQ'P?@T7.1#SY"85Z?46V8PDG=]*.56IK@5=BG3B MQWNB9"_<%X`53+3-5*9ML)0VNZ?S*I`T#/[S/_>1K'$:C'W)%$$W;'XLW>6` MXMF[:;"*-U:WM6\2[8WI"Q8 MY*%CL+SX0R=2JY7[XQ-Y9BTJWESFN+WVXEHZ54)7R!*;G&Y!*;6TE0)>OK*Z M=)VGYZ@1G1J'G]V!Z@2N,FH43^K,-WT]J.+:7LF;8Z&E]GUV[[R["J;Z'JI* M&Y7I8G5D(WZ+*;Q$C1J6^AL'"!!ZG3K&HH;)U);1-#1UKD`]A3T8_J`G8%[,`_6W@ZZHXBVX9TM$+4/+MQ] MRWX&:]SZ],UR+R9^BCWA'FF]3WRDZS1&15S,U:NF+JLO\Y!+.[KN&SC0TG5C M:UB][H*M/.`=?.(SOJ\A[2];:$&G[[?V7#[.O)_7L@>@ER'`,I? M0BT)[NB7*`$KV#N)@W1\YUTET4*2C[%A`1Q_@#YTK$`!`6DA#1+"83"@-"?X M"]CFH%G=2'G[($EG"7^RD@N\:!,2L_.*VS4+A]E0:$/J4X0`]LM"Y]#K19'C M1J7FY=(AD#N78SU!0M@ZX_`FB'5`#"L'^M@-4N=_L">%PGQIP"/%SL)A`25; MMNPER#R-J'Q8]BVBY=:7;C#L)E6[.?2&]Q_WL^O(\$B&9Q1Q*KY*SU.^&TN_ M#["\([:RCBV-WTW)=N"3'FY5%G8E?JI>6 MY25((:)XJ#AK?LNMA34L_6ZNN,4/YYYUW[V`PM\ M!\$^BXW>Z?%%KZ+ETM7)L:X!Q8Q"C?0;A<$-VUD&IQRY`U\0B=[HEP;1>@;S M'(;3G[6"2=HM\U&1#[-0*&TJ<):ZT@TFP7`1!>>C3T%_?HT&WW-2=E9*=NY@ M((5)(,#_[>1]!D[>;?P]_60^3Z:KO+K+GA8ANUUCY^Q7Y(4+E>JRMF^W)K[= MW)ZN_&HI+4+*N\V&2%'=,F.TE;.YTJQ7*^UN[>$$%2]NI6=K;3_6-D7;_NLO&V>0PA>'5$/T(%HX#>60DNI<0J7_4"8@5:(96 MASJ";7/VF^W*AESP&'>9/GL6S#VZPPAA]C%)?F2K/9P/N;!;WU+Z8K?2:;2V MNYB;G8-QOUH]=58\UVL#13^G!_YS^--"#7;!D2L,'&G!WXHCU(;`+4"-X\X0 MU#=5\H:LI)ZGT\6?\E5^V"U%C3M(-Q9]#Y+/L$38IMCN#KB)*+5(=OB#3.#4 M^PO^`7EE;5FX_@ZNN\1MMN)9"W(Y@9!J7-Y[![6CP];,>I'P,\`%\MN<`G=- M278L#GH&0?E%*W$=T.%J\%QL]8Z_.!UND^.W]+V>A6[^R1+M;UK_@[O9J70; M6RG_9=NR_QS$Q?K>SVO`$;6%>\>)@"Y.NOA$[ MK+QS-)0W3!:@A97U.K5SK=[BZN]'W;LJ8U<;^%D+Z8%+WL?&29$=XB#OD/WZ\^_:8ZJ6:H]OY?,'C!WC6DW3N1 M`R-T3!#)5YB/@/Y<5K37LVU6$=7N,E%E;:'M>*-P(FK]D;\0T;_Q]IY7GL33\\^P]E6Z?_UQC^X@=L_C@UD.4Y] M'@=+I"_?C)I[H+E95Y_8.?<5C_"W/0K._DH>75Y+M]IN51ME!U!`[4Z6]R0\ MN+SX9J?>;74>L'@M\$`T4Y[3!65-V4SZ.4FIT^EZ$GDGTL;RF*U-WVY71F?: MJ*GS!5'?7/-\MUQWN[K3A5\&NF4J:`:7U,FJ8*!?=*CUHE-=D\35.HR269=@ M@-K?W2@X2,?%P/M.]LP\['`/ ML'90;UB6^\19,@]^)_S1^=;ZY\X6OU3=B/!%YR.A[SR]1//OY"?<[C`++A#; M0?\QD[]F12K:K]PTN&D7)1L'LJ=F)=ENL;@EMG,7\LFJ:WXF=\^-=5D1K'4# M0V26G\?>YZ"?4M>'9D7Z%]N)9L'/8+"@6)`<-PUJ()Q,L+DY+TV@%NZJYS`96O\-8-]@L,VJIP+ MJJK=I4,S)E`I+"LB@9=E5>R7K:V21VA/@W&860V-@6K5!GLBX%2,JBI]D'23 M`@N"517,GRBD-[3)PRPK2QLOY\:E@O9X'@Y#S/:_"S;T).]V;81"^I^*".\LK)*^QU0NL5/*W[E]`K=XZ:E>[+5`.UYLM M?VZD%F`KP&L0(;B)\`8J(;"E$Z_;:;3:7>O)6#$'D/-__O*SGT;A>_PO_/-_ M`5!+`P04````"`#==5-$3IB]49D.```1P```%0`<`'!L<&PM,C`Q,S$R,S%? M8V%L+GAM;%54"0`#,0H%4S$*!5-U>`L``00E#@``!#D!``#576UOVS@2_G[` M_0>>%P>T'US;2?>EV?86WKCI&L@E09(N[MM"EFB'5YET*3F)[]??4)9LO?%% MMF7209$F#FL8\(HQ^Z@S>]3L(4Y\%A,X^=;X^=(U??_\;@J^/_^AVT17!87"!1LSOCNF4_8INO#F^ M0%\PQ=R+&?\5_>F%2_$)NR(AYNB2S1]\9L;N@2VYCS>\%N$B_.?9Z*P_.!^< MG0_^>AZ\>YV"!B,OAK_"Q^_AK_TS^#;X\#CX^0+^G9T;/BGVXF6T>5+_]9=^ M_WT?OM;D'T-"OUV(;Q,OP@A@H='%:T0^=7+ZO9R_8WS6.^OW![W__/OZP7_" MLGF MJ8M0]&`R(2S&_A-E(9NM"/6AH\Q[HFT/\%K.,8V'-/A,8Q*O!'A\GL@.^B3, MGSB>?NJ(3M+-NHB0X`<3VGBU@,$3$='W.ZAW&*%_]T)A[X@*_C.&\5&!I?&$252P;P^S)8QH.KMC M(?$)UMM:3]J*R-?,H]$59_-['`+:`8R=V$!<#5D[HA(*R%YR')!8*U]-VU:$ M&N$)#!#HRIL(QAJ7+VG?$KAT]HCY'!ZJMUA-VU:$NEQR<,_^:AC\=QG% MPKWH1)-3M"+@%7G%P3"*#$)C3=-V;,;F3D,S,0K4!:2LBY]SJZI&#K_5\ MDX120]92T)M$^/L21N7G9Y$KZ"-=??MC1^0#1.8C1>BM8WX4(<,@.,LHVO:7 M9O))"5JWWPC''@D;&;!$TK8%#2644]C)RV\\+O[PC`WEWYGAT;T$9R!BO!)3 M].]+LA#91U-E#\3^V*I_]CB%7Z,[S!^>8$I]0+5-61\?;6A)X&%BQ@N=$CX. MDNYY4,@;/N.8\[ZF>C9DT_J\L+'\!K1'F3Z&_#!,L:\+%@V5]_#5`7953Y'^%!:,T"%7@<2Y/Z^D5!]#.0=[/:#3]OXS(. M4$J/4@:IU)G<(?,+LH:B;L5X$?Q4U*0X-?6B25*A6D;=F>J)3]'`81]DG M23?I]@=IH>J'].._UOG^>C5LLV(2>A,<)H_]*VU7:M:S)[`H&D#_$?^)[/;9 M"T4_'\:7T-,!HUE2TY0K8DA>5C#7DX;<1XP'F'_J#/K][$D>]PL]J%HW3%OT M(I'&"49=`GTCHY]"OJ.R>&I=MHLR>61`B@YZP63V%(/\5I$<4^&B&%_=8$7/ M*[8RP^7,,BYUFCEG_G06$=UC'T/7$?D>CO6.0$EE!L^Y97A,-#\!N(K3HQV0 MDS`P`_&]$>GH4*CRSBNA.)9##40N6:L4=XP2(2ZVQ>:N9*L)&8OE8I MYTQ_&S]AOI;QAE%?YZ4DS5T)+!(HE$HZ!TFV0'P'/G]Z@8^#!9>Z=BOPP0I:[.09-LPGEB(5@N M$@M#8E^"'RZ#9(,=3RP;QYQ,EK%(81Z94$E^W*`*Y:'X6YU#;G8KZ0KLE9;V M M>.>18$S39$4Q]901V$_%6L578RCG@+T7._DH#K+][C##7LZ7R41AA*?$5^5V M)K3V,[Y6X38WGW/()YM24R0VQU:OEM1?=U\Q7UP(^]!9=KKU!L>WTT?O5=XC M]N%I/Q5MM:?L;V[G>E#57DVR5C=3.0EZ!^X:KB%YCP.,Y\G>M5K!URIG&T&' M<[$(JXH+NW!S,?&3>OW=S>4<]KD)^)`&3<:TGM+^"#?53KZJW0PXJZN_3314 M-%0J^K%7UO,:?K=Q4*+^$J7"J8ES\U,3Z$V!W]OCG?[07+944.B]2J$M(W0[ M13E6]IS+%\XB<81XJII'%!I9C8+/F"Y5U;EM"_N>K<:TE3!5U,>YT'/)(DAQ MOS`61`_@B52+1J6&]MVNWOP2[6I0Z%K>5+OV%'3V^76!::0:`#5-;:8NWH1Q M"'II93.529&P2-K;'\Q2",IYB5)CYP9X4LQ,Q*6Q%^KQJ6]N?[`;PZ/2USET MOL;9Q@WP5(I!7VYG?PG7%(]Z#9T#8DRC)1>YJ*@.D"A25U#J6]M?:#4%1:6M M<]"("(\3&;U0'(X5DWW/CQ\P?R8^CK0NS93>_NJG*7S-+.(<T[(!,0)?H9.I[CSS--=%(Y7O?Z5R:B MN!%1I.Z$+D'T:MFAKLOI:>V[$G,-2S#60^T:@`4I]]M'O`,K^T[F,/#NN5?# M%M;B.'MRVH7U-4*/#_:%[@%YS0FI75@"3D@#GR,P'[ M_+[Z&N%@3#=)T1`P>]:<>6W"PY78N_-DU,KLJB%$)YD:M;>PV_*L:3]P3F+% M5QS=V\Z_1]CGHE`*/GX&\8!BU7`R('5BGK@OBH8&.B"TU?N>Q2?Y@UWC*%KF M7P&60T'XA6;9[3$=HO;^X-KJ%QG`/5S:E@FP72O:$^],S0";]]Q_'"(_H= MC'I*,X1_<1EA4_.<`*[5>Z6;8%M';8;OA]/"5VZF$\`XO3FY89J5T1BO#YP4 MH&6;G`",V6L6&B;,!3)#,)U>[3&RS`G@F=RBG5Y)I[NJW8S:$%VGEXN:V.D$ M0#:Y_'B7B*OF9]@1G%YQVL^6)]`U\E?S-KPW=2=FAIW"S96O?10_F1ZQMVO8 MU1&&Z($TX>%L-;,YON8FNA M=L-38A2G@;PF%$?Z>[L5),YNM]@-Q%J#.`WAQHWP!R\$9Z*[I\N$UMEM&WMZ MVEH3.8UN_L7QYJZV2N7LEHW=$)69Q3DLZU^C?8M MJ]M,FZYD.'H6MSUCJ&92>QBCS6#=GC%4CL3=PP`W7KSD.'_5'UCG"Q,7_S*( M6'R[B[=P,.`GU$4C$ODABX`K1A<#0- MZMYA4Q#[0T5L($E.E92R_+9%A5@._@!D2(L,M>(.^F5Q-V1H0W>\[E$S=R]( M.ZCV">C(@@85<[.V1ARX=3NO M-_>*+9W2MZ,5=*C$RAP'E+!`M:^':UN1_!PFMV^U7HE*>,Q'DQ4JT!\OQD\B M_'T)WN#S<^$BC8+DE9"X)4,9G0-9B3([&50"I#H[06^RGXYXA;C$7JS)CZBY#D7KQ*\$DCSCMZ"V'F#C\2K7T*)X)6`6K9X2OW6XM'= M9.-7TQ<)*HF<.6%H^J8*-97]514#B)0'"4_D%11%H;]2;R[>J0+!6@RA)@C6 MDMI?#]H71H5%-.5OJRL=.2>O=);*=-X)5RG=A7"#U>OS"BJ[Y89ZP9+[#G=0 M**6S[S!-@*H6&0R,X9S/++QI;GL%`/P>(=^ M<6@#N^RIM6O2-Y!()">EE8Z\LMYAMD:-WFS8O\VY>R?FB"FJA2YC9(O*.HIV M_I@^*K'/YF%O'39.]M++.\R3=]F:&::R.*,S3/88!,]!R8-<-LH=AY8$?(38 M4[*YO`E$,+-.PZ*(Z#;9\Y+5^_P3K9M)4D@QLT2#PHIU/7/E%C/E-.47VPJ5 MBS)&2IWKBS2V]2K,P8QTTI1R;"N4*T&8Z5.M].1*$M:UD2_TFVE7F4DJ%_YM MJRLI!YBI6LFUI.4!VVJ6BP9F^M7D3Z4B@DJO-)L6WR:`.GSR?U!+`P04```` M"`#==5-$1/$T#JL6```:A`$`%0`<`'!L<&PM,C`Q,S$R,S%?9&5F+GAM;%54 M"0`#,0H%4S$*!5-U>`L``00E#@``!#D!``#M75MOXSBR?E]@_X,VBP5F'MR) MDTY?LM-GX=P&`7)#DIE=G)=`D6A;V[+HIN0D/K_^D))EZ\:;(XFECAJ-[L1F M457UD2S61>1O_WJ=^=8S(J&'@V\[PP][.Q8*'.QZP>3;SA_W@]']R<7%CA5& M=N#:/@[0MYT`[_SK?_[Z%XO^^>UO@X%U[B'?/;).L3.X",;XG]:U/4-'UN\H M0,2.,/FG]:?M+]@G^-SS$;%.\&SNHPC1+Y(''UD''SXYUF"@T.V?*'`Q^>/N M8MWM-(KF1[N[+R\O'P+\;+]@\CW\X&"U[N[Q@CAHW=?#/_OTG^'7A^'G(_IW_T#Q29$=+<+UD_9>O^SM M?=RC?Q+RWWPO^'[$_GFR0V116(+PZ#7TONUDY'LY^(#)9'=_;V^X^Y^KRWMG MBF;VP`L8/`[:2:E8+U5TPZ]?O^[&WZ9-2RU?GXB?/N-@-V5GW3/]UHW6!-G& MA[O)E]FFGJ#K#-.A=Q3&DEQBQX[B@2CER.*V8+\-TF8#]M%@N#\XH$"&[DZ* M4ZQL@GUTA\86^Y\.J/53YSX;[-Z3AR/D3`/LX\G2"QPZIF:[K.TNA78Q0T$T M"MRS(/*B)<.9S&+>J3QQYU."QM]VV'@:I*.)*RD;(1A-H\10S"\&=_,V1)' MD9,J5$S5.*,G=C@]]_&+%I\EHD;8O*;+(D%9K="I\3NF!N@$4WB)=$8I=]", MEA>SF4V6-^.1X^`%G='!Y!;[GN,AN:[EI(VP?(GM(#PG>':'?(JV2^=.I,"N MA*P95KV`(GM"D.M%4OXJVC;"U"EZHA.$CKE;>VD_L8XE2SZG?4/@!I,'1&;T MH7*-5;1MA*F3!:'+L[,T7N*`P53&-%TV9TAF( MW$^I2UVCV*I=MX\V;>G1AS&/EPY*^K$;#\]:(==\1IM^GZZT)$D]T\:?.\VKZOQV%, MT#Q?`8Y&NJRE-*V.232V%WZT]:!,R?,\TX^]P&-+']W)?,_QC5XC%+C(33EG M'=:;UJ0?LR[WDC]#:V"E5-D?Z8.LI`LKUT=+@E1G+W.<[U-VU[DN^O-F5XY< M:T5OI1V88+LZH9F3X4!=!NN77'^_MB:3).^9D^>C2)Y-1];-V,IV94"2-E9K/<#O>*W*[)K#5=:V.C(F.;8W98'A!T$#,:*R%JB5-! M`C?'[WZ1WY30RE*VQ'15;C?'[4&1VYC"2DG:TFU%OC?'YL>24F,*:T72EJ&1 MY'US+!^6S$N>VMJ0MZ5EA3QP3H22A\-5I?S?5Q\_KMU5MD6_H#^NY?7M)^3'SWY<-:YJNPN` M]8?LWE[`]D-^+U\>:B.2,K^*UBF&1),0X9%#MS-T<)[Y\=.^[81HDMT8CZG3 M)M7G2G=8*$%6P921'0L3%Y%O.\.]#2]T8"+WVTY$%A4B:Z,4(N?#!#_ONLA+ M`*(_%'&A'SU>HHGM)Z'!T:M7-99HJU*C6A&I3%7($,@K%O-9Y:J^124G_)RN MOCL(*WNC2;9@9T%Q9MU<=2\+1_ ML*WVRXE1]LGCJ6=3+]6]LP-G>AFY+`_QBIP%,X;WR!YC[%X$SM4J_572/^M" MHX?'VN')I^YU&QO=8\7(;5683AR?BR\,%%F]4J_HN`2`%WU M96QSURIPL+`?"4+<%4T@:8&T90NB"($=(E#@4$5B#HYE_1CS_=8C0+];C%#[C6*Y`.BI@=U9J34*2]O"'TT'+#%SO<+RBER M3Q>$IF4EJ3,]R9(G?A4P/'9526 MK%'N`4P:1QW/XA*@J:TV$S[;CX$[.Y@@<4@PT\1<$%!7^9@G`DR7*V:0&XW( M2G%5>.&DW2!?69$5BL[+`2Z`IZMKR$$Y#3R:";C5`\D5U>5L,9.!DFO6=LI( M,,*QF$N82\Z5_:JD\VRS!J9"74HOLJ MJ=P"1%OOJU1E4IA%,)TJY;,V<@Y5J7Y9YE"EC['HO2?#CB->1'%Q]GP[[,&980&@I) M*,]5K"M,E]9WY<$^FC'GJ;'-1M*]*3>\X9UO?;KIK#NO?WQDSJ_7/.B")4K3 MY\5G,F2?",_!O_("3.+#BI):&06/74!B-B*=XTKB27.:@W&(I;B48]A\\?M7 MV=[L^HGUV[_1UK_1)E,K2&\$]AMM[!`*NGNQ";6KYWA!A-7_U8T!OJ?&9[3N MM4)%K70GHJ[6=>/6\XJZ>LUS6GMJ44&S]]ZKLF+7;5M_2453KWE&N:MP@VJ] M"=3'Z[IMZ\Z=IEKSC'*7UP;5^O""E=6Z;OOX$;9:\XSRU/JQ2;72ENKC-=/Z M\1"X:@NL\I1[:+AFIK!MOWD)$`FGWGSSMLCQ,CG<5=U7%'3R^-E,%.FM[J), M))AQ124IKG'@;`["2YJ\$>NJ+G\JY+D"5C<%$[R1X%*:D0/!NE)C<3S&)UN<:TJ>)BT,X MS8W%]D3ZQRJR.8)5F`;YFJ77\33W>T=W;:=C^VT(0J!.2=00NJ0C<,#:,$(S*];"YN(OD M-AMPL9:LA.>VPTZ(62I$7"1D)C>R%9Q)HB\"$C`Q&"6F2JZ$8]AMQ=$ MRN&8ZM;&HC%R#(I."E]8:%O2(J\RKY_7WDQ`1JAI,2C`PS'UX`(Y&/-F[$"' M8C)+AC044VIK*!0CF2)\PP0]$E.U@"?7TD7'F!#\PBZ#L>?T&]&1I#J]M%Z' M4O,60RA7=T"^"!S"[FD[1\^3U[SU%^?TU"UEG>NB0BJFH[Z? M]%0F'L7CET[4X8BXA[E8:57MU53?V$4P542"&8//RY%91MBZDYQN13]A&[%S MQ`K]E%%6Z*J+2*N*!3-.SZ_B M3S[\6M.J.TW);DU'=E!W9U1^%=F#R5AI7LE9)VHUL5:AZ2??F\1%C0HW+4B)NU!HKRA&W>LB)R>2 M/8!!EA"I;&LJ&Z*F;- M^99@_>_H3@`._;;U$[Q5QCNN9I-K;>M MRTT5VY_Y#?R4^B*K7.5NNRSWY]0+7RB#5'S2Q0HPY4CU3U7\I976+A%V#*MJ M_IMT:=];5`-0Y;8E-JI% M;9!JJ$[P,PKLK8"J(.T88#P)>,"9K:DJ\&X3LO2"B=YF+D_5-;C*S/.0,EM( M]9XJ^FO8\.D6\W\!!.Z;#R/N%FPEUGD8?05107>"9S,K#B+OKRN;Y\[GV5SZUY/_NQ8.?=X=DL+O"&%QOL";Y@&J"_P5A,.J.FY?-LYZ6U7C&U3O\UAFVMT#!^W MQDQCG(IQL^?*WD]M@L+D\W-,3NQP*G*25/LP=0.2AHNK)0K,G<0MP0Y";GP/ M->/9#AQT0^YMGX[+9`/%QU)."QY#11%@[COB`7B'Y@OB3.T0N:/`O4.11ZK& MHV1&*O8"'D]M8;BVSWBT?7/XR^K5>N1N(M+9149PDKU>/^#1W4(<'K[FRP4V M@MP0;^(%ML\^3;)\RI!6D'8,19X$/.`.8:18[+D7)6_=7;)K,3*OW:FE7`Y* M*9=-CU;.'Y+O5G9=#DVYDZ7V%[5"KXYSH&_4$+_4$+ M%9KO#UH`C@+D'<#[.VBA[?L?MCQH07C7@]FP_!UB9S*YMS:U>`_$#D+;B8,X MQ\OL-V([H=,';"NBKPUHP?@LGS*'IZJM&1NSA=[YP`'W4=^&$&3[TP"*K9XT M<>H1Y-#&LN/@2NU,N2J"48]E['(]$[/VZ"::(L+>Z/"BF;R*O;HU;!LCDA!: MZJ_(JVR]XK4W8U6$FA:#`MR&U(,+9%OR9NP@1RPO41@BQ!*G[%590DWE)%9+ M>$/7&CNB'\9)U9"=[!!?K!,1:DH%!85;]??X&7CN_0UBP0R$C@BR;\8L9,O' MF5]<`#E57%$B2I:MN@./)+;2P73"U[5IQ2K7>1WVPCI MP,.HP#[0?69^9-VQ]]1>YW0K@:ZH+&?O$]D6>@&(/X#'4$H3KQ(&H.^/$ M`]1JSCX6:\Y6O5EQ=U:FO[[>K*\WZ^O-^GJSOMZLKS?[R="$'*%YM_5F6Y8S M=;R:"6Q0I<]@UYW!AE.1T&>P(5J]/H/]\V6PNY7`;B#:S-'HS7CL.8A0RWEE M!_8$$:%>.:U-'>^@IEX1TUR3WU<)0*H2,!MM[ZL$8-KIODK`4)4`QY:8^ M7K*GCR8$)3DUH3GA$YBR*)(9@)5YYQH6PV?5L:1+?`X'2[*L$B^BPHN*YJU? MB:1?5\'C&J:'7QIT*ALU,2`<>+`7V M%;9M!M.TC%_T8\$2S<]LM*GE9P^+^=E--U;23Y^7[?.R[RLO6YA)\EPLEP"V M9'!H:;UKE%HI#`M]&"66%YCYEV+RV9_3'3`)*NA0JT)JS M6V(8L+8D4$U8HP!"-VKU@MSN#?.,D=O5*;SK:*7X+G0!B2G;I3YSL+H@,-?* M:QRA?[/@@GQ[46IJ*G2NCX]0`NX.PVPNL+^.3/DZ,K-`]=>10=Y+]->1*2(( MV1'NKR.#N/"=,]VA2^^9G<4?V<'$HRO[*`Q1%!XOK^S_8G+BVZ'$7FEU`MMZ M;:$/:*^/"D38",`V7;)U5+LC,_9O&\B401=I#)R=-(4\9-O:^NB`;(,O/8>I M-9@HE%REY3$\$E.>X[:3M7A]FT@LKCMI."@ZQ21Z4+X\E-,0*$G`MD_&2MTR%GM*K0WP:^%")68>9D8F7@&-V`_;O&+OA*'"O<8#B]P<1 MND?DV7-0F*F62):,T7Q.\'-\;7UZ&;K(TZWI$?!'0*V2PLSWQ`'/F_&J*.:& MW'F3:73V2MTB+T2WA$JX_C)IE],GVKI(.2&YU0- MZ6[@AB3UJTEA$!]+.2UX#!5%X&'W%1YV8Q952>/SFMCE:+N)75D$;I#!;!25 M\;>QW1=!A.BJ$=U1V;.+B=@4RNG!@Z@A!A=(L^&BO`17=D3YCI:G5`)5\+(T M'0.LQ#H7I$QHB'?^Q>IS]L\3=6KI)_\/4$L#!!0````(`-UU4T1H(M0K4SD` M`+`A`P`5`!P`<&QP;"TR,#$S,3(S,5]L86(N>&UL550)``,Q"@53,0H%4W5X M"P`!!"4.```$.0$``-U]^Y/CN)'F[Q=Q_P.N]W8]$U$U_9@]>V=LKT/U:M>Y MNE17JA[?GF-C`D5"$CP4J0')ZI+_^@/`ATCB294*S-X)>[I'RH0^$!\3B40B M\8<_/6\2]$183K/TCV_>?_?N#2)IE,4T7?WQS>?%Z6QQ?GW]!N4%3F.<9"GY MXYLT>_.G?__O_PWQ?_[P/TY/T14E2?PCNLBBT^MTF?T>W>(-^1%])"EAN,C8 M[]%/."G%)]D530A#Y]EFFY""\"^J'_X1??_=;R-T>NK1[$\DC3/V^?ZZ;79= M%-L?W[[]\N7+=VGVA+]D[)?\NRCS:VZ1E2PB;5O;9)O\\X>+#^_>?__^P_?O M?WYZ_]WSDO?@`A?\6_[QO_)OWWW@_WK_P\/[W_W(__?A>\]?*G!1YNTOO7O^ MMW?O_O4=_Z=2_T-"TU]^%/]ZQ#E!?%C2_,?GG/[Q3:=_7[[_+F.KMQ_>O7O_ M]O]^NEE$:[+!IS05PQ.1-XV6:$6G]_Z''WYX*[]M1!7)YT>6-+_Q_=L&3MLR M_Y9:Y#M(3,+86Z'_-B4K/N"Q^*$?Q`^]_ZWX MH7^J/[[!CR1Y@X0DYZ&Q7S_TVJJ5WH8&>T<8S>++]##40^V)X/-WAQ4OZ$!7 M/W@7'K(")P>![VH&AWU+#GOB>[WP3YI/)^2P)]W1[,-.Q(UNW7;;>A;UVDV$L?G(I/3M^]KZWC/]4?_\QGW4V6+HHL^N43V3R2]D=D#__XQB+W=HA::,Q8 M`QVSR-'_6N)ME/')85N<)M63KM27+-M8?[Y^0)E%Z.?DL6VO>I+\)PW`>V*, MY-(#ɟ?2NIU+MO:3I^"/^$;$A:7/Y: MTF(GG#3N[J5%/GNFN:&W#IV0O/&"W^6050$,GWQ0#KE5B:*]+/J;D/Y/&#R; MQ3$5_B!.[C"-K]-SO*5\FK/:)(=.2)YYP>_RS*H`AF<^*(<\V^L@H<17.ZA6 M>RG3Q#+LM%F$2?:(3WZ6UG)1/N81HUOQRW=XAQ\3HN6.ET8(YHR`+GCC(3XY M:_PQ#CDCE5!7"]5J,*S3/2DP34E\B5E*TU5N-4LFX9#VR`ZX:XCTDI-SR0N> M8GJBJ-R4B7#=T059TH@6,/ASRT6][TZCHM"'].A95%=I607/(!WV64 M31X,KSQ`#MGUB:89$RY4(PV#6QW2/S"D30>LSJ?`^'/RHHQ;'*RF*-*D$8-&B7KA])MF)XN^;($I]@@BH_22#!!%L;1!@* M@Z&."^&01UTQ6'&##1'A)@***%->3%YY0*9UO2*7^E M]?T%Q9LLC>]Q&JUOBGB6QI?/)"K%S+<@>)EE\74:F1?[H]2#K?P/Z%0;!ABA M.SF;#@0\Y%G=`I)-(-X&XHV@MA54-\-=\^B8=BDGT7>K[.EM3&AEDOA?AI:( M?_3S#5GAY#(M^.I`,Y5I)4(PS0)-D$GS]>1\,6,:4D)*H4KL2%.2P0!]3+)' M`8BPU6Z1):5PKW.KS7%I!#,S?M!;RV(7GYP<_A@5_T4JH4H+M6HGPF"@;SY> M+KZ%X=HAX=&\UNY8!]H\M6V*Z07# M[879@.ZWP'12D_/`"4WQ9\LT1??9!J?HSUDB\FKSTRI*%X;0E'F$$?S+%[%Z>6!84`%]^("^N2MVWX:B`I?T-`P]T6GH MH(+5$V(O!Y`2"CAEHN`"*?K(;0,ZHUE!HG6:)=F*ZQZ/&L?Q,FXRG.:VE`N; M8$@OPPRTZV6H4I/3QPE-61H+073%>X_N2;4=?H=9($3),1! M+7@DM5MFU\2VIS7;-((F.+NA]U*=S>)@F.7&J.QI0S9-M245AG0G]]EQ)-=N M9[ON-Q:#-::!L+EB8SO6SQ_SU09#S-&0ASSM3JK'BCT?:?ZD*7_3SAF)J3WQ M1R<8=.XT`NW-G(H4&!(9H2FS)A?DE@Q5HC!H)F&X93N@_2"Q`SA\3NI)9CO9]#2_-L(;+NRM]\^54`\,] M?ZRZJ`4Z13,%;TB86AY)A2;"!<-F+=:8D3.^+KVKRS]CC;+NA0*<[KI;)Y6J](0402R&R;L!@R"&KMO=&1$)]=U?Z\I.M*^FPC7LI^T%P;#(ADYQ=+]DJ+N'=L4:!(\^M/\E./2APZ'F\Y__W^Q^T-'^5R$8H@,C"-'] M?/+QUX"QU4,X$:=)@231-A4\+'--7R2H6="`ZUF#SO>3D\`"2BVA4I=-@31E M<`,4EY%(?Q,;8=890R\:DADVL%V&Z.3`,,4"3IDM"$:7N2AV`(8L6SYS[>XX MRD(8)DKI(;)&WV@!3 M-LY**@^U6D#,VBQQ=&+#96Q*$L5[K$>*=4( M!2RP8@#8*:,RD)A\D*VPU)(HE1S*ED@]3OJ:QT@OY6ZU,#VS%2.RC)1E[\8F M'8P-;L@M+C-EB7JP)$QO05)8KM)66UXL&C>=;P/;" M^AJYR0GD`4Z92X0HZLB^[IYPO:?`O:-/.,4KP[Z.732857&`;4V*06YR.GB` MT\7+>OL^M=(KT>'\?O'0G'W>64LNF22#D<$.M>6"7@P&%:S8E.C)_0+MI8]1 M>D)N&P MM8AM@/M5B762D_/'"YZ2=-8*RRMJ<+J#09]/-*6;OI"!08-[CLP63^U\'S1I>0BKEZC(E(1D\3VH2.8G_.Q^ M_?LR05]_';S>Z]\5`,,#'2KE]:]D7LFIW._SBVU^LT.IEPOF3-I@MHZD3FCR MH78A&P[W;9:BJ).(L=TG8J1<%_&_E^2U(IK]C!&2BC.'EJ6F13K<;_D M-(K"8(D3G^W0>]QHU`Q!-$6?\$[0[>*IY4G M!L%@)+$";1FBE8)!#QLT;?$163'U<\KJ\F[[NA(OCD5Z<,%:D-L@.`D7S`6Y MM5+PN.`JR"UD7_.NZCO>JS7.29N'87$8K/)A[ZEVP.[?4FT0AD$Z&ZH; MG7T*#8PH9>L6[1:8V[JE1.LXMV:0G^3>#Q-L[?4?0^').>6+4'=^K9(_04)# M9/)5/(,4`;^A$4ESFJX\F$+C#I@]^N,&H3!<,N%4*TZ*N0)>LBJZXD8 MD==6)PF)BA(GJ,DHEZGDXMX)@F[Q!LBQABLJKI6\X2O\F(/FW1(N^RS/29&? M[3[AOV?L/,&Y+4]P5`LA:7E`U[I$':$.AKKC,2MU)V0+I[()M&\#58V@QQV2 MS2#9#BCC*=:6?\6,84<)`HU<2%8:87:YIPB!89@)V9!'M0R0M.=!]&)!HI)1 M8[E);ZT)#XR;NF`Y.CY4`<,I/YRV$%.[EP6#;K.TX,YF4M^ZV_3F\CE*RIC$ M(O0A\J[*0E9JG2\O,4O%M61WA%4E"W?Z!FS5V5[S%X-FY+W^H^NE];W>SX%Y MO5Z_CTJ"84]SC#11:5\JA.6N=`7J?+C&UDKV:/><%P5.@B%'YZX0[3 MC>C&_GR=A]+D?!R+5#F%5ZM6]Y%7EU%WM*>XC+Q"<4]65"!/"[&N&_3:+!;J M6G(;R.9N$"@FZ)`9*5$)204)C4.E;/R5Y(D?TFS+^F" MX#Q+27PMDJZ'L4H/^;#NI`-VWZTT"(,@D0_"(9.N\V9ABI'0//U%J*)&%U7* M?YJ.5#]E29D6F.VN:$+8,)IHD0M+(@/,/GD&0H!(HT=F(TNK@:3*A`RIC>$] MV6:LH.EJ4>"B-!/%)!YX#6L%/5C*:F4!L<<*T$BBW^2HU4"5"JI;FI!-DLWG M?!Y=96.%F*?,CT10$S1X3)$/J0H:F2G(\1=^9C0Z"K)\#`8;Y`) M2P8-O#X5.@*`B*"B,M"@$D12B9@1&=Z1T?\-";G'L'@%4/ MJM2JXC1!JXP:;?2W1A](AFR5P^N@X5`H:/*7%F`O7ZLG`89$6EC*3L1BM47#PG MZEL1DZ7JBX1DD@Y?5A4P$VUXE7*H=2$268($'C.[CJ./^YTRX,RIL@*G-SX^N2FFQA$ M(ZCOD<,@Q@79BFA#!YVF#)\\ M0*KU&IZYUU)79_B7?_JW#^_?_QYQ<1@4L\Y+4TQ(YIEH@BG(TS>Q.B60#,H- MQ8\TJ0X'I[',!%AG24Q8+HA<[!QQ9G_UL,6-QG6J7^O(3Q>,`1H)6*F$=#T[ MN[ZY?KB^7*!_P9OM[]'B87[^ES_/;RXN[Q>_09?_Y_/UPW^`(ZO?-HA-82)" M>FR(F*4ADF[(?\)*$JM]=$0QO%J8(I(THFNZ:)*' M.AABCL=L#'763<@2<'4CZ/)Y*^K&`9F\#R`J$%J.(B%\RHTEF.22*#C(L0!Q M^SNEF42]L.8%LA/*I311L2U+!PRUMC0:8/CE!=-6:4M6<*^U8)#M@C#ZA$6I M(6_;95<)&R!U@^_'2\WR8$CF`5*-IC8JK5<';,NYYOPA.X)VU0F=N-%[@38] M,/0;`=:^"U@W`,1!\[9N4]LT/TLVL?URQMZ\35=_<["C!H,V%R5YR/KO@'.' MR*$3=(+T@=^;(6T*8&R4#TK=71DY$H\'=>T4&*;=T)3,E^>,Q-1LFKHB88V2 M"JYOCO;?@V&)!I3BF\LOD9"$P8)SO*7"M!*R.*-I#\@H'38-V`JY MG_BK%07#&#L^-;E72M-_<%,B5=!>!P:;;K)T]4#81M2%=DY;)N&@=L8*N&=Q MM))@F&2%ITY-Z0H):5&)NS@1&]#B3-0%S:4K#H1+>]?,[?--YC([?&6P3K+) M.YX_S&Y09V,0!A=&;TY#V8X>MP']%6PYC]YD[F\I7UQ>79]?/\!@5:=Z@O4D ME"(6-K:M!]F/9O=EP+#%`$R-6'>+4>"R6&=,>CG_Z]V[DW?5_U$N:U2_>[=R>]^^TYNV;U_]]N3#_5_5VK-%>CBVVQ? MY0+A7$Y\)*HN./W^?77!J93[WV5*T/?OCG/EZ9&BFW$LSRKCY`[3^#JM/4)3 M9,TD'32&:8?<"UOJ18.R^8FPQRPGUC0O*TQERZ^51D+\]#I%M0(,2BDE9,3= M>Q&C6^LZT*$TD8&T=,!@+C4:$(VG&:;A-DY(.W[WI,`T)7%S4\DLBLI-*2-B M%V1)(V/XR42$+ MUY1I5-EC$=&M*S!6VP&1.%D[7S[@9\/S>4F#(8GZ\HYW"7QX:V"(_>(NJ#F- M\KT0&^!7&2-TE:)&$W5^#.U_#<8KH2[?KE-QL13O^9UX`/SY%`6CCV4AKP// M1"@I2PO^@#F459.VY+TV/*SQ:1?H+WD@]L7\(2W#"B`=M4_ZG=GN3_P&UGQR M3V)"-O+0O+9?U1-IRG3,-B*6:IQI#VDJK+-S>&?[[L_X=L#,&R\`/V0W;^"T MTP*P%%#UQ?:V`%/;:S_;"]V.FJJURB_1+)%CSQWL(D/BN&&,*3JC64&B=9HE MV0I(]IWK0))[7\*@!ND(F6/+1ZL#BWZ>:/43=$=9ADD!3]B=",H=9G,F*T#& M,A+=7)?JCKV8-2>*+-V?\,W\-?5 MF#2TJD*WQE7WXA!)9L!H)U==*7VO!91D\NHB;X(UTI.2JP_92JQ*%"ZI>OB\ M"%5I`"63^;X'/Y5):66XZ\%''B[!W/<\A+S@X2550J-L0]K*W(ZL'J-TV-JA M5LC],J):43"TLN-3BXL*:;0OHPZM8/H]>2)I:4P7W'\=-H[6!]6/C57?@2'$ M`)"ZS5=]#6.XS[.\F"\_9EF<+_CRTV@Z!U)A)R,MQ/[\TQ,!0P4]+G66R67J M\`*#.7CWD65Y?L>RI3&OH"<1D@X::%TJ=+Z&%2]2@0UY("50)0*#!O,M85CL MZ#9U.QR^A44^:*E%%^Q>N463,!@KXD*HQ+MK,2`%@OA+D;%9&M<'^&ITIJBJ M03AH[-H*N!>QUDJ"(8X5GI+TAA/,1#RZJF+V5[R",AD)BTCR7&:9B#L=Q`8@ M9_^"L"<:D=Q.*%_EP(4\1W1H4-+30Q,,`4?!'1*RJXP:%1B,E`<'Y8N5\EG? M8='TLD$-F@UNSY[I!,&PR89.765!R1;[7#0E%;B;;UI6#X5"LD,/L$N+O@08 M/FAA#8G0"L%@PW6:EPSS,1&A12JMFXD3>M&P43HSV'Z(3I4#PQ(+.#4X5XO" MX,H%V3(249D$:^A<7R3P-0<*N,$M!^WW8+B@`:6YXZ`5@4&#CR3EZS_A/\WB M#4VI6/N)I&F[V^'4"AJS\>M"+XYC5P%#*3^<2JBGTJK76GU-&*Q3@@Z^P8F) M0SU>(1Y8D4$3/'WJ&*P2NBWV:F/K)LN=1.E*3D(5%:J6+'LQH'11`"KWKS22 M2`C!(,QMEF;]#M2$=H26/?1"DLF[&UUJ.97`S&J^2/4W_M2;W-_4.M_"8-Y' M3%/Q'LS3YMC`/2[(O@HK]_X+5HI-^?PV*RY(3E>I")O.\C^3>"4?1"M@<@:. M^A-!/;17>#@]=^Z([8-Y2UZA4Y8BP;`.N[2G=ZRK$$4J;/A""[$?N>B)A&'6 M#Q6S4K(29+!-]7IX:MBBDFI<0Q@$N26%TR<I-U5P"6!ZB#IAR5 M(P4DKZ^+^`6GHP]H9S)2'7KF>70CT*S6H1U0*RSF>?_4'NSSG_M.7W%6B,U. MFI8<9KT,LT7ZW8KALW-].J(FZMJT8%E1;[PFTWI25Z8`=.1@R\B:NP#2]Q2] M:RIP.!;77IJ!#R#X=F5P#L&E!F;QX(]5O\CNZ;=+[H3S\EL@B5]U49>FIHLL MZ8)EM9AFX71/JDK,AD=TAR_GR M'.?KJR3[XCK`8E<)6Z/)#;Y?K`F9W9+\`SD4573$\-"&]GCQDQ[$NK_-38>]">+V'U;](X?B_`^8M><7. MJ7R0F]VW]>^AQA]H,)(3;'P,2VA17?NV3-RY( MQ,39I"O>%GTB*3%N>'OHA4WB]^Q&/[/?H02&Y;Y(-='*1D)XGS0.MB49L!$&4K/8<`?K=76'IK&L MD$L+P(VXPRYXW(S;J$`CGQ_W8+)+7_^9\446XL5:=N7&JTU+0W!D[#54]P%0T M@E6GWYJ.WS2-?"N8V>BC?0-0R7E!MEE.C<=7;`I3^X5]X"Y7L)(&3+H!1)OE M:T2ADNHZY4ME_FMC%A\]G6FII8%O9U='`3#!5)1&<\8YUD@#64ZHW9$YCU7V M6#'+'CV_%#K_579:C_+/##'TO+".F+HGWOTXN0EJ%EE+\LF@W6L831N71Z3 M3(H4BM)K;G,F]KJ@J2M6GODQ$B2M#0&@LD='/2AM:06,!3X8NBM!\OKVI\O% MF`3)@#7*\4ZF.%UES!%DU4H&K3YNAMHK-:Z*@6&8&9NFG*?\&F4I$O>R;N$< M,VPZ\9#-(HZ,$?["<.M=[,3=Q`5?4;9X'4_!IX$I".;?,1WOW-K@Z.@-62EU MS]&LA>.9+=$5?18':P#%O?SM^8LG!*@S]K7XG1>T12G MT1&<3FM#`*CLT5$/2EM:`6.##X;N(.J17XJ\FEAFSC7$P9)-1U" M/WLG-9#0A\>MSH[KSG-:556F8I@)O(ED0WEH9RH\L*IE37%:&[3NSO=7N&9^ M\5(,ZAKY96OCKR+<8\9M#/?<=8.'EG15)3U$RN' MBC/_-0?V^PD&]C*U5H,?!WS4L/)?]AO0@#7GRNTVD?7*<-*4.+M.EQG;R`.S MKO)SOMI!*]&-ZU*O*)V?*IC%XSB\2JFZSW=W-Y>?+F\?9C>HW49`U[=7\_M/ MLX?K^2V0?8,FI_$.4]/1_+[(%+?V=,'IKNP1WX,AC@:4UI+)(\QQR<14)*)9 M.X(9XOP"EF9:58%ZP,\BS=O"D8%4^#LJ%(CJA12M"""RZ'"-Y8NL]U^(1EZI M+I'85TJRO&3D%A?\W_/E_F8,/J%_S#BH4K M3<'%O2YJE&$8L@5=I71)(Y%CJO3O@3P79_S'?S$M=3R5@ZXT1W6HM]#TTH1F M&$>A#LM0IY&4NUB#72]O`^E4GL`X>G9(8Q@=FM",HA]<_:[E%=A=2['ANN^C MR_H9I4-7W[5`'M;_?)SGE;+J#2!M7)T0&.E#!I0*#0* MK<(DFLIE0Y6W`\<@R7V/?='-?-\_IW_FKQ[:9(WIU-"&^>A./E\>"%A+R@P> M*?==<.Q&F82GFR-M>TUZ25!D,L)33ZT^%F@O#>ZRH\4Z8T5S+8%B9+GR7D3'(AK0Q5KA=$Z,5A.*'^X!\7?(XC4QSB?3^9B$_ M4V/3F\#@N+NA,3MF)6C&QXE4V?!N[@:'=A_XX/9S_RB3C^*$]]9[QI[<6M!L MES?BKX:"QH(BCB6B=(:LI\UU87W.+/ MV$M_PSBN"1`,]3268_3A\];?D4IG#YS,!UOIXJ#66F M]49JNV`/ACF34-99$A.65V?117EC?ULV0C_L_?$CN]6_3-Y3&0H?#P7^FO1T MFK%/-,T8A]CD?OO9,K/6!`;-U06-53.I3#X;CL.IY"YFZ>EYEA:\^40DXL!* MZ!]VQM^\>6F&-&PCNM(U:1YJT(R9/^109'2:M*M2IOKN+Y?TLVD6M0F,FK,3 M&JMFU(%FUEQ`QUS_"23UJ]J9GR]O"%]^C/#&$YS_KZ83_..59[`Q'EV2&/H')K0S)T?W"'9^C?2=/1@&#Q# MIW)_TS>JA9!&\("N=B-*K0+.!#ISJP9)&'%7R,(S>L!?.N)Q9/FSU#`?L?KT,@S`T8^4" M^NJ<>LDASJ,=YH1^J/,XASN_XD.>1SGL">S4Y^=<%,W-"[KAD[WIZ/I0**3% MTP/LFKF^Q.1\LL(:(NW--E)ZZ`,HKDQJOOO M'8W]B4XD5&`PS)@KY6??_-5!9+UY6#M?73"L'`G8E*PI)U]@5TI>;[:8,H%G MSO@":9OE.*FN&;JA3R2NTO/\B'I84T$K`+Z@L[TR@0>T`X;,+P"O7#75-B4, MK[QL2K8!ZB[*2\Q$'6=1^'NQQHSXD=FI%9*WGEWH4M2A`H:-?CB'Q&NT1"%G M)/5@<*VMT^EI,8WBD]1%];%\!EDP?'(`U%R6)XJB/KQB4=3Y/0F&ZT3/)1@L&G$4B52:Q6194NJI5AS&17W+&3 M]RS,E_7%/3BY3O."E9M]Q-%@@SUU@YYC'=.=WE%6'\7)J7@(6N4\%M=%4EDX M\ZTZZNC#H.8LEC>+YK+4=%Z;\+KL5SSXTO"SM2,%AZGJ4Y[TB)+Y,"WDSFM7` M'JGMP+'JXSV.053[Y0V#>1..V1LU#$FY1=\F)*]NP^W\$HQ71B9I^ZV<]:+! M<^\]5LPZ.3!TLX!3,EX*ANEJS9\);:Y%.W92_;$N(_W22>MA6"%S=DA8;A[W\K5Y;04O?/8AB>]ZUT,UZ$Y?! MTW?#40ROKS0YS<8BM=B.+'K9>B(P_<: M:$U.JM%0'=Y7K03#I@E$^W!ZI=?%O&@S"HR<:6,A5YNH$K1)U*@RIP1 MAAZS[)?7=[TZZY-1GI=-;]HUI+_?95::W$2-16I=1H+RN8RKDX\LRTV'85U* M(-:/O0YXK1VEQN1<&P5S2+0'806/NEH\4E)*%)6;4E93N2!;1B(JM\3XWQ,B MRP>E\:R:[N7GQKZ;,B2.UGS09)8C/Y1>HLN1V@;S.ARY0WHGLO,CJ/LKMI=H M"MO&/9-1EHW+__P!ECOFA=4VCYZ@E`#Q]A<%9XP,Z8D(L6DK8R`4MG:U#F"_ M0'57`LQ;KX6EYE[40NAO4@S(M0XMK!N:DFO^5Y,[I1.]@#88,ZIOX564DM!IEO?\P4=$!?YK,PY M)?-\%O&9,)O;5#,F=DE[JT\E0%8X+&X568R$5% MRB"NA1&1TF")>4>82`[#*][!GS*1'-841,^;_OH_)Z_&)J;MB`X[6.S1$F12 M^\-7\JM;3<'T[$M*6+ZFVY;SL,A^GFT>:5K56:EJ\OR#Q->Q>"^75#B9U2*D MZ3-?P-SPCVDB\\SY=^6&Q)U5FN'!'NU7IG@]COR(=._-D7X"W`MUW'XI)R>? M(_X;XBU+]EHHXRX3PE4(NL"_D%1^`N.MD]<#7?-^D?BB9")MF3":Q;)T0=?Z MF%=0WOK!KXP:TRWERB@?93#L'HM869U)041E"ZC(T,?+!1!^MFFHYFPN6^C' M6WV:A&&_3NF3A^VZ<+@Y#O#("T4AA9V,_7.%H7P40>SL6<-4;BTPG/2&.I*- M$$-;^HY^SLFR3&[HTF0YO31!D%+MBA% MN?RF_^/\R#1.PC$?D-Z5.,8O@'F+7J5;QB,"?*W7_1FT_QW4_!`2`XLZ/R64 MU$IQL)R9%SX[E\MSO.:#YHT<^:'T\D:.U#:8]_#('5(*JQSKK0/GM+WPP5F/ M;1RI[:_HI3,?!#E*P_]57C?KT9+>NY;OWS72>]>B_KM&FG>->Z8HAU,+=7@7 ML4FTT9W3"H*AIPV=YL[G2'/E,RP':=@AE\=CD9^23E:?Q"@,EE8N MK\%(+7!>P+!G\V;?=K^=>[:[PY:#3:-:F)*#'EVSL=*B#I:G;LQ#YOXY2V)! MV<>=C#W&F*(SFA4D6J=9DJUVG,O15\3<_HM8B;SDV>G;`\=J6[='$L/+/R_*-,4W6<;G*+ZT_QTMF0TPC!>@/YY6IM_J96<[F2ST;?4B($AFAF; M+6@G+P4IVG(,G6+"L-S,?N]<3J91>CI.61U,@RA0;KF M%^1RN2216-_OS;/X^%[<)L!-.=V4&Z]G-+K-Z9AY8/?-_!W9(%"6']8+[;M` M]^\";59:C.N?H$VE_%6_%?CY^&]%T^97\%;TNW^$MZ)J\&M_*WJ]&/M65,H0 MWXI/N!!1W]T%!^KUP/H*T_%9!]Q,UJXT4"9J(+IHMJE5D"C*#H-=PC6:+ZL[ M4:]P)'*E=[:5DD4^:'5U%^Q>B763,!AFN1`JA_6%0YNU=]DV*K"63+I.N19. M#IVI*69=1%D50%/-M:`RT@W,4+@ M7,2L>P[7*>\2SLD%J?Z\REAUXL1\\&Y\,U,SW*>3+I;;V@#-=`_@#K;3N@44 MRQ-)DO!;V01<7E\^;RFKJAMQ1_G]B.>E:$[-7D-77(0=J('FJ!ZK@Y9?R5*H M&V[H'ND;]0J;FIB:FZ[.N:VJ7A\T6QV@U0N@.Y$AE*4HZ?%XHKIHLRAB)>F> MB3XW%Z@U"@>NB.91L<8-54F)K#3:"-Y$`])EFNOU@??8M>CL!AR&R>Y'Y/@K M;L^Z-HM/%Q=509NCHGM9,";6`=`5$5UR!80W<.J6C]IM.,:.!>`]IA?O*0%E MJ1_J47M&$,E[GJ7RSF-Y91C;Y-S"RT]R[JE?$>%_^Q'8JYT);QKQ[Z;E^A%W M(T#)[(_<1>BHU4,B(0M(54#SIML%R2-&MV+A.7K#KJ<+8U-4TQV__=&.(E". MVM'Z[YKN52%R4[Q^?KF14G#"]-(.4$MV*9<"RJ<.-!=YA"6#2)8[O&MZXI=$ MVE>8CCPZX&82=:6!DDD#44LJ1K:5I'MV?,7!Z$SWMUE!;&59PC]V#7C! M"$^\PS'JJ*&4ZZ%MI0?CY;\3[*%QL_(P=%V1"EO81PNQ7\2G)P+FA=;C4HOS M2"FO4"&$@(/_W*#1@A%4\)PE%!4PS/+#Z=XTR/!45Z@<[/J!FQ@L&+5W<,8E M<]Y=,]E[+DI\,C_2U:(3OM$]L);76,I!?7>[X'1\$64T2%2**FW%FF7E:@V1 M.&.#'D`"':."&_`#&NX@1F6!8`<)+'_"<@TWG.Z(JF.!&?5NZL'X.U M>M.1UM(-,T\U2D"I:49Z"!N?<%("V4H3%Y43^([D($,MDJ(+AR'@<[L#&@A[=>%&'>UGH![4$AN`O@J_>=R\.Q4$Z"3=C M!,^7-S@UG2[J"@2M_*T`ZQTO:;\%0Q0%DC+XXGX6/K^"*5381NHX;$^6&V>! M@]H*.P^_H+O]N?F`AL"P]"7H]=8,4-KN.=[2`B<2U_PQH2NYAAL>4QNF_CB4 M0I+4KP.]1"NK!AC:><'4\TL(H+@DPDN<;1E-$!_]#S`(-WA/[CG4R^820&OP M>D=<(P@O[&R'.1P`(85()01D%IH7:\+.L\V&%G(R=>]T6S6"OOINZ+VWW2P. MYP5W8E0N\MYLDZQ*NF[+\4#8V#Z7VR?4^\^EA2 M+5M(870'*1';NBTJ"7K(?FJM"&9#N]<1[XULJ07&6GA#M<8SRRUG8)78U^PA MR:^;7:F]78$5&'DR:^E M\-*?O!)3;0I!.>D$WB.C41H."UT0]?13^04I@"3M_)G(&_B897'.5R&W64JD M/TC(HM[U?V`XS7$DNEK-"[/MEF5/,K6IR9,Q/;3CM1^4O,=^+#VN'ZMQ.*_& MD7NDWF/W';?77[`(V/*5R4K\(0X09`A'OY:4$7G:+$E(5)0X0=ON_?`%PS%! M*=X`,>CG"<[S^?*O56?F[)ZNUL7E,V$1SYXHK97%0":9*!LKKN@2N2`P;)7Y7*9'E4Y?91AG:%V5.?TTH3%U%.JC ME>)ZA0'<)MND6@=V(V1US.L3V3SVU[@>XC_'611LJ/AOR6>(-0LW?ZSZ!4;> M#1GZU&-XK>&9+Y=G.!'V;+$FI+C+$AKM'LAS<<9-U"_*\-C%80V/%U;%UDLI M%-,\2K*\Y%ZJ2*7.EDOT6+7%IVO>&,*=/(0IQNUR0]B*&X./+/M2K,^SS1:G M.]?H^2C!&L,1B/U&DM0-\O6(:%&<]A!-3C&$%Q1OLC2^YZQ:WQ3B#,!E%>EZ MXLLOO.2+LNLT,IC)$;JP!G0\<&6&JUI`L@G$VY`KQK855#?CNFSZM4;U8Y)Q M2W&9Y>2#MXK#&S@OK<+@J)51IH59MJN$1TS6-*6:4Y//4Z(7H MI&`-A@VBXG,TLCNQ:!'77$QH]KK`'[YD'B/02L$=@2'$KV<$^-+3YRWHR`$> M!04DZ''XB8/.2HZ:LO@.,U'3WS`21DE88^&".1R-6IZ/`U?@JR"I,<5(2.)< MIS%]HG&)$],PZ,5@C8$5XW``I#"B>^EI_&!&HB)CYNE8D8#UR$WP5,^UDD-9 M.LE:?Y\R-FLSQ@Q/W"P*Z]$[$6882`,*!1.LT2[+5SKQ`TXO!>OY6C$KA@/L%VDM/M0[;4Z:Q MBLX7H"\(:P0<*&VO0%PK3'5?5IZ3PGI'5E<@\+Z>;8=6CTLI*B6E3E`M-^E# M-C]=<(_5\3PGNTK,YU*WR6]SLSW>$?>W=42GYF\'BN.)PWS4/L]X*M,0QU3, M*CBYDW6ZZS.(6ENA%P7TR%T(%6O2RJ.[JOXXJE4F&@VY.[O.DIBPO*H>QOVC MI(S%MGO&!-1943#Z6!9BP_8AN^5-BF(*6<(;6]D*Q!^G94!C?>0.:??)Z^9_ M@ZH?.$'M3Z#Z-U#W1T1R8?]GT/6TEU^J#\F/&Z#'>=28*0-TAV%,9-Q7]QL= MEPZ@L?*&:ID'J^U4*3[1('UD69[?L6RIOS"V\S6@1Z]#I>R%"AE4"4WT;-N3 MY/619?OY^$8(T',V8U,6V8TDNO0X>1WBF?/9*]N0&TX"ZU/?BT%\[AITYB=? M":-OA/BW$SW^Q@6P%!T8B`!Z["9DQGM5:L&)GO4M*?;\.-15'MT(H/$Z'+MR M?H84_=<'N*N[[[9(L18+$FYHM$=<_ M@35\'"<3=6HN2/7G=7I!&'W"(D_2$=+S5`4TK&,1:]Y0J8>^:5KX5L2C]HV@ MZ8.%A@)E'+H(#VO/P#A4``V@+U*U$KK40U4AMHXF:E2G)>V*'CJ]&&/[XVT"/'MVUJ^O'M'AF])PDNB,QJW/DXR+DI'Y MTAXL4*4`C9D%G/+^25&Q9NPL_/\F#C0B>:+Q/Z?:K:2KE"YIA--B%D7B8@RY MF9O02!RNT!TK':<):+1&`E9V.O?J:*^/F@8@#*:8E2_:PZ_6T3.(`AHN%T)M M&82]PI3C41\1:*#<,;+%-&ZVI&:/N7(GB9\&@-$9"50]#^'0G"I)H%,4QOK> M:`4!C(L?/O6.W'1U*HO9R+<'@`F[RACAAK;*?8QVGM;,K05HB$:`'8Y7K8H: M79CVKE,MV>F: MGGZB:<9D*F:U%^PYJ!YJ@(9S#%JU*J5VSQS8,%;7?#17'WD.HE,)T!#Z8]5> MMY.+M7.E"VSDN@'53O'4W',,1Z@#&LU#4*M7I'1#RMU6@(WPH*2T(RYB$@8T M>FZ,NBH:E0:J5"",BRPJWUWQ"%-O/B5F$0Q+H8/ZJ[D3M%><;C=M M20M3\NO^6T!/7P/*F:7W]9U1>?7ZJG`&="1@;51QKW^R=Q]%$ZAJH]Y&UL550)``,Q"@53,0H%4W5X"P`!!"4. M```$.0$``.U=;7/C-I+^?E7W'WBS=57)!\^,/7F;V>2V-'Z9JS]]0=`HL0W``V*%%J*4EL;QT:#Z'ZZ`72CT?CY;R_3V'LF M+(UH\LNKX]=O7WDD"6@8)9-?7OUZ?S2Z/[V\?.6EF9^$?DP3\LNKA+[ZVW_] M^[]Y_)^?_^/HR+N(2!Q^\,YH<'29C.E?O6M_2CYXGTA"F)]1]E?O-S_.Q6_H M1103YIW2Z2PF&>%_6'SX@_?N]0^!=W0$Z/8WDH24_7IWN>KV*\+_[_C]P_&/'_C_3MX!OY3Y69ZNOO3VY:>W;[][R_]9D/\< M1\GO'\3_/?HI\3@L2?KA)8U^>57B[^N[UY1-WIR\?7O\YG\^7]T'3V3J'T6) M@"<@KPHJT4L;W?'[]^_?R+\631LM7QY97'SCW9MB.*N>^5\C3?O22-+H0RJ' M=T4#/Y/:9?R,IVPA_NNH:'8D?G5T?'+TCJ.3AJ\*X4L),AJ3.S+VQ+^YEJR^ M.HN%!D>/$)UF4S05X;"K'SOF1 MG3\Q,O[EE5"2HT)%Q`C^`J'-YC-N/&DD=/^5]Z:?07_T8R'O^R="LM0TRM;& MPP_KUF=<-$\DBP(_MAIC*^4@`Q;&202"ZNJG3Q`.AI%R/IWZ;'XS'@4!S;E% M)Y-;&D=!1,RR-I,.,N0KZB?I!:/3.Q)SM$-N.QE@N`:R888:)1S94T;"*#.. MKZ7M((,Z(X_<0+C.W?IS_U%T;)CR%>T'`C>9/!`VY1\U2ZRE[2"#.LT9GYZ# M^2C\9YYF8GHQ#4U-,<@`+Z(7$H[2%+`TMC0=1F9T.J7)?4:#WXW":C8=9JJF MR1&?4S/^'[RCR662$492(Y8&LF&DY\^BS(^C?Y'PBO"-X,UC'$U@2S6`=)`A MEZ;5^0/CH>V89VO7VT M>,)"$)BX[$J/L]V."_%EV^7?QS[!UY!57Y1_XA;]&%5^YCR4C!2DR# MRNAC<0!$F4F*XC=?=&,=/:89X^I1=!3[CR26W7\1M##2-UT&NY2T/))*2?!Z M0I_?A"1Z(\8O?I",'+T]7AY(_87_ZLMB#'=D$HE/B\W@E+2,G#=M;UD?:%E! M1BSP*`L)XX@5??HLJ*A%\PQMV>+-3)ZJ'`5/4;S2J#%?^6U%N10;-3!2EBX? MPM8A..6,,#^^Y`;T\G MQJ-+67-_+**<@U`D+NB%7FL*E/X[C-)OY=H%#",^FE",Z"+V)^WBKS4!BOT[ M3&)OY=*%N!?G2ME%E`9^_+_$9UK%5[<&@O`])A!,O+M;>/]!XOCO"?V:W',_ MA28DO$S3G##=`JPD`2+S`R9D0%)P!\]O-,ZY!-E<)N6E.E@:38%P_(@/#@77 M#K>G"_N](S/*1'1QD2:HW:4J*("@_(0/%+T,W&$C=>243Z83RK2.0ZTA$(GW M^)!HY=@=`+?Y8QP%%S'UV[S^U:@KS<`^&S[IM[#K<&):QTKET4YZDV"@]+U5K+O'A.Q+07W<2T)O2>\M.]A4 MQ<9^^BCARM.CB>_/%GI&XBPM?E-7N.6OOZQ&>#.^B!(^IHC;`TTC0_!\20ZC MWMB"NK.WR)(Q,U)OYRJ2;B77JADI..E_/ML4C>7.'0I*H[FS`+M>PFTP*%C% M@8:XU<'G:?$OD7[T[,?B('*4G?J,\=EN(B^=J=$!DCN+S(.`H%U8P@3B92*. MC[GC=4TTEE1MY2QD8!P51%I."1;,J69T[14SB+Z'9"! M\(\5J6K"6@?0%!TX.PSH!3^M5)!`6680N'-P>!+0>F`W)T_;(ZZK9QPV&-I MU.!HD8[&W2%%5QB4**(.*14^Q?)>"F>5_X;E?&II,&#VMD"=N#ON@$/3[G=9 MR`@-N!V@W!2XP6(=78#;!9A.:?+,=UV1",C0C!1Z9L3*1`<%;+#@AC5@,$G@ M0.V,L.A97@"RL2\]%12QP>(>UHA!I(`#K]HLWC&@J*>&XC=8'&33M6T'`HHV MUK:)C0T6)>E]9[DO'N)93AYH[68Z(!AF((/B/5CD94.\05+!8IK-,FYM1EEN M!3YM1@I/&\\XT%C>(5<5PFK+#U`00#$:+)RR(48&2>"`JU)I`3#MJ=I#P4(; M.='*`0E6:Q9!FP\X*H-%/?J)2.[+5J-+^+F'@//)8+&1#>#=E1!S*3/?E.C6 M:`G%9[!0B/V:I>`6!Q:C,)2JQ97,C\++9+G":OQG%0$4F<%"'M;(&'CO/#4^ M$_9(4^)^:9 M"-H^4.$GJ:MT0[:RW?H'YZ6CT9!^);OK;M`="0F9RDSP5CX7$BHN4XRFXJA` MMXITZ0VJ0P/FZEBO*]VEAG5^L9DKX)@-%F/JU=W=%VLV!=Y`H2H%)11QY/$K MK5QZQ1_3=>?V%[8J=Y_?P>\^>]]4^OOVMKU?V@IQ(&4M1D83<;Q`H"U]>J M^T2K*@2D2.DK&:E8ZU+'"..FIV,=(\?;%L-;FY4MRW>Z+QMIE MI];0]>;`3OH*/G&`\(G15#S]--8=H50:N5[K[83?PM^NAT*6$WXR.7^9D20E M@()2&A+7VP`[.(V\X[`JKB24C9)PF=JZ'*PF1J5H[[H"BUG<%,0')FS$9$#2 M5!Z:B?)*(L;-.;HG[#D*2&K$"DKONOJ*+79VN" M+-96IN,:!S"_9L4U#K[YT6RHZ^U+FLM051JY;J^BBT*;3SBD/XGDG!6Q/HV"J=1 M(I_Y$A<\C4N'D=!Y,19;D("BP(%;@SD+7P=!R90-G9R]\UP7\KCBKCD`QW)C MYZ53.B+99'C7L;RF":URM]16TA5,!D(G`&L%T3C+(HEQKYKRFB^4TW<;D MSB_$9:8V2YWOT)7SJC`;:,"PV?#8+'S-]P67H0CO1DG..6VF(JA.Z_6TSFO/ MV&D"7!R[/D&R(,%@F.C=4$9X;O" MXEZ7O`GFRWM?Q>;RCOBQ/MO2I@_G=6ML$**=V<0$L8;C3L:)H+!-;T:Y+Q-Q M<5>WR.'^Z*=1,$K"LRC.,YWM&@F=U\6QPQHH"!R6^0\^GSP)?_R9;PPFY#J? M/A)V,Y8#+^6=@L'LVI_S*CMV&&\F-MS9N^))KHN8?E4D[WX/3]X5/7F+KE#< M-%IQ9G7#J(7*K4,L!G3+Z'/$X?XX_S4EX66RBL6/^';@>7%CSARJ[M`7GGM' M2C2;7G%'B>&8HH<-7@T6@^PN=;NPEM-:2D6EBE04J`AH$D3R:;;U@!]H;]8Z MS-=<)SQW,.@AQ8Y#L09,HQGNI`U'7"]%8A!@IR4]S%2^H2S>.3)9;B-^4[B>+*I`BBMT`GFK:V=)T>O0VD ME,QC,DC.K]2<0H,ND]9W#[2'`[`.7.=9;]$X+86Z!W45V\M07RYJ'.LN]YD( M7:>$;U%K@$+J`QW..AV].A73T`:;S*KLL&)\F7`7E7_- MTJ^HD#F_"N`4Z18)8@5;/HI>O-AF>-H:1NW\=H!3Z-7RQ*H!D$=FNRSS^OZ< MWQA`L?!#9(Y5;\KOI%J^:=FI,^?7$IQJ#%C:6-5EXTFE\Q2RGR%+[!,&_`"] MCP0/!'<=MJ@-]K+=]>Q,!<=BHYWVE#:D[&8"?C` M`T)">5=3IM$D`;D9EY]3ULSY`%KGERLV`*A1QA$H*7S(GE(^:[$L>HP)'-(& MD?/WB@?!4B$;?""NE([=^S%7/=/[3!!:YT\<#VN>K9+"A^Q5E!!Q^XGO%W35 MPC4DSA]$'@3'5KG@@Z\4TYW#I]4!]P? M[XL7)=@59;[YO\2Z\\Q7('%:2%A$P_I1@%HO['I!\.BRM69TD=-^ZL8H*YY] ME2_1V2I%@QS!`\L]:8-",IW58":UBP^/97\.9?AR@N*MY&'403#7BT*<)PC* MB-WGLUDLQ>3'A9@NDS%E4Q_X,BFT`TP/,4,5PE(Z.)R$HM;=K1]I[EM46[E_ M,]E2TNUU/,LL8P%#'.4_^"\B%T>/1ZTA%)+!XEZ;0M+*.+Y*,-=^EC-2?L.1 M+P&?*)_N3VD2$+:^<%VI"O.#=^2=16D0TY23\_]8]%-]PM'C77FR+Z_HK,-:+>N1`LQ328##'H%8M11:T4AASXPO2DCC**MB M<>\;%L=)9"W#!=$@5E:]Q`RW+B6=8ZN20:-UL8=T/6+(*@CO`8?=&=!KL3<; M^>#S$#D'O&?!^.(V3:LA';^M&]**S"OHL$S]YJB>JKW+O>8395F1]`396RK: M.Z[GJ4>BOF_4\HS/4EKSTBI6$L2IZF![7>`S)L] M`*G;G,?VT5F9JETOCO>(8"R;"9#6HL*WB2R56&TWP>\:RY^D\!8DPZQ[ZS'! M%[PV&I<.E!C)$XVYZJ:+W'11(L+*BBRZ0++NJ7&KNUJVTMFO=>^:)D>GFO<2 M*P;X?>/LNTKMK<@',<;/44(9!ZCX"M@BU80.S;(^*"N#!!'C,$43:C5[M!#+ M?EGB,E`J2KK6*P>W6V,C$Z74@R>[\,I]#&*2%[E,15A_!FR3&DJ7L189IKX9 M7Q&^K[=;(P&D.`S2B%D]$`.5R7[98_DF4:G\4)TBR:\B5"DSI=;X?%,*T1J]EJ._\X M+HPH+J@*QN:`:15([NRQS+ZAM!(7#H3O"%\@-%7;6KZ+G(``##WJTW9V]F]JT"FP@3 MASJ<^RSA?(M"(/=/7'9@Y(V$SE[)[!MDH(APX+FZ?0PW826%LQS=3@U`V MA4[A:]^,QQ_]6%3&NW\B!+"6"BH3D;,G('L#!<+EH+B<3PF;\`%_8O1K]G1* M^22>S&'HP$B=O=/8*T8V8L(Q^5WPQ5B6JKD9+RN>^?'Z:?'E0JR>"8'D[AYB M['M>M)(7#HA'H:P>F\I:`>ERXEA>R`IK?U0C;=>+N[<8^P:\B_1PX,Y=Z92/ M-I1"%T<.41CYXM7`&R;?D5O4B9=JNVY*PG,NI:R0C\;T>^K>W5N.`X0N^I,W M#A62:1S@;7%[:WXJ M17SI\97[<.):2)B+PNZK M@4'2'+14.`Y4S5C5J&QR ME(+.?HRH04],=L"(RG/%&..!KI4422+/ MI@!JQ((#1>GME[F\IDE@>K5<2X0D4<<>.8`H>GTQ`<^V4;O@:0L##+W<-0?9 M9>>(:;%3;I(^,9KJGO4UT.%8\,QX0?>,%7'@F"M'09!/A;QC@T1SG,:]*E?HFD0K+.]F?Q)5GL MTSIKK(9^S3?Y_`_/1+L,-XJ#P.KR>]^LNO]VZ,7:FM/^JO>K>W9:F&3Y,,M# MN;IF6_61:CN393=L9$C[WAC41CV2*K/E=`H,6''K)Y?\1\U6K*VM8\P4PM4C M4!K^:K'H`X64!*\G]/E-2*(%`/R'NMSYK[Y@E:A,X;]5HM`N2 M;AMW:<>U-0DOOG]&IWZ4M(NWVL*Q;-O$UA!L=<1KMZ;/%,*SR)_2)+SSD^#I M*@O%+N6%!+F8Y>Z)/Z;R3<7/9/I(F'+MLNC!V6:](LOH,BRUJ=)6DX)0#W@.K\H&S M*'^3+QQ^Q&?_!23R:C/7`2&`R-OXPB%RY:SX:TK&>7P5C37;-!"Q:XN`[T*@ M*W-3-#OEN-6+0,&=0=Y$S&F\Y?@CCG*BC>9Q=%<_*%JMZ,Z]R!W;E^OK,K3I^MHBD=OG[$AL0M MW)`9@//8WQ=P;)Z'L=-Z-GIO0D/BKF[(T,=Y>P=Z!WC0CQZTL1\YXG#EVTNL>I"=VW>?TN$,8J`WC]]UO&6T:S6+SC5ZEM!W/D&\_; MF4]?B^^))I4O8O'HA_#@47KL]1=5#8ZWHOFN^,^6_K*"6R1N;WUT`#]60X)C M@Z=51P,Z0SF,?X8;62"Y'RYF[?;%K'*IV@N:,^UM!55CS->M]`P.5#&_\E&^ MM,"E6FKL[,C15JH-!K<@U?OH!2S44EMG&=^6,FVPMP61WB1P/2VU=98=;2G2 M!GM;$.G#5PH6::FML^1C2Y$VV-N&2'E+N)Y66CM[8E3-%M?1ODXO_7UM>ZL.G$=7S+Z4P;_`R"A'8)6U.^C2<;%Q[\_6339$.CV M+EUG6PT"NTYZ^&*#5]1/4A'AO".R>!A7VJPE6M(>_ONI6=.7]^:)[KQE?]ZR MPVT&]X`\6=3_M>P/37590TBOM3&J@%Y'*+6U97&%\JIC`P3RE`0XPDD:!=2B M,E0(;X.,MB?*LM4["/QK^FP-1?-=0T7!!HXTA\;@3-D-2@(L=7T//QF`1BY5QO6<6O M%_<.%KN,38LM=KEJ:,,=UH=%C=->E>'HEO7WM]6U*$J0XSJ\%D4 M*A5!*SYF*-95&M?U538!LHU[)"CEY('6W![`&Q,&,M=%3BRQ@L@`85"%LW4S M/F4DC(!E+-XW(BF\"YDB)3O9:O1$,WAXR`34BH%$G`6CA"Z.(EX$RMEZK--,7QB!*F[F?+K:>'REC M]*MXR\&?\;_H:I':]>(<0,CR"EB&3'+"B_!E$C#Q!OP96?S[@K)%J3UM,4K[ MGEQ'/_I"&B(OO&B?O\RBQ?,L(@!P;`=P@]AU(*0O3!52P0MC.1Q7+H]I:["J M7EQ'3?HS5KV<<"`\"@*6DW*QVE-3U$M#XKK$:Q?LC!+8_2+O9;'`S-1A9F=/ M9C@0>HZCG7RSSWO.&5D>B((BGN_>UB.>JVZ\93_;#'J:>``'/N$=H3D`VODD M,5OP#MEAS@(UA^PPC('-0W88RJCF_F2'E4JR7/-M!#11S$#F.EAFES,&D@$. M!ZQ60<>RD)#S2YB;PM/D>:`+;[5OFFYFJIN[=HR`HM8S@N8_8`9BYCA+4T98HY9E*KBOTFYV"^(?&<= M"C&H*]<+UR8P6\@*(]3E=,PSD@8LF@FI0^%5DKL.X/>5HMHB$XPP"M4#1Y1D M6]=1^DT`*G.+$0WN:13#!$>.JC2N]Y>;H-/&/0Z4%!ZA\;#+1`=$ZT<<:,&D ML/L'7K>,S/PH+/9A:G@;#8%X_H0#3P6?"+/T:3(I?%;8F=5QL]Y!,O%$'^+T M:KM9^IK!6Q0V@'3B,J);/(]J>A2DU@[5\90-5(U77ZM\(3F54K]:JX'F"MM9 M5+MRJ1"X0G<"M3^)]2`D#MGTAVQZV_UU+&X.,C\6#Z/+:/-C'$VD-`&O(P"( M78=VK?+M+<0QT'E'N6R"Z;!#T=:U)PJ3N(8!5`ZH]+$"5ZT\A<_M79,8]6=.U2+K'3YYSR9RA\KY]#-!7OWQTJWN]6 MQ?OABPD[+WL]0#'A0^'KW@M?'Y)3E)-P(Y2T9WDI5J=O+82N91,[+9]=2K7:2)=L6IE?N]6 M,5PIS8/EEO2PK=RQ;.:MU5M]CPPS8*E5QUE!IW0ZIF,)OP_ M4\/-=#W9+F+3S@F.5*':V$R90HKFR%#1:5P-)`5#*!*&[OB.DD5!1D(Y.9M2 MA!3-78?4M1I60T/+,8[=\R'-L>?DE4.:XWZE.5YMIVCP<)5(]ZEHL)Q&950^ M+!=8O'_BDD@7O[^@[-1/GW0[,G@?KA<;<"S`7C`X`+UE-"`DE(]0BF'Z24!N MV+T?D=F.0N>_)2$HR2\(UG$VG378,?@ M7G;F*+F+<'#8LEAAUN40EA=/2;@.499G(TTQ:-M^=NIPV5Y`&,&]8=$D2OQ8 M_'9Q4@3&LY5TIXZA06)`&'KW9U&VN)UR)4K)EZZGP$+Q[QJA^'6/GNS2*_6Y MS=C\12XJKY0^#H[(:R@QQ!IW.0YO!.40?4<6'$$?;XQE?+.>W?);+^)9( M;(EG8J@?Y^:H%8AXAW`"\8,C'J\<*B3`!2+&@9N%?D+!1!<)XR,-<>H@F9>CO7687=,6GG&`<:A]N_A]N_ MA]N_Y4';W/[M/PZ'Y_;O)B?HJ[>ZYP_,3U+N30G/ZN.\_!?]C&/3!PZ#`,U' M-FSU>=&X'S!-.^&VMCC`L5=)#7##WED^BQ@)>&-3;926=JZW2&I=*5^N53*( M8_:ZR9X($]F9438U)\ZUM\:A]*`9J9V!TF$$(BA,\X^J/0XX=(IE``65@WU% MTI00$4D7%W`8GTTG4LO2&^X?<9DF$QEE3\7]4EEY7!7C+K(Y.O;GVDD'G\9L M)C`P&S@=\A8.>0O[=RZ.,%W>&-=AT MYO@,2R'0F_$X"@CCT^MG/_$GA&G%JFSM.BH+$ZZ!61P+Q.&8$$V*PN&8L-]C M0L4<=#Z=Q50^HSF:,+((J&NG(1V!ZYE(KS/EVHI]M'@F9>`"? M!<$[PG#$L,N'0+:0'4Y_D#E0B$]_:KIE/O%1$NP2'BH><)SLM`S/Y-9J2)#@ MHMW3'JF1P6C([QZO&N^J$LE]Z?F"4U!@L1TH%.: M@@LM-2U/G$2!K=-2\8$+E4',=5'/=\2G1 MH>;ZH>;ZH>:Z!2@741)EY"IZ%K4?,S^91'P&&*4IR=*/\\_^/RD[C?W4,,E9 M=8+,N'13GA5?.&[3:H:\'K!8F$U3HW5'.'#MH,]PT-L91S&Y7D4!2>1-./.Q M?7&XJB9QO8GLJ,6-"O(&F>"8@N^?*)/O],+>O5`TQV%^L)UD.P>E&VZ8T##& M+%0$2!#1:9<)&%Q3'.6.Y*T_%YIEG-M:VCJ_(JO7K,9#)"IN<7"G(@C4P/WFQSGIAEN9U+7OLBEL33$@0:UZ*`S*5=71[$P"I)EQ)``) M>_\HWNGY1&F8CI+PFB9$)K83'T])IS&)^&,UFC#[+)[F*MYYTODYO MGW"^&P?#W[=8<6B+#*' M=J;FS2;"P@$W\@>Q!MOQ'A[$VM:#6#\B@]#N02P\VV#7#XC^Y!S'PP.B&ST@ M^MXY@'^F!T1;>1V+0$L1ZK4$O48+CD+@1+U5$KN/NN!FO36X3#+"8N9?-?_/_4$L#!!0````(`-UU4T00MU1TH0H``$=R```1`!P`<&QP;"TR M,#$S,3(S,2YX!?8_<`TLT#XX\J5-FTPR@TQNF]W<$&B+"HYP=]X9[@QXBS.069?/CWF^3 M_LGD].JJAW[Y^6]_1?!W]/=^'UU08EN'Z(R;_2LVXS^A6^R00W1)&!%8NPWU#,39F.?O_<^ M+!_HYSEA'_U;S#YZO^/+L\OI_<&S._Q&_OME^?3[RH[/XSTNYL9H,!@:GV^N)P%=+R0\ M7-J4?2DC'QX<'!A!;4Q:H%Q.A1U#CPU5/<4>29"AEFKH*?,D9F:&WI()0YKX MO1%69DAI*>E^2$IC4HO4H_.]_AQC-Z&=86\:T$85AHJB_F#8'P]C%L89\YUR M#2TI#+ERB0%$?:`B@IHQGPK+A,NU,;,PG5(NB;E@W.;S%64FA+QCQ($+W=8F M#F'R@@OGC,RP;X.=OOK8IC-*K!Z26,R)5*'EN=@DS<#C<,6,<8AJZ,%1B2IS M70IA"P5_.5+^/13<)H^@%U(_H-_6:DK1&M`%?*7#";/.F:1RI?J#<((&>XA: MQSTMA1(!!`J$L,B,,AI(.@C_AJB/8O;T3Y`)A5@H!79DY&%2X+Y'K#OV<_#; M%<0#F(#I&@HBQHBD@LG$MNG;S7C6HI2R1`6Q\5_"';]B6W6^R8(0Z87VSQ;I M#3X"*ZMW((DL?LJ9QVUJ08F%(B`4(G76SEG['@M0%+3)^MU_MA7-\/ MZ$T&^&WG%V(DIO/N9G>NFN%`XU%WJ*C3^^.=SA]K1'0W0VO,SA-93YQB;W%A M\^<21ZRK]'YX7]\/"A(%F)T?B'$+\UI!TA$/P_$EAY0!3&@2$8W5F\GT_ME7 MHS1,@FWN`0X\A(#9?H$`$P6@*$+M/`0]Q7<<+%9WLQ/3Y#Y,;MC\'D+;I"3N M+QH"O5<^Y+T202FWK,%0C-9Y@QC7'#/O0G#G@=CJY0)CK$P\456I]\+'O!<" M&*1P4`2$(J3.`^`!RN!%="J(165D]G2)WM8'!5L#;S`J!-R=?2%Q(U/0#*QS MCU=X:I,H6Q,/B:P/>U8I9 M&;L+9;#OJ2\@`S)7)]:?OB?5##"T1,'K"CD[6P+PS/\0V=JG$-OU&K&N"/7(WM>D\ MO3BC(]#[H9!YIJ!0@(528)TSB)%*7E:/`E(1;*X7[:LJ]4XH))KIO&:%4D"= M`U3&/_7(5Q^T.W]2JU9QFI\KU9N\D%6N^5$(T)E:N[A2>Y&EWF++L)!ZZA=; MT)OX5[=RGTN5'E7^Z!43IJAL;L)>5ZJVNSV,[FC7:>;K%0 M%4\DXY+F;'J/%7+C>CM3Z$W2SMO.KW6G5(*#2>5*??'SU:>N6C8K]_+W@NA] M7LC--T[%HC:#.$A:?=L%P19!<(X%@T?OGHC)`@O2.``V`NB=7U@0V.3\N#T$ M#:*@Q<[QV_5^H*0NS/7N9NOO,T"V+5X!=9'TH=!P_UN]!^*&@SW#=--=3#3= M,R]W>UUBO6<;[*EW?JNSTU[A+!V%WD,;=N([K]3=GR_WS$8JK7?&F_?O.P?5 M2>*KWG$:"KUC-NSZ=UZIL7U:[A0=@=XGQ:\#4MNKG4>VV/2K\%`#!KW'"LLT MVDW!SH4-MPK+W5>76.^ZPGI-Y59BY[:Z&XQ5"=@&*KVC2A99-E49 M6(C]`W6]5O@OJB1$7U,EM9: MTB9"K,W03(B8;PLAR@]TUVP^9E#MOF_4HD?,O3E_@C"BF3/<%0V7\J@?_35S MW?:U9\AU[9(H,M`9VH`APU>DEX+[[G$OQ*)` MHM/CC&*',^L!WN"+:VFISF7MSN4^HX*8DHM"ORRK MV+FTYY`-\55PI$Y$5OCJZIU+?OHP M>4R6N@IC4&7MSN5>FS0.Z"J3%^IW+ON]X`[U/"Y6MUSFNF=%W<%]4#Y^9VG;)#?-9C=SIVE;)/:'+:K'3E3N7.AO# MLC!X:NIW+GOPG4Z4S14$KZILE=2%V7A5YU^8"^R19$)2DFE7T^Q< M!]TE@B>`*;`IDTEC+5H<_8IU:JYC2`$HZK3P2W3GY,.$*\_SPSLYXIY<5M5` MX+!N&EX$!=3ZWSI$N;IE*PD;+%RZ0_8=.XKHVJQ6L5[8:J5 MT]&V6<7UB*'1K8RHQ4K=4,9%,)Z'5VI4:U9-V6+U+OQ@R%M_D%:MGX:TQ0I6 M?!E6K>9&AA8KF_^L2C?>5U&V6KV-%R5L-<-Y!3.=N]DL?;%S(/'JD2SEKW9P M:5.RIJ>GVC:GDC'&BRQE$S$'JP#3LURH_^<#9JL*A6K2MD&M\KE)>`%!O7E, MGK9U09@:"_+7-&B&C6K2%BM8M;K-(;FZ*_& M`K6X6JSVIG.UU:K7YVRQ^KJ3J_7F7J]2;5ZA\9X=?=\/-_4$L!`AX#%`````@`W7531)C&2%=]90``#+T"`!$` M&````````0```*2!`````'!L<&PM,C`Q,S$R,S$N>&UL550%``,Q"@53=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`W7531$Z8O5&9#@``$<```!4`&``` M`````0```*2!R&4``'!L<&PM,C`Q,S$R,S%?8V%L+GAM;%54!0`#,0H%4W5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`-UU4T1$\30.JQ8``!J$`0`5`!@` M``````$```"D@;!T``!P;'!L+3(P,3,Q,C,Q7V1E9BYX;6Q55`4``S$*!5-U M>`L``00E#@``!#D!``!02P$"'@,4````"`#==5-$:"+4*U,Y``"P(0,`%0`8 M```````!````I(&JBP``<&QP;"TR,#$S,3(S,5]L86(N>&UL550%``,Q"@53 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`W7531+RX&,WZ)0``"H0"`!4` M&````````0```*2!3,4``'!L<&PM,C`Q,S$R,S%?<')E+GAM;%54!0`#,0H% M4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`-UU4T00MU1TH0H``$=R```1 M`!@```````$```"D@97K``!P;'!L+3(P,3,Q,C,Q+GAS9%54!0`#,0H%4W5X C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``"!]@`````` ` end XML 52 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long Term Debt (Tables)
 6 Months Ended
Dec. 31, 2013
Long Term Debt Tables  
Schedule Of Long Term Debt

As of December 31, 2013, the loan balance was:

 

 

Loan Principal   $ 10,420,791  
Less: Discount     585,000  
Net Loan per Books   $ 9,835,791